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French Summary
Ce manuscrit de thèse intitulé Base de données sur le signal d'autoﬂuorescence des tissus pour
améliorer le diagnostic per-opératoire des tumeurs cérébrales, traite d'aspects importants liés à
l'utilisation d'approches d'imagerie spectroscopique pour le diagnostic de tumeur cérébrale en per-
opératoire. Une telle étude a été motivée par la place prise par le cancer dans la société.
En 2011, Le ministère français de la santé et l'institut national du cancer(INCa) ont réalisé une
étude sur la perception de cette maladie. Les résultats ont montré que dans l'esprit des gens le
cancer avait toujours une connotation fortement négative. La plus part considérant que c'est la
maladie la plus mortelle, bien loin devant le SIDA. Alors qu'en réalité l'étude montre également,
que si un homme sur deux et une femme sur trois déclarent un cancer dans leur vie, le taux de
survie est aujourd'hui supérieur à 50% [1].
Néanmoins le cancer traîne toujours cette forte connotation négative, due à certaines formes très
agressives présentant encore une forte et rapide mortalité, laissant place à de nombreux déﬁs on-
cologiques. Les tumeurs cérébrales font parties des cancers présentant toujours un fort taux de
mortalité et donc déﬁs dans le processus de traitement. Les tumeurs cérébrales ne sont pas les plus
fréquentes, 17eme cancer seulement en terme d'incidence. Toutefois dans certains groupes d'âge, il
s'agit de l'une des formes les plus meurtrières. Une étude réalisée en 2016 a montré qu'il s'agissait
de la première cause de décès liés au cancer chez les 0 à 14 ans et la troisième chez les 15 à 39 ans
[8, 9].
Comme le montrent ces statistiques, le diagnostic et le traitement des tumeurs cérébrales sont des
sujets brûlants dans le monde de l'oncologie. Le principal déﬁ étant l'amélioration du taux de
survie à long terme des patients. Ceci est particulièrement un challenge en neuro-oncologie dû à la
nature majoritairement inﬁltrante des tumeurs, résultant en processus complexe pour atteindre un
diagnostic ﬁable. Aujourd'hui, le standard pour établir un diagnostic déﬁnitif sur la nature d'un
tissu cérébral est l'examen histologique, c'est-à-dire l'analyse microscopique ex vivo d'échantillons
de tissu extraits lors de la chirurgie et ensuite chimiquement traités (ﬁxation, coloration). Pour
un diagnostic per-opératoire, rapide et ﬁable de nouvelles méthodes et approches sont nécessaires
de manière urgente, tel que de nouvelles techniques d'imagerie ou de mesures en temps réel. C'est
exactement le rôle que pourrait jouer la microscopie optique à détection multimodale, en met-
tant l'accent sur l'imagerie d'autoﬂuorescence, ainsi que les routines d'analyses automatisées pour
l'analyse per-opératoire des tumeurs cérébrales présentées dans cette thèse.
Pendant ces trois années de doctorat j'ai mené des recherches au sein du laboratoire français IMNC
(Imagerie et modélisation en neurobiologie et cancer) dans le groupe de Darine Abi Haidar. Cette
équipe de recherche travaille avec un hôpital français (Le Centre Hospitalier Sainte-Anne, Paris,
France) aﬁn d'apporter de nouvelles solutions techniques pour améliorer la précision et qualité des
résections chirurgicales des tumeurs cérébrales, le but étant de prolonger l'espérance de vie des
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patients. Pour répondre à cette problématique, l'équipe a démarré, en collaboration avec l'hôpital,
un projet visant à développer un nouvel outil révolutionnaire, aﬁn d'intégrer l'endomicroscopie non
linéaire au bloc opératoire. Une base de données sur la réponse optique des tissus a également été
construite, pour être utilisée avec l'endomicroscope aﬁn de guider le chirurgien lors de la résection
des tumeurs et d'obtenir les meilleurs résultats possibles.
Ma thèse s'est inscrit dans ce projet large et interdisciplinaire, avec un focus particulier sur la
construction de la base de données multimodale et multi-échelle de la réponse optique des tissus
cérébraux. Ce manuscrit s'articule autour de cinq publications majeures écrites et publiés pendant
mon doctorat, une large introduction sur le contexte clinique et technique à l'origine de ce projet
est d'abord présentée, puis les cinq articles sont articulés aﬁn de répondre à cinq grandes questions
soulevées pendant ma thèse autour du diagnostic optique des tumeurs cérébrales. Le manuscrit ce
conclut par une discussion sur les résultats obtenus et les futures orientations et perspectives du
projet.
Le chapitre d'introduction est divisé en 7 sous-chapitres, commençant par un résumé des dif-
férentes formes de tumeurs cérébrales et de leur physiopathologie. Pour mieux comprendre les déﬁs
se rapportant aux tumeurs cérébrales, il est important de connaître les diﬀérents types de tumeurs
malignes pouvant provenir des cellules du cerveau et leur classiﬁcation. La classiﬁcation des tumeurs
cérébrales est basée sur leur cellule d'origine et leur agressivité. Deux groupes principaux peuvent
être dégagés: les tumeurs primaires et secondaires. Une tumeur primitive provient des cellules et
des tissus du cerveau et ne se propage généralement pas vers d'autres organes. Ce type de tumeur
peut être soit bénigne, se développant lentement avec une limite distincte présentant un danger
seulement si elle comprime une fonction vitale, ou alors maligne, se développant rapidement avec
des limites irrégulières et avec la capacité d'inﬁltrer les zones environnantes [10]. Environ la moitié
des tumeurs cérébrales primitives se développent à partir de cellules gliales et sont classées dans la
catégorie des gliomes, avec un grade allant de I à IV dépendant de leur agressivité [10]. Elles peuvent
également provenir des cellules nerveuses (tumeurs de Schwannome), de l'hypophyse (adénomes de
l'hypophyse), du cervelet (tumeurs médulloblastomateuses, les plus courantes chez les enfants), des
cellules germinales et également de la membrane entourant le cerveau, la méninge, ce qui entraîne
l'apparition de tumeurs appelées méningiomes [10, 11]. Les tumeurs secondaires, appelées métas-
tases, proviennent de cellules ayant migré d'une tumeur primaire dans un autre organe - poumon,
sein, peau, rein et côlon sont les origines les plus courantes des métastases cérébraux [10].
Au cours de cette thèse, les gliomes (principalement les glioblastomes de grade IV), méningiomes et
métastases ont été étudiés. Trois catégories pouvant présenter un caractère inﬁltrant, particulière-
ment les tumeurs gliales, rendant le diagnostic et traitement chirurgical très compliqué. Même si
le panel de tumeurs cérébrales est large, elles subissent toutes le même protocole de diagnostic et
traitement. Tout d'abord le patient doit passer par une phase de diagnostic, où en cas de suspicion
de tumeur au cerveau, une combinaison de techniques d'imagerie sera prescrite pour réaliser un
diagnostic préliminaire. Pour évaluer la présence ou non d'une tumeur, un scanner de tomogra-
phie axiale (CT-Scan) et une imagerie par résonance magnétique (IRM) sont prescrits. Ensuite,
si l'oncologue et les chirurgiens ont besoin d'informations plus précises et plus fonctionnelles pour
commencer à planiﬁer le traitement, ils demanderont une imagerie plus avancée (IRM fonctionnelle
(IRMf), tomographie par émission de positrons (TEP)). Dans le cas d'une masse détectée, ce ne
sera que la première étape vers un diagnostic ﬁnal. Pour avoir toutes les informations sur la nature
et le l'agressivité de la tumeur, une analyse histologique sur prélèvements après une biopsie, doit
être réalisée. Ceci amenant à un rapport pathologique déﬁnitif, qui sera alors analysé par une
équipe composée d'un oncologue, d'un radio-oncologue et d'un neurochirurgien aﬁn d'élaborer le
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plan de traitement. Les décisions de traitement sont individualisées et basées sur le type de tumeur,
la localisation, la malignité et le patient (âge, condition physique). Toutefois la méthode privilégiée
et appliquée en premier lieu est la résection chirurgicale, celle-ci peut être ensuite suivi de radio-
thérapie et chimiothérapie. Parfois, un seul type de traitement peut être nécessaire, mais la plupart
du temps, une combinaison de ceux-ci est recommandé. Dans ce processus de traitement l'étape
la plus compliquée et qui est à l'origine du faible taux de survie des patients, est la qualité de la
résection chirurgicale. Si les tumeurs sont fortement inﬁltrantes, il n'existe à ce jour aucun moyen
per-opératoire pour identiﬁer les zones inﬁltrées en marge de la tumeur solide. La seule méthode
pour s'assurer de la qualité de la résection est de faire l'analyse histologique des berges, cependant
ces analyses sont réalisées ex-vivo et donc coûteuses en temps et moyens.
Pour améliorer la qualité de la résection plusieurs approches ont été considérées, tout d'abord
chirurgicale, avec la chirurgie électro-stimulée et éveillée. Une méthode qui permet d'élargir au
maximum le résection tout en préservant les fonctions vitales du patient pour lui assurer une qual-
ité de vie post-opératoire. Ces techniques ont montré une amélioration du taux de survie et de la
qualité de vie du patient, toutefois la résection est toujours réalisée sans connaitre la réelle nature
du tissu réséqué, certaines régions enlevées peuvent être complètement saines et certaines cellules
tumorales oubliées dans les régions hautement fonctionnelles. Les chirurgies sont allongées, et par
conséquent coûteuses à l'hôpital et aux patients.
Une autre approche pour améliorer la résection des tumeurs cérébrales et se rapprocher d'une
résection totale, fût d'améliorer les techniques d'imagerie per-opératoire. La première direction
prise pour obtenir des évaluations per-opératoires en temps réel consista à introduire les techniques
d'imagerie préopératoires actuelles, telles que l'IRM ou l'échographie, dans la salle d'opération.
Malheureusement même si ces techniques oﬀrent plus d'assurance au chirurgien dans ces choix,
elles manquent toujours en résolution à l'échelle cellulaire et ne peuvent identiﬁer l'inﬁltration.
Ceci laisse place à une recherche interdisciplinaire, pour apporter la possibilité au chirurgien de
discriminer en temps-réel les berges tumorales. Une direction importante prise pour répondre à ce
déﬁ médicale est l'utilisation de la ﬂuorescence, et les diﬀérentes façons de l'imager.
En premier lieu la ﬂuorescence exogène a été explorée, des marqueurs des types cellulaires, des
protéines ou des gènes, sont introduits chez le patient, excités et leur signal émis collecté par
l'endoscope. Les ﬂuorophores les plus testés et répandus pour la résection des tumeurs cérébrales
sont la ﬂuorescéine de sodium, le vert d'indocyanine(ICG) et l'acide 5-aminoluvulinique(5-ALA).
Toutefois le développement des marqueurs exogènes a été ralenti dû au long et diﬃcile processus
d'approbation par les comités médicaux et la diﬃculté à trouver des marqueurs spéciﬁques de la
tumeur à l'échelle cellulaire. Ces limitations et la disponibilité des technologies d'imagerie à haute
résolution ont poussé les physiciens à envisager un autre moyen de contraste: l'autoﬂuorescence.
Dans tous les tissus, on peut trouver des molécules dans les cellules qui, lorsqu'elles sont excitées
à une longueur d'onde appropriée, deviennent ﬂuorescentes. Ces ﬂuorophores endogènes sont liés
aux propriétés morpho-fonctionnelles de la cellule et du tissu. Tous les changements intervenus au
cours de processus physiologiques et pathologiques ont une incidence sur la distribution des ﬂuo-
rophores et donc sur leurs caractéristiques d'émission. Il en résulte un outil puissant pour surveiller
directement l'état morphologique et physiologique d'un tissu et ou d'une région de cellules.
Le signal de ﬂuorescence peut être caractérisé par trois paramètres quantiﬁables: 1) le spectre
de ﬂuorescence, intensité de la ﬂuorescence en fonction de la longueur d'onde, 2) le rendement
quantique, eﬃcacité du processus d'émission et 3) la durée de vie de la ﬂuorescence, temps moyen
pendant lequel un ﬂuorophore reste dans son état excité. Les technologies de détection ont été
développées pour tirer avantage de ces paramètres et donner des indicateurs quantitatifs aux ré-
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gions observées. De plus, d'autres transitions peuvent être excitées et permettent également une
détection quantitative. Ils sont classés dans la spectroscopie Raman. Aﬁn d'améliorer l'information
donné au chirurgien, les nouvelles techniques de microscopie hautement résolues ont été développées.
Aﬁn d'essayer de produire des images à l'échelle cellulaire et de quantiﬁer les diﬀérents paramètres
de l'autoﬂuorescence. Les diﬀérentes techniques modernes de microscopie, plein champ, confocale
et multiphoton, ont vu l'intérêt s'accroître aﬁn d'obtenir des outils miniaturisés pour s'adapter à
l'environnement chirurgicale et être utilisé de façon per-opératoire. Les technologies les plus ré-
centes suscitant l'intérêt aﬁn d'assurer la diﬀérenciation en temps réel des cellules tumorales sont la
spectroscopie Raman et la microscopie multiphotonique. Ces techniques en sont encore au stade de
la validation de la conception et n'ont pas encore été appliquées dans des essais cliniques de phase
III et ne sont toujours pas dans les protocoles de routine. L'un des principaux éléments techniques
manquants dans le développement à ce jour est l'absence de détection multimodale, ainsi qu'une
base de données de haute qualité sur le tissu étudié. Par conséquent, la technologie actuelle ne
parvient pas à conférer une discrimination suﬃsamment ﬁable aux normes cliniques. Cela laisse
de la place pour le développement d'une technologie précise et ﬁable d'assistance à la chirurgie des
tumeurs cérébrales, car le tissu cérébral en particulier manque d'une base de données optique sur sa
réponse en autoﬂuorescence. L'équipe de recherche du Dr Darine Abi Haidar a choisi de travailler
sur cette question clinique en apportant son expertise technique. Ce groupe de recherche possède
une expérience en optique et en microscopie, plus précisément en techniques non linéaires. Grâce
aux collaborations de l'équipe, une large gamme d'échantillons de biopsie fut disponible au près
du centre hospitalier Saint-Anne(CHSA), ainsi que trois plates-formes d'imagerie. Un endoscope
visible placé au département de neuropathologie du CHSA pouvant mesurer la réponse spectrale à
un photon et la durée de vie de la ﬂuorescence. La plate-forme PIMPA (plate-forme d'imagerie du
petit animal) consistant en un microscope à deux photons avec quatre modalités de détection (im-
agerie par ﬂuorescence, SHG, spectroscopie et FLIM).Sur la ligne DISCO du synchrotron SOLEIL,
de la microscopie à excitation dans l'UV profond possible dans deux conﬁgurations : microscopie
plein-champ et spectroscopie.
Dans ces conditions de larges campagnes de mesure sur la réponse d'autoﬂuorescence des tissus
cérébraux ont put être menées pendant ma thèse, aﬁn de répondre à cinq grandes questions:
Des mesures optiques bimodales quantitatives sous excitation visible pourraient-elles discriminer
la nature du tissu cérébral ﬁxé ?
Les mesures spectrales et de durée de vie, sous excitation visible, ont-elles permis de discriminer la
nature du tissu cérébral fraîchement extrait ? Les mesures de ﬂuorescence sur tissu ﬁxé aurait-elle
pu être suﬃsante pour constituer une base de données optique?
L'excitation mono et bi-photonique pourrait-elle discriminer l'autoﬂuorescence des grades de ménin-
giomes ?
L'imagerie à deux photons pourrait-elle fournir des informations équivalentes au standard H&E
pour discriminer les tumeurs cérébrales primaires et secondaires ? La détection quantitative multi-
modale pourrait-elle améliorer le diagnostic des tumeurs cérébrales?
Comment une étude optique multi-échelle et multimodale pourrait-elle améliorer la précision et
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la ﬁabilité de la discrimination des tumeurs primaires et secondaires? Ces questions trouveront une
réponse dans les études publiés dans cinq articles écrits lors de mon doctorat et présentés dans la
suite de ce manuscrit.
Aﬁn de répondre à la première question : Des mesures optiques bimodales quantitatives sous
excitation visible pourraient-elles discriminer la nature du tissu cérébral ﬁxé ?, le chapitre 2 présente
une étude publiée dans Scientiﬁc Reports rapportant comment les coeﬃcients optiques, l'émission
d'autoﬂuorescence et les données de durée de vie peuvent mettre en évidence la structure du
tissu cérébral. Cette première étude analyse quantitativement la ﬂuorescence endogène en déri-
vant plusieurs indices optiques, à partir des résultats tiré d'un endoscope à détection bi-modale et
excitation dans le visible. Cette étude a été menée sur des coupes de tissus ﬁxés et inclus 28 pa-
tients. Les résultats ont montré la capacité de discriminer à partir d'indicateurs optiques les tissus
tumoraux des tissus sain. Cependant, pour appliquer ces paramètres optiques en per-opératoire, ils
doivent également être conﬁrmés sur du tissu cérébral frais.
Ainsi, le chapitre 3 décrit la caractérisation de tissus cérébraux fraîchement extrait après la
chirurgie sur 54 patients. Les tissus ont été analysés par microscopie à un ou deux photons détec-
tant l'autoﬂuorescence avec une détection multimodale (imagerie de durée de vie par ﬂuorescence, de
ﬂuorescence à deux photons et de génération de seconde harmoniques (SHG), ainsi que des mesures
spectroscopiques). Le but de cette étude également publiée dans Scientiﬁc Reports est de répondre
à la question : "Les mesures spectrales et de durée de vie, sous excitation visible, permette-elle de
discriminer la nature du tissu cérébral fraîchement extrait? Les mesures de ﬂuorescence établies sur
du tissu ﬁxé eut-elle été suﬃsantes pour constituer une base de données optique?" Ces analyses in
vivo ont montré la capacité de détection quantitative bimodale sur la ﬂuorescence endogène à dis-
criminer la nature des tissus. Cependant, cette conﬁguration ne présente pas de modalité d'imagerie
et donc la possibilité de comparaison avec le standard histologique, la coloration H&E. Pour pou-
voir fournir des informations comparables, la modalité d'imagerie doit combiner des informations
nucléaires et extracellulaires, la microscopie non linéaire est un excellent candidat car elle produit
deux signaux complémentaires : la SHG et la ﬂuorescence par excitation à deux-photons (TPEF).
Les images TPEF-SHG ont permis d'identiﬁer les structures typiques du standard histologique,
montrant que cette technique optique pourrait être équivalente à la coloration H&E avec le grand
avantage d'être plus rapide et d'être exempte de produits chimiques. L'excitation à deux-photons
permet aussi de réaliser des mesures quantitatives de spectroscopie et de temps de vie. Ces résultats
préliminaires sur une excitation à deux photons ont montré le potentiel de discrimination qualita-
tive et quantitative en ajoutant une troisième dimension spatiale par rapport à la conﬁguration de
conﬁguration visible.
Les résultats prometteurs trouvés sur cette petite cohorte de tissus de tumeurs cérébrales ont
ouvert la possibilité de les utiliser pour des problèmes neuropathologiques avec une précision com-
parable à celle de l'analyse histologique. Le chapitre 4 présente une étude publié dans Journal of
Biophotonics aﬁn de répondre à une autre question importante en neurochirurgie, à savoir si les
tumeurs de méningiome peuvent être classées selon leur grade utilisant la réponse d'autoﬂuorescence
excitée à un ou deux photons. Cette étude portant sur neuf échantillons de méningiome humain a
montré le potentiel de la méthode pour diﬀérencier le grade de ces tumeurs, une question impor-
tante à traiter lors d'une intervention chirurgicale car le grade détermine le pronostic du patient.
Les résultats majeurs sont: 1) des images fusionnées de TPEF et de SHG comparables au standard
histologique H&E; 2) La réponse spectrale à un et deux photons produisant une intensité plus élevée
pour le grade II que pour le grade I; 3) la durée de vie de ﬂuorescence résultant en une valeur plus
courte pour le grade II que pour le grade I; et 4) l'intensité de la ﬂuorescence corrélé à un indicateur
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de prolifération histologique, Ki-67. Avec cette étude, la microscopie à deux photons a montré son
potentiel pour aider à répondre à une question clinique relativement précise. Ces résultats nous
rapprochent de l'objectif plus large qui consiste à distinguer toute tumeur cérébrale d'un tissu sain.
L'étape suivante a consisté à concevoir une étude visant à trouver des critères optiques permet-
tant de distinguer les tumeurs primaires et secondaires des tissus sains, en utilisant une conﬁguration
au microscope à deux photons et des échantillons de tumeurs fraîchement extraites. Les résultats de
cette campagne sont présentés dans le chapitre 5, publié dans Scientiﬁc Report. Dans cette étude
un système de notation quantitative basé sur une analyse minutieuse des données d'imagerie non
linéaires a été développé pour obtenir une discrimination ﬁable des natures tissulaires. Ce travail
a été réalisé sur 25 patients. Pour exploiter au mieux les données de cette étude, trois indicateurs
quantitatifs ont été extraits: métabolique (rapport d'oxydoréduction), structurel (intensité du SHG)
et conformationnel (mesures de la durée de vie), aﬁn de créer un système de notation en 3D. Dans
cette représentation 3D, chaque type de tissu occupait une région spéciﬁque de l'espace, soulignant
la possibilité d'une discrimination automatisée utilisant l'analyse de la ﬂuorescence endogène. Les
types discriminés ainsi sont les tumeurs primaires des tumeurs secondaires. Cependant, on a égale-
ment appris à quel point une analyse statistique pouvait être sensible et qu'il existait une grande
variabilité d'un type de tissu à l'autre. Ces observations ont conduit à prendre conscience de la
nécessité d'aller plus loin dans l'analyse des données et de trouver d'autres molécules pouvant aider
à conﬁrmer le diagnostic. Pour obtenir plus de données pour l'analyse, pourquoi ne pas examiner
une plage d'excitation plus large, de l'UV profond au proche infrarouge?
C'est cette réﬂexion qui conduit à l'étude du chapitre 6, publié dans Frontiers. Une étude qui est
basé sur une cohorte de patients statistiquement pertinente, présentant un algorithme discriminatif
quantitatif basé sur des données d'autoﬂuorescence linéaires et non linéaires allant de l'UV au
proche infrarouge, et couvrant un large éventail de ﬂuorophores endogènes.
L'algorithme trouvé ici basé sur des approches multimodales et multi-gammes a permis une
discrimination ﬁable entre les tissus contrôles, les tumeurs primaires et secondaires. Les résultats,
notamment ceux basés sur l'algorithme multimodal, présentent un taux de faux négatifs inférieur
à 5%, ouvrant la voie à l'automatisation du diagnostic. Ceci est renforcé par le développement
d'algorithme non basé sur des notions de ﬁt, tel que le clustering, pouvant être la première étape
d'algorithmes de classiﬁcation automatisés.
Ces résultats ouvre la porte vers un diagnostic eﬀectué par une intelligence artiﬁcielle et non
par un opérateur humain. Dans les chapitres 2 à 6, une vaste base de données sur l'évaluation
des tumeurs primaires et secondaires par rapport à des tissus contrôles a été construite et a abouti
au développement d'un algorithme discriminant pouvant être automatisé dans un endomicrospe.
Ces résultats soutiennent le développement d'un endomicroscope à deux photons pour fournir au
chirurgien une réponse en temps réel au cours de l'opération. La thèse se termine par une dis-
cussion des résultats expérimentaux obtenus, ainsi qu'une ouverture sur l'utilisation des méthodes
pour discriminer d'autres types de cancer, comme les tumeurs de la vessie, et la présentation des
perspectives du projet, tel que de futures études in vivo.
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Chapter 1
Introduction
In 2011, the French Ministry of Health and The National Institute of Cancer (INCa) did a study
on the perception of cancer in the French society. The image stuck in people's heads was strongly
negative. Most people considered it as the most deadly disease, far ahead of AIDS. However the
study also showed that even if one in two men and one in three women have cancer some time in
their lives, the survival rate in reality is higher than 50% [1].
Nevertheless this disease still frightens society because some of its forms are strongly and rapidly
deadly resulting in major ongoing medical challenges. Using only current medical resources to un-
lock all the mysteries surrounding cancer doesn't seem enough. Medical research turns to other
domain of science such as chemistry and physics to perform interdisciplinary research in order to
improve diagnosis and treatment in the remaining deadly forms of cancer. It is in the context
of this fast growing ﬁeld of interdisciplinary research, that the work of my thesis takes place. I
have conducted my research for the last three years, in the French IMNC laboratory (Imaging and
Modelisation in Neurobiology and Cancer) in Darine Abi Haidar's group. This research team has
been working with a French hospital (Le Centre Hospitalier Saint-Anne, Paris, France) to answer
the problem of how to improve surgical accuracy during tumor resection to extend patient life ex-
pectancy. To answer that question the team started, in collaboration with the Saint-Anne Hospital
(Paris, France), a project to develop a revolutionary new tool to address several modern scientiﬁc
challenges by bringing nonlinear endomicroscopy to the surgical operating room. A database on
tissue optical response was also built and used with the endomicroscope in order to guide the sur-
geon during resection of tumor and to achieve the best possible results.
I will orient this thesis around the scientiﬁc articles that have been produced during the three years
of my project. The manuscript will be constructed as follows: there will be a long introduction
putting my work in context. Then the diﬀerent questions and answers arising during this thesis
will be illustrated in the scientiﬁc articles. Finally I will discuss the results obtained and show
the future directions and perspectives of the project. In this introduction I will ﬁrst explain the
terminology and biology of cancer with a focus on brain tumor. Secondly, the state of the art on
the current methods of diagnosis and treatments of brain tumors will be presented. Thirdly, I will
show the direction that the ﬁeld of optical research is taking to help surgeons tackle the issue of
cellular contrast during surgery. Finally I will show how my project takes place in this environment
and what I was able to bring to the ﬁeld.
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1.1. CENTRAL NERVOUS SYSTEM CANCER
1.1 Central nervous system cancer
1.1.1 Preambule
Cancer is a disease, that was ﬁrst described in the ancient times by the Greek Hippocrates. He
compared the tumors to a crab, to give it the ﬁrst names of "karkinos" and "karkinoma" (meaning
crabs) [2]. For a long time, cancer has been an incurable disease. Nowadays, however, one patient in
two survives cancer. This has been possible thanks to strong advances in prevention and diagnosis
in the last century [1]. Yet the word cancer still retains a powerful symbolic charge, associated with
particularly dark imagery. Even though undeniable progress has been made in management, reduc-
ing the risk of death, and consequently demystifying the disease. Our lifestyle maintains cancer as
a recurrent disease, and some forms of it remain highly deadly [3].
Cancer shouldn't be a singular noun because it refers to a very varied panel of diseases that concur
only in their way of emerging. Cancer is used as a generic name to regroup a large number of dis-
eases in any part of the body, deﬁned by the fast reproduction of abnormal cells that can migrate
and spread to other organs [4]. It is initiated by a lesion in the DNA that results in a transformed
cell able to indeﬁnitely divide itself and avoid programmed cellular death [5]. This process creates
a mass of cancerous cells in the organ of origin called a malignant tumor or a malignant neoplasm.
Non-malignant or benign tumors (or neoplasms) can exist and are not as dangerous as cancer (ﬁgure
1.1). At some point in their growth cancerous cells can develop the capacity to migrate to other
organs through blood or lymphatic vessels, and there to redevelop secondary tumoral masses called
metastases [5].
Figure 1.1  From the cancerous cell to a malignant tumor [6].
The mortality following a cancer depends on the types (organ of origin) and the population
group (children, young adults, adults, elderly). It is the second leading cause of death in the world,
with 8.8 million deaths in 2015, and the number of new cases is set to rise by about 70% in the
next twenty years [7].
In this work, the focus will be on a speciﬁc group of cancers, issuing from the brain and central
nervous system (CNS). Looking at the statistics on the whole population, brain and CNS cancers
are 17th in terms of new cases expected in 2018 and 10th in the number of expected deaths [8].
However, in certain age groups, it is one of the most common and deadly forms of cancer. A study
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in 2016 showed that it was the ﬁrst and most common in cancer-related deaths in the 0 to 14 age
category and the third in the 15-39 age group [8, 9].
As these statistics show, diagnosis and treatment of brain and CNS cancer are a hot topic in the
world of oncology, with the constant research to improve patients long- term survival rate. To
better understand these tumors and the challenges related to them, it is important to know the
diﬀerent types of malignant ones that can arise from brain cells and how they are classiﬁed.
Classiﬁcation of tumors is based on their origin and aggressiveness. Inside the brain two main
groups can be found : primary and secondary tumors. A primary tumor takes its origin from brain
cells and tissues and usually does not spread to other organs. This kind of tumor can be benign,
so it can grow slowly with distinct boundary and can be dangerous only if it compresses any vital
functions, or malignant, so it grows quickly with irregular boundaries and with the capacity to
inﬁltrate surrounding areas [10]. The primary tumors can be divided in subgroups according to the
types of cells and tissues from which they originate. About half of all primary brain tumors grow
from glial cells and are classiﬁed as glioma, with a grade from I to IV depending on aggressiveness
[10]. They can also arise from nerves (Schwannoma tumors), pituitary gland (Pituitary adenomas),
cerebellum (medulloblastoma tumors, the most common in children), germ cells and from the mem-
branes that surround the brain, which result in meningioma tumors [10, 11]. Secondary tumors,
called metastasis, come from cells that have migrated from a primary tumor in another organ -
lung, breast, skin, renal and colon are the most common origins of metastasis [10]. Subgroups in
secondary tumors metastasis are classiﬁed by their organ of origin [11]. In this work glioma (mainly
grade IV glioblastoma), meningioma and metastasis have been studied; their diﬀerent location are
show in ﬁgure 1.2 shows the diﬀerent locations. Each of them will be detailed in the following
sections.
1.1.2 Gliomas
Gliomas are the most common intra-axial primary tumor. These tumors, aﬀecting glial cells,
consist of a central mass surrounded with single invasive cells decreasing in number toward the
periphery of the main lesion. The diﬀuse nature of these tumors were discovered when the standard
surgical procedure of resection failed to eradicate them [12].
They are classiﬁed according their aggressiveness from grade I to IV by the World Health Orga-
nization (WHO). Grade I gliomas are usually astrocytomas occurring in young people. The most
common grade II gliomas consist of diﬀuse astrocytoma and oligodendrogliomas. Diﬀuse astro-
cytomas, mostly arise in young adults and are slow-growing, inﬁltrating neoplasms. This tumor
always inﬁltrates the brain parenchyma, making complete surgical removal practically impossible.
Diﬀuse gliomas transform most of the time into grade III or IV tumors. The timing of the transfor-
mation into such an aggressive tumor will deﬁne the patient outcome [13]. Oligodendrogliomas are
inﬁltrated glial neuroplasms commonly arising from the frontal lobe. They represent 6% of glial tu-
mors [14]. The architecture of oligodendroglial tumors is a highly cellular lesion with closely packed,
relatively small cells, that often inﬁltrate far away from the central lesion with prominent secondary
structure formation [15]. Grade III gliomas consist of anaplastic astrocytomas and anaplastic oligo-
dendrogliomas. This higher grade of astrocytoma or oligogendroglioma present atypical features
and increased mitotic activity. One quarter are new tumors and three quarters are the consequence
of lower grade tumor transforming into higher grade [16]. Grade IV gliomas are glioblastomas
(GBM). GBM represents 82% of malignant gliomas. These tumors are highly aggressive and are
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Figure 1.2  The diﬀerent types of brain tumor that were studied in this work [10, 11]
characterized by architectural features such as high cellularity and mitotic activity, vascular prolifer-
ation, and necrosis. These tumors are highly invasive, inﬁltrating the brain parenchyma. However,
they do not metastasize [17]. Recurrence is almost inevitable with glioblastoma, arising within
two centimeters of the original tumor site. About 10 percent are accompanied by additional non-
contiguous lesions [18]. In the last twenty-ﬁve years, multiple modalities of treatment have been
tried experimentally and are now standardized for this type of tumor. The treatments are cytore-
ductive surgery, radiation therapy, and chemotherapy [19, 20].
1.1.3 Meningioma
Meningiomas are the most common extra-axial tumor. Meningiomas are tumors aﬀecting
meninges, arising from arachnoid cells with a progressive enlargement compressing adjacent struc-
tures and leading to clinical symptoms (epileptic seizures, neurological deﬁcits, increased intracra-
nial pressure). These tumors are classiﬁed in three grades by the WHO, from Grade I to the most
malignant Grade III which has a ﬁve-year survival rate of 44% [21]. The main treatment for these
tumors is surgical resection which can cure or allow long-term control of the cancer. The capacity
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of completing a total resection on meningioma depends on the extent, and the localization of tumor
inﬁltration in the dura, bone and vascular sinuses. Residual left in any of these adjacent compart-
ments lead to high risks of tumor recurrence even for benign meningiomas [22].
1.1.4 Metastasis
Secondary tumors are the most predominant. For example in the US, two hundred thousand
cases of brain metastases occur each year, which is 10 times higher than the number of patients
diagnosed with primary brain tumors [23]. Brain metastasis results in high morbidity and poor
prognosis, even after diagnosis and the classical choice of treatment: surgical resection, radiother-
apy (stereotactic radio-surgery or whole brain radiotherapy), chemotherapy and immunotherapy.
Metastases are formed through the following mechanisms: cells dissociate from the bulk tumor
to invade neighboring tissue, then will invade new or pre-existing blood vessels, traveling through
vessels to other parts of the body and then extravating from the vessels to invade tissues growing
into micro-metastases and macro-metastases, namely secondary tumors [24]. The pattern in which
the metastases migrate into the brain can be very dependent on the origin of the primary tumor
(lung cancer, melanoma). To achieve invasion of the brain they degrade the extra-cellular matrix
[23, 25].
1.2 How to diagnose brain tumor
1.2.1 Imaging techniques
The ﬁrst step toward any medical treatment solution is to detect and diagnose the disease. In
the case of brain tumor the symptoms that will draw the patient to the doctor oﬃce are headaches
that worsen in the morning, seizures, stumbling, dizziness, speech problems, weakness on a body
side, nausea and vomiting [11, 26]. The doctor will ﬁrst obtain the patient's personal and family
medical history and perform a complete physical and neurological exam (memory, cranial nerve
function, muscle strength, coordination, reﬂexes, and response to pain). He can also order more
tumor speciﬁc test if he suspects a type of tumor with the described symptoms, such as audiometry
(detects hearing loss due to tumors near the cochlear nerve), endocrine evaluation (detect abnormal
levels caused by pituitary tumors) or lumbar puncture (examine cerebrospinal ﬂuid for tumor cells,
proteins, infection, and blood). From the results of all these primary exams if a brain tumor is
suspected, the next step toward a deﬁnite diagnosis is the use of imaging techniques [26].
An imaging diagnosis can conﬁrm the absence of tumor, but in the case of a detected mass it will
only be the ﬁrst step to a ﬁnal diagnosis. A conﬁrmed diagnosis will be given after tissue sampling
and histological analysis. Still with the imaging techniques available nowadays you can collect much
information on the tumors, and start planning the course of action to treat it. Imaging in the last
few decades has accelerated and improved the capacity to detect many diseases. It has become
in many cases the preferred ﬁrst step on the road to diagnosis and treatment, due to its greatest
advantage - non-invasiveness [2729]. Table 1.1 resumes the diﬀerent techniques used nowadays. All
these imaging techniques are not competing with each other but work together in a common aim. If
a brain tumor is suspected, to perform a high level preliminary diagnosis a combination of imaging
techniques will be prescribed. To assess the presence or not of tumor, Computed Axial Tomography
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Scan (CT-Scan) and Magnetic Resonance Imaging (MRI) are prescribed. Then if the oncologist
and surgeons need more precise and functional information to start planning the treatment course
of action, they will ask for more functional imaging (advanced magnetic resonance, functional MRI
(fMRI) and Positron Emission Tomography (PET)).
1.2.1.1 CT-scan
CT-scan is a computerized x-ray that can show a combination of soft tissue, bone, and blood
vessels. It was invented in 1972 by British engineer Godfrey Hounsﬁeld and South Africa-born
physicist Allan Cormack [38]. CT-scan was ﬁrst designed only to image the head and explore the
brain. The ﬁrst CT-scan scans were very slow, and the patient had to be completely still for a
long time. An acquisition could take hours. However the possibility of getting a 3D morphological
representation of any body part spurred fast development of the technology [39]. CT-scan tech-
nology has made great improvements in speed, patient comfort, and resolution. Faster scanning
helps to eliminate artifacts from patient motion such as breathing or peristalsis. Nowadays multi-
slice CT-scan systems can collect up to 4 slices of data in about 350ms and reconstruct a 512 x
512-matrix image from millions of data points in less than a second, making the CT-scan scan the
most widely available technology, and the ﬁrst exam prescribed if an intra-cranial mass lesion is
suspected [40]. It gives an initial work-up before using other technologies such as MRI. CT-scan
is the gold standard to diagnose the presence of acute intracranial hemorrhage, calciﬁcations, and
osseous anatomy. However CT-scan still has limitations compared to MRI. It suﬀers from a lower
contrast capability on soft tissue, fossa and spine regions, and the use of ionizing radiation. These
limitations make the MRI the real gold standard for pre-surgical planning, post-operative assess-
ment, pre-radiotherapy planning, and post-treatment assessment. Consequently MRI is the second
imaging always prescribed along with the CT-scan of a suspicion of brain tumor [41].
1.2.1.2 MRI
MRI is the other major breakthrough of the last century in medical imaging. The fundamental
principle was discovered in 1946 by Felix Bloch and Edward Purcell, who were awarded the Nobel
Prize in 1952. Up until the 1970s MRI was being used for chemical and physical analysis. The ﬁrst
image on tissue was performed in 1971 by Raymond Damadian, who showed that nuclear magnetic
relaxation times of tissues and tumors were diﬀerent, motivating scientists to use MRI to study
disease [42]. From that point on, MRI has has experienced fast development for implementation
in hospitals worldwide, becoming a standard in diagnosis. As with CT-scan, the MRI was ﬁrst
developed for neurology. It accelerated the knowledge of brain anatomy and the nervous system,
becoming the standard to give images of the central nervous system. It could distinguish white
matter, gray matter and cerebrospinal ﬂuid.
MRI's multi-planar capability, superior contrast resolution, and ﬂexible protocols have allowed it
to play an important role in assessing tumor location and extent. It provides good soft tissue
contrast, producing diﬀerent types of contrast by varying excitation and repetition times. MRI has
the capacity to give diﬀerent contrasts in the image with the use of diﬀerent acquisition protocols.
Each of the protocols provide diﬀerent and complementary information, contributing to the power
of contrast in the technology. The most common protocols are : spin-echo T1-weighted image
(T1WI), proton density-weighted image (PDWI), T2- weighted image (T2WI), and T1WI after the
administration of paramagnetic agent. Tumors appears hypointense on T1W1 and hyperintense on
T2W1, and can show intermediate hyperintensity on PDWI. Contrast can be facilitated by contrast
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Technique Image Highlights Limitations
Spatial
Resolution
CT
Mass eﬀect, herniation,
hydrocephalus,
hemorrhage, calciﬁcations
Low contrast capability
on soft tissue, fossa and
spine regions use of
ionizing radiation
0,5 to 1,5
mm [30]
MRI
Localizing the tumor and
surrounding structures
with a high-resolution
image, diagnosis of extra-
and intra-axial tumors
Diﬃcult to diﬀerentiate
brain neoplasms from
non-neoplastic mass
lesion lack of functional
information
1 to 3 mm
[30]
MR
diﬀusion
Reduced in highly cellular
portions of tumor.
Establishing spatial
relationships between
tumor border and white
matter
Problem can arise with
the simpliﬁcation in
tensor calculation. Long
scanning time so a system
sensitive to physical
motion.
0,8 to 1,2
mm [31]
MR
perfusion
Tumor/tissue vascularity
User dependent on : the
account for contrast
leakage eﬀects, deﬁne a
region of interest,
quantify the resulting
parametric information
around 1
mm [32]
MR spec-
troscopy
Obtaining biochemical
and metabolic
information about the
tumor, determining
tumor type and grade by
assessing the cellular
contents
highly operator
dependent, choose
interest region avoiding
areas of necrosis,
hemorrhage, calciﬁcation
and/or tumoral cysts
0,6cm3 per
voxel [33]
fMRI
Pre-operative functional
mapping, research into
treatment eﬀects
phenomenon of
neurovascular uncoupling
: cortex adjacent to the
tumor can show a false
variation
2 to 4 mm
[30]
PET
Metabolic assessment of
Tumor aggressiveness.
Shows highly metabolic
area in tumor
Exposure to radioactive
rays 10 to 20 min
acquisition time :
sensitive to patient
movements
2 to 5 mm
[30]
Table 1.1  Diﬀerent imaging techniques to diagnose brain tumors[3437] 15
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agents. The most commonly used in MRI for brain tumor is gadolinium (Gd). In brain tumors with
the possible disruption of the blood-brain barrier, Gd can accumulate in the extracellular space of
the tumor speciﬁc to it. This eﬀect results in an enhanced contrast of the tumor in T1W1 compared
to the surrounding normal brain tissue [19, 43].
MRI with or without contrast agents gives anatomical information on brain tissue. However it is
still diﬃcult based only on this imaging technique to always diﬀerentiate brain neoplasms from
non-neoplastic lesions, or to easily distinguish low grade from high grade tumors. Indeed this
assessment is based on the contrast intensity. However higher grade does not always induce contrast
enhancement [34, 41]. To have a more complete initial work-up on the tumor, new more advanced
MRI techniques have been developed to give physiological information (metabolic and molecular
state of brain tissue) as well.
1.2.1.3 MR diﬀusion
Two diﬀusion imaging techniques can be derived from magnetic resonance imaging. These are
the MR diﬀusion-weighted imaging (DWI) and diﬀusion tensor imaging (DTI). DWI is sensitive
to water molecule motion in tissues, and from it the apparent diﬀusion coeﬃcient (ADC) can be
calculated. The ADC maps can show relatively low values in certain brain tumors, and mostly in
high cellular tumors such as CNS lymphoma, and high grade glioma. DTI images water diﬀusion
with more directional information than DWI. It generates maps of the fractional anisotropy and
the mean diﬀusivity. This technique has been shown to diﬀerentiate between high grade and low
grade glioma, and distinguish glioblastoma from metastases. Tumors margins can also be detected
with more precision than in conventional MRI [34, 41]. These methods present certain limitations.
The map obtained in DTI imaging comes from tensor calculations, in which simpliﬁcations are
done along the way that could overlook some macroscopic eﬀects and adjust them to microscopic
features. Moreover this method presents long acquisition time making it hard to suppress the
physical movement of brain while imaging [44].
1.2.1.4 MR perfusion
MR perfusion is a technique that give complementary information about the blood ﬂow in brain
tumors and the surrounding tissue. Two approaches have been developed, with and without the use
of an exogeneous contrast agent. The method consist of either intravenously injecting a contrast
agent and monitoring the loss of signal during its propagation through tissue, or taking direct
advantage of the magnetically labeled blood itself as an endogenous tracer to quantify cerebral
blood ﬂow [45]. Brain tumors have the characteristic of showing neoangiogenisis (greater density of
vessels per volume unit) which will aﬀect these parameters. The disadvantages of this techniques are
some highly user-dependent steps in the process: the accounting for contrast leakage, the deﬁnition
of a region of interest, and the method of quantifying the resulting parametric information [34, 41].
1.2.1.5 MR spectroscopy
MR spectroscopy is an advanced MR based technique that relies on the phenomena of chemical
shift and spin-spin coupling. This technique highlights certain metabolites in the volume of interest.
The main metabolites that give information in brain tumors are N-acetylasparate (marks neuronal
integrity), choline (marks cellular membrane turnover), creatine (marks bioenergy storage), and also
lipids and lactate (marks necrosis and hypoxia). These indicators will change in the presence of
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malignant brain tumor, where, for example an increase of choline and a decrease of N-acetylasparate
can be observed. The drawbacks of the technique are high operator dependence and the need
to avoid necrosis, hemorrhage, or calciﬁcation areas while choosing the region of interest for the
measurement [34, 41].
1.2.1.6 fMRI
fMRI uses the relative changes in blood oxygen level dependence to translate brain activity. It
is based on the principle that neuronal activation within grey matter utilizes oxygen supplied in
the form of oxygenated blood to a greater degree than areas of grey matter at rest or in a state of
inhibition. In diagnosis of brain tumor it is used to pre-operatively map the brain area responsible
for locomotion and language nearby the lesion [34, 41]. One drawback to be attentive to is the
phenomenon of neurovascular uncoupling. In normal brain the regulation of cerebral blood ﬂow
is an interaction between neurons, glia and vascular cells. fMRI measurements are based on the
fact that this interaction is still viable in presence of tumor. However some tumors can lack this
interaction, phenomenon of neurosvascular uncoupling, resulting in regions of cortex adjacent to
the tumor that can show a false variation in fMRI parameters [46, 47].
1.2.1.7 PET
The standard for functional information is PET which uses a radioactive substance to quantify
the metabolic activity of cells. A small amount of radioactive tracer is injected into a peripheral
vein and the emitted radioactivity is detected. Tracers are labelled commonly with isotopes such
as oxygen-15, ﬂuorine-18, carbon-11, or nitrogen-13. The radiolabel 18-ﬂuorodeoxyglucose (FDG)
accumulates on glucose analogue allowing the measurement of the glucose consumption rate. Malig-
nant tumors metabolize glucose at a faster rate than benign tumors, making the technology of use
in the clinical discrimination of tumoral tissue by tracing their metabolic activity. A scan usually
takes from 10-40 minutes [48].
The technology behind a PET is far from new and was actually discovered before CT-scan and MRI
in 1950s. However, for a long time it stayed as a strictly research tool and only emerged as a clinical
tool in the 1990s-2000s. The reason is that PET requires the use of a tracer, and the road to ﬁnding
one both suitable for the target clinical application, and then approved by the hospital's committee
was long. PET was able to take oﬀ when the tracer FDG was approved for its use in oncology. PET
has since been combined with the other technologies of CT-scan and MRI, giving complementary
information in an attempt to improve the power of discrimination of imaging techniques. However
it remains a very new and hybrid technology that has to prove the real extent of its potential. A
pitfall of PET scan is the relatively long acquisition time 10 to 20 minutes acquisition for a whole
brain, making it very sensitive to patient movements or intracranial movements that will blur the
resulting image [49].
CT-scan is a cheap, fast and good technique, so it is the ﬁrst to be prescribed in the course of
diagnosis. However contrast on MRI gives higher resolution and is more suited to evaluate brain
tumors. It is the gold standard for this reason and has to be included in the initial workup. The goal
of this initial assessment is to identify the lesions in order to determine if surgery can be avoided.
Classical MRI giving only anatomical information can be insuﬃcient to distinguish neoplastic from
non-neoplastic tumor, and low grade from high grade. It is in these cases that advanced MRI
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Figure 1.3  Frameless stereotactic biopsy system that relies on neuronavigation systems for lesion
targeting [52].
(diﬀusion, perfusion, spectroscopy and functional) can be done to get more information, identify
the type of lesion, and make a more suitable decision on the next course of action. If surgery is
chosen, fMRI will often be used to map the highly functional area surrounding the tumor.
1.2.2 Biopsy
Even though all of these techniques have witnessed growing developments in the last few decades
allowing the detection of tumors at earlier stages, none of them are able to give a conclusive and high
reliable diagnosis on the degree of malignancy and on the precise type of tumor in glial subgroups.
The result is a continuing need for tissue samples for histopathological analysis [50]. This last step
in diagnosis of brain tumor is called a biopsy, and remains the gold standard for assessment of
tumor presence and malignancy. It consists of the surgical extraction of tissue samples to perform
in depth ex vivo analysis by an experienced neuropathologist. The traditional biopsy method has
been through a craniotomy, open skull surgery, but this procedure appeared in some cases to not be
required or indicated, leading to the development of less invasive methods such as the stereotactic
biopsy (SB). Stereotactic neurosurgery appeared in 1908, and involves a physical 3D-frame ﬁrst
developed by Horsley and Clarke. The goal is to perform a minimally invasive procedure using an
electrode guide based on the 3D cartesian coordinate system [51].
It was ﬁrst used in intracranial targeting for psychiatric and functional dis- orders, and saw re-
duced use through the end of 1960s. The development of CT-scan and advanced imaging techniques
revived stereotactic neurosurgery with numerous new applications. This breakthrough was made
possible with the publication, in 1979 by Russell A. Brown, of a new device called the N-localizer
that enables the guidance of stereotactic surgery with imaging obtained on other devices, such as
CT-scan, MRI or PET. The device is built with rods that form a capital "N" shape to relate the
spatial information of a tomographic scan to spatial information in the physical world [53]. Stereo-
tactic surgery is now widely used for delivery of radiation, surgical targeting of electrodes, and
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resection to treat tumors, epilepsy, vascular malformations, and pain syndromes [51]. Classical SB
without assistance had a rate of conclusive diagnosis up to 68% to 98%. It is presented as a safe,
eﬃcient and valuable procedure, but it still can have fatal complications, with a morbidity rate up
to 0,9 to 15%, and a mortality rate of 0 to 4.2% [54]. To improve SB, the imaging technologies
previously described were used pre-biopsy to build a map to guide the procedure. Moreover the
classical frame has been abandoned in most cases for scalp ﬁducials, which provide a physically
less crowded system of external markers (ﬁducials) used to create reference points for surgery. This
current method is referred to as a frameless stereotactic neuro-navigation system and is presented
in ﬁgure 1.3. The protocol for the frameless neuronavigated biopsy is the following : 1) Head
secured and ﬁducials are registered into the computerized navigation system. 2) A small incision
is marked out and an opening in the skull (the size of a quarter) is made and the dura is opened.
3) A stereotactic biopsy needle, with a diameter around 2mm [55], is introduced into the target
guided by the neuronavigation system to obtain biopsy samples [56]. Multi-planar neuro-navigated
SB has given a 98-99% of conclusive diagnosis, a 0.7-0.9% of hemorrhage related morbidity, and no
mortality [54, 57].
1.2.3 Histology
Once the sample has been extracted using one of these techniques, it needs to go through
diﬀerent processes (histopathological analysis) to obtain a deﬁnite diagnosis by an experienced
neuropathologist.
1.2.3.1 Classical process
The most widespread process is to ﬁrst perform a chemical ﬁxation of the tissue, in order to
preserve tissue from degradation, and to maintain the structure of the cell and of the sub-cellular
components such as cell organelles (nucleus, endoplasmic reticulum, mitochondria). The most
common ﬁxative is formalin (10% neutral buﬀered formaldehyde in water). Then to highlight the
tissue structure, a stain is applied with one or more pigments. The table 1.2 summarizes the
available stains and their purpose.
The most commonly used stain is still the combination of hematoxylin with eosin (H&E stain-
ing). It was introduced more than a century ago, and has remained the standard stain for histologic
examination of human tissues [59]. H&E is commonly used mainly because it is an inexpensive dye
working well with a large number of ﬁxatives and highlighting a large panel of cytoplasmic, nuclear,
and extracellular matrix structures [60, 61]. The hematoxylin will stain the nuclei in blue and the
eosin will stain the cytoplasm and extracellular connective tissue matrix in diﬀerent shades of pink.
Once stained, histological slices are examined under a microscope [58]. The histological method
of diagnosis has to be done ex vivo and in a neuropathology laboratory. In this procedure the
most time consuming step is the chemical ﬁxation which requires between 16 to 24 hours and more
when special ﬁxatives are used. Once the analysis is complete the medically trained specialist, a
neuropathologist, formulates a pathology report. This report, usually produced several days after
excision of biopsy, is the basis for assessing tumor nature and is required to choose the treatment
protocol [62]. The other major limitation is the indirect diagnosis, when it is used to locate the
region that should be later resected, the brain shift can be diﬀerent once the surgeon opens the
skull again and the coordinates of regions to resect are not exactly the same anymore.
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Stains Common use Higlight structures
Haematoxylin General staining when
paired with eosin
Nucleus, Cytoplasm,
nucleic acids and
endoplasmic reticulum
Eosin General staining when
paired with haematoxylin
Cytoplasm, red blood
cells, collagen ﬁbers,
elastic ﬁbers and reticular
ﬁbers
Toluidine blue General staining Classical features and
mast cells granules
Masson's trichrome
stain
Connective tissue Classical features and
cartilage and muscle
ﬁbers
Mallory's
trichrome stain
Connective tissue Classical features and
Keratin, Cartilage, Bone
matrix and Muscle ﬁbers
Weigert's elastic
stain
Elastic ﬁbers Nucleus and elastic ﬁbers
Heidenhain's
AZAN trichrome
stain
Distinguishing cells from
extracellular components
Classical ﬁbers and
muscle ﬁbers, cartilage,
bone matrix
Silver stain Reticular ﬁbers, nerve
ﬁbers, fungi and reticular
reticular ﬁbers and nerve
ﬁbers
Wright's stain Blood cells Classical features and
neutrophil granules,
rosinophil granules,
basophil granules,
platelet granules
Orcein stain Elastic ﬁbers Nucleus, red blood cells,
elastic ﬁbers and smooth
muscle
Periodic acid-Schiﬀ
stain
Basement membrane,
localizing carbohydrates
Nucleus, collagen ﬁber,
and glycogen and other
carbohydrates
Table 1.2  The most common stain in histology [58].
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1.2.3.2 Peri-operative process
The classical lengthy process far from operating room reality has spurred the development of
peri-operative assessments with shorter processing time. Two techniques can be identiﬁed: the
frozen section and the cytologic smear. As shown previously the factor limiting intra-operative as-
sessment in the classical procedure is the long ﬁxative process. In frozen section protocol, extracted
tissues are immersed in liquid nitrogen (N2) and isopentane on dry ice, resulting in a ﬁxative state
that can be then sliced using a cryostat and stained. This method of ﬁxation is much faster, from
10 minutes to an hour maximum and requires less equipment, making it possible to use during
surgical procedure to help determine the next step in surgery, such as perioperative determination
margin resection clearness [62].
In cytologic smear preparation, developed to give intraoperative neuropathologic diagnosis, the ex-
tracted piece of tissue is placed between two slides and gently squashed to obtain a thin smear.
Then it goes through ﬁxation by being immersed for ﬁve minutes in 95% ethylalcohol and is stained
with papanicolaou for a few minutes processing, and can also have hematoxylin and eosin staining
[6365]. Compared to frozen section, cytology smear preparation requires less tissue leaving more
for the deﬁnitive ex vivo diagnosis. It also avoids freezing artifacts, is simpler and quicker, around
10 minutes overall, and gives higher details in nuclear, cytoplasmic and ﬁbrillary processes features.
Nowadays, the two techniques are used together to improved diagnosis. It agrees with the ﬁnal,
gold standard histological analysis in 95% of CNS cases [64].
1.2.3.3 Limitations of peri-operative process
Even if these techniques have been shown to be faster than the classical paraﬃn-embed sam-
pling, they still do not oﬀer real-time diagnosis. The turnaround time is around 20 minutes for
frozen section [66] and 10 minutes for squash smear [67]. The frozen section technique is also a
costly technique. It requires access to a frozen environment (cryostat, liquid nitrogen,...) and a
pathologist available to perform evaluation at the same time as the surgery [68]. Moreover DiNardo
et al. have shown that the accuracy drastically drops in the case of positive margins. The accuracy
was of 71.3% in the evaluation of close or positive ﬁnal margins compared to a 98.3% on solid
tumor. This lack of accuracy compared to the cost of technique is evaluated with a cost-beneﬁt
ratio of 20:1 [69]. The smear preparation was preferred in CNS lesions not only to reduce the cost
and to avoid frozen artifacts but also to enhance cellular morphology. However the technique has
a lower accuracy than with frozen section [70], failing primarily in assessing glial tumor grading
due to inadequate sampling and lack of histological features [65]. Moreover heterogeneity inside a
tumor can result in a low malignancy assessment within overall very aggressive tumors. This error
is due to biopsy being performed on a fraction of a tumor [65]. These peri-operative assessments
will be suﬃcient in biopsy surgical procedures where the intra-operative consultation only aims to
show the presence of "lesioned tissue". However, for tumor grading and histological typing of the
tumor during resection surgery, where speciﬁc diagnosis is required, these techniques will lack the
needed accuracy [64]. So challenges still remain for improving intra-operative diagnosis. Moreover,
even if faster, these neuropathological techniques still require tissue extraction and staining with
external agents, introducing a bias versus the in vivo tissue condition and fail to provide real-time
analysis for the surgeon during resection surgery.
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Figure 1.4  The treatment of choice for each type of brain tumors [28].
1.3 How to treat brain tumor
1.3.0.1 General treatment choice
Now that images and pathology reports are available, a team consisting of an oncologist, a
radiation oncologist, and a neurosurgeon can together make the plan of action for the treatment.
Treatment decisions are individualized and based on tumor type, location, malignancy, and the
patient (age, physical condition). Classical ways to treat brain tumors include surgery, radiotherapy
and chemotherapy. Sometimes just one type of treatment can be required but most of the time a
combination of it is needed. Clinical trials would also be proposed as an option for some high-grade
tumors [26, 28]. Figure 1.4 shows the classical combination of treatments depending on the tumors
type.
1.3.1 First choice of treatment for brain tumors
In order to surgically remove a brain tumor, the surgeon performs a craniotomy, an operation
where he makes an opening in the skull. If the complete removal is not possible without sustaining
brain damage, he will remove as much as possible to help relieve symptoms. Three procedures
have ﬂourished in the last few decades: maximum extent resection, electro-stimulated surgery, and
awake surgery.
1.3.1.1 Maximum extent of resection
A theoretical principle of neurosurgical oncology is that a maximum resection will reduce mass
eﬀect and tumor burden resulting in improved diagnosis and prolonged survival. However some
brain tumors such as high-grade glioma are very inﬁltrative and their removal can be challenging.
The recent preferred approach is to perform maximal surgical resection, but these tumors can be
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located in highly functional area (language, motor, memory, ...) and resection of these regions
have to be avoided at all cost to preserve a certain quality of life for the patient. The principle of
brain tumor resection consequently become to achieve a maximal resection while monitoring the
oncological-functional balance to preserve brain functional area. Such surgeries are based on the
evaluation of tumor margins with previous biopsies and imaging analysis, combined with mapping
of surrounding functional areas using advanced MRI techniques. So far the best pre-operative com-
bination of functional imaging to a successful maximal resection surgery, is fMRI and DTI imaging,
showing increase survival and better motor function post-surgery [71].
One of the major drawbacks of basing the surgical plan on pre-operative analysis is the phenomena
of brain shift during craniotomy. The human brain is plastic by nature, and can be very ﬂexible
and easily deform once an open surgery is started. This phenomenon, called "brain shift", has been
documented in the last years [72]. Diﬀerent factors happening during a surgery can play a role
in this shift, such as the mechanical action of resection, gravity, evacuation and drainage of ﬂuid,
cystic components and others. The displacement of a cortical target region preoperatively can be
from 0.8 to 14.2 mm once the dura is opened [73]. This highlights the strong limitations of actual
neuro-navigation methods which are established on preoperative data.
1.3.1.2 Electrostimulated surgery
To solve this issue and to improve surgical outcomes, new surgical methods have been devel-
oped. The ﬁrst successful approach was to use electro-stimulation during surgery in order to map
the cortical and subcortical function during the resection and to adjust it in order to insure the
conservation of important functions for the patient post-surgery. If used under general anesthesia
electro-stimulation can allow mapping of the motor functions. Bipolar electrodes are placed on the
surface brain for few seconds with a current in the range of 2 to 16 mA, and patient is watched
for movement response. If a region of the brain show activity when a movement is stimulated,
the surgeon will stop resecting this area to preserve the essential function. However language and
cognitive function could not be identiﬁed during surgery with this method [74]. If this method
show great advantages over pre-operative function mapping by solving the problem of brain shift,
there are still some limitations. Electrostimulation can result in some false negatives. Because the
patient is under anesthesia any motor stimulations are external, and not coming voluntarily from
the patient as they would be normally. Further external stimulation excites the largest axons and
neurons ﬁrst, where in voluntary movement stimulation can start from smaller neurons. Conse-
quently these small neurons will not be activated with the external stimuli and may be wrongfully
resected [75]. Another limitation that often results in false positive is the propagation of the signal
along axons. Even if it is an advantage by highlighting the connectivity in the brain, it can also
show signal after stimulation in a region that could have been resected [75].
1.3.1.3 Awaken surgery
To have access to all vital functions related to brain activity, the process of awake surgery was
developed. The process of such surgery is asleep-awake- asleep protocol, the patient is asleep for
scalp opening and bone removal and then fully awake for speech function mapping. The distance
of the resection margin from the nearest language site is critical to hope for post-operative intact
language function. A 40% language deﬁcit is expected if the resection comes within 10 mm of
important language sites. However, for distances greater than 1 cm, no permanent deﬁcit can
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be expected [74]. A recent study of awake surgeries with electrostimulation for function mapping
showed that in 107 patients with glioma of grade II to IV, surgeons were able in 80% of cases to
have a resection superior to 90% [76]. Also 74% of patient were able to resume their employment
activity. They determined that with this technique, maximal functional-based resection, an increase
in both survival and quality of life was possible [76]. Even if this surgical technique showed an
improvement in patient survival and quality of life, the resection is still performed "blind" in the
inﬁltrated margins and performed maximally to be sure to reach the 90% rate of resection [77].
However some resected regions may have been completely healthy and some cells may have been
left in the highly functional regions.
1.3.2 Other standard treatment
If complete removal is not possible without sustaining brain damage, the surgeon will remove as
much as possible to help relieve symptoms. The rest of tumor left can be treated with the additional
and complementary options of radiation therapy and chemotherapy. Radiation therapy, also called
radiotherapy, uses high-powered rays to damage cancer cells and stop them from growing. It can be
done by two diﬀerent processes. External radiation coming from a large machine is generally given
over ﬁve days during several weeks, depending on type and size of tumor and the patient's age [10].
The other method is internal radiation therapy (brachytherapy), where radioactive implants are
put directly in the tumor after resection of the tumor. With this process the radiation is impacted
the ﬁrst few millimeters of tissue in the resection cavity, where residual inﬁltration could sustained
[10]. This limits radiation to other parts of the body, however the patient has to stay in the hospital
for several days while the radiation is most active. In most of cancer another method of treatment,
to avoid recurrences, is chemotherapy. Chemotherapy, is a treatment based on the use of drugs
to eradicate cancer cells. The drugs are usually given orally or by injection (in bloods or muscle),
they aim to disrupt mitosis to result in the death of abnormal cells and shrink the tumor [10].
However for a long time it has been considered ineﬃcient for brain tumor due to the selectivity of
the blood-brain barrier (BBB). Indeed to regulate the uncontrolled diﬀusion of most molecules into
the brain, this one is surrounded by the BBB. It prevents harmful toxins and bacteria contained in
the blood stream from entering the brain, enabling access only to selected substances and molecules
like water, some gases, and essential nutrients. If it stays intact through appearance of malignant
tumors, what should be seen as a life-saving defense, is also in reality a diﬃculty for treatment by
blocking many drugs and agents from reaching brain cells and tissues [20, 78]. Recently new drugs
appeared, with small size or high lipid solubility, naturally able to pass through the BBB, allowing
eﬃcient brain tumor chemotherapy. However even if these improvement, this technic still has to
prove real impact in brain tumor management, especially in high grade glioma [79].
1.4 Current technologies of assisted resection with intra-operative
imaging
To answer the problem of brain shift on pre-operative mapping and the limitation of electro-
stimulated surgeries, another approach had been to ﬁnd ways to give contrast at the cellular scale
for the surgeon during his surgery. For this, intra-operative imaging techniques have been developed
and have started to make their appearance in the operating room. The ﬁrst direction taken to get
real- time intra-operative assessments was to bring the current pre-operative imaging techniques,
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such as MRI or Ultrasound into the operating room [80].
1.4.1 ioMRI
One of the more advanced intra-operative non-optical technologies is the intra-operative MRI
(ioMRI) [81, 82]. The ﬁrst attempts began in the 1990s with a collaboration between researchers and
physicians from Brigham and Women's Hospital in Boston (Massachusetts, USA), and engineers
from General Electric Medical Systems, resulted in a pioneer 0.5THz intra-operative MRI system.
Since then few other systems have been invented. Siemens produced a 0.2THz open-conﬁguration
system that was implemented and used in several places (Los Angeles, Heidelberg,...). Philips devel-
oped a high ﬁeld 1.5T MR scanner with a pit conﬁguration that requires in and out displacement of
the patient between surgical actions and imaging [81]. These systems give the surgeon anatomical
and functional information, helping to make a more precise decision on tumor margin delineation.
ioMRI has a high sensitivity on soft tissue discrimination and allows 3D visualization of the oper-
ative site. It also helps the surgeon to adapt his surgical trajectory to a safer and more eﬃcient
option by enhancing the contrast of intra-cranial lesions. Consequently, the extent of resection can
be optimized and the risk of critical hemorrhage greatly reduced. The studies of the use of ioMRI
in brain surgery have shown little improvement in the quality of gross total resection. Eljamel et
al showed that patients undergoing high grade glioma resection had a gross total resection rate
of 70% with the use of ioMRI. Although this rate was assessed to be an improvement compared
to non-assisted surgery, it was lower than with intra-operative ultrasound and ﬂuorescein guided
surgery [83]. Cobuger et al. showed that in low grade glioma resection ioMRI correlated signiﬁ-
cantly with the histo-pathological diagnosis (p<0.006), however no test was done on the impact on
gross total resection [84]. Kubeen et al. tried to compare ioMRI to conventional neuro-navigation
guided surgery and did not ﬁnd signiﬁcant advantage with respect to extent of resection, clinical
performance, and survival using ioMRI [82]. ioMRI has not shown signiﬁcant results in assisting
brain tumor resection and presents important drawbacks. It is a costly and time-consuming proce-
dure, requiring specialized non-magnetic tools and a long acquisition time that disrupts the surgical
workﬂow [80, 85]. Moreover some residual neoplastic tissue cannot be identiﬁed by this imaging
modality. There is not always a correlation of contrast enhancement with presence of neoplastic
tissue. Even if an increase in contrast correlates with tumor, a lack of contrast does not always
correlate with the absence of lesions [86].
1.4.2 ioUS
Another technique implemented in the operating room is the intra-operative ultrasound (ioUS).
It is a real-time imaging technique and inexpensive compared to ioMRI. The imaging scan can be
performed several times during the surgery without major disruption to the workﬂow [80]. This is
based on the technique of ultrasound imaging that uses high frequency sound waves which are sent
to the examined area and the return echo is registered. A computing process gives a live image
of the observed region inside the body. The probe is made of acoustic transducers that generate
pulses of sound. When these pulses ﬁnd a material with a diﬀerent density, a wave is reﬂected
back to the probe and detected as an echo. The system measures the time the echo takes to return
and calculates the depth of tissue that generated the echo. In medical imaging the frequency of
the pulses is in the range of 1 to 18 MHz. In ioUS the transducer is in direct contact with the
examined organs, giving the advantages of avoiding any signal degradation due to air, bone, blood
25
1.5. NEW CONTRAST IN INTRA-OPERATIVE IMAGING: THE . . .
or overlying tissue [87]. Petridis et al showed that in low grade glioma it gave better results than
other intra-operative neuro-navigation systems. On 34 patients with low grade glioma, 15 were
treated using ioUS and in all cases the tumor was identiﬁed. Nineteen were treated with standard
neuro-navigation, which failed 5 times to identify and locate the tumor [88]. These results showed
that used before resection, ioUS gives a useful and promising contrast on identifying low grade
glioma and delineating its margins. The shortcomings showed in this study and others before is
that once the resection have been performed ioUS image quality at the resection border decreases
signiﬁcantly and remaining tumors can be confused with artifact, such as the "rim eﬀect". Another
major shortcoming of ioUS is that it requires an experienced and trained operator to correctly
interpret the images, which makes it diﬃcult to include in a surgical workﬂow [80, 89].
Despite all their technical and computing advances, ioMRI and ioUS still do not provide the accu-
racy and precision required to assist with extended resection. Ultrasound, MRI and CT imaging
are still not able to discriminate tumor heterogeneity and can not give precision at the near-cellular
scale [90].
1.5 New contrast in intra-operative imaging: the ﬂuorescence
1.5.1 Exogenous ﬂuorescence
A new contrast of imaging that has been emerging in the area of biology and physics in the last
decades, is the ﬂuorescence. The principle is an incident light exciting an electron to an orbital
state that will relax, emitting a photon. The ﬁrst type of ﬂuorescence to be explored was exogenous
ﬂuorescence. Fluorescent markers were introduced into target cell types, proteins, genes, where
they will then be excited and their emitted signal collected by the endoscope. The ﬁrst step is to
ﬁnd a speciﬁc probe for the analyzed tissue and cells. Some ﬂuorophores are now able to provide
reliable results in intra-operative diagnosis, and the next diﬃcult step is to win approval for clinical
application from diﬀerent European and American committees. The most tested and widespread
ﬂuorophores are ﬂuorescein sodium, indocyanine green (ICG) and 5-aminoluvulinic acid (5-ALA).
We are going to review their discovery, performance and limitations [91].
1.5.1.1 Fluorescein
Fluorescein was the ﬁrst marker to be clinically used by Moore et al in 1948 on glioma surgery. It
accumulates in glioma tissue and give a homogenous yellow ﬂuorescent signal that can be observed
with naked eye. However ﬂuorescein will accumulate everywhere there is blood and will become
highly non-speciﬁc [92]. These brought large debate and dispute in the literature on the real capacity
of ﬂuorescein to be tumor speciﬁc. Even though it was the ﬁrst tested ﬂuorophore, ﬂuorescein is
not FDA (Food and Drugs Administration, United-States) approved even today, and can only be
used in clinical research study.
1.5.1.2 ICG
Another interesting marker is ICG. It has to be excited in the near infrared range and it emits
ﬂuorescence in the same range. NIR light is in the therapeutic window of tissue, resulting in less
26
CHAPTER 1. INTRODUCTION
absorption and is safer with regard to tissue damage. ICG has shown great results in the techniques
of ICG video angiography, and has been used in other surgical procedures, assessment of blood ﬂow,
vessel patency, and not only intestinal perfusion but also in gastrointestinal oncology [9395]. ICG
could be used to show blood ﬂow in glial tumor surgeries. The ﬁrst studies showed that used alone it
failed to give enough ﬂuorescence. The most promising results have been when ICG was conjugated
to other molecules enhancing the signal such as 5-ALA [96]. Still one of the major drawback of this
ﬂuorophore is the necessity to display the image on a monitor and use specialized detectors and
instruments due to excitation and collection in the infrared region [90].
1.5.1.3 5-ALA
Where ﬂuorescein and ICG are passive agents, accumulating in tissue by diﬀusion processes, 5-
ALA is a metabolic targeting agent. This means that a metabolic process activates a non-ﬂuorescent
component into a signal-generating form in targeted tissue. It is an intermediate metabolite, that
after oral administration the patient will convert to protoporphyrin IX (PpIX) an endogenous
ﬂuorophore emitting in near infrared (620-710nm) [97]. 5-ALA was ﬁrst introduced in glioma
surgery by Stummer et al. in 1998 [98] on 9 patients. They reported the usefulness of 5-ALA-PpIX
in 7 of them to detect and remove residual tumor tissue. Later on, with a phase-III study in Europe,
Stummer et al. demonstrated that the use of 5-ALA contrast resulted in higher rates of gross total
resection (65% vs. 36%) and, in patient older than 55 years, an improved 6-month progression-free
survival (41% vs. 21.1%) [99]. In Europe 5-ALA has been approved by regulation committees and
used more and more by surgeons to assist their resection surgeries. It has shown great results in
high glioma, more especially in GBM.
Still it has its limitations, in low grade glioma. Due to the needed blood-brain-barrier disruption,
the accumulation of ﬂuorophore can decrease and consequently decrease contrast [90]. These ﬁrst
studies were made using a 405 nm excitation source, that induced considerable photobleaching.
Kantelhardt et al conducted a study of the PpIX ﬂuorescence in orthopic glioma model using a two-
photon imaging set-up (DermaInspect, JenLab). They were able to get a higher structural deﬁnition
of the tumor tissue, with the high resolution of the two-photon microscopy [100]. Discrimination
of ﬂuorescence from the cytoplasm of tumor cells from the 5-ALA induced PpIX ﬂuorescence of
normal brain parenchyma adjacent to tumor were possible [100]. 5-ALA more and more used in
clinical setting and evaluated by the diﬀerent national ethical committees for general approval, have
consequently be questioned on the eventual secondary eﬀects that patient will suﬀer. The impact of
5-ALA has recently raised diﬀerent arguments. Bi and Law have published a review of the literature
were they assert that transient allergic reactions, including generalized edema, and photosensitivity
have been described after 5-ALA administration in several case series [22]. However in a letter
Stummer has answered that it was a single case of mucosal edema and that in 500 patients closely
monitored no issues of this nature have been encountered and that no other case has been reported
to the European Risk Management plan [101]. Coming to a conclusion on the impact that could
have 5-ALA on patient safety, is a hard task and is one of the reasons that this exogenous method
will take time to be accepted and used on a larger scale. Consequently, other methods must continue
to be explored to tackle the question of assisted resection surgery.
1.5.2 Endogeneous ﬂuorescence
Exogenous markers development was slowed down by diﬃcult regulatory approval processes
and the hard task of ﬁnding tumor speciﬁc markers at a cellular scale. These limitations and the
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availability of high resolution imaging technologies, pushed physicists to consider another mean of
contrast - autoﬂuorescence. This is a signal from native components of biological tissue. It has been
seen for a long time as a noise in exogenous ﬂuorescence optical detection, recently gaining interest
as a direct mean of contrast for optical tumor diagnosis. In all tissues, we can ﬁnd molecules in
cells, that when excited at a suitable wavelength becomes ﬂuorescent. This emitted ﬂuorescence, an
intrinsic property of cells, is called autoﬂuorescence in contrast with previously described exogenous
ﬂuorescence. Endogenous ﬂuorophores are link to the morpho-functional properties of cell and
tissue. All changes during physiological and/or pathological processes impact the distribution of
ﬂuorophores and so their emission features. It results in a powerful tool to monitor directly the
morphological and physiological state of a tissue and/or region of cells.
1.5.2.1 Fluorescent molecules in brain tissue
Autoﬂuoresence originates primarily from mitochondria (molecules such as reduced nicotinamide
adenine dinucleotide (NAD(P)H) and ﬂavin adenine dinucleotide (FAD) coenzymes, porphyrins
and lipopigments), lysosomes (lipofuscins in cells), extracellular matrix (structural proteins such as
collagen and elastin) and various aromatic amino acids (such as tyrosin and tryptophan)[102104].
Figure 1.6 shows the distribution of these ﬂuorophores as a function of on their optimal excitation
wavelength and their emission spectrum [105].
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aging for the detection, differential diagnosis, staging or 
characterization of malignant and premalignant lesion in 
these and other body sites. If the goal of early detection of 
primary or recurrent tumors can be achieved, this may in- 
crease the likelihood of successful radical treatment and re- 
duce complications. 
Additional potential applications of these techniques are 
to provide guidance in locating the optimum sites for biopsy 
(7), to define the surgical margins for tumor resection 
(73,105,106) and to optimize and monitor PDT treatments 
(21,94,107,108). A controversial but recurring concept is 
that of the optical biopsy, where it is envisaged that diag- 
nosis based on in situ optical measurements could be per- 
formed without tissue removal for histopathological exami- 
nation. Focusing on this (probably unachievable) goal de- 
tracts from the valuable and realistic uses of fluorescence 
and other optical techniques. 
The potential clinical advantages of fluorescence tech- 
niques include: the high signal sensitivity, especially if point 
measurements are used; the particular suitability for exami- 
nation of tissue surfaces (compared to the volume imaging 
of most radiological techniques); flexibility in the anatomical 
sites that can be investigated, especially using small-diam- 
eter optical fiber probes; reduction in the use of random tis- 
sue biopsies and the ease of use by the clinician. The poten- 
tial for reduced health-care costs as a consequence of the 
minimally invasive nature and speed of the techniques and 
the improved patient outcome may be significant. However, 
as will be indicated in the applications section below, it is 
critical that the clinical (and associated laboratory) studies 
to evaluate fluorescence spectroscopy and imaging are per- 
formed in a medically relevant context. Thus, for example, 
there is little benefit in showing that tumors that are visible 
to the naked eye also fluoresce if this does not alter patient 
management or outcome, or if the procedures have signifi- 
cant toxicity or only incrementally improve lesion detection 
compared to established techniques. 
FLUOROPHORES 
Each class of fluorophore outlined above, namely endoge- 
nous, endogenously synthesized and exogenous, has distinct 
advantages and limitations for different clinical applications. 
Endogenous fluorophores 
As recently surveyed by Richards-Kortum and Sevick-Mur- 
aca (8) ,  most endogenous fluorophores are associated with 
the structural matrix of tissues or are involved in cellular 
metabolic processes. The most important of the former are 
collagen and elastin, the fluorescence of which is the result 
of cross-linking between amino acids. Fluorophores involved 
in cellular metabolism include reduced nicotinamide adenine 
dinucleotide (NADH) and flavins. Other fluorophores in- 
clude the aromatic amino acids (e.g. tryptophan, tyrosine, 
phenylalanine), various porphyrins and lipopigments (e.g.  
ceroids, lipofuscin) that are the end-products of lipid metab- 
olism. In addition, red porphynn fluorescence due to bacteria 
may be significant in certain body sites and/or lesions. 
Characteristics that are important to consider in optimiz- 
ing and interpreting clinical studies include the following: 
(a) Each fluorophore has a distinct excitation and emission 
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Figure 1. Fluorescence excitation (A) and emission (Bj spectra of 
various endogenous tissue fluorophores. Spectral shapes are shown 
for the best relative excitatiodemission conditions (derived from 
Richards-Kortum and Sevick-Muraca (8), Wolfbeis (1 1) and Botti- 
roli et al. (78). 
spectrum (Fig. 1). (b) Any given tissue contains a mixture 
of many fluorophores of different concentration. (c) The 
fluorophores are not uniformly distributed in tissue and, in 
particular, may vary markedly with depth below the tissue 
surface. For example (Fig. 2) ,  in hollow organs such as the 
bronchus, GI tract or bladder, there is a distinct layered 
structure (mucosa, submucosa, muscularis), each of which 
has a different fluorophore composition. Thus, the fluores- 
cence spectrum measured at the tissue surface has different 
contributions from the fluorophores in each layer. 
The detection of premalignant lesions or early cancer us- 
ing autofluorescence then depends on changes in one or 
more of (1) the fluorophore concentration or spatial distri- 
bution; ( 2 )  the metabolic status: e.g. NADH is fluorescent 
only in its reduced form; (3) the biochemicalhiophysical 
microenvironment of the tissue, which may alter the fluo- 
rophore quantum yield, spectral peak positions and line 
widths; (4) the tissue architecture, such as mucosal thick- 
ening or loss of layered structure, which affects the relative 
contributions to the measured fluorescent signal at the inti- 
ma1 tissue surface and ( 5 )  the wavelength-dependent light 
attenuation due to the concentration and distribution of (non- 
fluorescent) chromophores, particularly hemoglobin. 
The degree to which the fluorescence signal measured in 
vivo is altered by these metabolic or morphologic changes 
Figure 1.5  Fluor scence excitation(A) and emission(B) spectra of various endogenous ﬂuorophores
[105].
NADH has a favored absorption wavelength at about 365 nm and emits ﬂuorescence in the
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420-490 nm region. The ﬂuorescent properties of NAD(P)H change with enzyme bidding and as
a consequence a shift of the main emission peak can be observed. NADH is mainly involved in
oxydoreduction reaction during energy production, which makes it a good metabolism indicator
[106]. FAD has an absorption maximum at 445 nm and emits ﬂuorescence around 525 nm. It
is an oxidized form of the metabolic process of energy production in cells and as for NADH, the
monitoring of its ﬂuorescences give access to metabolic information [106]. Lipopigments, a product
of lipid oxidation can be excited in the 340-440 nm range. The main peak of emitted ﬂuorescence
is at 600 nm with a broad width [106]. The signal is produced by granules that accumulates in
cell cytoplasm and are associated with tumoral condition [107, 108]. This motivated the use of
lipopigments as a diagnosis tool. Porphyrins, molecules involved in transport of oxygen, catalysis
and pigmentation, emit ﬂuorescence at 630 and 670 nm if excited in the visible range. Porphyrins
have been observed as an indicator in necrotic tumors [109]. Some amino acids are also endoge-
nous ﬂuorescent molecules. They are best excited with wavelength under 280 nm, and three of
them can emit ﬂuorescence : tryptophan around 340 nm, tyrosin around 300 nm and phenylanine
around 280 nm. Their ﬂuorescence response is inﬂuenced by structure, spatial conformation and
microenvironment, making it an interesting tool to monitor tissue state [106]. Proteins themselves
can also result in an autoﬂuorescence signal, such as structural collagen proteins. The maximum
absorption of collagen is around 340 nm with an emission peak at 400 nm. Collagen is one of the
main component of the extracellular matrix (ECM) and presents diﬀerent types, at least eleven.
These proteins are able to produce ﬂuorescence through formation of covalent cross-links [106].
During most cancers the ECM is altered through diﬀerent mechanisms, which can result in increase
of collagen or/and a more oriented alignement. Being able to quantify the amount of collagen could
be a hallmark of tumoral nature. Also some types of collagen (I,II and V) have a very distinct triple
helical structure, which make them, as shown before, a source for SHG signal and so an indicator
of structural change in the ECM, such as ﬁber orientation [110].
Using this intrinsic contrast signal in multi-photon microscopy showed promising results, over
linear microscopy, to give information at a cellular scale. Teams have worked on mouse models
of gliomas to count cell density imaging two-photon autoﬂuorescence of NADH and FAD [100].
Lepert et al. have applied multi-photon microscopy on ex vivo murine tumor and human brain
tumor [111]. In murine tumor, the images of the autoﬂuorescence response were compared to the
gold standard H&E staining in histology. The demarcation between tumor and healthy tissue were
identiﬁed in the multi-photon images with a cellular scale. The invasive tumor cells were identiﬁed
at a single cell level and some sub-cellular structures too. They also explored some human ex vivo
samples taken from macroscopic edge and solid tumor tissue after resection of a glioblastoma. In
the margin, they showed single invasive cell as in murine tissue [111].
1.5.2.2 Metabolic activity
The metabolic activity of the brain is the sum of all the biochemical processes responsible
for cerebral functions, like maintaining cell life and enabling their functions in the tissue. The
brain is one of the most energy consuming organs, using 20 to 23% of the total body energy re-
quirement [112]. When a cerebral stimulation occurs the metabolism activated requires higher
adenosine triphosphate (ATP) production than typical basal state. Being able to measure this
cerebral metabolic activity gives access to monitoring changes in brain activity and irregular phys-
iological conditions such as hypoxia, hyperoxia and even acute ischemia [112, 113]. The two major
pathways for brain metabolic activity are glycolysis and oxidative metabolism. These two process
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are shown in ﬁgure 1.6. In these reactions co-factors NADH and FAD play role of electron donors
and acceptors. NAD(P), an electron acceptor, has only its reduced form, NAD(P)H, that ﬂuoresce.
FAD a primary electron and proton acceptor has only its oxidized form, FAD, that ﬂuoresce. Aut-
oﬂuorescence measurements of these co-enzymes consequently gives a way to monitor the energetic
metabolism [103, 112, 114].
Figure 1.6  Diagram of the major metabolic pathways in brain tissue [112].
A recent study has shown that measuring the ﬂuorescence ratio of NADH over FAD could
translate the diﬀerent perturbations in the diﬀerent metabolic process such as enhanced glycolysis
and glutaminolysis, extrinsic and intrinsic mitochondrial uncoupling, and fatty acid oxidation and
synthesis [115]. In cancerous tissue it was observer that the glycosis pathway was favored. This
phenomenon is called the Warburg eﬀect [116]. An increased glucose consumption even in the
presence of oxygen resulting in a change in the energy production and so a change in the ratio
between NAD(P)H and FAD.
The method of the redox ratio were proved to be a tool to monitor such changes, diﬀerent
group have therefore proposed an experimental deﬁnition of this redox ratio as an indicator of
malignancy of tissue. The deﬁnition of the redox ratio is not always consistent in the literature
[117]. Skala et al. deﬁned the redox ratio, as the ratio of the ﬂuorescence intensity of FAD and
NADH, measuring it in a dimethylbenzanthracene (DMBA)-treated hamster cheek pouch model of
oral cancer [118]. The redox ratio was diﬀerent from one type of cell to another in the epithelial
layers however these results were not observed in precancerous tissue. Ranji et al. and Drezek
et al. used another deﬁnition of the redox ratio [119, 120]. They presented it as the ratio of the
ﬂuorescence intensity of FAD and the sum of the ﬂuorescence intensities of FAD and NADH .
Ranji et al observed apoptosis in myocardial cells and found a higher ratio in initiation of apoptosis
[119]. Drezek et al. measured it in fresh section of normal and dysplastic cervical tissue [120]. A
decreased redox ratio in dysplastic tissue sections was observed in one-third of the paired samples,
which indicates increased metabolic activity. There are still very few studies reporting on the redox
state in brain tumors versus normal brain tissue despite a growing use of ﬂuorescence spectroscopy
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in brain cancer diagnosis. Chung et al. looked at in-vitro human brain tissue. A diﬀerence
between normal and cancerous in term of intensity was found in both measured NAD(P)H and
ﬂavin ﬂuorescence, however the computed redox ratio did not change from normal to cancerous
[121]. Croce et al. investigated the autoﬂuorescence properties of normal and neoplastic brain
tissues on patients aﬀected by glioblastoma. They used a ratio of ﬂuorescence intensities at 520
(approximatively FAD emission peak) and 470nm (approximatively NAD(P)H emission peak) to
monitor the change in the spectral shape with neoplastic growth. It gave a higher ratio in neoplastic
tissue than in non-neoplastic tissue [103, 122].
1.5.3 Methods of measurements based on ﬂuorescence signal
Fluorescence of molecules is the radiative transition from its ﬁrst singlet state S1 to the ground
singlet state S0. This transition is characterized by three parameters : 1) the ﬂuorescence spectrum,
ﬂuorescence intensity as a function of wavelength, 2) the quantum yield, eﬃciency of the emission
process and 3) the ﬂuorescence lifetime, the average time during which a ﬂuorophore remains in its
excited state. Detecting technologies have been developed to take advantage of these parameters and
give quantitative indicators on the observed regions. Moreover other transitions besides ﬂuorescence
can be excited and also result in quantitative detection. They are classiﬁed under the Raman
spectroscopy. This section will described in details the quantitative methods used in this thesis to
measure the ﬂuorescence signal, the spectroscopy and ﬂuorescence lifetime.
1.5.3.1 Methods of spectroscopic measurements
Fluorescence spectroscopy (FS) is based on the measurement of ﬂuorescence intensity which
is the number of photons emitted at a speciﬁc wavelength. This measure is a function of the
ﬂuorophore concentration, the absorption, the scattering and the ﬂuorophore quantum yield. This
signal is a linear combination of the emitted ﬂuorescence of each molecule in the tissue. This gives
biochemical and morphological information based on the scattering and absorption dependence.
Diﬀusive reﬂectance spectroscopy (DRS) excites tissue with a broad-band light source resulting in
a series of absorption and scattering interactions producing a diﬀusely reﬂected light. The intensity
of this reﬂected light will be measured by a detector deﬁning the reﬂectance spectrum. With this
technique the absorption and scattering coeﬃcient of a tissue can be measured, translating the
concentration of absorber into the size and density of cellular and subcellular structures [123]. The
two methods are compared in the ﬁgure 1.7
A combination of the diﬀuse reﬂectance and intrinsic tissue ﬂuorescence were used in a large
study on primary and secondary brain tumors compared to control tissues. Algorithms were de-
veloped to ﬁnd a discrimination criteria combining these two quantitative modalities. Lin et al.
pursued their work with two-step algorithms [124]. Other groups have also started using intrinsic
ﬂuorescence and diﬀuse reﬂectance to ﬁnd discrimination criteria in brain tumors [125]. However
strong limitations lie in the fact that they use the complete spectral response over a large range of
wavelengths and do not try to quantify biomarkers.
Method only based on the ﬂuorescence spectroscopy were also developed [117, 126128]. The
spectral response over a large emitted wavelength range was analyzed. Either by developing ﬁttings
methods to get the area under emission peak[127, 128], or directly take the intensity value from the
curve on speciﬁc emission band [117, 126]. These methods show statistical discrimination between
normal and cancerous brain tissue in rat [117, 128] or human samples [127].
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Figure 1.7  Schematic overview of two optical spectroscopy methods. (A) Diﬀuse reﬂectance
spectroscopy(DRS). (B) Fluorescence spectroscopy(FS) [123].
1.5.3.2 Methods of ﬂuorescence lifetime measurements
When a molecules absorbs a photon, it can result in the photo-physical process of ﬂuorescence.
The time required by a population of N electronically excited molecules to be reduced by a factor
of e in this process is called the ﬂuorescence lifetime, τ , which is on the order of nanoseconds [129].
Fluorescence lifetime is an intrinsic property of the ﬂuorophore, independent of intensity-based
parameters (intensity of excitation, detection gain, optical loss in setup, ﬂuorophore concentration,
microscope focusing, photobleaching). It is sensitive to environmental factors such as temperature,
pH, oxygen and ion concentration, viscosity, molecular association (binding to other molecules,
proteins) and polarity. These dependencies create the opportunity to use the ﬂuorescence lifetime
technique as a probe of the local microenvironment of the ﬂuorophore [129131].
1.5.3.2.1 Detection technique
Fluorescence lifetime can be measured either in the time-domain or in the frequency domain.
The major diﬀerence between these two methods is the type of excitation used. In the time domain
short pulses of light with signiﬁcant delay between the pulses are sent to the tissue. In the frequency
domain a sinusoidally modulated light at a high frequency is used to excite the tissue [129]. The
Figure 1.8 illustrates the detection methods for time-domain and frequency domain ﬂuorescence
lifetime techniques.
In the time domain, there are two major methods to detect and measure ﬂuorescence lifetime.
These are time-gated integration and time-correlated single photon counting (TCSPC).
In the time-gated method the excitation pulse is split in two in order to excite the samples
and to trigger a gated CCD. The ﬂuorescence emitted is detected and integrated during a certain
time gate on the CCD, and gates with several delays are record to reconstruct the decay histogram
[130]. This is not a photon counting method and can avoid the pile-up limitation. Consequently it
can be used in conﬁgurations with higher photon ﬂuxes and imaging rates. However it has so far
never shown the same precision as the TSCPC method and is preferred in situations where speed
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Figure 1.8  Methods of single point lifetime measurements. (a) analog measurements of decay
proﬁle, time-gated method. (b) time-correlated single-photon counting (TCSPC). (c) frequency
domain measurement of change in phase and modulation depth of ﬂuorescence with respect to
excitation signal [132].
prevails over resolution [132]. In the TSCPC method a voltage is recorded at each arrival of a
photon and is related to the excitation pulse start, resulting in a time decay histogram by binning
individual recordings in the same time frames. The main advantages of TCSPC are low sensitivity
to shot noise, high photon economy, and high dynamic range. One drawback is the relatively low
acquisition time, thus requiring low intensity. However in most recent electronic development this
has been reduced and is less important than general limitations of ﬂuorescence lifetime techniques
such as photon pile-up [130, 132].
In the frequency-domain, a sinusoidally modulated excitation source will produce a ﬂuorescence
signal with the same periodicity but with a diﬀerent modulation range and a delay in phase. The
ﬂuorescence lifetime is calculated from two parameters, relative modulation and phase delay). Data
are acquired with photomultipliers or charge-coupled devices equipped with a gain modulator [130,
132].
The choice of either time or frequency domain to perform FLIM measurements will dependent
on the observed molecules. Frequency domain is more adequate to evaluate short-lifetime. The
choice of FLIM instrumentation therefore depends on the particular. Time domain is more ﬂexible
and can access longer-lifetime molecules, which is better suited for tissue measurements where a
broad range of molecules can be observed.
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1.5.3.2.2 Analysis method
Time-domain and frequency approaches are mathematically the same. There is only a Fourier
transform needed to convert data from one domain to another. Therefore the data analysis meth-
ods are the same for both [129]. The most popular analysis technique is curve ﬁtting analysis,
but other non-ﬁtting methods have been developed. The collected data from ﬂuorescence lifetime
measurements can be analyzed with various methods. From the literature three major methods
can be extracted: multi-exponential ﬁtting, Laguerre polynomial ﬁtting, and phasor plot analysis
[130, 132].
Multi-exponential ﬁtting is the most widespread technique, due to the relative simplicity of
implementing it. Fluorescence lifetime measured in a region of interest in tissue is the convolution
of the instrument response function (IRF) and the intrinsic ﬂuorescence decay. The ﬂuorescence
lifetime of a unique molecule is an exponential decay. If you have a mixture of molecules, the
response is a linear combination of the exponential decay of each of the molecules. Consequently
in multi-exponential ﬁtting two approaches can be applied: a deconvolution of the response by
the measured IRF and several exponentials, or a tail ﬁt where you ﬁt only the second part of the
decay after the IRF inﬂuence. The optimization of the ﬁtting is usually done with an iterative
least-squares method that minimizes residuals and chi-square goodness of ﬁt (χ2) [130].
A second method is the Laguerre polynomial ﬁtting, the measured decays are individually ﬁtted
by a set of unique and discrete Laguerre functions in an orthogonal basis. The advantages of this
technique over the polynomial ﬁtting are the fact that no assumption is made on the decay form.
The information on all pixels are processed simultaneously resulting in faster ﬁtting and a unique
best ﬁt [130].
The third technique is the phasor plot analysis, which was ﬁrst developed to analyze frequency-
domain FLIM (Fluorescence Lifetime Imaging). In this method the modulation and the phase are
transformed according to Eq 6.5 1 in order to be graphically represented as a phasor vector on the
plot [130].
x =Mcosϕ
y =Msinϕ
(1.1)
Time-domain FLIM can also be analyzed by this method using pulsed frequency to go into the
phasor space with modiﬁed equations [133]. The ﬂuorescence lifetime information behind each
pixel is represented in a 2D plot where analysis can be rapidly performed by identifying cluster of
pixels. And a color can then be attributed at each cluster and projected in the 2D acquired image
to obtain a pseudo-colored lifetime map. This type of analysis has the advantages on the other
method to being free of "ﬁtting", and oﬀers a representation accessible to non-experts [130, 132].
1.5.3.2.3 Application of ﬂuorescence lifetime to brain tumor imaging
Kanteldhard et al. performed a ﬁrst study using two-photon imaging and FLIM measurements
on mouse models and a few ex vivo samples of fresh brain tumor just after resection [134]. This study
did not have enough samples to give statistical evaluation of the discrimination power (sensitivity
and speciﬁcity). However they did show diﬀerences in lifetime in the diﬀerent structures and found
that the ﬂuorescence lifetime of tumor-adjacent brain was consistently longer than that of normal
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white matter [134].
More in-depth ex vivo studies were performed by Marcu et al., who showed on 23 samples (9 GBM,
9 cortex and 5 white matter) that the average lifetime was longer in tumor tissue than in normal
white matter and cortex [131]. The study also showed, looking at 460nm emission wavelength,
that GBM have a dominant form of bound NADH (average lifetime 1,3 ns) whereas normal tissue
are dominated by the free form of NADH (average lifetime 1 ns) [131]. Butte et al performed a
study on 17 patients (34 biopsy extracted) with primary brain tumor of diﬀerent grades, and they
showed that they could discriminate low grade from high grade glioma, and from normal cortex
and white mater, with speciﬁcity and sensitivity in a range from 75 to 100% [135]. The ﬁrst in
vivo measurements were performed by Sun et al. who implemented FLIM detection in their ﬁber
probe design for performing image-guided brain tumor surgery. They were able to perform a ﬁrst
exploratory clinical trial, on three patients undergoing craniotomy, evaluating the signal from 14
sites, and showed that GBM had a signiﬁcantly more irregular excitation lifetime distribution as
compared to normal cortex[136]. Butte et al. also reported in vivo measurements on glioma with
two studies, they showed that low grade glioma had a shorter lifetime decay than normal tissue
[137]. The high grade glioma could also be separated from low grade glioma and normal tissue,
however with a lower sensitivity and speciﬁcity.
1.6 Optical developments in optical endomicroscopy
In order to answer limitations presented for ioMRI and ioUS, new miniaturized probes have
been developed based on optical technics. Optical imaging is a ﬁeld that has developed rapidly in
the last few decades and has showed high resolution in bench-top conﬁgurations, if developments
are able to brought these set-ups to clinical standard for intra-operative use, it will answer the lack
of resolution and crowding of current techniques.
1.6.1 Optical coherence tomography
Optical coherence tomography (OCT), appeared in the 1990s. It is an optical imaging technique
based on the interference of low-coherent light that detects singly backscattered light to reconstruct
two and three dimensional images of tissue [138]. To get contrast OCT uses the scattering opti-
cal properties of tissue and get tomographic images with a micrometer spatial resolution at a few
millimeters of depth [139, 140]. OCT has revolutionized the ﬁeld of ophthalmology [141], gastroen-
terology [142] and cardiology [143], giving a 3D rendering of human tissue at a millimeter depth
while being a non-invasive tool. More recently it started to be explored to image and diagnose
cancerous tissue. In 2015 an ex vivo and an in vivo study were performed on brain gliomas (grade 2
and 4). They were able to discriminate ex vivo the grade with high sensitivity, and showed on a few
in vivo patients that there were signal changes in inﬁltrated region, as histologically diagnosed [144].
If OCT probes showed promising results as a tool for optical biopsy, with the main advantages
to give a large ﬁeld of view and to be non-invasive, and a no-contact probe which integrates itself
very well in the surgical ﬁeld. This technique still suﬀers from some important drawbacks, the max-
imal resolution that can be obtained is 10 to 30 microns which is still higher than the cellular scale
and have been proven to be insuﬃcient in tumor margin identiﬁcation [145]. Another disadvantages
is that this technique use a slow scan system, in general 4mm requires 8 seconds, and during this
time the respiratory and arterial cycle can induce movement of several millimeters that will result
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in distortion in the image or completely move out of the region of interest [139]. Added to that
OCT scan cannot access any functional information about the tissue which reduces the quantity of
collected information [146].
1.6.2 Wide-ﬁeld endomicroscopy
The ﬁrst and most common microscopy technique to have been used in endoscope is the wide-
ﬁeld microscopy. This technique refers to low power surgical microscopy, where the whole ﬁeld of
view (FOV) is seen at once (10-100 mm of FOV) and is acquired continuously with an eyepiece
and/or a fast digital detector (CCD, charge coupled device, or CMOS, complementary metal oxide
semiconductor). These systems have a magniﬁcations of x5 to x40, and a spatial resolution from
10 to 100 microns, again much higher than the cellular level [90, 117]. The advantages of such
techniques are, the capacity to view the full surgical ﬁeld, to have a real-time assessment, an ease
of use that does not interrupt the surgical workﬂow, all at a very low cost [140]. However strong
limitations and drawbacks must be pointed out. One of the main drawbacks is ambiguity at the
margins. The low resolution, higher than the cellular scale, results in the ﬂuorescence intensity
decay to even vanishing in regions where tumor cells density decline. However, on histological
slice these regions show that there is still glioma cell inﬁltration [117]. Another limitation is the
sensitivity to the variation in optical properties such as absorption and scattering of tissues that
results in a subjective heterogeneous ﬂuorescence [147]. The sensitivity in low grade tumor is also
very low, with visible ﬂuorescence not produced in 95% of cases [90, 117]. Moreover the geometry of
excitation and collection causes much light loss compared to a point detection technique, and even
today the state of the art shows no possibility to perform spectrally resolved data, giving access
only to anatomical information [140].
1.6.3 Confocal endomicroscopy
1.6.3.1 Principe of confocal microscopy
To address the limitations of wide-ﬁeld imaging, the world of intra-operative imaging has looked
at other microscopy techniques to bring into the operating room. One of the major breakthroughs
in the modern area of microscopy was the invention of confocal microscopy, in 1957 by Marvin
Minsky [148]. Its aim was to answer the current limitation of wide-ﬁeld imaging. In wide-ﬁeld,
the whole sample is illuminated and the all ﬂuorescence emitted is conjugated to a CDD to obtain
a image. In the confocal conﬁguration, in the detection path a pinhole is conjugated to the focal
point to eliminate out-of-focus signal and performed a point-by-point detection.
The image's optical resolution, particularly in the sample depth direction, is much better than the
one in wide-ﬁeld microscopy, due to the presence of the pinhole. This diﬀerence is shown in the
ﬁgure 1.9.
However the point-by-point detection made it mandatory to have a scanning system to obtain
images with the same ﬁeld of you than wide-ﬁeld imaging, resulting in a slower imaging system.
The pinhole also reduces the quantity of ﬂuorescence detected in each point, very sensitive detectors
are consequently needed, making this technique also more costly than wide-ﬁeld.
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Figure 1.9  Wide-ﬁeld microscopy (a,b,c) against confocal microscopy(d,e,f) [149].
1.6.3.2 Adaptation towards a clinical use
Bench-top microscopy technology cannot be brought directly to the operating room due to spa-
tial crowding, and the architecture of the excitation path making impossible to introduce object at a
centimeter scale under, such as human brain. Miniaturization was required to see these technologies
used intra-operatively. This was made possible with the development of three miniaturized tech-
nologies : optical ﬁber to guide the light to the sample, micro-optics, and a miniaturized scanning
system to achieve centimeters scale tools that would also be easy for surgeons to handle.
Optical ﬁber The arrival of step-index ﬁber to serve as a light guide and allowing remote
excitation light delivery was the ﬁrst step to endomicroscopy. For confocal endomicroscopy, single-
mode ﬁber (SMF) is well suited and easily available commercially. SMF ﬁber has a core refractive
index usually 1 to 2% higher than the cladding index, with a numerical aperture equal to the sine of
the half angle of the emitted light and a core diameter around 3 to 7 micrometers (for set-ups using
a visible excitation) [150]. The SMF can be used in two conﬁgurations for confocal imaging. In one
the single SMF serves for both excitation and collection, with a very small core size serving as the
detection pinhole. In the second conﬁguration (dual-axis imaging), two SMFs are placed apart from
one another at an angle. One will excite and the other will collect the light. This conﬁguration,
compared to the ﬁrst one, oﬀers a longer optical working distance, no oﬀ-axis aberrations, and
good axial resolution with economical objective lenses, at the cost, however, of harder alignment
and less collection eﬃciency. Another type of ﬁber widely used on confocal endomicroscopy is the
ﬁber bundle. The ﬁber bundle consists of hundreds of individual step-index ﬁbers in a packed
arrangement, with a diameter from hundreds of microns to a few millimeters. The advantage of
such system is the possibility to use proximal conventional scanning systems. However one strong
limitation is the low resolution due to image pixelation [150]. More recently few teams have been
trying to use multimode ﬁber to perform confocal endomicroscopy and resolve some limitations
of the other conﬁgurations. Multimode ﬁbers can independently guide several spatial modes of
light in cross-sectional diameter around 100 µm, consequently allowing the transmission of multiple
pixels image with diﬀraction-limited resolution. This solves the limitation of the SMF conﬁguration
that transmit only light with Bessel intensity proﬁle and the limitation of the bundle conﬁguration
which has a low resolution due to the ﬁber spacing. However distortion through the multimode
ﬁber propagation requires heavy computing processing to reconstruct the right image at the output
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Figure 1.10  Scanning mechanisms in miniaturized microscopy. (a) Proximal scanning of a ﬁber
bundle [152]. (b) Mechanical resonance of ﬁber tip with piezoelectric actuators [152]. (c) a MEMS
mirror [21].
[151]. This limitation is the reason that SMFs are still the most used method to perform confocal
endomicroscopy.
Scanning system One of the most challenging parts of an endomicroscope conﬁguration is
the scanning system. Diﬀerent architectures have emerged, divided into two big families: proximal
scanning (placed between laser source and ﬁber probe) or distal scanning (placed at the tip of the
ﬁber probe). Proximal scanning is classically used with ﬁber bundle probes and consists of a pair of
galvanometric mirrors placed at the entrance of the bundle (Fig 1.6.a)[152]. A bundle of hundreds
of ﬁbers is scanned by the laser beam at the proximal end of the probe. Each ﬁber serves as a
point source as well as a detection pinhole for imaging. The resonant galvanometer can go up to
15 frames/s [153].
Where a single ﬁber is used to excite tissue, distal scanning systems have been developed.
Two technology have emerged: a piezoelectric placed at the distal end of the ﬁber, and a micro-
electromechanical systems (MEMS) mirror placed after the distal tip of the ﬁber. For piezoelectric
technology (Fig 1.6.b), when supplied with a signal closed to the resonance frequency of the ﬁber, a
2D scanning pattern is generated, which can be a lissajouls, or more often a spiral. The resolution of
such a system is determined by the driving signal, but can achieve quite good performances. Some
teams have shown imaging of organs with this scanning system [154]. The other distal technology for
scanning is the use of a MEMS-mirror at the end of the ﬁber probe. It allows a fast X-Y scanning,
and can be miniaturized at a very small scale (around 1mm). The linear scanning pattern makes
it easier to reconstruct an image than with the diﬀerent patterns accessible with the piezoelectric
conﬁguration. It was ﬁrst used in OCT conﬁgurations, but now the endomicroscopy community is
showing interest [155157].
Miniaturized optics The third component for a successful confocal endomicroscopy system
is the access to a miniature objective to focus the excitation light and to collect the emitted ﬂu-
orescence. Recent advances in the development of micro-optics have largely contributed to the
development of endomicroscope. The speciﬁcation needed to achieve confocal endoscopy is a high-
NA (numerical aperture) objective with a millimetric or sub-millimetric size and diameter.
Preferred are GRIN lenses (gradient index lenses) due to their small outer diameter, ranging
from 350-1,000 µm. Cylindrical GRIN lenses exhibit a refractive index that declines approximately
quadratically with radius. They are usually used as a combination of two GRIN to form an objective.
There is a ﬁrst lens with a typical 0.4 to 0.6 NA, to reach a micrometer scale resolution and then
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a relay lens to reach deep tissue [150]. However GRIN lenses usually failed to reach a suitable
correction of the chromatic aberration and curvature of ﬁeld, often problematic in ﬂuorescence
confocal endoscopy [158].
Other lens designs have been studied to avoid these limitations. A solution is the use of custom-
designed lens system [158]. Teams have developed systems combining ﬁve to six lenses [159161].The
combination is composed of aspheric and achromatic lenses to work around the limitations found
with the GRIN lens and reach an optimal collection eﬃciency for ﬂuorescence imaging. However
one diﬃculty to consider is the fabrication process for miniaturized aspherical or achromatic lenses
that can be costly and technically diﬃcult. To tackle that point systems of semi [161] or all plastic
[160] lenses have been studied. The critical remaining point is the length of such an assembly that
is still on the order of ten millimeters, which reduces the ﬂexibility needed to reach certain organs
compared to GRIN lens [158].
A last solution that is found in the literature is the use of vari-focal liquid lenses often combined
with an aspheric lens to reach the high-NA required [162]. The ability to adjust the focal length
avoids regions in tissue not clearly imaged due to tissue irregularity [163][164]. However there are
still limitations to such systems. The axial resolution is only in the order of 20 µm that can be
a limitation for certain diagnoses based on structures with smaller size. The system can also be
aﬀected by pressure and temperature changes, parameters which can ﬂuctuate in an operating room
[164].
Computing System In order to reach a real-time assessment in vivo embedded computing
systems had to been developed, combining advances in electronic and data analysis. To be able to
process at a high rate the data recorded by the detector and to produce an image to the surgeon,
FPGA (ﬁeld programmable gate array) boards have been used. An FPGA is a reconﬁgurable
logic circuit with logic elements allowing programming with ﬂexibility on the number of inputs
and outputs. An algorithm can be developed and loaded onto the FPGA chip and then combined
to a display device as an output [165]. Diﬀerent algorithms to reach a high quality image can
be programmed in the board such as arithmetic, neighborhood and convolution operation ﬁlters.
Teams have also added a daughter boards to serve as a Z-depth controller and to perform 3D
imaging in real time [166].
1.6.3.3 Commercial system
The combination of these miniaturized technologies has allowed confocal microscopy to come
into the operating room. Confocal endomicrsocpy has been extensively tested in other medical
applications such as Barret's oesophagus [167], urothelial bladder neoplasia [168] and cervical in-
traepithelial neoplasia [169]. These research projects have resulted in two commercial systems:
the Optiscan FIVE 1 (Optiscan, Australia) and the Cellvizio (Mauna Kea Technologies, France).
These techniques provide a better contrast than wide-ﬁeld imaging by suppressing the out-of-focus
background with the use of a pinhole in the optical path. It also allows in-depth imaging. With the
Optiscan FIVE 1, 250 microns can be scanned, and with the Cellvizio up to 70 microns. Its ﬁrst
use in neurosurgery experiments was reported in 2010, with the use of in vivo confocal probe in a
mouse tumor removal surgery [90, 170]. It appears in this study to be able to give real-time images
close to histopathological standard without the long staining process [171]. The Cellvizio was used
in a preliminary in vivo study on 9 patients with low and high grade glioma using two contrast
agents used: 5-ALA or intravenous ﬂuorescein. They reported diﬀerences between healthy and
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Figure 1.11  Comparison between confocal(a) and multi-photon excitation(b) process [178].
pathological tissue, however they were not able to have enough speciﬁcity to diﬀerentiate low-grade
from healthy [172]. Diﬀerent studies were then performed with the Optiscan on human brain tumor
using ﬂuorescein as an exogenous marker [173]. Another study was performed with the Optiscan
endoscope where ten patients with WHO Grades I and II gliomas underwent microsurgical resection
with 5-ALA. Intra-operative confocal microscopy identiﬁed tumor ﬂuorescence at a cellular level,
where with macroscopic tumor ﬂuorescence it was not evident [174].
1.6.3.4 Limitations
The preliminary studies with confocal endomicroscopy have showed promising results, how-
ever the medical community has not been easily convinced that it should become a standard in
medical procedure. Important drawbacks : 1) the diﬃculty of interpreting the given image for
non-specialist, such as surgeon, 2) the small ﬁeld of view, 3) limited resolution at a scale higher
than cellular structure, making it, for example, non-discriminant for low grade and inﬁltrated re-
gions in glioma suspected regions, 4) access to only one contrast, resulting in diﬃculty in reliability
and reproducibility of the results, and 5) limited penetration depth has also been an obstacle in
ﬁelds like gastrointestinal surgery, where some important deeper layers could not be imaged. Newer
techniques like two-photon endomicroscopy could remediate these current limitations [145, 175].
1.6.4 Multi-photon endomicroscopy
1.6.4.1 Confocal vs multi-photon
Linear microscopy has not succeeded in giving enough information to discriminate tumoral
nature of tissue at a cellular scale. To address the limitations of confocal microscopy, the ﬁeld has
turned its attention to the new fast-growing technique of non-linear microscopy. This microscopy
technique is based on the combination of several photons passing the energy gap and exciting the
samples. Multi-photon excitation requires high spatial and temporal conﬁnement resulting in no
excitation of tissue outside of the focal points. This property, shown in the Figure 1.11, results
in a 6 to 20 times better signal-to-noise ratio [176], allow less photo-bleaching compared to linear
technology and higher optical sectioning giving a better imaging depth [177].
Another advantage of multi-photon microscopy is that NIR-near infrared excitation is in the
therapeutic window, where the water and hemoglobin absorption of light is low, resulting in an
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increase of the possible imaging depth. In the literature it is reported that the maximum depth
can be up to 1mm [179]. One of the major assets of multi-photon microscopy is an excitation
wavelength (NIR range) far from the emission range (visible). There is no spectral overlap between
the two, oﬀering a better contrast due to less noise in the signal of interest.
These advantages of non-linear techniques such as two-photon imaging have been highlighted by
Bao et al [180]. The same samples were observed in one-photon and two-photon imaging, and
three parameters were compared: resolution, depth of imaging, and the risk of photo bleaching. In
these three domains two-photon imaging showed an improvement over confocal technology. More
structures were identiﬁable, two-photon could give an image 40 microns more in depth, and after
10 minutes of continuous scanning no change in intensity was observed, which is two times better
than for one-photon excitation. Multi-photon also provides other contrasts than ﬂuorescence such
harmonic generation, which will be discussed in the next-paragraph.
1.6.4.2 Second harmonic generation
Using two-photon excitation on tissue gives access to another imaging contrast besides emitted
ﬂuorescence. Incident photons can be scattered with a harmonic up-conversion process; It is coher-
ent scattering, and the radiation patterns are highly sensitive to phase [181]. When two photons
are combined, the process is called second-harmonic generation (SHG), producing emitted photons
with twice the energy. Structures able to produce such signals have a speciﬁc molecular orienta-
tion, generally non-centro-symmetric molecular structures [182]. Some biological materials such as
collagen [183], muscle myosin [184] and cellulose [185] present large non-centrosymetric structures
and are able to produce a SHG signal. SHG imaging is able to give information on molecular or-
ganization both at the micro and nano scale level. In a diseased state, such as cancer, where there
is often alteration in the secondary, tertiary or quaternary structure of proteins, these changes
will aﬀect the level of SHG, making it a useful tool for diagnosis [182]. With the same excitation
it is possible to observe the autoﬂuorescence response of tissue and the SHG signal, resulting in
two images modality with one set-up. Some molecules such as collagen can be found in diﬀerent
types of tissue in the human body and resulted either in a ﬂuorescence signal or a SHG response.
In ovarian cancer, an analysis method using the spatial structure and the intensity of SHG, has
already been implemented. Indicators can be, for example, the ratio between elastin and collagen
(SAAID, SHG to autoﬂuorescence aging index of dermis) or the orientation of the collagen ﬁbers
at the tumor-stroma boundary (TACS, tumor-associated collagen signature). Nadiarnykh et al.
have shown that in ovarian cancer, compared to normal tissue malignant tissue had a denser and
more ordered collagen [186]. Other groups also used the SHG signal in the detection of breast
cancer. For example Conklin et al. have found that an increased presence of collagen ﬁbers aligned
perpendicularly to the tumor boundary (TACS-3) was associated with decreased survival [187].
1.6.4.3 Optical ﬁber
To achieve an endomicroscope architecture for multi-photon microscopy, new eﬀorts are required
in the development of optical ﬁbers. Indeed, the ultrashort optical pulses (80 to 250 fs in duration)
used for in vivo two-photon imaging generate a light-matter interaction while propagating in the
glass ﬁber core of a SMF. This process will result in distortion of both the pulse shape and spectrum
through a nonlinear process known as self-phase modulation (SPM), making it diﬃcult to excite
eﬃciently with the SMF used for linear imaging [150]. SMFs have a small numerical aperture
and ﬁber core, so when used in a two-photon conﬁguration the system aberrations are increased,
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resulting in fewer photons to form an image. A solution could have been the multimode ﬁber, but
it cannot be focused to a spot size adequate to produce a nonlinear excitation, which requires high
spatial conﬁnement. A new type of ﬁber, photonic crystal ﬁber (PCF), which has appeared in
the last decades has revolutionized the ﬁeld. They had the properties able to overcome previous
limitations. Traditional ﬁber is the association of two mediums with diﬀerent refractive indexes
guiding light with total internal reﬂection. PCF on the other hand uses a photonic crystal as a
mechanical guide for light, surpassing the limits of traditional ﬁber.
Diﬀerent architecture can be found and have been tested for non-linear ex- citation and imaging.
They are shown in the Fig 1.12.
Figure 1.12  Diﬀerent types of ﬁber used in multi-photon endomicroscopy [152]
One way to reduce SPM is to have a larger core size in the ﬁber. The advantages of PCFs
over SMF for that, is that you can design a PCF that will have a larger mode area or even with
an endless single-mode-operation. So the ﬁrst group of ﬁbers to be developed was the large-mode-
area (LMA) PCF with large core size (up to 35 microns of diameter) and a single-mode guide for
wavelengths where silica is transparent. This design strongly reduces the nonlinear eﬀect for short
pulse delivery, for 3nJ pulses at 800nm, you can deliver 140 fs pulses over 1.3m [188]. If these ﬁbers
have suitable characteristics for nonlinear excitation, the low NA make them more limited for an
imaging setup.
Another design alternative is hollow core PCF. It oﬀers high power for a good non-linear excitation
and there is no need for a pre-compensation unit, but the collection of visible light cannot be per-
formed by the same ﬁber due to a low NA. A point that could be a drawback in certain cases is that
the hollow core ﬁber is designed to work a few tens of nanometers around the central wavelength,
so it cannot be used in a tunable setup, and cannot collect the visible backward emitted light [189].
A design that could play this dual role of excitation and collection is the double clad crystal ﬁber
(DCF). They possess a LMA core to reduce nonlinearity at the excitation and an inner cladding with
a high NA and large diameter to propagate visible and near infrared light with a high eﬃciency that
serves as a dual tool to excite and collect [190]. The drawback is the need for a pre-compensation
unit to maintain a femtosecond pulse at the output. However, we will see in the next section that
eﬃciency developments have been made to achieve that. Consequently, these ﬁbers are the ﬁber of
choice for recent developments of imaging non-linear endomicroscopes.
The latest popular design in PCFs is the highly non-linear PCFs, which exploit nonlinearity eﬀects
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rather than avoiding them. Core sizes are very small, (around 1 micron) surrounded by microstruc-
tures, creating high nonlinearity. They are designed to have a zero-dispersion wavelength of choice,
in visible and near infrared spectra [191]. This conﬁguration generates a super-continuum with a
bandwidth as large as sunlight however ten thousand times brighter, making it very eﬃcient for
multi-photon microscopy [192]. However, the drawbacks are the narrow window for excitation mak-
ing not suited for tunable lasers and it cannot be used in a dual conﬁguration of excitation-collection
[152].
1.6.4.4 Pre-compensation unit
Two of the ﬁber designs presented in the previous section required pre- compensation in order
to keep a very short pulse after long distances in the ﬁbers. A ﬁrst idea was to use pre-ﬁber with a
negative dispersion that will compensate the dispersion from the second exciting ﬁber. However this
solution implies never changing the excitation ﬁber length, nor changing the whole setup. The more
fully developed solutions in the literature are passive pre-compensation units that can be adjusted
to the characteristics of the second excitation ﬁber. Diﬀerent solutions have been developed in the
last decades, and are presented in the Table 1.3.
A ﬁrst approach was to ﬁnd system that compensate for second-order dispersion (SOD). Pas-
sive dispersive lines such as grating lines and prism lines were tried [193, 194]. With these methods
pulses in the range of 100 fs could result at the output of the excited ﬁber for pulses of similar
duration in a 1 or 2 meter ﬁber.
Still with these methods the third-order of dispersion (TOD) was not corrected resulting in pulses
still suﬀering from temporally broadening through propagation. New combinations of passive sys-
tems were studied to compensate for SOD and TOD simultaneously, such as chirp mirrors before
a prism line [194], or grism line (association of prism and gratings) [195]. These conﬁgurations re-
sulted in pulses even shorter than at the input after several meters of propagation in the excitation
ﬁber, making it a solution of choice for two-photon endomicroscopes [196198].
Two-photon microscopy setups still require the same system elements as needed in confocal
endomicroscopy and they can be translated fairly easily. The scanning systems are the same, the
miniaturized objectives change in requirements (NA, focal length, wavelength of choice) but use the
same technologies (GRIN, customized assembly), and the processing units are based on the same
electronic technologies. Only the data process algorithms change.
1.6.5 State of the art in multi-photon endomicroscopy
Few research teams have already tackled the task of developing a miniaturized technology using
two-photon excitation. The setups diﬀer in the choice of excitation wavelength, modality of de-
tection, ﬁber design, miniaturized objectives and scanning techniques. Their designs, advantages,
and limitations will be discussed in this section and the ﬁrst studies conducted with them will be
presented.
The group of Laura Marcu at UC Davis University (California, USA) has been working for the
past decade on the use of autoﬂuorescence to improve medical diagnosis, for example, in tumor
margin delineation [135]. They developed a probe system, compatible with peri-operative clinical
use, based on the FLIM technique, as shown in Figure 1.13. The system uses as an excitation
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Dispersive
line
Prism line
Chirped
mirros +
prism line
Grism line
Set-up
references [193] [194] [194] [195]
Architecture
1m SMF + a
pair of 1200
grooves/mm
diﬀraction
gratings
a 4 prisms line
one or two pairs
of dispersive
mirrors + a 4
prisms line
0.5m SMF +
grisms line (2
prisms +
gratings)
Corrections
SOD
+10.104fs2.
Transmission
around 35%
SOD corrected
TOD
+62000fs3
Transmission
31%
SOD and TOD
corrected
Transmission
around 31%
SOD and TOD
corrected
(−1, 28.105fs2,
−8, 22.104fs3
respectively)
Fiber for
light
delivery
ﬁber bundle
(Fujikura,
30000 cores, 3.8
µm core
spacing, 1.7
µmm core mode
ﬁeld radius,
0.35 N.A.)
0.6m
LMA-PZ-800
(Crystal Fibre)
Mode ﬁeld
diameter of
20µmm
NA=0.04 at 800
nm
1.6m
LMA-PZ-800
(Crystal Fibre)
Mode ﬁeld
diameter of 20
µmm NA=0.04
at 800 nm
2m SMF ﬁber
with 3.5 µmm
core
Endoscope
perfor-
mances
100 fs at 75
MHz at 830nm
=> 250 fs after
1m
- 24 fs after 1.6m
150 fs at 76
MHz at 830nm :
45 fs after 2m
Table 1.3  Diﬀerent pre-compensation units in the literature
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Figure 1.13  Design of a ﬁberred endomicroscope by the team of Laura Marcu at UC Davis
University(USA) [199].
source a Ti:Sapphire laser (Chamelon, Coherent) with 690-1040 nm tuning range, 2.5 W, 140 fs
pulse duration and 80 MHz repetition rate. The light is brought to the sample using a double clad
photonic crystal ﬁber (DC-PCF) from Crystal Fibre (DC165 16, Crystal Fibre, Denmark) and a
GRIN lens (GRIN, GT M0-080-018-810, GRINTECH GmbH, Germany) which serves as an objec-
tive at the end of the probe. Their setup doesn't use a pre-compensation unit before the excitation
ﬁber, and the laser pulse is consequently temporally broadened during propagation from 140 fs to 1
ps in the focal plane [199]. However they were able to make measurements with this conﬁguration
using a 714 nm excitation wavelength, but will not be able to use it with a long excitation ﬁber
(no more than 1 m). This point is a serious limitation for a clinical application, where the minimal
ﬁber length must be around 5 m to ﬁt into the surgical environment and workﬂow. This setup has
been tested only on a few exogenous ﬂuorescent molecules (Rhodamine, Coumarine) and in vivo
muscle tissue, and was able to give a diﬀerent lifetime value for each type of sample. However no
large study on human tissue has been started with this set-up [199].
Towards the end of the 1990's the Medical Faculty of the Friedrich Schiller University (Jena, Ger-
many) formed a company, JenLab, to commercialize CE-marked femtosecond laser based-technology
for medical applications [200]. They initially worked on dermatology applications, with multi-
photon microscope DermInspect, which has an imaging head at the head of a moving arm in order
to be adaptable in a clinical setting or examining room [201, 202]. They then developed a tech-
nology more intended for in vivo optical biopsy. Called MPTﬂex, it was a commercial portable
multi-photon tomograph, that performs FLIM measurements [134]. See ﬁgure 1.14. The optical
setup of the MPTﬂex consists of a titanium:sapphire laser (pulse width of 100 fs, repetition fre-
quency 80 MHz, in situ mean power 2-50 mW, wavelength range 710-920 nm) as an excitation
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Figure 1.14  Design of the MPTﬂex instrument (JenLab,Germany) [134].
source [134]. It has an image acquisition time of 6 to 10 seconds per frame. Kanterldhart et al.
used this tool to image human brain tumor. In their study the authors presented three stages
of testing, from the murine tumor model, to the ex vivo human biopsy and ﬁnished with in-situ
tests on patients with diverse human brain tumors (metastasis, meningioma, glioma) [134]. In ex
vivo biopsy, multi-photon technology showed its capacity to highlight structure at a cellular scale
concurring with the histology standard. In vivo only an exploratory campaign was performed to
show the capacity to get a highly resolved image in the region that would be resected [134].
The team of Professeur Louradour, at the XLIM laboratory, the last years has been working on the
development of a multi-photon endomicroscope. Ducourthial et al. recently published the technical
speciﬁc of the technology with a few ex vivo and animal in vivo test [203].
The conﬁguration of the endomicroscope is presented in Figure 1.15a. They used a Ti:Sapphire
laser at a chosen wavelength of 810nm, a frequency rate of 76MHz and excitation pulse of 150 fs.
A pre-compensation unit with a GRISM line was used to insure a 39 fs pulse at an average power
of 20mW at the output of a ﬁve meter custom-made air-silica double-clad photonic crystal ﬁber
(DC-PCF). A piezoelectric scanning system and a home-built achromatic triplet composed the head
of the probe. TPEF (two-photon excited ﬂuorescence)+SHG images were performed on a few rat
and human ex vivo samples in order to demonstrate the ability to form an image. They also tried
the setup in vivo on anesthetized mice, and looked at healthy and ﬁbrotic kidney, highlighting the
changes in the SHG signal. However, the architecture was not built for clinical use and doesn't
provide quantitative information [203].
Recently an even more compact set-up has appeared for multi-photon endomicroscopy. The
design is presented in Figure 1.15b. Zhao et al. have used a new very compact infrared femtosecond
ﬁber laser (pulsewidth, 250 fs, output power, 180 mW, wavelength, 1580 nm). They combined it to
a frequency doubling system to obtain an excitation wavelength suitable for two-photon excitation
on endogenous ﬂuorescence. This was followed by a MEMS scanning system and a focusing lens
46
CHAPTER 1. INTRODUCTION
(a) XLIM endomicroscope conﬁgurations
[203].
(b) Design of a compact multi-photon
handheld probe developed by Zhao et al
[204]
assembly and the all was packaged in a handheld probe [204]. At this point this system has never
been used in any biomedical experiments, and is still a proof of concept technology. Even though
the main advantage is the very compact system due to the use of a ﬁbered laser, it can also be
seen as the main drawback allowing only one wavelength. Consequently if one wants to change the
excitation to target a new application, the whole system has to be changed.
1.7 Thesis project
1.7.1 Context
In this comprehensive, wide-ranging review of the literature, the medical challenges remaining in
the treatment of brain tumors were presented. The diﬀerent technical solutions tried in the last few
decades were described and the needs still facing by surgeons explained. Technologies able to image
or give information at a cellular scale have been adapted and designed for intra-operative clinical
use. The latest technologies attracting interest and attention for being able to provide real-time
diﬀerentiation of tumor cells are Raman spectroscopy [205] and multi-photon microscopy [134, 199,
204] based on the intrinsic ﬂuorescence. These techniques are still at the proof of concept stage and
have yet to been implemented in phase III clinical trials and in routine protocols. One of the major
technical missing elements in the development to this point is the lack of multimodal detection,
along with a high quality database on the studied tissue. Consequently current technology fails to
give discrimination reliable enough for clinical standards. This leaves room for further development
of a precise and reliable technology to assist brain tumor surgery, since brain tissue in particular
lacks of an optical database on its autoﬂuorescence response.
The research team of Dr Darine Abi Haidar at the IMNC laboratory have chosen to work on
this clinical question bringing their technical expertise to the medical world. This research group
has experience in optics and microscopy, more precisely in non-linear techniques. Drawing on the
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strength of their expertise, they created a project with clinical partners, to bring to the operating
room a new intra-operative technique. Looking at the various directions and approaches described
in the literature, and based on their experience, they sought a technology capable of a high spatial
resolution, miniaturized and adapted to the surgical operating room, with reliable and reproducible
multimodal detection. The technical solution chosen by Dr. Abi Haidar's team is a two-photon
endomicroscope with multimodal detection combining two imaging modalities (emitted ﬂuorescence
and second harmonic generation). In addition there are two quantitative modalities (spectroscopy
and lifetime measurements) to monitor the autoﬂuorescence of tissue.
It is in the context of this project that I was recruited to do my Phd. When I arrived, this
dynamic research team had already reached several milestones in the development of such a tool.
An intra-operative probe combining ﬂuorescence and lifetime detection with a visible excitation,
375 and 405nm had been developed and tested on rat brain tissue [128]. The promising results
obtained in these tests, brought this ﬁrst set-up at the Sainte-Hospital close to the operating room
to acquire data and suggested the development of a more advanced technology. They worked on the
development of a two-photon endomicroscope, with a miniaturized probe to achieve the diameter
of a surgeon's trocar, a tool with a 1.9 mm inner diameter. They worked on the development of
a compensation unit based on the process of a GRISM line [195], and looked at the best ﬁber to
achieve simultaneous excitation and collection in a two-photon microscope conﬁguration [196]. They
chose ﬁrst to characterize various commercially available double clad ﬁbers in order to determine
if one could be suited to this application [196]. Then they looked at the resolution and collection
eﬃciency that could obtained combining these DCF with GRIN objectives [197]. These studies
reached conclusions about an available architecture for a two-photon endomicroscope, however the
best suited ﬁber did not yet exist. So they described the ideal ﬁber as a combination of some
of the tested ﬁbers, thus leading to the development of a custom made DC-PCF. These results
showed the technical relevance and the possibility of two-photon endomicroscopy, however to bring
a new technique to the operating room, its ability to answer the medical challenges has to be
proved. In brain tumor has shown by the review of literature, there is only a few things done
on two-photon imaging and quantitative detection of tissue ﬂuorescence. In order to give sense
to our technical development and to prove that medical practice could be revolutionized using
optical endomicroscopy, a large project of establishing a database on the autoﬂuorescence response
of tissue was developed. This was the task of my PhD, working on brain biopsy samples, diﬀerent
optical excitations and methods of detection were tested to collect a large amount of data and
developed reliable and reproductible algorithm to discriminate the nature of brain tissue. Several
collaborations were developed to reach the most extensive and accurate database possible.
1.7.2 Actors and partners
I conducted my PhD at the IMNC laboratory a mixed unit of the CNRS (National Center
of Scientiﬁc Research) and the French university (University of Paris Saclay and Paris Diderot).
This lab contains several research teams all working on developing themes at the interdisciplinary
boundaries of physics, biology and medicine, hosting talents from each ﬁeld in the same environment.
The three leading problems of the laboratory are: multimodal, pre-clinical and peri-clinical imaging
(optical and isotopic), the modeling of tumoral processes and new approaches in radiotherapy. The
lab contains a technical services and a biology team in addition to several research teams in the
diﬀerent themes. In this context, Dr. Darine Abi Haidar has formed a group developing non-linear
endomicroscopy to improve, by optical methods, the quality of surgical procedure. With this project
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she was able to receive several funding from the CNRS, "plan Cancer", and create a ﬂourishing
environment for such a technological project. Consequently several collaborations were initiated.
For the technical development of the endoscope two collaborations were put in place. The
team of Alexandre Kudlinsky of PhLAM (Physique des Lasers, Atomes et Molècules, Lille, France)
lab. They work using a dedicated platform on the development of photonic crystal ﬁbers (PCF)
with properties adapted to the targeted application. A collaboration was put in place with them to
develop a customized double clad photonic crystal ﬁber (DC-PCF) for the multi-photon endomicro-
scope answering the speciﬁcations deﬁned through the characterization of commercial ﬁbers [128].
The second collaborator for the technical development is the Sainte-Anne Hospital Center, (CHSA,
Paris, France) specialized in psychiatry and neurology. This hospital is known to be one of the
most active research centers. During the last century it has been the catalyzer of ground breaking
techniques, such as the use of neuro-epileptic or stereotactic surgery. In the last few decades they
developed a very strong department of neuro-oncology, able to diagnose and treat all types of tu-
mor of the central nervous system (brain, meninges, nerve, ...). Developing a surgical tool without
surgeons advice and guidance will lead nowhere. To envision a successful future endomicrosocpe,
surgeons were questioned during various phases of design in order to build a tool adapted to their
habits and workﬂow.
Sainte-Anne Hospital was also the main collaborator for the development of an optical database
on brain tumor tissue. Their neurosurgery and neuropathology departments have been working
closely with us to provide a large number of biopsy samples of diﬀerent brain tumors and control
tissues. They brought their knowledge on tissue diagnosis and analysis of histological staining to
the project, and discrimination criteria were found in collaboration with them.
The second collaborator on the optical database was Synchrotron SOLEIL (Source Optimisée de
Lumière d Energie Intermédiaire du LURE) located in the city of Saint-Aubin in France. SOLEIL
is a particle (electron) accelerator producing synchrotron radiation. The emitted light source has
a brilliance ten thousand times brighter than sunlight, with a spectral range from infrared to hard
X-rays. Further, it can be polarized and pulsed. We worked on the DISCO beamline (Dichroism,
Imaging, mass Spectrometry for Chemistry and biology), that delivers deep ultra-violet (DUV)
excitation and oﬀers a detection station optimized at these wavelengths. Two setups are available
at the DUV imaging center : A micro-spectrometer called POLYPHEME and a fast full ﬁeld
microscope with Z scanning and 3D reconstruction known as TELEMOS. This collaboration gave
us access to a larger range of excitation to study the autoﬂuorescence of tissue and have a better
understanding of the studied response.
1.7.3 Design of the project
Due to these diﬀerent collaborations and the previous work done by this research team, a large
set of biopsy samples were accessible from the CHSA and three imaging platforms. First, at Sainte-
Anne Hospital a visible endoscope in the neuropathology department could measure one-photon
spectral and ﬂuorescence lifetime response of tissue. Second at the IMNC, the PIMPA (plateforme
d'imagerie du petit animal) platform consisted of a two-photon microscope with four modalities
of detection (ﬂuorescence imaging, SHG, spectroscopy and FLIM). And third, At SOLEIL, DUV
microscopy was possible on two setups with imaging and spectroscopy detection.
From this several problems could be considered and tackled :
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Could quantitative bimodal optical measurements under visible excitation discriminate ﬁxed
brain tissue nature ?
Were spectral and lifetime measurements, under visible excitation, able to discriminate freshly
extracted brain tissue nature? Were ﬂuorescent measurements established on ﬁxed tissue suitable
enough to build an optical database ?
Could mono and bi-photon excitation discriminate label-free ﬂuorescence emission of menin-
gioma tumor grade?
Could two-photon imaging match the performances of H&E standard discrimination of primary
and secondary brain tumor? Could multimodal quantitative detection improve brain tumor diag-
nosis ?
How could multi-range and multimodal optical study improve the precision and reliability of
primary and secondary tumor discrimination ?
These questions will be answered through the articles written during my PhD project. In the
last part I will discuss the place in the literature of such results, and to what extent we were able to
shown a discriminative power on low density tumor cell regions. Finally, the future perspectives of
such a project will be presented along with the new paths already being explored to improve such
technology to furnish them to surgeons and hospitals.
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Could quantitative bimodal optical
measurements under visible
excitation discriminate ﬁxed brain
tissue nature ?
2.1 Context of the study
A bimodal endoscope under visible excitation able to acquire quantitative measurements was
build and tested on rat by previous members of my research team [128]. It tracks the spectral
response and the ﬂuorescence lifetime of intrinsic molecules.
Fluorescence emission is very dependent on the absorption and the scattering of tissues and
surrounding environment (hemoglobin, water). These two parameters can be known by calculating
optical coeﬃcients of absorption, scattering and anisotropy [206]. Diﬀerent set-ups and methods
of analysis have been tried in the literature. The knowledge of the optical properties of the tissue,
obtained with diﬀerent optical techniques can help to :
 Correct the spectral response of the diﬀerent environmental absorbers, such as water, hemoglobin,
ﬁbers, melanin, ...
 Understand the variation of the emitted spectral intensity from one tissue to another.
 Diﬀerentiate tissue nature following scattering, depending on cells morphological structures,
and absorption, depending on chromophores (blood, water, melanin, fat, yellow pigments)
content.
Diﬀerent studies from the literature attempt to characterize optical properties of health and
tumoral human brain tissues. The major results are summarized in table 2.1.
These studies, performed on human brain tumor samples and healthy white or grey matter,
have highlighted diﬀerences between healthy regions and tumors. In the majority of the studies the
absorption of tumor tissues (glioma, GBM, meningioma) is higher than in healthy regions [207
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Paper Wavelength Samples Results
Eggert et al.
1987
200nm to
900nm
Frozen samples from 13
human cadavers White
matter, grey matter,
glioma, GBM and
meningioma
No statistical diﬀerences
between tumor types,
White matters
signiﬁcantly diﬀerent of
all tumors for absorption
and scattering,GBM and
meningioma showed
higher absorption than
grey matter
Van der zee
et al. 1993
500nm to
1000nm
2 post mortem neonatal
brain samples, 2
postmortem adult brain
samples
Comparison between
white and grey matter
µagm = 0.035mm
−1 and
µawm = 0.002mm
−1,
µsgm = 62mm
−1 and
µswm = 47mm
−1
Bevilacqua
et al. 1999
674, 811, 849
and 956nm
2 patients with in vivo
measurements during
brain surgery
µatumor(0.09mm
−1) >
µahealthy(0.03mm
−1),
explained by higher
vascularity in tumor. No
signiﬁcant diﬀerences in
scattering
Yaroslavski
et al. 2002
360nm to
11000nm
7 postmortem patients
with healthy brain, 6
meningioma biopsy, 4
astrocytoma biopsy
Tumor tissue presented
slightly higher scattering
coeﬃcients than normal
grey brain
µsgm ∈ [5, 10]mm−1 and
st µst ∈ [10, 20]mm−1
White matter compared
to grey matter
µagm ≈ 0.002mm−1 and
µawm ≈ 0.01mm−1
Gebhart et
al. 2006
400 to
1300nm
83 samples on 12 patients
acquired during tumor
resection open
craniotomy
Signiﬁcant diﬀerences
with the scattering
coeﬃcient : white matter
> tumor > grey matter.
In absorption glioma are
higher than grey matter
after 700nm
Table 2.1  Summary of literature on measurements of optical coeﬃcient from brain tissue
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210]. One group explained this diﬀerence by the presence of denser vascularity in tumor [208].
Hemoglobin being a strong absorber, the absorption coeﬃcient will drop. Diﬀerences could also be
found in the scattering. Two groups found a higher scattering in white matter than grey matter
[209, 210], but one group found an opposite variation [211]. In two studies a higher scattering
was found in tumor compared to grey matter [209, 210]. The literature contains collected data,
on brain tumor tissue highlighting diﬀerences in the optical properties of tissues, and suggests the
possibility of discriminating them based on intrinsic optical technique. Moreover it shows that the
measurement of optical coeﬃcients could be a diagnosis tool by itself.
A limitation noted in the literature is the lack of extensive study on large statistically signiﬁcant
cohort. Of the ﬁve articles three were based on fewer than 10 patients [208, 209, 211]. The other
two contained 13 [207] and 12 patients (with 84 samples taken over the twelve patients)[210]. This
lack of statistical signiﬁcance combined with very diﬀerent experimental conditions and deployed
algorithms from one study to another results in values that are hardly comparable. Because the
data values in the literature were very speciﬁc to the set-up conﬁguration, tissue conservation, and
method of analysis, it would have been biased to choose one as a standard.
In this ﬁrst test of a bi-modal endoscope with visible excitation on human tissue, the question
set to be answered was : can quantitative measurements of endogenous ﬂuorescence signal dis-
criminate brain tumor tissue type ? A study was designed, where spectral and lifetime endoscopic
measurements were coupled to the measurement of optical parameters. Biopsies from twenty dif-
ferent patients were used to ﬁnd quantitative discrimination between tumor types, and relate it to
the intrinsic properties of tissue (absorption, scattering and anisotropy).
Methods A cohort of twenty-eight ﬁxed in alcohol samples of brain tumor biopsy was analyzed
at three diﬀerent wavelengths, 375, 495 an 430nm , on two diﬀerent set-ups. The samples were slices
of 200 and 600 microns, from 10 healthy cortex, 10 metastasis, 4 diﬀuse glioma and 4 GBM. An
integrating sphere set-up was used to determine the optical coeﬃcients with a 430nm excitation
diode laser. The second set-up was the bi-modal endoscope used in the previous rat study [128].
Spectral and lifetime measurements were done using 375 and 405 nm excitation.
Results and discussion A threshold value was found between control and tumor in both scat-
tering and absorption coeﬃcient. Looking at the scattering parameters, tissues with µs<26 mm−1
were healthy and the ones with µs>29 mm−1 were tumoral, in the interval where µs∈[26,29]mm−1
no conclusion could be drawn on the tissue nature. For the absorption a threshold value around
1mm−1 could be determined between control and three tumoral groups, glioblastoma, meningioma
and metastasis. However the absorption coeﬃcient of diﬀuse glioma wasn't signiﬁcantly diﬀerent
from control. The metastasis could also be signiﬁcantly discriminated from the other tumors using
the absorption coeﬃcients. These diﬀerences from tumor to healthy tissue could be explained by
changes in tissues architecture and environment during tumor growth. In tumor, denser networks
of collagen ﬁbers form, which is a notable source of scattering. The meningioma is a tumor with
particularly dense structures of collagen (psamome, enrollment of collagen ﬁber,...) and it resulted
in the higher scattering coeﬃcient. The increase in absorption was explained by the presence of
denser vascularization in tumor, hemoglobin being a strong absorber of light. Metastasis, a tumor
with formation of a highly dense vascular network resulted in the highest absorption coeﬃcient
signiﬁcantly diﬀerent from the other tissues. Even if it is diﬃcult to truly compare values to the
literature, the experimental conditions were very close to Yaroslavsky et al. and the values found
were very similar to theirs [209]. These results highlighted that the intrinsic optical signal will
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change from one tissue type to another as its optical coeﬃcients are diﬀerent, and could be a dis-
criminative tool when monitored with quantitative measurements. However these diﬀerences in
optical parameters also show that scattering and absorption could be an indicator for diagnosis,
and that combining the results of both will give signiﬁcant results from all types of tumor compared
to control, even diﬀuse glioma.
The second part of the study was analysis of these biopsy samples using the bi-modal endoscope.
The ﬁrst response to be observed was the emitted spectral intensity and shape using 375 and 405nm
excitation wavelengths. A higher emitted intensity in healthy tissue compared to all tumor types
was found at both excitation wavelengths. This conﬁrmed the conclusions made by looking at
the optical properties. The variation of intensity from one tissue to another was in line with
the observed change in absorption and scattering coeﬃcients. An algorithm to ﬁt the spectral
response of the molecular contribution, allowed monitoring of a metabolic indicator, the redox ratio
(NADH/FAD ratio), and the ratio between NADH and porphyrins, an indicator of various process
such as transport of oxygen and catalysis [106]. The two indicators resulted in a signiﬁcantly higher
value in control than in tumoral tissue : at 375nm excitation for the redox ratio and a 405nm
excitation for the NADH/Porphyrin ratio.
To conﬁrm these results, a second parameters of ﬂuorescence was evaluated, the ﬂuorescence
lifetime. The ﬂuorescence lifetime is sensitive to diﬀerent factors than is spectral response. It
will be inﬂuenced by the molecular environment and conformation, whereas spectral response is
more sensitive to the concentration of molecules. The lifetime of each molecules contributing to the
ﬂuorescence response was measured. A discrimination was found between control, glioblastoma and
meningioma looking at the NADH lifetime at both 375 and 405 excitation. The porphyrin lifetime
measured under 405nm excitation had a diﬀerent value for each of the ﬁve groups of tissue while
control tissue had the longer lifetime. As in the rat studies [128], porphyrin was revealed to be an
important indicator of tissue nature, giving a discriminative response between each type of brain
tissues, healthy or tumoral.
This ﬁrst study on the quantitative analysis of the endogenous ﬂuorescence, using a visible
endoscope with bi-modal detection, showed promising results for discriminating brain tissues. These
results were obtained on a signiﬁcant cohort including twenty-eight patients. However this ﬁrst
study was done on ﬁxed ex vivo samples and it has been shown in the literature that the optical
parameters will certainly change in in vivo conditions [206]. Concentration of blood and water can
be diﬀerent and this will cause variation in optical response. All these observations lead my research
project answering a second question : can we also quantitatively discriminate fresh biopsy with a
bi-modal endoscope and how will the results diﬀer from to ex vivo measurements ? This was the
work of a second study that will be developed in the next chapter.
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2.2 Paper: Optical properties, spectral, and lifetime measure-
ments of central nervous system tumors in humans
1SCIENTIFIC REPORTS | 7: 13995  | DOI:10.1038/s41598-017-14381-1
www.nature.com/scientificreports
Optical properties, spectral, and 
lifetime measurements of central 
nervous system tumors in humans
F. Poulon1, H. Mehidine1, M. Juchaux1, P. Varlet2,3, B. Devaux4,5, J. Pallud3,4,5 & D. Abi Haidar  1,6
A key challenge of central nervous system tumor surgery is to discriminate between brain regions 
infiltrated by tumor cells and surrounding healthy tissue. Although monitoring of autofluorescence 
could potentially be an efficient way to provide reliable information for these regions, we found little 
information on this subject, and thus we conducted studies of brain tissue optical properties. This 
particular study focuses on the different optical quantitative responses of human central nervous 
system tumors and their corresponding controls. Measurements were performed on different 
fixed human tumoral and healthy brain samples. Four groups of central nervous system tumors 
(glioblastoma, diffuse glioma, meningioma and metastasis) were discriminated from healthy brain 
and meninx control tissues. A threshold value was found for the scattering and absorption coefficient 
between tumoral and healthy groups. Emission Spectra of healthy tissue had a significant higher 
intensity than tumoral groups. The redox and optical index ratio were thenn calculated and these also 
showed significant discrimination. Two fluorescent molecules, NADH and porphyrins, showed distinct 
lifetim values among the different groups of samples. This study defines several optical indexes that can 
act as combinated indicators to discriminate healthy from tumoral tissues.
The success of oncological surgery, the most widely used curative treatment for solid tumor whatever its histo-
pathological type, is based on the accurate identification of the tumor’s boundaries in order to achieve a complete 
tumor resection. For tumors of the central nervous system, the goals of oncological surgery are identical but their 
realization is made more difficult by their infiltrating character, especially the diffuse gliomas, within a highly 
eloquent organ. The main challenge of any neurosurgical oncological intervention is to define the limits of the 
resection while optimizing the onco-functional balance1. Resection is based on the limits of tumor infiltration, 
which should be removed, and on the identification of eloquent brain areas, which should be respected. The 
actual identification of the tumor infiltration at the cellular scale is not possible intraoperatively and requires the 
development of an efficient and reliable intraoperative imaging tool, based on an imaging database of the main 
tumors of the central nervous system (diffuse gliomas, metastases, meningiomas, and healthy tissues).
The development of an intraoperative probe/device should be accompagnied by the construction of a large 
database of endogenous fluorescence response of tumor tissues. This intraoperative tool, in association with 
knowledge on collected optical response, will lead to an “optical biopsy” giving a real time result, and providing 
additional relevant morphological and physiological information during surgery, which may guide the surgical 
resection.
The optical properties of biological tissues have a major importance in several medical applications for diag-
nosis and therapy2. Knowing the optical properties of brain tissues results in quantitative information3, which 
allows the optimization of imaging techniques and the possibility of modeling the light path, the fluorescence 
distribution, the penetration depth and the possible interaction between fluorophores in the tissues. These param-
eters are related to the density and the distribution of sizes of the ultrastructure of a tissue, thus allowing the char-
acterization of the tissues, particularly the differentiation of tumoral tissues from healthy ones–in other words, 
detection of the evolution of a pathology. Current knowledge of optical properties of healthy and tumoral brain 
1IMNC Laboratory UMR 8165-CNRS/IN2P3, Paris-Saclay University, Orsay, 91405, France. 2Neuropathology 
Department, Sainte-Anne Hospital, Paris, 75014, France. 3IMA BRAIN, INSERMU894, Centre de Psychiatrie et 
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2.2.1 Introduction
The success of oncological surgery, which the most widely used curative treatment for solid
tumor whatever its histopathological type, is based on the accurate identiﬁcation of the tumor's
boundaries in order to achieve a complete tumor resection. For tumors of the central nervous system,
the stakes of oncological surgery are identical but their realization is made more diﬃcult by the
inﬁltrating character of several tumors of the central nervous system, especially the diﬀuse gliomas,
within a highly eloquent organ. The main challenges of any neurosurgical oncological intervention
is deﬁning the limits of the resection while optimizing the onco-functional balance1. Resection is
based on the limits of tumor inﬁltration, which should be removed, and on the identiﬁcation of
eloquent brain areas, which should be respected. The actual identiﬁcation of the tumor inﬁltration
at the cellular scale is not possible intra-operatively and requires the development of an eﬃcient
and reliable intra-operative imaging tool, based on an imaging database of the main tumors of
the central nervous system (diﬀuse gliomas, metastases, meningiomas, and healthy tissues). The
development of an intra-operative probe/device should be accompanied by the construction of a
large database of endogenous ﬂuorescence response of tumor tissues. This intra-operative tool,
associated with a knowledge on collected optical response, will lead to an "optical biopsy" giving
a real time result, and providing additional relevant morphological and physiological information
during surgery, which may guide the surgical resection.
The optical properties of biological tissues have a major importance in several medical ap-
plications for diagnosis and [208]. Knowing the optical properties of the brain tissues results in
quantitative information[209], allowing the optimization of imaging techniques and the possibility
to model the light path, the ﬂuorescence distribution, the penetration depth and the possible in-
teraction between ﬂuorophores in the tissues. Theses parameters are related to the density and
the distribution of sizes of the ultrastructure of a tissue, thus allowing the characterization of the
tissues and in particular the diﬀerentiation of the tumoral tissues from healthy ones (detection of
the evolution of a pathology). The knowledge of optical properties of human brain, healthy and
tumor tissues is currently insuﬃcient and do not exist for diﬀerent tumoral variety [206, 212, 213].
There is a lack of data in the visible spectral range, especially for 405 nm excitation wavelength,
which is optimal to excite diﬀerent endogenous ﬂuorophores such as nicotinamide adenine dinu-
cleotide (NADH), ﬂavins (FAD), lipopigments and porphyrins, but also a lack of results on human
brain tissues[208, 209] where at the contrary we can ﬁnd a large literature on rats, mice, pigs and
kidney[214, 215]. Willing to answer the surgeon needs, this lack of guidance in the literature moti-
vate our exploratory study on the optical coeﬃcients, absorption, scattering and anisotropy. These
optical parameters are required to apprehend correctly the signal from endogenous ﬂuorescence of
tissue, but to have a quantitative answer in real time of tissue nature. The most suited and growing
technique is to follow the spectral response. Few research teams have already started to work on
spectral emission of healthy or tumoral brain tissue [102], still none of them have really tackled
a large type of brain tumors. Our previous study on the grade of malignancy of meningiomas in
adults [216], gave us interesting results through the spectral response to dicriminate tissues. Here,
this will be applied to a larger cohort and will also be used to follow the metabolic changes. In-
deed, we can ﬁnd in the literature that some groups have started to calculate the ratio between
the contribution of the molecules in the emission spectra to track the metabolic reaction [118, 217,
218]. Another quantitative response appear with the progress in nonlinear optics and the access
to femtosecond pulsed laser, which is the measurement of the ﬂuorescence lifetime[129, 137]. This
measure is not inﬂuenced by the concentration, but by the conformational or environmental changes
surrounding the ﬂuorescent molecules. A study of the optical properties, the spectral response and
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lifetime of the endogeneous ﬂuorescence on brain tissue, will allow to have an understanding of the
evolution of the hyperstructure, the metabolic process and environment going from a healthy region
to a tumoral region. In this paper, we studied a wide cohort of brain tissues, including four tumor
types and a control group (epileptic cortex). To span the wider range of tumor type, we chose
primary (glioblastoma, meningioma and diﬀuse glioma) and secondary (metastasis) tumors of the
central nervous system. Several optical properties were looked at, using integrating-sphere tech-
niques and employing an inverse Monte Carlo technique. The absorption, scattering and anisotropy
coeﬃcients were measured using 405 and 430 nm excitation wavelengths. Moreover, spectral and
lifetime ﬂuorescence measurements were acquired on these tissues using 405 nm and 375 nm exci-
tation wavelength. The 405 nm excitation wavelength was used to excite and collect eﬃciently the
ﬂuorescence signal of ﬁve endogenous ﬂuorophores : NADH, FAD, lipopigments, porphyrins and
chlorins. The 375 nm excitation wavelength was used to excite eﬃciently the NADH and the FAD.
The 405 and 430 nm excitation wavelengths were used in the integrating sphere technique to study
the eﬀect of the wavelength on the optical coeﬃcients. Through the analysis of all these quantitative
data, we were able to deﬁne several discriminatory indicators between control and tumor samples
and also we were able to discriminate several tumor types and grades of malignancy.
2.2.2 Materiel and methods
2.2.2.1 Samples
An approval of the Sainte-Anne Hospital - University Paris Descartes Review Board (CPP Ile
de France 3) was obtained for this study in collaboration with the Neurosurgery and the Neu-
ropathology Departments of the Sainte-Anne Hospital (S.C.3227). All the following methods were
performed in accordance with the relevant guidelines and regulations from this protocol and a
informed consent was obtained from all participants and/or their legal guardians.
Healthy 10
Metastasis 5
Thyroid carcinoma 1
Colloid adenocarcinoma 2
Primary renal carcinoma 1
Cell lung carcinoma 1
Diﬀuse Glioma 5
Glioblastoma 4
Meningioma 4
Table 2.2  Summary of the cohort used in the paper
A cohort of twenty height samples was used , the repartition is resumed in the Table 2.2. A
group of ten healthy cortex samples was obtained from epileptic surgery and compared to four
diﬀerent groups of central nervous system tumor. The tumoral cohort contains four Isocitrate
Deshydrogenase (IDH) wildtype glioblastomas, ﬁve IDH-mutated diﬀuse gliomas, ﬁve meningiomas
and ﬁve carcinoma metastases originating from diﬀerent part of the organism
Once received from the hospital, the samples were stored at -80◦C. Few hours before cutting
they were put at -20◦C. Then, the tissues were cut at -18◦C into 200 µm and 600 µm slices using
a cryostat (CM 1950, Leica Microsystems). After, tissues were ﬁxed with ethanol at 100◦ and
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stored at 4◦C until the experiment. The slices of 200 µm were used in the integrating sphere set-up
to measure the optical coeﬃcients and the slice of 600 µm were use in the endoscopic set-up for
spectral and lifetime measurements.
2.2.2.2 Integrating sphere set-up
A standard set-up was used for the measurements of transmittance T(λ) and reﬂectance R(λ).
It consists of an integrating sphere (model : IS200-4 thorlabs) including four identical ports, each
port has a 12.7 mm diameter, and a ﬁfth port with a 3 mm diameter used to collect light from
the sphere to a spectrometer (HR2000-Ocean optics) using an optical ﬁber (QP60-600µm diameter,
Ocean optics). The excitation was achieved with two laser diodes, emitting at 430 nm (LDH-
P-C-430B, Picoquant Germany) and 405 nm (LDH-P-C-405B, Picoquant Germany ) respectively
with a maximal power of 5.1 mW and 1 mW respectively. To have a 1 mm laser beam diameter,
a diaphragm was placed just after the laser diodes. For collimated transmittance measurements,
the integrating sphere is not used, three diaphragms were aligned in front of the laser, and an
absorbant ﬁlter (OD=2.3) is placed to reduce the laser intensity. In each sample, ﬁve regions of
interest (ROI), selected in area of same visual appearances, for the transmittance, the reﬂectance
and the collimated transmittance were measured. The average of these ﬁve measurements was used
to determine the optical coeﬃcients of the sample.
2.2.2.3 Spectral and lifetime measurements
Details of this setup were published elsewhere [198, 216] .The excitation is performed with two
pulsed diode lasers from Picoquant, emiting at 405 nm (LDH-P-C-405B, FWHM 60 ps, Picoquant-
Germany) and 375 nm (LDH-P-C-375B, FWHM 45ps, Picoquant-Germany). The diodes are con-
trolled by a driver (PDL-808 "Sepia", PicoQuant GmbH, Berlin, Germany), the repetition frequency
used for this study is 40 MHz. A single-core ﬁber with a 200 µ m diameter, is used to bring the
excitation to the sample, the signal is then collected through a single-core optical ﬁber with a 365
µm diamter. Then the collected signal goes through a long pass ﬁlter (SR420, Semrock) to cut the
signal from laser reﬂection. For spectral measurement, a spectrometer (QEPro 6500, Ocean Optics,
1.5 nm spectral resolution over a 365-950 nm spectral range) was used. For lifetime measurements
a ﬁlter wheel (FW102C, Thorlabs, Newton, USA) with ﬁve ﬁlters (Semrock, New York, USA, 450
± 10 nm, 520 ± 10 nm, 550 ± 30 nm, 620 ± 10 nm and 680 ± 10 nm) in front a photomultiplier
link to TCSPC acquisition card (PMA 182 and Time Harp 200, Picoquant, Germany) was used.
2.2.2.4 Data analysis
2.2.2.4.1 Optical properties
Reduced scattering (µs'), absorption (µs) and anisotropy coeﬃcients (g) of the samples were
obtained from measured values of the reﬂectance, transmittance and collimated transmittance using
the Inverse Adding Doubling (IAD) algorithm developed by scott Prahl (http://omlc.ogi.edu/software/iad/)
[219]. This algorithm solves iteratively the radiative transport equation until the numerical ad-
justment and the experimental values of reﬂectance, transmittance and collimated transmittance
matches, it takes also the parameters of the sample, the laser beam and the integrating sphere
used into account to ﬁnd the optical coeﬃcients desired Noting that µs' is the reduced scattering
coeﬃcient, we will deduce the scattering coeﬃcient µs using the equation 2.1
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µs =
µs′
1− g (2.1)
According to the literature [206, 208], the refractive index of human brain tissues is between 1.33
and 1.53. We have considered that the refractive index is n = 1.4 for all samples [208].
2.2.2.4.2 Spectral analysis
At the excitation of of 375 and 405nm ﬁve ﬂuorophores are excited : NADH, FAD, lipopigments,
porphyrins and chlorines. The measured spectra present the sum of the emission spectrum of these
endogenous ﬂuorophores. Spectral data are processed from a Matlab program developed previously
by our team and already used in a previous publication[216], using this program we can determine
the contribution of each molecule by adjusting the measured data to the equation 4.1.
Stotal(λ) =
∑
i = 1(fi.Si(λ))
Stotal(λ) : measured spectra
i : the ﬂuorophore
Si(λ) : emission spectra of ﬂuorophores i
fi : multiplying coeﬃcient
(2.2)
NADH spectra is adjusted by a spectra obtained from a previous experiment done by our team
on rats at 375 nm [128]. FAD spectra is adjusted by a spectra taken from the literature [220], The
other spectras of Lipopigments, Porphyrins and Chlorins are given by Gaussian adjustment.
2.2.2.4.3 Lifetime analysis
The measured ﬂuorescence decay curves obtained are adjusted by a mono-exponential ﬁt using
FluoFit software (Picoquant,Germany), which allows us to extract the ﬂuorescence lifetime of the
curve.Two criteria are taken into account to validate the ﬁt : χ2 must be -1.2 <χ2<1.2, and the
residuals must have a distribution around 0 in an interval of [-4,4].
2.2.2.4.4 Staistical analysis
Optical coeﬃcients(scattering and absorption) and ﬂuorescence lifetime results were evaluated
using a one-way analysis of variances (ANOVA). If the ANOVA was statistically signiﬁcant, a post-
hoc t-test was performed. A probability value (p) <0.05 was considered statistically signiﬁcant.
2.2.3 Results
Figure 2.1 summarizes the scattering (µs) and absorption (µa) coeﬃcient for diﬀerent types
of brain tissues at two diﬀerent excitation wavelengths. Figure 2.1.a and .b show the scattering
coeﬃcient results for healthy (control) and tumoral (diﬀuse gliomas, metastasis, meningioma and
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glioblastoma tissues). The tumoral tissues present a signiﬁcantly (p<0.001) higher scatering co-
eﬃcient Figure 2.1.c and .d represent the absorption coeﬃcient of tumoral and control tissues.
Metastasis, meningioma and glioblastoma are signiﬁcantly (p<0.001) diﬀerent from control tissues.
Diﬀuse gliomas other than glioblastoma have an absorption coeﬃcient not signiﬁcatly diﬀerent to
those of control tissues (p=0.09).
Figure 2.1  Distribution of scattering coeﬃcient values for tumoral and healthy control tissues
excited with 405 nm(a) and 430 nm(b) , and of absorption coeﬃcient using 405 nm(c) and 430 nm
(d) excitation wavelengths.
The anisotropy coeﬃcient could also be calculated for 405 and 430 nm excitation wavelength.
The results for the diﬀerent groups are plotted in ﬁgure 2.2. Three groups of tissues had already
been examined in the literature and allowed us to compare our values, the meningioma with a
g=0.87 [209] where we found 0.87 and 0.86 , the control tissue with a g=0.86 [209] where we found
0.85 and 0.865 and the diﬀuse gliomas with a g=0.88 [209] where we found 0.90 and 0.20. Our
value were in line with the previous literature which validate our set-up and protocols. We also did
measure two other types of tumor that were not tackled before, adding information to the existing
literature. A trend can be extracted from the value, the tumoral tissues tend to have higher g value
than the control tissues, nevertheless this is not statistically signiﬁcant.
Having seen these diﬀerences in the fundamental optical properties of the tissue, we needed to
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Figure 2.2  Average of anisotropy coeﬃcient g, under 405 and 430 nm wavelength excitation and
compared to the g values found in literature.
look at other measurements of the endogenous ﬂuorescence, that could be implemented more easily
in vivo and could also give an insight on the metabolic state of the tissue. Through a ﬁrst bi-modal
device developed in our group [221] , we did measure consequentially the spectral and ﬂuorescence
lifetime response from tissues. Figure 2.3 presents the emitted ﬂuorescence of each type of tissue
at the 375 and 405 nm excitation wavelengths. The shapes of the spectra change with 405 nm
excitation wavelength. At this wavelength, we were able to excite ﬁve endogenous molecules. With
375 nm, we eﬃciently excite NADH and FAD only, thanks to their higher absorption cross section
at this excitation wavelength. We can underline a diﬀerence in the ﬂuorescence intensity between
each type of tissue. The gap between control and tumoral tissues was signiﬁcant and encouraging.
At both wavelengths, the healthy tissue has signiﬁcantly higher intensity than tumoral tissue. This
is explained by the lower absorption and scattering coeﬃcient in healthy tissue that results in more
ﬂuorescence emitted and collected by our set-up.
Every spectra is the sum of emission spectrum of ﬁve ﬂuorphores : NADH, FAD, lipopigments,
porphyrins and chlorins. In addition, by calculating the integral under the curve of the emission
spectra of NADH, FAD and the porphyrins, using a Matlab program developed by our team[128],
we obtained two diﬀerent ratios under 405 nm and 375 nm excitation wavelength.
Under 375 nm excitation wavelength, we calculated the redox ratio [217] :
ROx =
FAD −NADH
FAD +NADH
(2.3)
Under 405 nm excitation wavelength, we calculated the optical index ratio[222] :
OIR =
NADH
Porphyrins
(2.4)
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Figure 2.3  Fluorescence spectra of all tissues excited with 405 nm wavelength (a) and 375nm (b).
At 375 nm, the calculated ratio has negative values because NADH is more present in brain
tissues than FAD at the excitation wavelength [128, 223]. As shown in Figure 2.4.a, the healthy
tissues have a higher ROx than tumor tissues (p<0.001), which is inline with the literature [217].
At 405nm, the Figure 2.4.b also shows a signiﬁcative diﬀerence (p<0.001) tumoral and healthy
tissues. Similar results were obtained on bladder tumor tissues [223].
Figure 2.4  (a) Variation of the ROx report of all tissues excited with 375 nm and (b) Variation
of the NADH/ Porphyrins of all tissues excited with 405 nm.
To complete our study, we also collected data from a promising quantitative technique, the
ﬂuorescence lifetime. As previously done, we used two excitation wavelengths, 375nm and 405nm.
We had a closer look at two molecules emitting endogenous ﬂuorescence, this choice was motivated
by our previous study on a cohort of fresh samples that highlights the changes in NADH and our
study on brain rats that show a variation in porphyrins [128, 223].
In Figure 2.5.a and .b we see that at both excitation wavelengths, the NADH presents a dif-
ference in lifetime between glioblastoma, meningioma, and control samples. Nevertheless, at 405
nm excitation wavelength, control has a shorter lifetime than healthy tissue, where at 375nm the
control has a longer lifetime. The meningioma is very well distinguished from the control tissue
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Figure 2.5  Comparison of mean ﬂuorescence lifetime in diﬀerent types of tissues. Evolution of of
NADH lifetime at 375nm (a) and 405nm(b) in three types of tissues (control, glioblastoma, Menin-
gioma). Evolution of porphyrins lifetime at 405nm between control, glioblastoma and meningioma
(c), between diﬀuse gliomas and control (d) and between metastasis and control (c).
(p=0.002 at 405nm; p=0.004 at 375nm ). In Figure 2.5.c the results for the porphyrin, well excited
at 405nm are presented in all the tumoral tissues (Glioblastoma, Meningioma, Diﬀuse glioma and
Metastasis) a signiﬁcantly shorter lifetime than the control tissue, respectively with a p-value of
p=0.05, p=0.001, p=0.02 and p<0.001. The Figure 2.6 illustrates this diﬀerence between a tumoral
tissue and a control looking at the histogram of ﬂuorescence lifetime decay.
2.2.4 Discussion
In this study, an integrating sphere was used to measure the optical parameters of sample from
healthy brain tissues and from tumor of the central nervous system of human patients. Diﬀerent
tumor tissues were selected, from primary or secondary tumors and with diﬀerent grades of ma-
lignancy. We measured the optical properties with diﬀerent excitation wavelengths. The results
improved our understanding on the evolution of the absorption coeﬃcient and scattering coeﬃcient
on diﬀerent types of tissues. We could observe a trend from these results, the scattering coeﬃcient
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Figure 2.6  Histogram of lifetime ﬂuorescence decay of the porphyrin component with a 405nm
excitation between astrocytoma and control (a) and between metastasis and control (b).
of healthy tissues is lower than those from the diﬀerent tumor tissues. This diﬀerence can be ex-
plained by the fact that tumor tissues have more collagen ﬁbers and a strongest vascularization
than healthy ones, source of a stronger scattering. A threshold can be determined to discriminate
between healthy and tumor, regarding this coeﬃcient a tissue with µs<26 is healthy and with a
µs>29 is tumoral, in the interval where µs [26,29] no conclusion can be drawn on the tissue nature .
The absorption coeﬃcient also discriminate meningioma, glioblastoma and metastasis from healthy
tissue, it can be explained by the stronger vascularization in tumoral tissue. In addition, the higher
the grade of malignancy, the more the chromatin is condensed, so the absorption is higher (seen
in the evolution µa of from healthy, diﬀuse glioma to glioblastoma). The obtained values for the
diﬀerent coeﬃcient were closed to the literature for the studied tissues in similar conditions or when
applied on animals [209].
The spectral response conﬁrmed the conclusions made on the optical properties. The evolution of
spectra from a tissue to another one is in line with the observed change in absorption and scattering
coeﬃcient. These spectral measurements have been established in a "ﬁbered" conﬁguration to be
as close as possible to clinical intra-operative conﬁguration. These spectral results gave us another
technique to look at the discriminating indicator found with the optical coeﬃcients. Nevertheless,
we exploited a bit further the spectral response by looking at the metabolic ratio in order to get
a more robust indicator of tissue nature. In our previous work [128], we noticed that in rat brain
tissues the porphyrin showed diﬀerent responses in term of ﬂuorescence lifetime depending on tissue
nature. Observing the important presence of porphyrins in the human brain tissue spectral response,
we wanted to exploit our knowledge on rat and look at the ratio between NADH and porphyrins
to obtain more discriminatory informations. This ratio will link the metabolic and vascular aspect
of tissues and consequently bring decisive information. To ﬁnalize the study and obtain more
quantitative data, the ﬂuorescence lifetime have also been measured with the intra-operative device
conﬁguration using 375nm and 405nm as excitation wavelength. Results are interesting and showed
the sensibility "of the measure to the nature and state of conservation of tissues". If we compare
these results on ﬁxed tissues to the ones previously obtained on fresh tissues with same same set-up
[223], we can observe the variability of the results. For example for the NADH in cortex-control
ﬁxed tissue the mean lifetime is of 4.44 ns, whereas for the fresh tissue in our previous article the
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mean lifetime is of 3.38 ns. We can also conclude, as in the rat studies, that porphyrin is a strong
indicator of tissue nature, giving us a discriminatory response between tumoral and the healthy
tissues and in between the tumors (glioblastoma, diﬀuse glioma, metastasis and minigioma), we
went also further in this study showing that NADH had also a ﬂuorescence lifetime diﬀerent from
one tissue to another, signiﬁcantly discriminating meningioma from healthy tissue.
We intended to present an original study, based on the autoﬂuorescence response of healthy
and tumoral brain tissues observed with diﬀerent modalities, either in a ﬁber conﬁguration or in
a integrating sphere set-up. All these techniques allowed to established a group of discriminating
indicators between healthy and tumoral. To our knowledge, such a study on a substantial cohort of
human samples have never been performed. To go further, we wish to expand our cohort to tumor
margins, samples where the concentration in tumor cells is very low, in order to test the reliability
of the indicators we demonstrated here.
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Chapter 3
Could spectral and lifetime
measurements, under visible
excitation discriminate freshly
extracted brain tissue nature ? Were
ﬂuorescent measurements established
on ﬁxed tissue suitable enough to
build an optical database ?
3.1 Context of the study
It was highlighted in the literature [206], that in the in vivo condition many elements will vary,
such as blood, water and collagen content, impacting the light scattering and absorption. These
elements are not as present in the ex vivo ﬁxed condition, in which the ﬁxative will stop the tissue
in one state and hemoglobin will be altered [224]. Few teams have tried to evaluate the impact
of the ﬁxation with formaldehyde on tissue autoﬂuorescence response [225228]. They all pointed
out that the intensity increase in ﬁxed tissue compared to fresh analysis. This has been attributed
to enzyme degradation, dehydration, along with changes in blood [227, 228]. Fillipidis et al. [225]
and Xu et al. [227] showed that in monitoring over two to four days the spectral shape in human
abdominal aortia and mouse skeletal muscle was not signiﬁcantly aﬀected by formaldehyde ﬁxation.
Majumder et al. [226] and Gabrecht et al. [228] looked at the impact of ﬁxation when using spectral
response to discriminate breast and bronchial tumor tissues from healthy ones. Majumder et al.
showed that even if the spectral shape (the collagen contribution) and the intensity were impacted
by the ﬁxation process, the relative diﬀerences between cancerous and normal breast tissue were
preserved and a discrimination could still be done [226]. Gabrecht et al. showed that neoplasic
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and normal tissue could be discriminated, however all the pre-neoplasic tissue had undiﬀerentiated
response after ﬁxation, whereas they were able to be discriminated in fresh tissue [229]. These
studies conﬁrmed the hypothesis that optical parameters intensity will change in unﬁxed vs. ﬁxed
tissue, suggesting further focus on investigation of fresh tissue samples.
To study fresh biopsy material the bi-modal endoscope set-up was placed at a hospital, very
close to the operating room. The tissue were brought to the set-up in less than two hours after the
resection and could be analyzed close to intra-operative conditions.
To have more relevant results than on the ﬁxed tissues study presented in chapter 2, in this work
all the samples were compared to their appropriate control and the statistics was increased, ﬁfty-four
patients were included in the cohort. Three tumoral groups were analyzed : intra-axial primary
glioma and secondary metastasis tumor that were compared to cortex control samples. Extra-
axial tumor, meningioma were also studied and compare to healthy dura matter. This bi-modal
endoscope didn't give access to an imaging modality that could allow comparison with histology
gold standard H&E staining, consequently an exploratory study on 13 samples of this cohort was
done using a two-photon excitation. The two-photon excitation using a bench-top microscope
gave access to a merged image of the ﬂuorescence emission and the SHG showing cellular and
extracellular information. These spatial measurements were also combined to make quantitative
assessments, in order to track at a molecular scale the changes in tissue. Five molecules that emit
an autoﬂuorescence signal were followed in this study : NADH, FADH, lipopigments, porphyrin
and chlorine, giving information on metabolism and structure. Their responses were analyzed using
a spectral detection and ﬂuorescence lifetime imaging.
Methods Biopsy samples taken from ﬁfty-four patients were analyzed in this study. They
were originated from cortex-control (n=11), healthy dura matter (n=5), intra-axial glioma (n=16)
and metastasis (n=14) tumors and extra-axial meningioma tumor (n=8). Two set-ups were used
to measure the autoﬂuorescence response of tissue. The whole cohort was ﬁrst analyzed on the
bi-modal endoscope used in chapter 2. This set-up performs spectral and ﬂuorescence lifetime
measurements using a 375 and a 405nm excitation. A portion of the samples (n=13) were used
in an exploratory study on a two-photon set-up. A bench-top multi-photon microscope (TCS SP8
MP, Leica, Germany) coupled to Ti:Sapphire laser (Mai Tai Deepsee, Spectra-Physics, USA) with
a tunable cavity from 690nm to 1040nm for two-photon excitation. For this study, two excitation
wavelengths of 810 and 890nnm were used. The set-up was used to perform ﬂuorescence and SHG
imaging, spectroscopy and ﬂuorescence lifetime measurements.
Results and discussion Under visible excitation a decreased intensity in tumoral tissue com-
pared to their respective controls was observed, for all excitation wavelengths and ﬁtted molecules.
This decrease has been attributed to two phenomena, the Warburg eﬀect that decreases the amount
of NADH in tumor cells [116] and also presence of structures such as necrosis (up to 87% of glioblas-
toma in the present series), tumor hyper-perfusion or neo-angiogenesis which are a high source of
absorption [230]. Using 405 nm excitation wavelength, ﬂuorescence lifetime measurements were
signiﬁcantly shorter in glioma group than in control group for NADH (p = 0.008), FAD (p = 0.035)
and lipopigment (p = 0.035). In metastasis we observed the same trend but the values were not
all signiﬁcantly diﬀerent. At 375nm we could not extract a discrimination. Meningioma could be
discriminated with a statistical signiﬁcance from their control at both 405 and 375 nm excitation
wavelengths. The lower NADH lifetime could be explained by changes in NADH bound/free ratio
or in the distribution of NADH enzyme binding sites [231, 232].
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Intensity
(a.u.)
control-
cortex
RId(%)
Glioma-
control
RId(%) :
metastasis-
control
Lifetime(ns)
control-
cortex
Chapter 2
- ﬁxed
samples
455 55 53 4.44
Chapter 3
- fresh
samples
10 60 75 3.38
Table 3.1  Comparison between ﬁxed and fresh results on intensity and ﬂuorescence lifetime of
NADH emission at 470nm. RId : Relative intensity decrease
To evaluate the impact of ﬁxation on tissue, the results acquired on the visible bi-modal en-
domicroscope can be compared to the ﬁndings of the previous chapter. Table 3.1 compares the
results of spectral and lifetime measurements of the NADH acquired on ﬁxed and fresh samples
for diﬀerent tumor tissues. As in the literature [227], the intensity is higher in ﬁxed tissue than
in fresh ones. This is due to the impact of ﬁxation on hemoglobin [224] and also some chemical
process degrading enzymes and dehydrating the tissue. The increase in ﬁxed tissue found in the
literature were very variable. One study found a factor of 2.6 between 72 hours to 5 days [229],
while another found a factor of 20 after 4 days [227]. In this chapter's study the results were in
the range of the second group results, a factor of 40. Knowing that the samples had been ﬁxed
for several days or weeks could explain the higher value. Also the probe to sample distance wasn't
precisely controlled from one experiment to another, which could also explain the higher value
than in literature. Then, to understand if discrimination was still possible once ﬁxed, the relative
decrease in intensity between control and tumor were compared both in glioma and metastasis.
For both tumors a diﬀerence higher than 50% was measured for fresh and ﬁxed tumors. However
the decrease was more signiﬁcant in fresh tissue. These results translate to what was seen in the
literature [229], that ﬁxation diminishes the speciﬁcity, and consequently low grade tumors are hard
to diﬀerentiate from healthy regions in ﬁxed state. The lifetime results showed a decreased of 1 ns
between ﬁxed and fresh measurements which is non-negligible. However in the one reference found
about ﬂuorescence lifetime in fresh and ﬁxed tissue, a signiﬁcant change in the lifetime value and
the amplitude factor was found [233]. Consequently it is diﬃcult to draw conclusions about the
reliability of the ﬂuorescence lifetime response in ﬁxed tissue. A more extensive study has been
performed in our group in parallel of this work, on the impact of ﬁxation on the spectral and ﬂuo-
rescence lifetime response. study should be performed to conﬁrm or contradict the result that was
found here. As in literature, a systematically longer ﬂuorescence lifetime was found in ﬁxed tissues
compare to freshly extracted ones. However the relative diﬀerence between ﬂuorescence lifetime of
two tissue types did not appear to change from on condition to another. In conclusion using fresh
tissue appears mandatory to have the best speciﬁcity for discrimination and exploit precise value of
ﬂuorescence lifetime. However to test the feasibility of a method, on diﬀerent histological groups,
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NADH/FAD FAD/(NADH+FAD)
Control 0.28 0.76
Glioma 0.31 0.75
Table 3.2  Diﬀerent redox ratio at 405nm excitation wavelength
ﬁxed tissue will be suﬃcient.
In this paper, the diﬀerent molecules contributing to the autoﬂuorescence signal were studied
separately looking at the spectral and temporal response. Signiﬁcant discrimination was found for
most of the molecules, p-value < 0.05. Being able to track molecules individually, such as NADH
and FAD that are involved in metabolic processes opens doors to build metabolic indicators in order
to precisely monitor tissue state. As shown in the introduction. Two formula of the ratio tried in
the literature, FAD/(NADH+FAD) and NADH/FAD, were evaluated on the results of this chapter
(table 3.2) to see if this method could be further developed in our analysis.
The NADH/FAD ratio gave a signiﬁcant diﬀerence and could be a good quantitative indicator
in further study to evaluate the metabolic state of tissue. The second ratio gave a less signiﬁcant
diﬀerence but still showed the same trend as in the literature.
These in vivo analyses showed the capacity of bi-modal quantitative detection on endogenous
ﬂuorescence to discriminate tissue nature. However this set-up lacked an imaging modality and the
possibility of comparison to histology gold standard for diagnosis, the H&E stained images. The
H&E are a combination of two stains, the nuclear information appears in purple-blue and cytoplasm
and extracellular matrix are revealed in pink. The H&E stain, based on this dual information and
the changes in contrast and textures, give access to vast intracellular information (mitochondria,
ﬁlaments, mucous sites, lipides, vessels walls) and provides pieces of information on the functional
status of the cells [60]. It makes H&E the standard for pathological diagnosis with a high accuracy.
To be able to give comparable information, the new imaging modality must also combine nuclear
and extracellular information. Non-linear microscopy is the best candidate because for example
two-photon excitation produces two complementary signal : SHG from the light interaction with
ECM ﬁbered organization, and emission ﬂuorescence highlighting cytoplasmic-nuclear information.
The TPEF-SHG images of control-cortex and each tumoral groups were compared to their H&E
equivalent stain. Typical structures of histology were identiﬁed in the ﬂuorescence images. SHG
signal highlighted lobules in metastasis, necrosis in glioma, and vessels in control. TPEF showed
signal in cytoplasm cells, with lobular arrangement in meningioma, in dense areas of glioma can-
cerous cells, and in triangular neurons in control. These structures are standard elements used
to make a diagnosis, showing that this optical technique could be an equivalent to H&E staining
with the strong advantage of being faster and chemical free. Spectral measurements using the two-
photon excitation resulted in similar spectral shape as the one-photon results, leading to the same
quantitative molecular analysis as in the one-photon conﬁguration. In the lifetime measurements
diﬀerent mean values were found for each tissue types, but the smallness of the group of samples did
not allow a statistical comparison. These preliminary results on a two-photon excitation showed
the potential of qualitative and quantitative discrimination using the addition of a third spatial
dimension compared to the visible set-up conﬁguration. To tackle more in depth clinical questions
70
CHAPTER 3. COULD SPECTRAL AND LIFETIME . . .
with multimodal optical analysis of autoﬂuorescence signal, the two-photon excitation would be
preferred. The promising results found on this small cohort of brain tumor tissue, opened the
possibility of using it on neuropathological challenges with a comparable precision to the histolog-
ical analysis. To evaluate the capacity of the two-photon conﬁguration, a study on tumor grading
was then established to compare qualitative and quantitative optical analysis versus the H&E and
immunohistochemistry analysis of neuropathologist. The results will be presented in the chapter 4.
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3.2 Paper: Multimodal optical analysis discriminates freshly
extracted human sample of gliomas, metastases and menin-
giomas from their appropriate controls
1Scientific RepoRts | 7:41724 | DOI: 10.1038/srep41724
www.nature.com/scientificreports
Multimodal optical analysis 
discriminates freshly extracted 
human sample of gliomas, 
metastases and meningiomas from 
their appropriate controls
Marc Zanello1,2,3, Fanny Poulon1, Johan Pallud2,3, Pascale Varlet3,4, H. Hamzeh5, 
Georges Abi Lahoud2,3, Felipe Andreiuolo3,4, Ali Ibrahim1, Mélanie Pages3,4, 
Fabrice Chretien3,4, Federico Di Rocco6, Edouard Dezamis2,3, François Nataf2,3,  
Baris Turak2,3, Bertrand Devaux2,3 & Darine Abi Haidar1,7
Delineating tumor margins as accurately as possible is of primordial importance in surgical oncology: 
extent of resection is associated with survival but respect of healthy surrounding tissue is necessary 
for preserved quality of life. The real-time analysis of the endogeneous fluorescence signal of brain 
tissues is a promising tool for defining margins of brain tumors. The present study aims to demonstrate 
the feasibility of multimodal optical analysis to discriminate fresh samples of gliomas, metastases 
and meningiomas from their appropriate controls. Tumor samples were studied on an optical fibered 
endoscope using spectral and fluorescence lifetime analysis and then on a multimodal set-up for 
acquiring spectral, one and two-photon fluorescence images, second harmonic generation signals 
and two-photon fluorescence lifetime datasets. The obtained data allowed us to differentiate healthy 
samples from tumor samples. These results confirmed the possible clinical relevance of this real-time 
multimodal optical analysis. This technique can be easily applied to neurosurgical procedures for a 
better delineation of surgical margins.
Surgical resection, whenever feasible, remains the first line of therapy to treat central nervous system tumors1,2. 
The extent of resection is a major prognostic factor, whatever the histopathological subtype3. Although maximal 
resection is required, preserving surrounding healthy brain areas is warranted to equilibrate the onco-functional 
balance: improving the outcomes through maximal tumor removal and preserving the postoperative quality of 
life. The identification of the tumor limits, in case of gliomas, metastases and meningiomas may be difficult intra-
operatively. Intraoperative microscopy, intraoperative ultrasonography, or intraoperative MRI are insufficient to 
resolve tissue microstructure and discriminate between tumor induced tissue alterations and surgically induced 
changes, such as contusion, ischemia or edema4–6.
The most notable achievement concerning optical imaging for brain tumor margin delineation was realized 
by Stummer et al. with the use of external dye, δ -aminolevulinic acid (ALA)7. Clinical studies have shown an 
increased extent of resection and improved overall survival using ALA8,9, however, its sensitivity can be improved, 
especially in infiltrative areas10,11. Moreover, any dye has contraindications and side effects. Our group tries to 
overcome these limits by analyzing human tissue endogenous fluorescence. First attempts of label-free optical 
imaging were made during 1990’s and active research is still currently underway in this field with no major clini-
cal translation12–16. Meanwhile, nonlinear microscopy technique has emerged over the last 20 years17,18. It differs 
from classical confocal microscopy by its ability to use several endogeneous contrasts, especially second harmonic 
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3.2.1 Introduction
Surgical resection, whenever feasible, remains the ﬁrst line of therapy to treat central ner-
vous system tumors [234, 235]. The extent of resection is a major prognostic factor, whatever
the histopathological subtype [236]. Although maximal resection is required, preserving surround-
ing healthy brain areas is warranted to equilibrate the onco-functional balance: improving the
outcomes through maximal tumor removal and preserving the postoperative quality of life. The
identiﬁcation of the tumor limits, in case of gliomas, metastases and meningiomas may be diﬃcult
intra-operatively. Intra-operative microscopy, intra-operative ultrasonography, or intra-operative
MRI are insuﬃcient to resolve tissue microstructure and discriminate between tumor induced tis-
sue alterations and surgically induced changes, such as contusion, ischemia or edema [82, 237, 238].
The most notable achievement concerning optical imaging for brain tumor margin delineation was
realized by Stummer et al. with the use of external dye, δ-aminolevulinic acid (ALA) [98]. Clinical
studies have shown an increased extent of resection and improved overall survival using ALA [99,
239], however, its sensitivity can be improved, especially in in ltrative areas [173, 240]. Moreover,
any dye has contraindications and side eﬀects. Our group tries to overcome these limits by analyz-
ing human tissue endogenous ﬂuorescence. First attempts of label-free optical imaging were made
during 1990's and active research is still currently underway in this ﬁeld with no major clinical
translation [124, 125, 137, 241, 242]. Meanwhile, nonlinear microscopy technique has emerged over
the last 20 years [150, 243]. It diﬀers from classical confocal microscopy by its ability to use several
endogeneous contrasts, especially second harmonic generation and two-photon ﬂuorescence without
introducing exogenous dye. The near infrared excitation source allows a deeper penetration and
a lower level of photodamage compared with confocal microscopy, which helps to preserve tissue.
Autoﬂuorescence analysis is diﬃcult primarily due to the low signal to noise ratio: the combination
of multiple modalities could help distinguish tumor margins more precisely than techniques that
oﬀer a unique modality [144, 244, 245]. In this work we implement spectral and lifetime ﬂuores-
cence in spatial imaging. This quantitative information provides additional information on the
physicochemical environment and molecular interaction.
The present study investigated the ability of visible and nonlinear optical imaging techniques to
discriminate between tumor and control healthy tissues. For this purpose, metastasis, glioma and
meningioma samples were compared to their appropriate controls: healthy brain samples and dura
mater samples, respectively. In this study, thin human samples, freshly extracted, are analyzed to
be as close as possible to clinical conditions. We made qualitative and quantitative measurements
on these diﬀerent sample groups. This comparative study was made on two set-ups: endoscopic
ﬁbered set-up and multimodal microscope. With the optical ﬁbered endoscope we acquired spec-
troscopic and lifetime measurements on freshly extracted human samples as a ﬁrst step before in
vivo clinical measurements. It allows excitation with two diﬀerent visible wavelengths, 375 and 405
nm. These wavelengths are well known [128, 216] to excite diﬀerent endogenous molecules, like
reduced nicotinamide adenine dinucleotide (NADH), ﬂavins (FAD), lipopigment, porphyrins. Our
team is currently working on a new surgical tool that allows performing nonlinear optical analy-
sis of endogenous ﬂuorescence in real time during neurosurgical procedures. To further enhance
the speciﬁcity and sensitivity of the optical analyses, four diﬀerent contrasts will be studied: (1)
one and two-photon spectral detection, (2) time domain measurement and two-photon Fluorescence
Lifetime Imaging, (3) second harmonic generation imaging and (4) one and two-photon ﬂuorescence
imaging. The aim is to help neurosurgeons to realize maximal resection of brain tumors based on
the endogenous contrast between the ﬂuorescence of tumor tissue and healthy surrounding tissue.
As a ﬁrst step before this ﬁbered multimodal optical surgical tool, we have chosen to use a
73
3.2. PAPER: MULTIMODAL OPTICAL ANALYSIS . . .
multimodal bench top microscope. It allows us to (i) test the safety of multimodal excitation on
fresh human samples, (ii) obtain the four diﬀerent contrasts previously discussed, (iii) compared
ﬂuorescence images with gold standard histopathology and (iv) discriminate potential diﬀerences
between the diﬀerent samples (glioma, metastasis, meningioma, and healthy cortex).
3.2.2 Materiel and methods
3.2.2.1 Samples
The inclusion criteria for this monocentric prospective collection of fresh samples were: (1)
adult patients; (2) newly diagnosed central nervous system tumor at the Sainte-Anne Hospital
(Paris, France); (3) available fresh samples to be analyzed on optical set-ups in addition to the
routine histopathology protocols; (4) selection by a senior neuropathologist of representative and
homogeneous samples (meningioma, glioma, metastasis, and control). The institutional review
board of the Sainte-Anne Hospital center  University Paris Descartes approved the study proto-
col (number SC3227), all the following methods were performed in accordance with the relevant
guidelines and regulations issue in this protocol. Moreover informed consents were obtained from
all the samples coming from human subjects. Sample size varied from 32 mm3 (4x4x2 mm) to
750 mm3 (15x10x5 mm). They were maintained in normal saline solution to avoid desiccation, in
a temperature-controlled dark room dedicated to optical imaging. They were cut with a scalpel
to obtain a planar surface. The sample was studied ﬁrst on a visible set-up then on a nonlin-
ear multimodal set-up. The whole process took less than 120 min. The fresh samples were then
ﬁxed with 4% paraformaldehyde, embedded in paraﬃn and stained with Hematoxylin-Eosin then
digitized using Digital Slide Scanner NanoZoomer 2.0 (Hamamatsu Photonics K.K, Hamamatsu,
Japan). Detailed clinical data including age at diagnosis, past medical history and histopathologi-
cal data including presence of mitosis, necrosis, neoangiogenesis and immunohistochemical analysis
were recorded. We examined non-tumor brain parenchyma fresh samples as control samples for
intraparenchymal tumor samples (glioma and metastasis) and dura mater samples for meningioma
samples. The non-tumor brain parenchyma samples (n = 11, the so-called control group) provided
from patients operated for a drug-resistant temporal epilepsy during the same period. Dura mater
control samples (n = 5, the so-called meningioma control group) provided from dural boundaries
far from meningioma resection. A senior neuropathologist performed a central review of deﬁnitive
Hematoxylin-Eosin staining of the study's samples, without prior knowledge of the two-photon
analysis status (performed or not). Detected tissue alteration were reported to the investigators.
3.2.2.2 Optical endoscope architecture
Two pulsed diode lasers, one emitting at 405 nm and the other one at 375 nm, from PicoQuant
(GmbH, Berlin, Germany) were used as laser sources. The diode 375, FWHM 45 ps and 405 nm,
FWHM 60 ps were used. The same Sepia driver controlled the diodes. Repetition frequency can
be set between 2.5 and 40 MHz. Repetition frequency used for this study is 40 MHz. Excitation and
collection were acquired thanks to a bi-ﬁbered conﬁguration. The ﬁbres used for tissue excitation
and collection had a core diameter of 200 µm and 365 µm, respectively, with a numerical aperture
of 0.22. The spatial resolution was of 500 µm. A beam Splitter divided and sent the collected
ﬂuorescence into two detectors: 70% of the signal toward a computer controlled cooled spectrometer
(Ocean optics QP600-1-UV-VIS) for spectroscopic analysis and 30% toward a Photomultiplier Tube
a Photomultiplier Tube (PMT) (PMA-182 NM, PicoQuant GmbH, Berlin, Germany) for lifetime
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Figure 3.1  Optical ﬁbered endoscope setup. Spectral and lifetime measurements were acquired
using this set up and under 405 and 375 nm excitation wavelength. Two ﬁbered was used for
excitation and ﬂuorescence collection.
measurement. The synchronization output signal from the diode driver and the start signal from the
PMT were connected to their respective channels on the data acquisition board Time-Correlated
Single Photon Counting (TCSPC) (TimeHarp 200, PicoQuant GmbH, Berlin, Germany). A ﬁlter
wheel was used to select the spectral emission band during lifetime measurement. Five ﬁlters
were used when exciting with 405 nm (450 ± 10 nm, 520 ± 10 nm, 550 ± 30 nm, 620 ± 10
nm and 680 ± 10 nm). Using theses ﬁlters we can respectively detect the emitted ﬂuorescence
from NADH, FAD, lipopigments, porphyrin I and porphyrin II. Two ﬁlters are used when exciting
with 375 nm (450 ± 10 nm and 520 ± 10 nm) for NADH and FAD (Fig. 3.1). Each lifetime
measurement lasted 2 seconds. Data were adjusted by a mono-exponential ﬁt via FluoFit software
(PicoQuant, GmbH, Berlin, Germany) to recover the lifetimes from the measured ﬂuorescence
decays. Spectral acquisition was accomplished for several longitudinal lines of each sample thanks
to a speciﬁc mechanical support mounted on a motorized microtranslator stage ( Thorlabs, Newton,
USA) [128] and it lasted 5 to 10 minutes per sample. The spectral measurements were processed
using a homemade Matlab program, as previously described [128]. The same ﬁve ﬂuorophores
were considered: reduced Nicotinamide adenine dinucleotide (NADH), ﬂavins (FAD), lipopigments,
porphyrin I and porphyrin II. Data were adjusted by a mono-exponential ﬁt via FluoFit software
(PicoQuant, GmbH, Berlin, Germany) to recover the lifetimes from the measured ﬂuorescence
decays.
3.2.2.3 Microscopic multimodal setup: Confocal, two-photon and FLIM imaging of
endogenous ﬂuorescence
A Mai Tai DeepSee Ti:Sapphire laser source (Mai Tai DeepSee, Spectra-Physics, Santa Clara,
USA) with automated dispersion compensation. The average power is around 2.4 W at 800 nm
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excitation wavelength. It's tunable from 690 to 1040 nm. The repetition rate of the laser source
was 80 MHz and the output pulse duration was around 70 fs. This laser is combined to a TCS SP8
MP confocal microscope from Leica Microsystems (Leica Microsystems, Wetzlar, Germany). This
set up was used for confocal, two-photon and ﬂuorescence lifetime (FLIM) imaging of samples. The
presence of two additional ﬁlters (FF01-448/20-25 and FF01-520/35-25, Semrock, New York, USA)
on the dichroic cube set the detection band for each path toward one of the two external hybrids.
This optical set-up recorded four diﬀerent optical signals on the Regions Of Interest (ROI): (1)
one and two-photon Spectral analysis, (2) two-photon FLIM measurement, (3) second harmonic
generation imaging and (4) Fluorescence imaging under one and two-photon excitation. Analy-
ses were performed using the dedicated Leica software (Leica Microsystems, Wetzlar, Germany).
Fluorescence and second harmonic generation images processing were made using the dedicated
Leica software as well as Matlab and imageJ. For FLIM measurements, three positions at least
per sample were analyzed using 810 and 890 nm excitation wavelengths. The data were collected
and analyzed via the software Symphotime (PicoQuant, GmbH, Berlin, Germany). On each FLIM
image, twelve ROI were selected on the diﬀerent structures and ﬁtted by a mono or bi-exponential
decay to extract the ﬂuorescence lifetime.
3.2.2.4 Statistical analyses
Fluorescence intensity and lifetime results were evaluated using a one-way analysis of variances
(ANOVA). If the ANOVA was statistically signiﬁcant, a post-hoc Wilcoxon test was performed. A
probability value (p) < 0.05 was considered statistically signiﬁcant. All statistical analyses were
performed using JMP software (version 11.0.0, SAS Institute Inc).
3.2.3 Results
3.2.3.1 samples
Clinical and histopathological characteristics are summarized in ﬁgure 3.2. Fifty-four samples
(tumor and control samples) were analyzed. Thirty-eight fresh human tumor samples from 38
patients (21 men, 17 women, mean age at diagnosis 58.3 ± 12.1 years) have been analyzed on the
endoscopic ﬁbered set-up and ten of these 38 samples (26%) have also been analyzed on the nonlinear
microscopic set-up. This cohort was divided into two parts: intra-axial tumor part, subdivided in
Glioma group (n = 16) and Metastasis group (n = 14), and extra-axial tumor part, Meningioma
group (n = 8). Each part was compared to appropriate controls: healthy cortex samples (n =
11) for intra-axial tumor part, named Control Group and healthy dura mater samples (n = 5) for
extra-axial tumor part, named Meningioma Control Group.
No signiﬁcant diﬀerence in tissue alteration was noticed between the samples analyzed with the
optical endoscope only and the samples analyzed on both set-ups.
3.2.3.2 Fibered set-up results
3.2.3.2.1 Spectral measurements of endogenous ﬂuorescence
. As shown in Fig. 3.3, glioma group auto ﬂuorescence is almost two times lower than control
group autoﬂuorescence. At 405 nm excitation wavelength and at 375 nm excitation wavelength,
ﬂuorescence intensity from glioma tissue was lower for all investigated endogenous molecules than
the control group. This diﬀerence was signiﬁcant for NADH (p = 0.018), lipopigment (p = 0.038),
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Figure 3.2  Clinical and Histopathological Characteristics of our human samples series. *Only one
sample had a calculated proliferation rate.
and porphyrin I (p = 0.048) whereas a trend existed concerning FAD (p = 0.054), and porphyrin II
(p = 0.126) without reaching statistical signiﬁcance. At 375 nm excitation wavelength, ﬂuorescence
emission from glioma tissue was also reduced for NADH (p = 0.007) and FAD (p = 0.005).
Metastasis group emitted signiﬁcantly less autoﬂuorescence than control group. At 405 nm and
at 375 nm excitation wavelengths, ﬂuorescence intensity was signiﬁcantly reduced at all investigated
emission wavelengths compared to control group. With 405 excitation wavelength, ﬂuorescence
emission of each molecules from glioma samples are lower than control: NADH (p > 0.001), FAD
(p = 0.002), lipopigment (p = 0.006), porphyrin I (p = 0.033) and porphyrin II (p = 0.029). At
375 nm excitation wavelength, ﬂuorescence intensity was also reduced for NADH (p = 0.009) and
FAD (p = 0.012).
Glioma and Metastasis groups did not exhibit signiﬁcant diﬀerences. However, ﬂuorescence
intensity was reduced for NADH in Metastasis group compared to Glioma group with 375 nm and
405 nm excitation wavelengths without reaching statistical signiﬁcance.
Meningioma group presented a 4-fold decrease in autoﬂuorescence compared to meningioma
control group (Fig. 3.4). At 405 nm excitation wavelength, ﬂuorescence intensity was signiﬁcantly
reduced at four investigated endogenous molecules compared to meningioma control group: NADH,
FAD, porphyrin I and porphyrin II (p = 0.028, p = 0.028, p = 0.019, and p = 0.019, respectively).
At 375 nm emission wavelength, ﬂuorescence intensity was reduced for both NADH and FAD (p =
0.019, and p = 0.028, respectively).
3.2.3.2.2 Lifetime measurements of endogenous ﬂuorescence
. Lifetime values of glioma, metastasis, meningioma and respective control group using 375 and
405 nm excitation wavelength are resumed in ﬁgure 3.5.
Using 405 nm excitation wavelength, ﬂuorescence lifetime measurements were signiﬁcantly shorter
in glioma group than in control group for NADH (p = 0.008), FAD (p = 0.035) and lipopigment (p
= 0.035). As shown in Fig. 3.6, no signiﬁcant diﬀerence existed using 375 nm excitation wavelength.
Concerning metastasis group, the same trend as glioma group is observed as shown in Fig. 3.6.
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Figure 3.3  Results of spectroscopic endogenous ﬂuorescence measurements for intra-axial tumor
part. Fluorescence intensity of NADH and FAD when exciting with 405 and 375 nm for Glioma,
metastasis and control samples. Results for Lipopigment, porphyrin I and II are presented for 405
nm excitation wavelength. F F Under a bar denote statistically signiﬁcant diﬀerence (p < 0.01).
Figure 3.4  Results of spectroscopic endogenous ﬂuorescence measurements for extra-axial tumor
part. Fluorescence lifetime of NADH and FAD when exciting with 405 and 375 nm from meningioma
and control samples. Results for Lipopigment, porphyrin I and II are presented for 405 nm excitation
wavelength.
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Figure 3.5  Fluorescence Lifetime measurements of our human samples series.
Fluorescence lifetime values were signiﬁcantly shorter in metastasis group than in control group
for NADH (p = 0.009), FAD (p = 0.026) and lipopigment (p = 0.040). No signiﬁcant diﬀerence
existed at 375 nm excitation wavelength. With 405 and 375 nm excitation wavelengths, ﬂuorescence
lifetime values were signiﬁcantly reduced in meningioma group compared to meningioma control
group. Figure 3.7 present this tendency.
3.2.3.3 Results on multimodal microscopic imaging set-up
.
3.2.3.3.1 Choice of the excitation wavelength
. A speciﬁc spectral study was accomplished to deﬁne the best excitation wavelength able to excite
endogenous ﬂuorescence as well as second harmonic generation signal. For this purpose we made an
excitation-emission matrix, thanks to the tunable Ti:sapphire lasers (from 690 to 1040 nm). This
study reveals that 810 nm was best suited to excite endogenous ﬂuorescence, whereas 890 nm was
the adequate wavelength to excite ﬂuorescence as well as second harmonic generation signal and
conﬁrmed our previous results [216]. These two wavelengths was used as excitation wavelength for
our study.
3.2.3.3.2 Multimodal nonlinear analysis of endogenous ﬂuorescence under nonlinear
excitation
Figure 3.8 illustrates the results of this multimodal analysis of intra and extra- axial tumor analysis.
A-Glioma group . Using two-photon excitation, at 810 nm excitation wavelength, glioma
samples showed a peak centered at 540 nm and a second peak at 660 nm. At 890 nm excitation
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Figure 3.6  Boxplot of endogenous ﬂuorescence lifetime measurements for intra-axial tumor
part.Lifetime variation of NADH and FAD when exciting with 405 and 375 nm from Glioma,
metastasis and control samples. Results for Lipopigment, porphyrin I and II are presented for 405
nm excitation wavelength.
wavelength, besides the two described peaks, second harmonic generation signal was visible at 445
nm. At 810 nm excitation wavelength, FLIM study found out two components with lifetimes values
of 2.40 ns and 0.40 ns, always longer than the values of control group.
B-Metastasis group . At 810 nm excitation wavelength, metastasis samples exhibited one
peak centered at 540 nm. At 890 nm excitation wavelength, the same peak centered at 540 nm was
observed as well as second harmonic generation signal was detected around 445 nm. At 810 nm
excitation wavelength, FLIM study found out two components with lifetime's values of 2.57 ns and
0.50 ns, once again the values increased compared to control group.
C-Control group . At 810 nm excitation wavelength, control samples showed a peak centered
at 520 nm. At 890 nm excitation wavelength, the same peak was observable. At 810 nm excitation
wavelength, FLIM study showed two components with lifetimes values of 2.10 ns and 0.35 ns.
D-Meningioma group . At 810 nm excitation wavelength, meningioma samples emitted
three peaks centered at 520 nm, 580 nm and 640 nm with a broad ﬂuorescence emission. At 890 nm
excitation wavelength, a peak at 445 nm was visible corresponding to second harmonic generation
signal. At 810 nm excitation wavelength, FLIM study showed three components with lifetimes
values of 2.30 ns, 1.8 ns and 0.40 ns.
Using one photon excitation, all tumors spectra were red shifted and presented lower ﬂuorescence
intensity than control samples. These statements were less visible with two-photon excitation.
Spectrum shape and intensity were quite diﬀerent for each tissue type. Extra-axial and intra-axial
tumors strongly diﬀerentiate with a broader spectrum in extra-axial due to a higher contribution of
porphyrins and chlorins, a diﬀerence is also noticeable in the three types of intra-axial tissues, glioma
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Figure 3.7  Boxplot of Endogenous Fluorescence lifetime measurements for extra-axial tumor
part.Lifetime variation of NADH and FAD when exciting with 405 and 375 nm from tumorous and
control tissue. Results for Lipopigment, porphyrin I and II are presented for 405 nm excitation
wavelength.
appears narrower in the principal peak, explained by a very low lipopigment signal, compared to
metastasis and control tissue.
3.2.3.3.3 Comparison with gold standard histopathology
. Figure 3.8 represents illustrative cases and we observed variability in spectral acquisition from a
sample to another. Two-photon images revealed the same structures as than gold standard H&E
images. The second harmonic generation signal, in green, delimitated lobules in metastasis and
necrosis in glioma whereas it was absent from the control sample. It corresponded to the spectral
acquisition made at 890 nm excitation wavelength. Autoﬂuorescence signal, in red, underlined cell
cytoplasm and, for instance, showed the lobular arrangement in the meningioma sample. Image
from nonlinear set-up showing SHG signal in green corresponding to collagen ﬁbers and two distinct
zones of red ﬂuorescence, one pale corresponding to necrosis and the second intense corresponding
to glioma cells. Hematoxylin-Eosin staining showing necrosis and collagen ﬁbers.
3.2.4 Discussion
We have, for the ﬁrst time, carried out a multimodal optical analysis in a cohort of 58 fresh
human brain tumors samples compared to their appropriate control samples. We showed that: (i)
glioma, metastasis and meningioma emitted signiﬁcantly lower ﬂuorescence than their controls at
405 and 375 nm excitation wavelengths; (ii) at 405 nm excitation wavelength, lifetime values of
glioma, metastasis and meningioma were shorter than their controls and at 375 nm we did not ﬁnd
any diﬀerence; (iii) multimodal nonlinear analysis of human brain samples provided new insights
in the tissue architecture upon analyzing FLIM, two-photon ﬂuorescence and second harmonic
generation signal. Altogether, those results suggest multimodal optical analysis as a promising tool
to help the intra-operative identiﬁcation of tumor margins.
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Our study conﬁrmed that ﬂuorescence emission was signiﬁcantly reduced in tumor tissue as
compared to healthy tissue in accordance with previous reports [122, 124126, 135, 137, 242, 246].
The autoﬂuorescence decrease we observed in tumor tissues had been ascribed to reduction of NADH
amount in tumor cells due to the Warburg eﬀect, the increased metabolization, almost tenfold, of
glucose to lactate by neoplastic tissue compared with healthy tissue in aerobic condition [116, 247].
However, this point is still a matter of debate with a recent review quoting a possible increase of
NADH with mitochondrial dysfunction in tumor [248]. It might be possible that tumor necrosis (up
to 87% of glioblastoma in the present series), tumor hyperperfusion or neoangiogenesis explained,
at least in part, the observed lower emission ﬂuorescence [158, 249]. Previous studies reported a
shift in the emission wavelength between the diﬀerent tissue types [122, 242]. In the present series,
we observed a redshift using one photon excitation. This trend was less evident with two-photon
excitation but the main peak was centered at 540 nm for metastasis and glioma versus 520 nm
for the control samples. Even if analysis of ﬂuorescence intensity seems promising to discriminate
tumor inﬁltration from normal zones, some drawbacks must be taken into account: spectral shape
was quite variable, blood contamination during surgery can drastically decrease the collected signal.
Distinguishing tumor borders from healthy tissue should be more diﬃcult than diﬀerentiating solid
tumor and healthy tissue. In this way, multimodal analysis seems mandatory [250].
Fluorescence lifetime is a sensitive technique for recording low-level signals with high precision
[251]. To our knowledge, our lifetime measurements are the only ones using 375 and 405 nm excita-
tion wavelengths. The absence of any previous work using the same excitation wavelengths makes
harder comparison with literature. Lifetime values that we obtained are in accordance with general
review on this topic but not with the previous work on human brain samples [131, 135137, 252,
253]. However, the values remained in the same order of magnitude. For instance, Yong et al. used
a 337 nm excitation wavelength and found out lifetime values at 390 nm emission wavelength equal
to 1.27 ns for cerebral cortex; 2.3 ns for normal white matter; 1.4 ns for low grade glioma; 1.4 for
high grade glioma and 2.0 ns for high grade glioma with necrotic change. At 440 nm and 460 nm,
emission wavelengths closer to the studied emission wavelength in this paper, this trend was less
evident. In our multivariate analysis, 470 nm corresponding to NADH, 520 nm corresponding to
ﬂavins and 580 nm corresponding to lipopigments had signiﬁcantly longer lifetime values in the
control group than tumor groups using 405 nm as excitation wavelength. This is in accordance
with a previous work by our team on rats tissues and literature [128, 231]. NADH lower lifetime in
neoplastic tissue can be explained by change in NADH bound/free ratio or changes in the distri-
bution of NADH enzyme binding sites [231, 232]. Our literature review found out some works of
multimodal nonlinear optical microspectroscopy on brain or nervous system [254, 255] but only one
multiphoton analysis of human brain samples was performed with 750 nm excitation wavelength
using the DermaInspect set-up [256]. FLIM results ranged from 1.4 ns (brain parenchyma sam-
ple) to 2.1 ns (glioblastoma sample) [256]. Correlation between gold standard histopathology was
made only on rat samples and no second harmonic generation study was performed. We worked
on a dedicated set-up for nonlinear analysis and we recorded four diﬀerent types of signals: second
harmonic generation, FLIM, one and two-photon ﬂuorescence imaging. This preliminary study
conﬁrmed the potential of nonlinear microscopy for human brain investigation: mosaics composed
of second harmonic generation signal and ﬂuorescence signal at 890 nm excitation wavelength are
presented in Fig. 5. Second harmonic generation signal revealed collagen ﬁbers, present in necrosis
for example. Fluorescence showed multiple focal points, corresponding to cell cytoplasm or mito-
chondria. A pathologist made a comparison between nonlinear images and H&E slides. Matching
mosaics and H&E slides was possible in the ten cases. No macroscopic tissue alteration was found
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Figure 3.8  Multimodal analysis of intra and extra-axial tumor analysis of glioma(A) and metasta-
sis(B) samples versus control samples (C) and meningioma control sample (D). From top to bottom:
Axial MR slice on contrast enhanced T1-weighted sequence. Spectra at 890 nm excitation wave-
length from nonlinear set-up showing a clear peak of SHG at 445 nm. Image from nonlinear set-up
showing SHG signal in green and ﬂuorescence in red. Hematoxylin-Eosin staining Images. Scale
bars: 100 µm. Spectra analysis: X-axis: emission wavelength (nm) and Y-axis: Fluorescence in-
tensity (a.u.); Fitted by Matlab so ware: blue, purple and green line represent respectively NADH,
FAD and lipopigment ﬂuorescence emission spectra. Red and purple dot lines for porphyrin I and
porphyrin II.
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out after two-photon excitation. Despite the limits of such macroscopic analysis, this results was
in accordance with previous results [257, 258]. Our FLIM measurements were in accordance with
a previous study performed on ﬁxed meningioma samples [216]. Two-photon FLIM measurement
diﬀered from the results of endoscopic visible set-up due to several reasons: (1) the excitation wave-
length and the focal volume (due to the diﬀerent setup conﬁguration) were not the same and by
consequence the lifetime could diﬀer; (2) the absorption eﬀective section of the various molecules
was diﬀerent under two-photon excitation; (3) under two-photon excitation, we collected the global
emission spectra without any selective ﬁlter in front of detectors as in the endoscopic set-up. Ex
vivo condition was the major limitation of this study. However, the whole process took less than
two hours ensuring the fresh condition of our samples [259] and this delay was essentially due to
the transportation of samples. Even if we presented the largest cohort of ex vivo fresh human brain
samples to date, another limit was the deﬁnition of our groups: gliomas vary by subtypes and grade
and metastases vary by their primary. Such subgroup analyses were not possible to maintain robust
statistical analyses. The same consideration remained true for the eﬀects of oncological treatment
on ﬂuorescence signal. Finally the control group (healthy brain tissue) used in the study could not
have same ﬂuorescence/optical characteristics as the normal brain tissue surrounding the tumor but
this control group deﬁnition ensured that our control samples were healthy, without any tumoral
inﬁltration. Moreover, the small number of samples analyzed on the multimodal microscopic setup
precluded any relevant statistical calculations.
These results represent the ﬁrst step in producing optical signatures from human brain tissue
with multimodal analyses using one and two-photon excitation. This emerging database needs
to be widened. A nonlinear endomicroscope adapted to the intra-operative condition is under
development by our group. Given that the aim of this surgical tool is to distinguish inﬁltrated and
healthy tissue, it seems mandatory to combine second harmonic generation signal, spectral analysis,
lifetime values and two-photon ﬂuorescence to detect inﬁltrated tissue and not only solid tumor.
Multimodal analysis may potentially help diﬀerentiating tumor inﬁltration from healthy zones,
allowing the improvement of the quality of life and the survival of patients harboring a central
nervous system tumor. Such nonlinear endomicroscopy presents obvious advantages: (1) easy to
use in the operating room; (2) fast time acquisitions; (3) and low cost [125]. Moreover, subcellular
investigation of human brain can help current research on many topics such as age related diseases
or psychiatric diseases.
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Chapter 4
Could mono and bi-photon excitation
discriminate label-free ﬂuorescence
emission of meningioma tumor grade
?
4.1 Context of the study
As presented in the introduction of this thesis, Meningioma is one of the most common brain
tumors. So large cohort of patients were available thanks to the collaboration with the Sainte-Anne
Hospital.
In the literature, there are few studies on this tumors. Using a 337nm excitation, Butte et al.
showed the discrimination between meningioma and healthy dura matter with a 90% level of conﬁ-
dence [252]. In an exploratory study on ex vivo brain tumor tissue, Kantelhardt et al. looked at one
WHO grade I meningioma using a two-photon microscope. They showed high ﬂuorescence intensity
of the cytoplasm of tumor cells and low-signal-intensity nuclei in the TPEF images, and distinctly
longer lifetimes than for tumor-adjacent brain [134, 256]. The scarcity of detailed literature on the
endogenous response of meningioma leaves place for more in-depth work.
In the previous chapter, the performed quantitative discrimination on freshly extracted tissue
using one-photon endoscopic conﬁguration was presented, and it was hinted that similar results
could be obtained using a two-photon excitation. Moreover, two-photon excitation allows to obtain
a multi-contrast image (TPEF-SHG), revealing structures which are very close to H&E gold stan-
dard. To grade meningioma based on the H&E images, neuropathologists use structures such as
ﬁber arrangement, vessels organization and cells density. These structures have been identiﬁed in
TPEF-SHG of the previous chapter exploratory study. There the clinical need of grading menin-
gioma tumor would be a suited challenge to perform a ﬁrst complete study using a two-photon
conﬁguration.
The questions that arise are : is it possible to detect these structures with a two-photon imaging
system, without any coloration of the tissue and then to perform a diagnosis ? Could quantitative
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discrimination be found and lead to further automated decisions ? To evaluate the potential of the
two-photon microscopy, and compare it to the previous one-photon technique, a study on grading
meningioma tumor was designed. The chosen meningioma tumor cohort contained WHO grade
I and II samples. Neuropathologist compared the TPEF-SHG images obtained to ﬁnd standard
hallmark of grade. Quantitative spectral and FLIM measurements were then acquired to test if
discriminative indicator could be extracted.
This study does not answer yet the complete problem set in thesis, the discrimination of brain
tumors from healthy regions, but it could be seen as a starting point to evaluate the capabilities of
two-photon endomicroscopy. Answering this challenges will be the ﬁrst step to tackle larger clinical
problem such as the discrimination of primary and secondary brain tumor.
Methods Nine formaldehyde ﬁxed meningioma samples were used in this study, four WHO
grade I and ﬁve WHO grade II. The samples were analyzed using 405nm excitation wavelength
on the bi-modal set-up presented in the two previous chapters. Then they were analyzed using a
two-photon bench-top microscope using 810 and 890 nm excitation, performing ﬂuorescence, SHG
and FLIM imaging, as well as spectral and ﬂuorescence lifetime measurements. H&E staining were
performed on the samples, as well as a Ki-67 immunohistochemical staining to calculate the mean
Ki-67 proliferative index.
Results and discussion In this study, the question of the discrimination of meningioma
grade was tackled for the ﬁrst time by monitoring endogenous ﬂuorescence with multimodal optical
set-ups. The study showed: 1) that merged images of TPEF and SHG are comparable to H&E
histological standard; 2) that the spectral response with both one and two photon excitation resulted
in a higher intensity for grade II than I; 3) that ﬂuorescence lifetime resulted in a shorter value
for grade II than grade I; and 4) that when ﬂuorescence intensity was compared to a histological
proliferative indicator, Ki-67, a correlation was found.
Using two photon-excitation gave access to another imaging modality besides TPEF, the SHG
response. The molecules producing ﬂuorescence were predominant in cells cytoplasm and intercon-
nective tissue, where the SHG is generated by non-centrosymmetric structures, such as ﬁbers or
vessels walls. These secondary signals were particularly advantageous in meningioma tumor, where
ﬁbrillar collagen is dominant and where changes in its architecture are a strong marker of tumor
grade. Diﬀerent structures were identiﬁed in the TPEF images that serve for neuropathological di-
agnosis on H&E images: whorls, psammoma and winding ﬁbers of collagen. Moreover blood vessels
walls also resulted in SHG, and thus could be used as a diagnosis marker since vascular architecture
is strongly modiﬁed through the tumor process. With this study it has been shown that the visual
grading of meningioma done on H&E stained images could also be performed directly on the TPEF-
SHG images. An H&E image requires chemical manipulation and long preparation time, several
hours to a day, while the optical image combining TPEF and SHG is acquired in a few seconds
and can be measured directly on the tissue without any manipulation. Being able to perform the
diagnosis on TPEF-SHG images will speed up considerably the process of histopathology analysis
and reduce the bias due to chemical manipulation, resulting in faster medical decision and better
care for the patient.
However the real advantage of the optical method is the possibility to use quantitative mea-
surements that will be more reliable than the human judgement. As in one-photon, two-photon
excitation was used to measure the spectral response of tissue. In both conﬁgurations the grade
II tissue resulted in a higher ﬂuorescence signal than the grade I. The grade II meningioma in
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this study were deﬁned as "intrinsic", tumor marked by an increased in mitotic activity, and a
denser cellularity [260]. These two characteristics of grade II are sources of a higher intensity of
ﬂuorescence, due to a higher concentration of cells and increased metabolic activity explaining the
higher signal in grade II tumor. In histopathology, techniques have been developed to get access
to indicators oﬀering quantitative results and assessing changes at a molecular scale. One direction
has been to monitor antigen in tissue using an antibody binding technique. This is called immuno-
histochemistry (IHC) and localizes speciﬁc proteins in cells or tissue [261]. IHC can highlight cells
proliferation, proteins of regulatory cycle, hormone receptors and growth factors, it has been used
to improve routine histological grading. In meningioma, a proliferation marker is used, the Ki 67,
a nuclear protein active during the mitotic phase and showing diﬀerent values for cell proliferation
in each grade of meningioma [262]. The mean Ki-67 proliferative index was calculated to grade
the tumors, and the tissue spectral intensity detected by our set-up was compared to this value.
A correlation was found. Higher were the proliferative index (translating to higher grade), higher
the spectral intensity was. These results are very encouraging. In histopathology two staining
techniques are used: ﬁrst the H&E staining to evaluate the type of tumor and then an IHC stain-
ing to have molecular information and give a grading to the tumor. With the multimodal optical
microscope, one set-up can give the spatial and molecular information at the same time.
As with the one-photon set-up, ﬂuorescence lifetime is also measured with the two-photon con-
ﬁguration. In the previous study longer lifetime values were found in healthy tissue compared to
tumor, so here it was expected to ﬁnd longer value for grade I than grade II. This was the case
at 375 and 810nm excitation wavelength, however at 405 and 890nm, this trend could be seen for
some molecules but was not always signiﬁcant. Still, a distinction could be done between grades by
also using the ﬂuorescence lifetime imaging.
With this study, two-photon microscopy has shown potential to help answer a relatively simple
clinical question which is the grading of meningioma using ﬁxed tissue. These results bring us
a step closer to the larger objective of discriminating any brain tumor from healthy tissue. The
next step took was to design a study to ﬁnd optical criteria discriminating primary and secondary
tumor from healthy tissue, using two-photon microscope conﬁguration and freshly extracted tumor
samples. The results of this campaign will be the object of the next chapter.
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Meningioma is the most frequent primary central nervous
system tumor. The risk of recurrence and the prognosis
are correlated with the extent of the resection that ideally
encompasses the infiltrated dura mater and, if required,
the infiltrated bone. No device can deliver real-time in-
traoperative histopathological information on the tumor
environment to help the neurosurgeon to achieve a gross
total removal. This study assessed the abilities of non-
linear microscopy to provide relevant and real-time data
to help resection of meningiomas. Nine human meningio-
ma samples (four World Health Organization Grade I,
five Grade II) were analyzed using different optical mod-
alities: spectral analysis and imaging, lifetime measure-
ments, fluorescence lifetime imaging microscopy, fluores-
cence emitted under one- and two-photon excitation and
the second-harmonic generation signal imaging using a
multimodal setup. Nonlinear microscopy produced images
close to histopathology as a gold standard. The second-har-
monic generation signal delineated the collagen back-
ground and two-photon fluorescence underlined cell cyto-
plasm. The matching between fluorescence images and
Hematoxylin and Eosin staining was possible in all cases.
Grade I meningioma emitted less autofluorescence than
Grade II meningioma and Grade II meningioma exhibited
a distinct lifetime value. Autofluorescence was correlated
with the proliferation rates and seemed to explain the ob-
served differences between Grade I and II meningiomas.
This preliminary multimodal study focused on human me-
ningioma samples confirms the potential of tissue auto-
fluorescence analysis and nonlinear microscopy in helping
intraoperatively neurosurgeons to reach the actual bound-
aries of the tumor infiltration.
Correspondence between H&E staining (top pictures)
and the two-photon fluorescence imaging (bottom pic-
tures).
J. Biophotonics 10, No. 2, 253–263 (2017) / DOI 10.1002/jbio.201500251
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4.2.1 Introduction
Meningioma represents the most frequent primary central nervous system tumor [263]. Menin-
gioma arises from arachnoid cells and their progressive enlargement compresses adjacent structures,
leading to clinical revelation through epileptic seizures, neurological deﬁcits, or increased intracra-
nial pressure [264]. These tumors are histologically classiﬁed into three grades, from Grade I to
Grade III, according to the World Health Organization (WHO) classiﬁcation. Most meningiomas
are classiﬁed as Grade I tumors and up to 10% exhibit a more aggressive pattern, leading to their
classiﬁcation as atypical (Grade II) or anaplastic/malignant (Grade III) meningiomas [264]. These
latter have a greater risk of recurrence with increased mortality: The ﬁve-year survival rates are
78% and 44% respectively for Grade II and Grade III mengingiomas [21].
The gold standard for therapeutic management of meningiomas is gross total surgical resection
en-compassing, whenever possible, the dural insertion, the perilesionnal dura mater and the over-
lying bone if inﬁltrated. The postoperative management consisted of radiotherapy, if required, for
grade II and Grade III cases [265]. The extent of the dural resection, measured by the Simpson
grading system, is correlated with the risk of recurrence [266, 267]. However, repeated surgeries
and extensive resections are associated with operative risks and quality of life impairment [268].
To improve the beneﬁt-to-risk ratio, neurosurgeons used intra-operative tools such as ultrasonogra-
phy, neuro-navigation, macroscopic induced ﬂuorescence using 5-aminolevulinic acid or indocyanine
green, radioisotope, intraoperative magnetic resonance imaging (MRI) or intraoperative computed
tomography [269275]. None of these devices can currently deliver suﬃcient information on the
histopathological nature of the perilesional dura mater. An intra-operative tool, able to provide
real-time multiple data on dural inﬁltration, extrinsic brain invasion, or histopathological grade
during surgery could help the neurosurgeon to achieve gross total removal of a meningioma.
Progresses in optical technologies make it possible and optical devices are currently being ex-
plored in the ﬁeld of surgical neuro-oncology [137, 170, 174, 244] 18 . Their micrometric resolution
oﬀers a new type of medical imaging and allows for quickly obtaining details on the tumor envi-
ronment and architecture with fast time acquisition. However, they are frequently associated with
the use of external markers, such as 5-aminolevulinic acid or indocyanine green, and their devices
are a wide-ﬁeld or a laser scanning confocal microscopy system [270, 276]. Nonlinear microscopy
presents several advantages: visualization of deeper structures, reduced phototoxicity due to bet-
ter localization of the excitation and additional imaging modalities [170]. However, multiphoton
endomicroscopy is still under development [196, 197]. On the other hand, the analysis of tissue
ﬂuorescence emitted by endogenous brain ﬂuorophores, namely autoﬂuorescence, seems to be a
promising way to avoid any bias and metabolic alteration related to external markers [137]. To our
knowledge, no series investigating human meningioma samples has combined autoﬂuorescence and
nonlinear multimodal microscopy.
In this exploratory analysis, we ﬁrst assessed the ability of multimodal optical analyses (spec-
tral analysis, ﬂuorescence lifetime imaging microscopy (FLIM), time-domain measurement, second-
harmonic generation (SHG) imaging, and ﬂuorescence under one- and two-photon excitation) to
individualize pathological features associated with meningioma and we compared the images to
histopathology as the gold standard. Secondly, we investigated the diﬀerences between the optical
signatures of Grade I and Grade II meningiomas.
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4.2.2 Material and methods
4.2.2.1 Samples
Nine formalin zinc-ﬁxed meningioma samples (4 Grade I, 5 Grade II) were included. None of the
patients had familial history of meningioma, neuroﬁbromatosis or previous oncological treatment,
including surgery or radiotherapy. We collected only the samples taken two months ago in the
Sainte Anne Hospital Neurosurgery Department with enough material to allow complementary
analysis if necessary. All samples had an immunohistochemical staining of Ki-67 (1 : 200, MIB-
1, Dako Denmark A/S, Glostrup, Denmark). Immunostainings were performed and evaluated
semiquantitatively (number of labeled cells per total number of tumor cells, excluding endothelial
and lymphomonocytic cells). Mean Ki-67 proliferative index was less than 1% (range: < 1%
to 4%) for Grade I meningioma and was 13% (range: 5% to 20%) for Grade II meningioma. The
institutional review board of the Sainte-Anne Hospital Center - University Paris Descartes approved
the study protocol (number SC3227).
4.2.2.2 Spectroscopic and time resolved measurements on a visible setup
The visible setup consisted of two-pulsed laser diodes from Picoquant used as laser sources.
One emitted at 405nm (LDHP-C-405B, FWHM 60 ps, Picoquant GmbH, Berlin, Germany) and
the other emitted at 375nm (LDHP-C-375B, FWHM 45 ps, Picoquant GmbH, Berlin, Germany)
with a maximum power of 1 mW. The diodes were driven by PDL-808 Sepia (PicoQuant GmbH,
Berlin, Germany). The power and the repetition frequency could be adjusted. The repetition
frequency could be set between 2.5 MHz and 40 MHz. Excitation was performed via a ﬁrst ﬁber
and ﬂuorescence was collected via a second ﬁber (silica/silica step index ﬁbers of inherent spa-
tial resolution of 0.5 mm). A long-pass ﬁlter (SR 420, Semrock, New York, USA) was used to
remove the laser excitation's contribution to ﬂuorescent signal. A beam splitter divided and sent
the collected ﬂuorescence into two detectors: 70% of the signal for spectroscopic analysis and 30%
for lifetime measurement. For spectroscopic measurement, the collected ﬂuorescence was directed
toward a computer-controlled cooled spectrometer (QE 6500, Ocean Optics, Dunedin, USA) of
1.5 nm spectral resolution over a 200-1000 nm spectral range. A speciﬁc mechanical support was
mounted on a motorized microtranslator stage (Thorlabs, Newton, USA) for XY scanning. The
X-dimension scanning velocity was 100 µm/s and the acquisition time during X-line scanning was
3 s per ﬂuorescence spectrum. Spectral acquisition was accomplished for several longitudinal lines
of each sample. For time-resolved measurements, the collected ﬂuorescence was guided to a photo-
multiplier tube (PMA-182 NM, PicoQuant GmbH, Berlin, Germany). The temporal resolution of
the photomultiplier tube was 220 ps. The synchronization output signal from the diode driver and
the start signal from the photomultiplier tube were connected to their respective channels on the
data acquisition board time-correlated single-photon counting (TimeHarp 200, PicoQuant GmbH,
Berlin, Germany). A motorized ﬁlter wheel (FW102C, Thorlabs, Newton, USA) was placed in
front of the photomultiplier tube allowing selection of the spectral emission band. With a 405 nm
excitation wavelength, we used ﬁve ﬁlters (Semrock, New York, USA): 450 ± 10 nm, 520 ± 10 nm,
550 ± 30 nm, 620 ± 10 nm and 680 ± 10 nm. With a 375 nm excitation wavelength, we worked
only with the 450 ± 10 nm and 520 ± 10 nm ﬁlters. Lifetime and spectroscopic measurements were
acquired on the same setup and 2 s were required to measure each ﬂuorophore lifetime.
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4.2.2.3 Confocal, two-photon microscopy and ﬂuorescence lifetime imaging on a mul-
timodal setup
A Mai Tai DeepSee Ti:sapphire laser with automated dispersion compensation (Spectra-Physics,
Santa Clara, USA) and a TCS SP8 MP confocal microscope (Leica Microsystems, Wetzlar, Ger-
many) performed confocal microscopy as well as two-photon microscopy and ﬂuorescence lifetime
imaging of the samples. The laser cavity had over 2.4 W of average power at 800 nm and was tunable
from 690 nm to 1040 nm. The repetition rate was 80 MHz and the temporal width at the output of
the cavity was around 70 fs. The laser was controlled with the Leica software, including easy adjust-
ment of the prechirp unit. Two supersensitive Leica hybrid non-descanned (HyD NDD) detectors
recorded the faintest structures from deep-tissue sections. For two-photon imaging experiments,
ﬂuorescence was collected after the microscope objective via a dichroic beamsplitter, transparent
to wavelengths greater than 680 nm. The collected visible spectrum was split by another dichroic
cube (FF495-Di03-25 x 36, Semrock, New York, USA) into two channels toward the HyD NDD
detectors. This conﬁguration minimized loss in the ﬂuorescence collection. The presence of two
additional ﬁlters (FF01-448/20-25 and FF01-520/35-25, Semrock, New York, USA) on the dichroic
cube set the detection band. Microscope objectives were long working distance water-immersion
Leica objectives (HCX IRAPO L 25X NA 0.95 or HC PL APO 40X NA 1.1 CORR CS2). An
electro-optical modulator adjusted the laser power at the entrance of the confocal system. This
was particularly useful to automatically compensate for energy loss due to scattering as the focus
moved inside the samples. Spectral unmixing software allowed elaboration of multicolor multi-
photon experiments. The spectral acquisition was performed using an internal hybrid detector.
Fluorescence was dispersed by a prism and a speciﬁc motorized split mirror selected the spectral
detected band before the hybrid detector. With this spectral detection we made diﬀerent images of
selected ﬂuorescence for XY imaging plane. The system coupled the single-photon counting tech-
nology ﬂuorescence lifetime imaging with spectral acquisition: it integrated hardware and software
(PicoQuant GmbH, Berlin, Germany) with the high-end confocal system Leica TCS SP8 MP. This
optical setup recorded four diﬀerent optical signals on the region of interest (ROI): 1) one and
two-photon spectral analysis, 2) two-photon ﬂuorescence lifetime imaging measurement, 3) SHG
imaging, and 4) ﬂuorescence imaging under one- and two-photon excitation.
4.2.2.4 Data analysis
4.2.2.4.1 Analysis of spectroscopic measurements from a visible setup
The spectral measurements were processed using a homemade Matlab program, as previously
described [128]. These spectra represented the diﬀerent endogenous ﬂuorophores emissions. To de-
termine the contribution of each ﬂuorophore (intensity, maximum wavelength emission and integral
under the curve), we adjusted data following Eq. 4.1 where Stotal(λ) was the measured spectrum,
i the ﬂuoro-phore, Si(λ) the emission spectrum of the ﬂuorophore i and fi a multiplicative fac-
tor of this spectra. Five ﬂuorophores were considered: reduced Nicotinamide adenine dinucleotide
(NADH), ﬂavins, lipopigment, porphyrin and chlorin. We did not use an appropriate excitation
wavelength to excite the ﬂuorescence of collagen. For both excitation wavelength of 375 nm and 405
nm, the spectrum of ﬂavins (SFlav (λ)) is adjusted by an emission spectrum taken from literature
[105], while for NADH (SNADH(λ)) we used the spectra obtained during our previous experiment
on rat under 375 nm excitation [128]. The other 3 peaks, (SLipo(λ)), (SP620(λ)) and (SP680(λ)),
are ﬁtted by Gaussians.
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Stotal(λ) =
∑
i = 1(fi.Si(λ)) (4.1)
4.2.2.4.2 Analysis of lifetime measurement from a visible setup
Data were adjusted by a monoexponential ﬁt via FluoFit software (PicoQuant, GmbH, Berlin,
Germany) to recover the lifetimes from the measured ﬂuorescence decays. The criteria for an
acceptable ﬁt were: 1) a χ2 value less than 1.0 and 2) residuals randomly distributed around
0 within the interval +4 and -4. The instrument response function was calculated by placing the
probe on a Teﬂon block and on a mirror. The instrument response function of our system, measured
with 1.1 µW excitation power at 405 nm, was around 240 ps (FWHM = 120 ps).
4.2.2.4.3 Analysis of lifetime measurements from a multimodal setup
For ﬂuorescence lifetime imaging measurements, two positions at least per sample were analyzed
using appropriate excitation wavelengths. The depth was equal to that used for spatial image
acquisition. The image size was 128 x 128 pixels, at 100 Hz and represented the average of 20
frames. The data were collected and analyzed via the software Symphotime (PicoQuant, GmbH,
Berlin, Germany). On each ﬂuorescence lifetime image, twelve ROI were selected on the diﬀerent
structures and ﬁtted by a mono- or biexponential decay to extract the ﬂuorescence lifetime. The
criteria for an acceptable ﬁt were: 1) a χ2 value less than 1.0 and 2) residuals randomly distributed
around 0 within the interval +4 and -4. Results were the mean of the twelve selected ROI.
4.2.2.4.4 Analysis of spectral analysis, SHG imaging, and ﬂuorescence imaging under
one- and two-photon excitation from a multimodal setup
All the analyses were performed by the dedicated Leica software (Leica Microsystems, Wetzlar,
Germany). Spectra were obtained from spectral acquisition using the Leica software, then they
were ﬁtted using the described methodology. Fluorescence and SHG images reconstruction were
acquired by using the dedicated Leica software as well as an open source-image-processing program
ImageJ.
4.2.3 Results
4.2.3.1 Determination of optimal excitation wavelength on a multimodal setup
The optimal excitation wavelength to work on human brain samples is not perfectly known as
endogenous ﬂuorescence of each tissue type is the combination of diﬀerent ﬂuorophores. To deﬁne
the optimal excitation wavelength, we used two NDD HyD detectors, each one sensitive in a speciﬁc
wavelength range. Figure 4.1a and b show, respectively, the emission ﬂuorescence intensity of one
sample collected by every detector at each excitation wavelength of the tunable laser cavity from
690 nm to 1040 nm. At a 810 nm excitation wavelength, the NADH ﬂuorescence emission was lower
compared with a 405 nm excitation wavelength and chlorin was not excited. At a 890 nm excitation
wavelength, ﬂuorescence emission of endogenous ﬂuorophores was lower compared with a 810 nm
excitation wavelength, except for chlorin. At a 890 nm excitation wavelength, SHG emission related
to noncentrosymmetric molecules like collagen was visible around 440 nm. We decided, as shown in
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Figure 4.1  (a) Average ﬂuorescence intensity (in arbitrary unit) detected by non-descanned hybrid
detector 1 according to the excitation wavelength. (b) Average ﬂuorescence intensity detected by
non-descanned hybrid detector 2 according to the excitation wavelength. (c) Superposition and
normalization of the emitted ﬂuorescence by a WHO Grade I meningioma sample using diﬀerent
excitation wavelengths: 405 nm (black line), 810 nm (dotted line) and 890 nm (line with points).
The peak around 400 nm at 405 nm excitation wavelength was the laser reﬂection. The peak around
440 nm at a 890 nm excitation wavelength was the second-harmonic generation signal.
Figure 4.1c, to use two diﬀerent excitation wavelengths: 1) 810 nm, the double of one wavelength of
the visible setup (405 nm) and 2) 890 nm with emission of ﬂuorescence as well as the SHG signal.
4.2.3.2 Multimodal optical imaging on a multimodal setup
The correspondence between H&E staining and the acquisitions made on a multimodal setup is
represented in Figure 4.2 .
Diﬀerent images representing features of meningiomas such as collagen fascicles (Figure 4.2a, c,
e and g), whorls (Figure 4.2b and f), and blood vessels (Figure 2d and h) were quite recognizable by
neuropathologists on the corresponding two-photon ﬂuorescence images. The histopathology slices
and ﬂuorescence images were similar.
Figure 4.3 represents a mosaic of numerous images combining the two-photon ﬂuorescence signal
and SHG. The size of the two-photon ﬂuorescence signal images was enlarged to ﬁt gold standard
histopathology. As shown in Figure 4.3, the SHG signal in green delineated whorls and collagen
ﬁbers and two-photon emitted ﬂuorescence in red delineated meningothelial lobules. This resolved
image is matched with the correspondent H&E slides.
4.2.3.3 Optical signature of Grade I and Grade II meningioma on both setups
4.2.3.3.1 Multimodal analysis
Figure 4.4 represents the MRI characteristics, the macroscopic appearance and ﬂuorescence
images obtained with the multimodal setup with corresponding histopathological slices of repre-
sentative cases of Grade I and Grade II meningiomas. The protocol for matching ﬂuorescence to
histology was previously described [244]. It appeared that the MRI and macroscopic appearance
were similar, whereas the ﬂuorescence images were quite diﬀerent: the SHG signal was stronger and
cell-emitted ﬂuorescence emitted was brighter in Grade II meningioma than in Grade I meningioma
due to more abundant collagen fascicles and cell density, as demonstrated on histopathological
slices.
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Figure 4.2  Correspondence between H&E staining (top pictures) and the two-photon ﬂuorescence
imaging (bottom pictures) are, respectively, presented. Bundles of collagen (Figure 2a and e),
psammoma bodies (Figure 2b and f), winding collagen ﬁber (Figure 2c and g) and vessels walls
(Figure 2d and h). Scale bars at 100µm for ﬂuorescence images and Hematoxylin and Eosin staining.
These modalities were complementary. For instance, some bright ﬁbrillary formations appeared
discreetly with confocal imaging. These formations were whorls, formed by the rolling-up of some
cells ﬂattened around a big round cell or around a small vessel with a ﬁbrous wall and were clearly
discriminated with two-photon excitation, thanks to the SHG signal of the collagen ﬁbers. Another
example of this complementarity was the possibility to distinguish round collagen ﬁbers from vessel
walls with FLIM.
4.2.3.3.2 Spectral emission using visible and multimodal setups
Figure 4.5 highlights representative cases of emission spectrum with 405 nm (Figure 4.5a and
b) and 890 nm (Figure 4.5c and d) excitation wavelengths and the mean spectrum for Grade I and
Grade II meningiomas at the same wavelengths. Two Ki-67 stains, one weak and the other strong,
are showed in Figure 4.7A with the correlation between ﬂuorescence intensity and Ki-67 staining
(Figure 4.7B).
The mean spectrum of each grade was measured on three ROI for each sample (n = 27) at
the 405 nm excitation wavelength on the visible setup. As observed, we globally collected a high-
emitted ﬂuorescence from Grade II meningioma. On average, Grade II samples were 26.6% more
ﬂuorescent than Grade I. Using the 890 nm excitation wavelength, the ﬁve endogenous ﬂuorophores
(NADH, ﬂavins, lipopigment, porphyrins and chlorins) were observed as well as SHG. We observed
the SHG at 445 nm and the emitted autoﬂuorescence under two-photon excitation. On average,
Grade II samples were 84.6% more ﬂuorescent than Grade I samples. The signal from Grade I
samples was lower than the signal from Grade II samples in all cases. Given the diﬀerence of Ki-67
proliferative index between our Grade I and Grade II meningioma, we investigated the relationship
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Figure 4.3  Correspondence between the macroscopic view of a meningioma sample, the superim-
position of two-photon ﬂuorescence and second-harmonic generation, and the histopathology as a
gold standard. Left top image shows the macroscopic view of the meningioma sample. Left bot-
tom image shows the superimposition of the two-photon ﬂuorescence (ﬂuorescence signal in red)
and the second-harmonic generation (signal in green). Right top image shows the macroscopic
view of the Hematoxylin and Eosin staining of the same meningioma sample. Right bottom image
shows the enlarge Hematoxylin and Eosin staining. Scale bars at 500 µm for macroscopic views
(top). Scale bars at 100 µm for microscopic views (bottom).
between the Ki-67 proliferative index and ﬂuorescence intensity. This latter increased with the
Ki-67 proliferative index.
4.2.3.3.3 Lifetime of the diﬀerent excited endogenous ﬂuorophores with visible and
multimodal setups
The ﬂuorescence lifetime characteristics of our cohort are summarized in ﬁgure 4.6 . On the
visible setup, at the 375 nm excitation wavelength, lifetime values of NADH and ﬂavins of Grade I
samples were always longer than the lifetime values of Grade II samples: 5% and 10%, respectively.
At the 405 nm excitation wavelength, NADH, ﬂavins, lipopigments; porphyrin, but not chlorin of
Grade meningioma I samples had longer lifetime values than Grade II samples. On the multimodal
setup, at the 810 nm excitation wavelength, NADH and ﬂavins were the two excited ﬂuorophores.
At the 890 nm excitation wavelength, the best ﬁt was obtained with three components for Grade I
meningioma, interpreted like NADH, ﬂavins and SHG signal. For Grade II meningioma, a fourth
component (τ2) appeared for all studied samples with a ﬂuorescence lifetime of 1.8 ns. The lifetime
values from Grade I and Grade II meningiomas were similar.
4.2.4 Discussion
The present study described, for the ﬁrst time, multimodal optical imaging on a series of human
meningioma samples. We showed that: 1) an excitation wavelength of 890 nm allowed two-photon
ﬂuorescence and a SHG signal to be obtained; 2) multimodal analysis could be easily compared with
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Figure 4.4  Illustrative case of WHO Grade I meningioma (A). From top to bottom: Axial MR
image on contrast enhanced T1-weighted sequence; macroscopic view of meningioma sample; ﬂu-
orescence image at 405 nm excitation wavelength; two-photon ﬂuorescence image at a 890 nm
excitation wavelength with ﬂuorescence in red and second-harmonic generation signal in blue; ﬂu-
orescence lifetime imaging microscopy; gold standard Hematoxylin and Eosin staining. Illustrative
case of WHO Grade II meningioma (B). From top to bottom: Axial MR image on contrast en-
hanced T1-weighted sequence; macroscopic view of meningioma sample; ﬂuorescence image at a
405 nm excitation wavelength; two-photon ﬂuorescence image at a 890 nm excitation wavelength
with the ﬂuorescence signal in red and the second-harmonic generation signal in green; ﬂuorescence
lifetime imaging microscopy of the square in F with diﬀerent lifetime values in the same structure;
gold standard Hematoxylin and Eosin staining. Scale bars at 100 µm for ﬂuorescence images and
Hematoxylin and Eosin stainings. Scale bars at 500 µm for macroscopic views.
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Figure 4.5  Representative emission spectrum of a sample (a) at a 405 nm excitation wavelength
on a visible setup and the ﬁts of the ﬁve endogenous ﬂuorophores; (b) Mean emission ﬂuorescence
intensity of WHO Grade I meningiomas (red line) and WHO Grade II meningiomas (black line)
at 405 nm excitation wavelength on the visible setup; (c) Representative emission spectrum of
a sample at a 890 nm excitation wavelength on the multimodal setup and the ﬁts of the ﬁve
endogenous ﬂuorophores (the peak at 445 nm was the second-harmonic generation signal); (d)
Mean emission ﬂuorescence intensity of WHO Grade I meningioma (continuous line) and WHO
Grade II meningioma (dotted line) at a 890 nm excitation wavelength on the multimodal setup.
Figure 4.6  Fluorescence lifetime characteristics of our cohort under visible and IR excitation
wavelength. ROI: Region of interest.
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gold standard histopathology; 3) Grade II meningioma emitted more autoﬂuorescence than Grade
I meningioma; 4) the ﬂuorescence lifetime of Grade I meningioma was longer than the ﬂuorescence
lifetime of Grade II meningioma and Grade II meningioma exhibited a distinct lifetime value on the
visible setup; and 5) the ﬂuorescence intensity and Ki-67 proliferative index seemed to be correlated
in meningioma.
Since the early 1990s, only sparse studies have investigated the capacity of autoﬂuorescence to
distinguish between pathological and healthy brain tissue [122, 125, 137, 241]. Only three references
studied brain neoplasms with visible setups. Nazeer et al. worked with two excitation wavelengths:
320 nm and 410 nm [126]. The ﬁrst detected collagen, NADH, and ﬂavins around 380nm, 460nm,
and 510nm, respectively. Excitation at 410 nm gave the emission values of ﬂavins, phospholipids and
porphyrin around 500 nm, 590 nm and 630 nm to 695 nm, respectively. Collagen and phospholipid
peaks were less intense for tumor tissue than healthy tissue. Nazeer et al. concluded that collagen
and lipid levels in brain decreased as tissue became tumoral. Less porphyrin but more collagen
was present in extra-axial tumors, such as meningioma, as compared to intra-axial tumors, such
as glioblastoma. No analysis was performed based on the WHO grading system. Butte et al.
performed a two modalities analysis: spectral and lifetime analysis [252]. They had a clear peak of
ﬂuorescence around 390 nm for Grade I meningioma whereas two peaks (390 nm and 440 nm) existed
for dura mater. Lifetime analysis revealed that the ﬂuorescence intensity time-decay characteristics
were wavelength dependent and clearly distinct between dura mater and meningioma. Butte et al.
concluded that there were at least two distinct types of collagens and their crosslinks contributing
to ﬂuorescence emission of dura mater and meningioma and that these ﬂuorophores were not the
same between these two tissues. For dura mater, "P" and "M" ﬂuorophores were cited based on
a previous chromatography study [277]. For meningioma, collagen type I and collagen type III
were responsible of the most important part of the meningioma ﬂuorescence emission according to
Butte et al. Using spectral and time-resolved values, the sensitivity and the speciﬁcity to diagnose
meningioma were equal to 89% and 100%, respectively, far better than spectral analysis used alone
with a sensitivity of 61% and a speciﬁcity of 73%. Saraswathy et al. reported a statistically
signiﬁcant diﬀerence in spectral emission between meningioma (without a clear WHO Grading)
and surrounding normal tissue: meningioma exhibited less autoﬂuorescence than normal tissue and
the peak around 600 nm, attributed to porphyrins, was more intense that the two other detected
peaks (500 nm and 550 nm attributed to collagen and ﬂavins) in meningioma contrary to the
normal tissue spectrum [246]. Only one previous work reported signal of a Grade I meningioma
under two-photon excitation [256]. Kantelhardt et al. showed that the cytoplasm of meningioma
cells exhibited high ﬂuorescence intensity, contrary to the low signal from the nuclei. Lifetime
increased at higher excitation wavelengths and the tumor had longer lifetime than tumor-adjacent
brain. This study was performed with a nondedicated setup, designed for dermatologic analysis
(DermaInspect) and did not explore spectral and SHG signals.
The present work was the more complete optical analysis made on Grade I and Grade II menin-
gioma samples. Non-centrosymmetric ﬁbrillar collagen possesses a tremendous nonlinear suscep-
tibility. This is of particular interest in the ﬁeld of neuro-oncology since, apart from the high
proportion of collagen presented in meningioma; this signal underlines vessel walls and necrotic
zones, two classical signs of aggressive behavior for brain neoplasms. In the present study, neu-
ropathologists were able to compare ﬂuorescence images under nonlinear excitation with diﬀerent
histopathological key criteria. Here, Grade II meningiomas showed a signiﬁcant increase of aut-
oﬂuorescence intensity as compared to Grade I ones. This is of particular interest since there are
two types of Grade II meningiomas: 1) intrinsic ones with increased mitotic activity or three or
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Figure 4.7  (A) From left to right: Representative case of a Grade I meningioma sample weak Ki-
67 stain- ing with the insert showing a stained cell; Representative case of a Grade II meningioma
sample strong Ki-67 staining with the insert showing numerous stained cells. (B) Relationship
between ﬂuorescence intensity at 890 nm and Ki-67 proliferative index.
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more of the following features: increased cellularity, small cells with a high nuclear/cytoplasmic
ratio, prominent nucleoli, uninterrupted patternless or sheet-like growth and foci of 'spontaneous'
or 'geographic' necrosis [260], 2) extrinsic ones with brain invasion [260]. The Grade II menin-
giomas under study consisted exclusively of "intrinsic" Grade II. Hence, the observed diﬀerence in
autoﬂuorescence intensity was probably explained by the increased cell density with an increased
level of metabolic activity in Grade II meningiomas as compared to Grade I ones. NADH and
ﬂavins had been widely used to evaluate oxidative metabolic state in cells and tissues [278] and
NADH was considered as the most prevalent endogenous ﬂuorophore. The correlation between
Ki-67 staining and spectroscopic ﬂuorescence intensity corroborated this assessment. The Ki-67
antigen is a nuclear protein present only during mitosis [262]. The lower ﬂuorescence intensity
found with the multimodal setup compared with the visible setup could be explained by a small
two-photon absorption section of NADH at a 810 nm excitation wavelength [279]. The variation
in ﬂuorescence intensity could be a potential criterion to diﬀerentiate WHO Grade I and Grade
II meningiomas with nonlinear excitation, as with the visible setup. We did not rely on the col-
lected autoﬂuorescence of meningioma in this study to collagen because we did not use excitation
wavelengths able to excite the collagen ﬂuorescence [102] and this explained why we ascribed the
major part of the spectral response to NADH and FAD, two well-known endogenous ﬂuorophores.
However, endogenous ﬂuorescence of human tissue is always due to several ﬂuorophores and it may
be possible that collagen crosslinks contributed to the collected signal.
The lowering of lifetime values between Grade I and Grade II meningioma on the visible setup
was in accordance with our previous work on mouse brain tumor model [128]. The healthy tissue
had longer lifetime values than tumoral tissue so it seemed logical that Grade I meningioma exhib-
ited longer lifetime values than Grade II meningioma. Our results on the multimodal setup were
close to those previously described [256] but we did not ﬁnd the same decrease in lifetime values
between Grade I and Grade II meningiomas. During oncogenesis, a shift from cellular oxidative
phosphorylation to cellular glycolysis for ATP production occurs. This is called the Warburg eﬀect
[248]. The endogenous ﬂuorophore NADH is the principal electron acceptor in glycolysis and an
electron donor in oxidative energy metabolism. NADH has two lifetime components: 1) short when
it is in its free state and 2) long in a protein-bound state [132]. The changes in metabolism due to tu-
mor growth modiﬁed the equilibrium between free and bound form of NADH and the conformation
of protein-bound NADH [118]. Considering that Grade II meningiomas are more aggressive than
Grade I ones and that the distinct lifetime value found in Grade II meningiomas (1.8ns) was closer
to free NADH, the greater amount of free NADH could explain this distinct ﬂuorescence lifetime
value presented only in Grade II meningiomas. Another explanation of this distinct ﬂuorescence
lifetime value could be the presence of elastin in Grade II meningioma due to the numerous vessels
present in these tumors.
These results have to be conﬁrmed in vivo, if possible during neurosurgical procedures, formalin
ﬁxation altering tissues ﬂuorescence. An easier ﬁrst step could be the study of meningioma cells
implanted in an alive rat brain, having an optical window and the tracking of the optical answer
evolution over several weeks. Despite the limits of the present study, multimodal optical imaging
could overcome the current limits of actual optical technics and could provide clinically useful
intra-operative information.
100
Chapter 5
Could two-photon imaging match the
performance of H&E standard in
discriminating primary and
secondary brain tumor ? Could
multimodal quantitative detection
improve brain tumor diagnosis ?
5.1 Context of the study
In the two previous chapters, it has been proved that the combination of TPEF-SHG imaging
shows a high resolution and the capability to highlight typical tissue structures comparable to those
seen in H&E stain. In the literature two-photon microscopy has already been used on other types
of tumor to ﬁnd cellular and tissular architecture comparable to the histological standard. Diﬀerent
studies went further than just highlighting similar structures and performed pathological analysis
directly on the TPEF images, evaluating the accuracy of such method compared to the results of
the H&E standard.
A ﬁrst team used only the ﬂuorescence response imaging to match H&E diagnosis with unstained
images.
Hong et al. studied gallblader cancer [280]. They identiﬁed high ﬂuorescence signal in cytoplasm and
a lack of signal in nuclei which gave enough contrast to identify cells morphology and organization.
The mucosa, muscularis and serosa were also distinguished using TPEF. The modiﬁcation in shape
and organization of these structures could be tracked as in H&E images to evaluate cancer presence
and stage. A pathological diagnosis based on TPEF images, and blind to histology results, was
performed and resulted in 96.4% precision [280].
Other teams used the combined TPEF-SHG images to have the closest correlation to H&E-
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stained images.
Wu et al. looked at breast masses [281]. Breast tissue presented a lot of ﬁbrous structures resulting
in high SHG signal, where changes could be tracked as in H&E slices. They asked a pathologist
to analyze TPEF-SHG images, blind to H&E diagnosis. The sensitivity, speciﬁcity and accuracy
of these diagnoses were evaluated at 88.89%, 83.33%, 87.50%, respectively. The false negative rate
was 11.11%.
Yan et al. studied liver cancer [282]. They identiﬁed cells architecture, hepatocyte cords, blood-
ﬁlled sinusoids, glandular and tubular structure of vascular septa in the TPEF image and collagen
architecture in the SHG channel. Based on these observations they performed a blind analysis on
the TPEF-SHG images and classiﬁed them between two states: cancerous or benign, obtaining a
96.32% sensitivity, 96.43% speciﬁcity, and 96.34% accuracy.
The standard in histology and the previous described methods were all based on human judge-
ment to perform diagnosis. Some teams used another approach to diagnose tumor using two-photon
microscopy to avoid this limitation. They used all the possibilities of optical detection and devel-
oped a quantitative method to have an automated diagnosis.
Yan et al. used the TPEF signal to measure [282], in each image, the redox ratio between the
NADH and FAD component, using NADH/FAD formula. They found a higher ratio in cancerous
cells, with a p<0.001.
Other teams used SHG signal to extract quantitative information and build scoring system to
evaluate tissue nature. Strupler et al. looked at the SHG organization in renal tissue and build a
three-parameters scores to discriminate tissues [283]. Xu et al. evaluated neck margin in pancreatic
cancer measuring the pixel density of collagen between in SHG images [284]. Xu et al. identiﬁed
intramural metastasis in esophageal carcinoma using the quantiﬁcation of ﬁber 3D-orientation and
directional variance [285].
In the two previous chapter of this thesis it was shown that a bi-modal detection of the spectral
response and ﬂuorescence lifetime could discriminate tissues. Moreover structures in brain tissue
such as neurons, extracellular matrix arrangement, necrosis, blood vessels or dense regions of tumor
cells could be identiﬁed in the TPEF-SHG images. o get the most of a two-photon analysis of
brain tissue, the two approaches of the literature were considered in the design of this study. A
qualitative and quantitative analysis of the biopsy samples would be performed to ﬁnd a scoring
system that could discriminate diﬀerent tumor types. Here a larger clinical question, than the
grading of one tumor type in the previous chapter, was chosen : the discrimination of primary and
secondary brain tumor compared to control cortex tissue. TPEF-SHG modality was ﬁrstly used
to characterize typical structures and perform a blind reading and diagnosis. Then quantitative
measurements were analyzed computing diﬀerent powerful indicators of molecular states in the
tissues. The spectral intensity of NADH and FAD were used to monitor metabolic activity, the
SHG intensity was used to quantify the ﬁber organization and density and the average ﬂuorescence
lifetime to translate the molecular distribution. The combination of these quantitative answers was
tried as a scoring system of tissue nature.
Methods A protocol for samples to arrive fresh few hours after excision at the IMNC lab-
oratory was designed in collaboration with the Sainte-Anne Hospital. The cohort for this study
contained 25 patients, 7 control biopsies issued from cortex, 10 metastasis and 8 glioblastoma.
A dedicated transporter was chosen (360◦) to bring the samples from Paris to Orsay (Essonne,
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France). Once in the lab, a multiphoton bench-top microscope was used with a Ti-sapphire pulse
laser, as an excitation source, to perform a multi-modal analysis on the biopsy samples. TPEF
and SHG images were acquired, spectral emission-excitation matrix were analyzed over the 690 to
1040 nm excitation range and ﬂuorescence lifetime images were acquired under 890 nm excitation
wavelength.
Results and discussion The two-photon imaging results on brain tissue highlighted neuronal
cells as a hypo-intense structure in TPEF images, vessel walls as an intense signal in the SHG
channel, and disorganized stroma and dense blood vessels of metastasis as an SHG signal. Cellular
disorganization with vascular proliferation of GBM was observed with combined intense signal in
TPEF and SHG images. Based on all these observations, a neuropathologist was asked to perform
a diagnosis on TPEF-SHG images while blind to the H&E diagnosis. Pathologists answered two
questions on the TPEF-SHG images : Were tissues tumoral or healthy ? If tumoral, was it a primary
or secondary tumor ? For the healthy vs. tumoral discrimination, they could achieve a sensitivity
of 76%, a speciﬁcity of 50% and an accuracy of 72%. The lack of sensitivity was due to 27% of
false negative, that were tissues in which the pathologist couldn't decide on any diagnosis. And the
lack of speciﬁcity is due to 28% of false positive that were healthy tissues diagnosed as glioblastoma
tumor. The rate of false negative could be reduced with a longer training of neuropathologist on
recognizing important structures in TPEF-SHG images. In the literature the study with the best
results, an accuracy higher than 95% [282], had trained the neuropathologist on 60 samples before
performing the blind analysis. Training in this study used only 25 samples. The discrimination
between primary or secondary tumor types resulted in sensitivity of 89%, a speciﬁcity of 71% and
a accuracy of 81%. An already very promising results on a small cohort.
Another direction improving the performance of the direct diagnosis on TPEF-SHG images and
avoiding the issue of training neuropathologists, is to use algorithms to create virtual H&E images
from the ﬂuorescence images [286, 287]. Two studies can be referred: Rivenson et al. used wide-
ﬁeld microscopy images and transformed them into virtual H&E, and Jones or Masson's trichome
stains with a deep-learning algorithm [286]; Bocklitz et al. them, transformed CARS/TPEF/SHG
multimodal images into pseudo-H&E images using multivariate statistics [287]. In the ﬁrst study
[286], once a tissue type is trained in the algorithm, for any new images the computing time is on
the order of 0.6 s. Comparison of results with traditional H&E stains resulted in a diﬀerence lower
than 5%. They used the pseudo-H&E to show to the medical community that optical images can
recoup the same amount of detail as in the standard stains in histology. With these results it was
shown that without any staining, two-photon imaging can quickly produce images providing the
same details as H&E standards for a precise diagnosis. A direction that could be investigated in the
future to improve the accuracy of the diagnosis based on TPEF-SHG images found in this chapter.
However to have a robust and reproducible diagnosis, there is a need for quantiﬁcation and au-
tomation of the process. The two-photon set-up used in this chapter gave access to two quantitative
techniques : spectral measurements and ﬂuorescence lifetime imaging. The ﬁrst quantitative mea-
surement was to evaluate cerebral energetic metabolism, using the ratio of the spectral intensity of
NADH and FAD, an indicator already studied by our team on rat brain tissue [128]. In this study,
a higher ratio was observed in tumoral tissue compared to control samples. A second indicator
extracted from the spectral response, was the SHG intensity, to indicate tissue organization. The
highest was detected in metastasis, and GBM tended to be slightly higher than control, however
this diﬀerence was not signiﬁcant in all GBM. These two quantitative measurements did not give
signiﬁcant discrimination in all tissue types and could not be used alone as a diagnosis tool.
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Another modality, ﬂuorescence lifetime, was explored in this study to try to ﬁnd a reliable
quantitative optical response. In this article average lifetime obtained from bi-exponential ﬁt was
monitored in all tissue types. Longer values were found in tumoral tissue compared to control
(p<0.001). Moreover GBM and metastasis had distinguishable values (p<0.001). This modality
which depends only on conformational change, environmental factors (pH, temperature,viscosity)
and ionization was more robust in the exploration of brain tissue. In the literature few groups have
looked at brain tumor spectral and ﬂuorescence lifetime measurements. Butte et al. performed a
study on meningioma healthy dura matter and cortex using these two contrasts [252]. Using the
spectral intensity they discriminated tissue with a sensitivity of 61% and a speciﬁcity of 73% [252].
Looking at the ﬂuorescence lifetime they discriminate tumor tissue with a sensitivity of 84% and a
speciﬁcity of 100% [252]. They also found that ﬂuorescence lifetime is more suited to brain tumor
tissue than spectroscopy alone. They developed an algorithm combining the spectral response and
the ﬂuorescence lifetime and found a discrimination for tumor tissue of 90% sensitivity and 100%
speciﬁcity.
The conclusion of these results is that taking advantage of multimodal detection results in a
reliable discrimination algorithm. To best exploit the data on this study a similar strategy was
applied, adding SHG emission as a third modality in addition to spectral response and ﬂuorescence
lifetime. Three quantitative indicators were extracted : metabolic (redox ratio), structural (SHG
intensity) and conformational (lifetime measurements), to build a 3D scoring system. In this 3D-
plot each tissue type occupied a speciﬁc region of the space, which highlighted the possibility of
automated discrimination using analysis of endogenous ﬂuorescence.
In this chapter the possibility of discriminating primary and secondary tumor was demonstrated.
However it was also learned how sensitive statistical analysis could be and how there was a large
variability from one type of tissue to another. These observations lead to the realization of needing
to go further in data analysis and to ﬁnd other molecules that could help to conﬁrm the diagnosis.
To achieve more data for analysis why not look at a larger range of excitation, from the deep-UV
to the NIR ? And try new analysis methods such as spectral clustering on the phasor approach ?
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5.2 Paper : Real-time Brain Tumor imaging with endogenous
ﬂuorophores: a diagnosis proof-of-concept study on fresh
human samples
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5.2.1 Introduction
Surgical resection aims to maximize tumor removal while minimizing morbidity for both pri-
mary and metastatic brain tumors [288, 289]. Such an approach requires the identiﬁcation of the
surgical margins that can be deﬁned by the limits of normal tissue and/or the extent of tumor
inﬁltration. For normal tissue, particularly eloquent areas, that represent the corticosubcortical
functional pathways, need to be preserved. Even if eloquent cortico-subcortical pathways can be
identiﬁed intraoperatively using brain mapping with direct electrical stimulations under awake con-
dition [290, 291], the identiﬁcation of tumor boundaries remains challenging. Nowadays, tumor
margins are identiﬁed based on the neurosurgeon's experience and with the aid of operating micro-
scopes, MRI-based and/or ultrasonography-based neuronavigation, and intraoperative MRI [74].
Unfortunately, none of these techniques have suﬃcient spatial resolution to identify tumor inﬁltra-
tion at the cellular level and to discriminate inﬁltrating tumor from surgically-induced brain tissue
alterations (i.e. contusion, ischemia or edema) [82, 237]. The assessment of tumor borders at the
cellular scale can be performed using pathological intraoperative examination, however this tech-
nique is not adapted for use during surgery due to time and sampling technique constraints. The
inspection of endogenous brain ﬂuorophores, such as reduced Nicotinamide Adenine Dinucleotide
(NADH), Flavin Adenine Dinucleotide (FAD), lipopigments, and porphyrins I and II, all of which
considered as biomarkers of cell energy metabolism [102, 218], is a promising key to perform optical
imaging at the cellular scale. Interestingly, by examining tissue autoﬂuorescence, one is avoiding
prejudice that results from the use of external markers, such as 5-Aminolevulinic Acid (5-ALA)
that enhances protoporphyrin IX (PpIX) ﬂuorescence. In addition, although such markers induce
ﬂuorescence, they do so through molecular links or processes that are not natural and could there-
fore result in artifact in the ﬂuorescence response. Evaluating intrinsic optical signals using two
photon microscopy (TPM) gives access to two imaging contrasts; ﬂuorescence and second harmonic
generation, which both act as complementary modalities giving high resolved spatial information.
This has motivated its use in real-time optical biopsy in diﬀerent cancer types, such as breast
tumor masses [281], liver cancer[282] or even pancreatic cancer[284]. Moreover, the ability to com-
bine this technique to quantitative measurements such as spectroscopy and ﬂuorescence lifetime,
results in reliable and reproducible discrimination in clinical settings based on an endogenous con-
trast. Compared to other endomicroscopy techniques, such as confocal laser endoscope . TPM
provides multiple advantages [177] such as 1) intrinsic sectioning up to 1 mm; 2) no out-of-focus
photobleaching and photodamage; 3) localized phototoxicity and photobleaching; 4) deeper pen-
etration into biological tissue compared with confocal microscopy (up to 1mm) [292], and 5) no
spectral overlapping between excitation and emission signals. To top it up, four diﬀerent optical
contrast mechanisms which are: 1) spectral analysis; 2) two photon Fluorescence Lifetime Imaging
Microscopy (FLIM); 3) Second Harmonic Generation (SHG) imaging [293], and 4) Two Photon
Excitation Fluorescence (TPEF), can be extracted with the use of TPM to provide complementary
information for improved tissue characterization. The aim of the present study was to evaluate the
ability of TPM in diﬀerentiating tumorous brain tissue from normal tissue in order to support the
development of an intraoperative two-photon endomicroscope, that will be able to give a real-time
answer to the surgeon. We investigated TPM autoﬂuorescence signal analysis from the visible to
the infrared domains, exploring all known endogenous molecules coming from freshly extracted
brain tissue, including normal (control) tissue, glioblastoma (GBM), and brain metastasis collected
from adult patients. In this study, we evaluated: 1) the capacity of TPM in distinguishing between
tumorous and normal tissue; 2) the correlation between the optical signatures extracted from TPM
and the histopathological diagnosis derived from the gold standard, whereby we can evaluate the
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Metastasis (n=10) Origin Number
Thyroid carcinoma 1
Larynx and esophagus carcinoma 1
Bronchial adenocarcinoma 2
Mammary adenocarcinoma 1
colon carcinoma 2
Heel melanoma 1
Otorinolaringologia carcinoma 1
Table 5.1  Origin of the metastasis tissues used in this study
clinical relevance of TPM as a more robust intraoperative diagnosis modality, and 3) the predictive
power of TPM imaging features in diﬀerentiating malignant gliomas from normal tissue as well as
from brain metastasis.
5.2.2 Materiel and methods
5.2.2.1 Samples
This prospective longitudinal study was conducted at a tertiary referral neurosurgical center for
brain tumor patients, between March 2015 and May 2017. The human research institutional review
board of the Sainte-Anne Hospital  University Paris Descartes (CPP Ile de France 3, S.C.3227)
approved the study protocol. All methods were carried out in accordance with relevant guidelines
and regulations. An informed written consent was obtained from all patients prior to enrollment.
Twenty-ﬁve individuals (25 patients, 13 males, 12 females; mean, 51.2±15.2 year-old; range, 19-69
year-old) were included Fresh human tumor brain tissue specimens (n=18 from 18 individuals)were
obtained from the planned surgical margin surrounding the tumor core (10 metastasis samples,
originating from thyroid, larynx, oesophagus, colon and otorinolaringologia carcinoma, bronchial
and mammary adenocarcinoma and heel melanoma, summed up in Table 5.1; and 8 glioblastoma
samples, GBM). The gross location of each specimen was recorded intraoperatively with MRI-
based neuronavigation (BrainLAB, AG, Feldkirchen, Germany). Control brain tissue specimens (7
patients with no history of brain cancer) were obtained during surgical removal of drug-resistant
mesial temporal lobe epilepsy.
Fresh samples in excess to what was needed for routine histopathological diagnosis were ob-
tained directly from the operating room. Half of each fresh sample under study was sent to
histopathology (solution of serum Physio, ambient temperature, black box), where it was formalin-
ﬁxed (4% paraformaldehyde), paraﬃn-embedded, stained with H&E for histopathological analysis,
and digitized using Digital Slide Scanner NanoZoomer 2.0 (Hamamatsu Photonics K.K, Hama-
matsu, Japan). The other half was carried to the PIMPA platform under similar conditions (so-
lution of serum Physio, ambient temperature, black box) and imaged with TPEF, SHG, FLIM
and spectral imaging without tissue ﬁxation. No specimen was excluded from TPM or histopatho-
logical analysis. Samples were 1.25±0.45 cm (range, 0.5-2.0) in size and 3.36±1.05mm (range,
2-5) thick. TPEF, SHG, FLIM and spectral imaging were recorded sequentially without tissue
processing within a mean time interval of 1±0.2 s (range, 0.8-1.2s).
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5.2.2.2 Correlation between TPM and histopathology
We initially collected 25 paired TPM and H&E images from 25 samples (10 metastasis, 8 glioblas-
tomas, 7 controls). A senior neuropathologist performed an initial histopathological analysis, while
blind to the TPM results. No specimen was excluded due to lack of histopathological representativ-
ity. To control for intra-observer bias, we presented a Web-based survey of TPM images (png ﬁle
of the superimposed image of TPM and SHG response) to two senior neuropathologists six months
after the initial H&E based diagnosis pertaining to 25 randomly selected patients (control, n=7,
GBM, n=8, metastasis, n=10). They were asked to classify the sampled tissue in four categories:
1) GBM; 2) metastasis; 3) healthy tissue; or 4) unclassiﬁed. The neuropathologist had access to
clinical data typically available along with the TPM images. This includes patients' age, gender,
clinical presentation, tumor location, and the pre-operative MR images. The neuropathological
blind analysis of TPM images and its corresponding ability to discriminate between control, GBM,
and metastasis tissues was evaluated using the classiﬁcation properties deﬁned as the sensitity,
speciﬁcty and the accuracy of a diagnostic test, respectively following Eq. 5.1 , Eq. 5.2 and Eq.
5.3.
Se =
TP
TP + FN
(5.1)
Sp =
TN
TN + FP
(5.2)
Acc =
TN + TP
TN + FN + TP + FP
(5.3)
TP = True Positive, FP= False Positive, TN= True Negative and FN= False Negative. Their
signiﬁcation depended on:
 Discriminating tumor tissues (GBM, metastasis) from control tissues: TP=tumoral tissue
classiﬁed as tumoral, FP=control tissue classiﬁed as tumoral, TN=control tissue classiﬁed
as healthy and FN=tumoral tissue classiﬁed as healthy.
 Discriminating GBM tissues from metastasis tissues: TP=metastasis classiﬁed as metas-
tasis, FP=GBM tissue classiﬁed as metastasis, TN=GBM tissue classiﬁed as GBM and
FN=metastasis classiﬁed as GBM.
5.2.2.3 Fluorescence and SHG image acquisition
This study was conducted on the multimodal two-photon microscope at the PIMPA (multi-
photonic imaging platform for small animals) platform of the IMNC laboratory, Orsay, France. A
Mai Tai DeepSee Ti:Sapphire laser source with automated dispersion compensation was used for
two-photon excitation. The source's average power was 2.4 W at 800 nm excitation and was tun-
able from 690 nm to 1040 nm. The repetition rate of the laser source was 80 MHz and the output
pulse duration was set to 70 fs. The laser was combined to a confocal and multiphoton microscope,
the TCS SP8 MP (Leica Microsystems, Germany) and was controlled through the Leica software,
Symphotime x64. Diﬀerent visible excitation diodes were also included in the setup, including
the 405 nm excitation wavelength. Two super sensitive non-descanned hybrid detectors (Leica,
Germany) were used to collect the two-photon ﬂuorescence signal. The collected signal passed
through a transparent dichroic ﬁlter ( 680 nm.) to laser reﬂection, then through a second dichroic
ﬁlter (FF495-Di03-25x36) to direct the light towards the two hybrid detectors. An additional ﬁlter
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(Semrock, FF01-448/20-25, FF01-520/35-25) was placed in front of the detector to deﬁne speciﬁc
spectral bands. Two diﬀerent water-immersion Leica objectives were used (HCX IRAPO L 20X
NA 0.95 and HC PL APO 40X NA 1.1 CORR CS2). Images were 512 by 512 pixels in size. The
speed scan was 400 Hz and the pixel size was 866.65 nm by 866.65 nm (no zoom factor). The pixel
dwell time was 1.20µm and the frame rate was 0.52 frames per second. Large regions of interests
were selected with Leica's acquisition software for image and spectral
5.2.2.4 Spectral imaging and analysis
The spectrally-resolved ﬂuorescence intensities were detected by a hybrid detector (HyD, Leica,
Germany) placed in the confocal head of the microscope piloting the grating and mirror in front
of the detector. The spectral resolution was 10 nm, covering the range from 380 nm to 780 nm.
A spectral mosaic was acquired on a 3x3 image area i.e. a spectral measurement was made for
each image of the mosaic then the software merged the information to give its mean ﬂuorescence
spectrum. The spectral excitation-emission matrix was acquired by varying the excitation wave-
length and detecting the ﬂuorescence across the whole emission band. The power at the output
of the microscope objective was measured using a power meter (Nova II, Ophir, USA) so that
the ﬂuorescence spectra were adjusted according to the corresponding excitation power. The ac-
quired spectra were treated with Matlab scripts developed at the IMNC laboratory [128], , where
the ﬂuorescence and SHG signal of ﬁve endogenous molecules were spectrally decomposed (NADH,
FAD, lipopigments, porphyrins I and II). Five ROIs, each corresponding to 200µm in diameter were
chosen for spectral analysis. The SHG, NADH and FAD peak intensities were extracted at 890nm
excitation wavelength to calculate two quantitative markers, the SHG peak intensity and the redox
ratio (ROx) [217] . The ROx is deﬁned in Eq. 5.4 as:
ROx =
NADH
FAD
(5.4)
5.2.2.5 FLIM acquisition
The microscope integrated a FLIM module from PicoQuant (GmbH, Berlin, Germany), in order
to acquire ﬂuorescence lifetime imaging. Each ROI (512x512 pixels) was also imaged in FLIM mode
at a repetition rate of 100 Hz, where the ﬁnal image was the result of averaging twenty single frames.
For each pixel, the ﬂuorescence decay proﬁles were ﬁt to a mono- or bi-exponential function using
the Symphotime software (Symphotime x64 bit, PicoQuant, GmbH, Berlin, Germany) to recover
the lifetime values. Ten to ﬁfteen ROIs were selected from diﬀerent structures observed in the FLIM
image. The goodness of ﬁt was assessed by calculating χ2-value as deﬁned in Eq. 5.5:
χ2 =
∑
i
(xi − µi)2
σ2i
(5.5)
µi: mean, σ
2: variance
The criterion for an acceptable ﬁt was having χ2-values of around 1.0 (χ2 range 0.8 to 1.6).
Additionally, the residuals had to be randomly distributed around zero within the intervals 4 and
-4. The average lifetime ( τavg) for each ROI was measured using Eq. 5.6.
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τavg =
∑
i aiτi∑
i ai
(5.6)
5.2.2.6 Scoring system
Three quantitative indicators were used: (1) Redox ratio: NADH/FAD, (2) ﬁtted SHG intensity
and, (3) the average lifetime, all under an 890nm excitation wavelength. The three measurements
were performed on the same region of interest that could be projected in a 3D space with these
values as coordinates. The scatter cloud of a group was ﬁtted by a Gaussian ellipsoid using the
mean and the standard deviation as parameters for the covariance so that the ellipse can cover 95%
of the total probability mass. The percentage of overlap between the ellipses for each group was
then calculated to assess of the performance of such algorithm.
5.2.2.7 Statistical analysis
Statistical analyses of the SHG and ﬂuorescence intensities, along with the spectral widths were
performed in Matlab (R 2013a), using an ANOVA test for the three tissue groups. This was followed
by applying the Bonferroni method to determine which mean values are signiﬁcantly diﬀerent within
a 95% conﬁdence interval. The statistical values found in Figure 7 (B, C, D) were computed using
the software R (x64 3.2.0), where the computed p-values < 0.05 were considered to be statistically
signiﬁcant.
5.2.3 Results
The routines of the TPM procedure match the requirements for clinical use of freshly resected
brain tissue. Specimens from twenty-ﬁve patients, comprising 10 metastasis, 8 GBM, and 7 epileptic
patients with no history of brain tumors, were included in the cohort. Fresh samples were either
sent to histopathology and/or to the multimodal imaging platform (PIMPA), providing similar
imaging conditions for TPEF, SHG, FLIM and spectral imaging. In the histopathology circuit,
the samples followed a ﬁrst protocol of ﬁxation, paraﬃn embodiment and hematoxylin and eosin
(H&E) coloration that lasts several hours, then the stained samples were imaged and analyzed by
neuropathologists. In the multimodal imaging platform circuit, the samples were directly placed
(without any preparation or chemical modiﬁcation) under the multiphoton microscope, from which a
multimodal imaging protocol (TPEF/SHG, spectral, FLIM) was performed within several seconds,
after which the results were analyzed. Being a crucial point to take into account, the time required
to obtain imaging data from brain samples was compared in each of the above circuits. The standard
histological H&E staining method, that results in the most precise diagnostic and that yields the
nature and the grading of the tumor, required 450±30 min. Surgeons can also use a faster method
during surgery, with the help of a neuropathologist, based on frozen sections that can be evaluated
in 20 min in parallel to the operation and yield some information on the lesioned nature of tissue.
However, both these techniques were more time consuming than the required time of 0.01±0.005
min for the optical analysis method by TPM, which included data from TPEF, SHG, FLIM and
spectral imaging (p<0,001), with a real-time discriminating algorithm. Additionally, TPM has a
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Figure 5.1  Comparative H&E (a,b,c) and TPM images (d,e,f) . (a,d) Control sample, stars:
neurons, arrow: brain vessels in the SHG, scale bar 100 microns, (b,e) Brain carcinoma metastasis:
scale bar 100 microns, stars: tumor cells, arrow : dense vascularization forming a dense network
around the tumor cells, (c,f) GBM sample scale bar 40microns: stars : proliferative endothelial
cells, arrow : zoom on a proliferating vessel.
major advantage over both histological techniques, the analysis is performed in vivo on unlabeled
tissue.
TPM images match standard histopathology with H&E staining The work then comprised a
thorough comparison between the TPM based images and the H&E-stained images. The PIMPA
platform provides simultaneously two diﬀerent images obtained by the two external hybrid de-
tectors: a TPEF image at the maximum ﬂuorescence peak (ﬁlter 520±20nm) to capture tissue
characteristics; and a SHG image (ﬁlter 448±20nm) to detect non centrosymmetric structures such
as collagen ﬁbers and vessels walls. The TPEF and SHG images were merged using ImageJ to
obtain a superimposed image showing the complete morphological structures of the tissue. For
each sample, a senior neuropathologist was asked to identify normal or tumorous cellular com-
ponents (neuron oligodendrocyte, astrocyte; endothelial cell, carcinoma cell) and/or a particular
morphological aspect (necrosis, neo-angiogenesis and microvascular proliferation, calciﬁcation) on
H&E-stained images that served as a reference, and was then asked to localize these patterns in
the merged TPEF and SHG images. In all samples (n=25), the senior neuropathologist was able to
identify in TPEF and SHG images the features that were ﬁrst identiﬁed on H&E-stained images.
Examples are shown in Figure 5.1.
In control non tumoral brain samples, cellular nuclei appeared as hypointense structures in a
homogeneous matrix-dominated background. Neuronal cells were easily discernable in both H&E
stained images as well as merged TPEF-SHG images (black and white stars in ﬁgure 5.1 A-B).
In brain metastasis, typical cytoarchitecture hallmarks such as hypercellularity and disorganized
stroma with numerous blood vessels generated a particular SHG signal (black and white arrows
in ﬁgure 5.1 C-D). In GBM samples, a highly cellular disorganized tumoral cell architecture was
observed with microvascular proliferation. In general, the SHG signal highlights collagen structure
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Figure 5.2  "Blind" histological analysis on TPM images. (a) Flowchart summarizing the results of
the pathologists' diagnosis based on TPM images, sensitivity (Se,Sew), speciﬁcity (Sp) and accuracy
(Acc,Accw) of this method were calculated with the unknown classiﬁcation (Non-diagnosed, n=5)
either excluded (Se, Acc) or taken into account as False Negative (Sew, Accw). (b) Results of
the pathologists' diagnosis of tumoral tissue, discriminating GBM from Brain metastasis. The
sensitivity (Se), speciﬁcity (Sp) and accuracy (Acc) were also calculated.
and metastasis samples had the densest collagen network. The control and GBM samples revealed
sparse SHG signals representative of vessel walls.
5.2.3.1 "Blind" analysis of TPM images
We next assessed the clinical application of TPM imaging and its capacity to show speciﬁc
patterns of the diﬀerent brain tumors needed in clinical practice to discriminate them. Twenty-ﬁve
TPM images (control, n=7, GBM, n=8, metastasis, n=10) were given to neuropathologists blind
to the nature of tissue. They were asked to classify the tissue in four categories: 1) GBM; 2) Brain
metastasis; 3) Normal brain parenchyma or 4) impossible diagnosis. The neuropathologists were
asked to use TPM derived markers, as determined in the previous section (cell, cell density, collagen
ﬁber density and organization, angiogenesis, microvascular proliferation, and necrosis) to propose
a diagnosis. The results are summarized in 5.2. Discriminating tumorous tissue from control tissue
using TPM resulted in a sensitivity of 88% and a speciﬁcity of 71%. The accuracy of this procedure,
which means the probability to correctly classify tissues, was 72%. Interestingly, from the results of
the neuropathologists, the ability to discriminate GBM tissues from metastasis tissues using TPM
could also be evaluated. This resulted in a sensitivity of 62% and a speciﬁcity of 80%. The accuracy
of this procedure, was found to be 72%.
5.2.3.2 Quantitative analyses of TPM signals
To determine reliable discriminating criteria, quantitative analyses of spectral and FLIM images
were performed on each sample (n=25; n=10 metastasis, n=8 GBM and n=7 control). Diﬀerent
wavelengths (from 730 nm to 960 nm) were applied to the three subgroups to deﬁne the optimal
excitation wavelength for collecting spectral and FLIM images as well as the SHG signals. The
variation of endogenous ﬂuorescence was measured in order to build an excitation-emission matrix
for control, GBM, and metastasis samples. The results are presented in Figure 5.3.
The ﬂuorescence intensity decreased by 70% as the excitation wavelength changed from 730 to
900 nm. However, secondary maximal ﬂuorescence intensity was present at 890 nm (60% of the
maximum intensity) in a region where SHG signal peaks. Control samples and GBM samples had
a comparable decrease of 15% in the ﬂuorescence intensity when the excitation wavelength varied
from 730nm to 760nm. Interestingly, metastasis samples had a faster rate of decrease (30%) in the
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Figure 5.3  Analysis of emitted ﬂuorescence for the diﬀerent groups. (a,b,c) Topological represen-
tation of the emitted ﬂuorescence spectra at diﬀerent excitation wavelength for the control group
(a,d,g), the metastasis group (b,e,h) and the GBM group (c,f,i). (d,e,f) represent colormaps of the
Emission-Excitation matrix for each type of tissue. The ideal excitation wavelength is highlighted
by a red line and the part of the map corresponding to the SHG signal is identiﬁed by a green
arrow. TPEF images (g,h,i) of the selected region is also shown with a scale bar of 100 microns.
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Figure 5.4  Spectral decomposition and comparison of emitted spectra at 890nm for each group.
(a,b,c) Example of ﬁtted spectra for control (a), metastasis (b), and GBM (c), under 890 nm
excitation . (d) Mean spectra and standard deviations determined from 25 fresh human samples
(10 metastasis samples, 8 GBM samples and 7 cortex samples) along with representative images of
TPEF (red) and SHG (green) corresponding to each tissue group.
ﬂuorescence intensity. In all three subgroups, the overall emitted ﬂuorescence intensities remained
similar upon excitations ranging from 850 nm to 900 nm. The emission spectra then decreases
when ﬂuorophores are excited at longer wavelengths. This optimal 850-900 nm spectral range for
excitation coincides with the emission spectral range optimized for SHG detection. Consequently,
further TPM based imaging were conducted under an 890 nm excitation. It is clear that the emission
spectra are red-shifted when the longest excitation wavelengths are used. Additionally, ﬂuorescence
emitted around 470 nm, which is mainly attributed to NADH autoﬂuorescence is greatly suppressed.
This is explained by NADH's suboptimal absorption cross section at wavelengths longer than 800
nm. FAD on the other hand showed a second maximal absorption cross section around 900nm [294].
In all cases, the spectral shape diﬀered between subgroups indicating the diﬀerences in the
relative amounts of individual ﬂuorophores present in the three tissue groups. An example of the
ﬁtted spectra at 890 nm of each subgroup is shown in 5.4.
Figures 5.4a,b,c show a spectrally decomposed ﬁtted spectra (n=1) for a sample from each tissue
group. The ﬂuorescence coming from ﬁve endogenous ﬂuorophores was recovered, namely, NADH,
FAD, lipopigments, porphyrins I and II. The SHG peaks were also extracted. The control sam-
ples (Fig. 5.4.a) presented a broader ﬂuorescence spectrum compared to both metastatic and GBM
samples. Spectra from GBM and metastasis samples (Fig. 5.4.b and c) were particularly dominated
by FAD ﬂuorescence followed by Porphyrin I. The metastatic samples showed a uniquely high SHG
peak corresponding to the presence of dense vessels network, as shown in the TPEF/SHG image,
which was always signiﬁcantly higher than that from healthy and GBM tissue (p < 0.001: SHG
signal: Mmetastasis=0.057, MGBM=0.0069 and MControl=0.0054). ). GBM and healthy tissues
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exhibited similar SHG peaks suggesting that both types have comparable microvascular density.
GBM did show larger blood vessels, facilitating angiogenesis on the corresponding TPEF/SHG im-
ages. Moreover, the full width at half maximum, L, computed from the total ﬂuorescence spectra
of control samples were found to be signiﬁcantly diﬀerent from the ones extracted in Metastatic
and GBM tissue (Lmetastasis=128nm, LGBM=134nm, LControl=185nm). A summary of the spec-
tral analysis at the reference excitation wavelength of 890 nm is presented in Figure 5.4.d. GBM
samples exhibited an overall lower ﬂuorescence intensity than control samples supposedly due to
the necrotic areas in these samples. This was conﬁrmed by the TPEF images showing a global
darker background. In the emission range of 600 to 650nm, the mean emitted ﬂuorescence was
signiﬁcantly lower (p<0.001) in the GBM samples as compared to control and metastasis sam-
ples (MGBM=0.0055, Mmetastasis=0.0221 and MControl=0.0160).Metastasis samples exhibited an
overall higher ﬂuorescence intensity than control samples due to the higher tumor cell density as
previously conﬁrmed by the TPEF images showing a high density of bright red spot, identiﬁed
as tumor cells. In the emission range of 500 to 550 nm, the mean emitted ﬂuorescence was sig-
niﬁcantly higher (p<0.001) in the metastasis samples as compared to control and GBM samples
(Mmetastasis=0.0435, MGBM=0.0035 and MControl=0.0045). One limitation to spectral response
studies prevails in identifying tissue samples, the intensity is dependent on the ﬂuorophore concen-
tration, which can be very low in peripheral tumor volumes and in tumor margins. To overcome
such an obstacle, we studied ﬂuorescence lifetime, which is a quantitative optical measurement that
depends on environmental conditions such as pH, temperature, viscosity, and structural changes
including molecular conformation and binding partners, but not on ﬂuorophore concentration. We
quantiﬁed the ﬂuorescence lifetime on all samples (n=25; n=10 metastasis, n=8 GBM and n=7
Control) through the FLIM technique. Figure 5.5 shows representative results for each tissue
group.
The control samples had the broadest FLIM distribution (FWHMControl=0.856 ns compared
to FWHMmetastasis=0.764 ns and FWHMGBM=0.557 ns) due to a heterogenous range of compo-
nents with short and long lifetime values that were present in similar quantity. GBM samples had
a narrow FLIM distribution; the blue-green structures represented neo-angiogenesis. The metas-
tasis samples had the shortest average lifetime at maximum (metastasis=0,7344 ns compared to
GBM=1,47 ns and Control=1,78 ns) compared to the Control and GBM samples as a result of
the presence of a dense vascular network. However, the tissue background color in between vessels
corresponds to longer ﬂuorescence lifetimes than that of GBM samples (FWHMmetastasis=0,764 ns
> FWHMGBM=0,557 ns).
5.2.3.3 TPM signals scoring system
To translate TPM imaging into the operating room, we aimed to develop quantitative parameters
derived from the spectral analysis and the ﬂuorescence lifetime imaging to construct a scoring system
combining three quantitative tissue dependent variables: the redox ratio, the average lifetime and
the SHG intensity. The redox ratio and the SHG intensity were calculated from the spectral ﬁtting
results whereas the average lifetime was calculated from the exponential-decay ﬁt of the lifetime
measurements. The three derived values were used as coordinates to plot each sample in a 3D
space. Figure 5.6 summarizes these results.
Taken separately, each of the quantitative indicators were not always statistically signiﬁcant
while discriminating between the diﬀerent tissue types. The average lifetime of both GBM sam-
ples and metastasis samples were notably shorter than those of Control samples (τGBM=1.13ns -
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Figure 5.5  FLIM representation at 890nm for each tissue type. (a,b,c) FLIM images of control
sample (a), metastasis sample (b), and GBM (c). Scale bars 100 µm, (d,e,f) give the color scale of
FLIM imaging with the histogram of the average lifetime; shorter lifetimes (blue) are on the left
side of the color scale, and longer lifetime (red) on the right side, two measurements were taken
and the full width at half maximum of distribution and the average lifetime of the maximum. SHG
is not a ﬂuorescent but diﬀusing process, appearing as very short lifetime corresponding to the
instrument response function (IRF), which is of the order of 0.06 ns and shown in blue in the FLIM
images. The typical vascular structures of each tissue are consequently as recognizable as in the
TPEF images.
Figure 5.6  (a) 3D scatter plot of three quantitative tissue indicators: the redox ratio, ﬂuorescence
lifetime, and SHG signal averaged for each tissue subgroup, (b) box plot of the average lifetimes,
(c) bar graph of the redox ratios for each tissue type with the errors corresponding to the standard
deviations across all measurements, and (d) overlaid TPEF and SHG intensity images.
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τcontrol=1.59ns, p<0.001; τmetastasis=1.37ns - τcontrol=1.59ns, p<0.001). In addition, the average
lifetime of GBM samples was remarkably shorter than those of metastasis samples ( τGBM=1.13ns -
τmetastasis=1.37ns, p<0.001). On average, cancerous tissues had higher redox ratios (ROXcontrol=0.256±0.030,
ROXMeta=0.264±0.030 and ROXGBM=0.357±0.030), compared to normal tissues. Although it did
not reach statistical signiﬁcance, the larger trend was observed between GBM and control cases
(ROXcontrol=0.256, ROXGBM=0.357, p=0.08). On the other hand, the SHG intensities were partic-
ularly helpful in discriminating metastatic samples from the remaining two types (SHGmetastasis=3.8,
Control=0.35, p<0.001 and SHGmetastasis=3.8 - SHGGBM=0.46) Consequently, in order to have a
more vigorous mean of discrimination, these separate indicators were combined in a unique scor-
ing system, Figure 5.6.a. The performances of the multimodal algorithm were generated using a
Gaussian ellipsoid ﬁt, where the control tissue never overlapped with any tumorous type in 95%
conﬁdence, and GBM-metastasis only had 16,6% of overlap.
5.2.4 Discussion
In this prospective study, we compared TPM derived optical contrasts measured from diﬀerent
fresh human brain tumoral and non tumoral samples to gold standard neuropathology. We have
demonstrated that: 1) TPM can readily be integrated into the operating room as the acquisition
times are short; 2) The merged TPEF and SHG images showed some similar features as those
observed by standard neuropathology particularly the vascular and stromal network 3) TPM imag-
ing was capable of discriminating tumorous from normal tissue at a sensitivity and speciﬁcity of
88% and of 71% respectively. Interestingly, TPM also allowed the discrimination between GBM
and metastasis tissues with a sensitivity of 62% and a speciﬁcity of 80%; 4) Quantitative TPM
signals also categorized tissues according to their groups (control, GBM, metastasis) ; and lastly, 5)
the combined scoring system, i.e. combining redox ratios, average lifetimes, and SHG intensities,
allowed tissue samples to be discriminated, with no overlap between control and both GBM and
metastasis response.
An important point to ﬁrstly stress on is the clinical beneﬁt in acquiring TPEF in real-time
compared to standard histological examination (tTPM=0.01min < tH&E=450min. A classical H&E
image is time and labor consuming given the multiple steps and resting time that are required in
order to obtain a stained slice. On the contrary, optical images are recorded in a few seconds
without any tissue manipulation of the sample, samples being imaged freshly resected directly
under the microscope. This point demonstrates the power of optical imaging in giving quick and
highly resolved images as well as its ability to be used intraoperatively.
Second, having established the technical advantages of TPM, it was crucial to evaluate its ca-
pacity in discriminating tissues. Therefore, a typical comparison between TPEF-SHG images and
histology gold standard H&E staining was performed, and a strong correlation was established
between the two imaging modalities for each tissue type. The cortex could be identiﬁed by the
presence of numerous neurons associated with thin branched vessels highlighted by SHG signal.
Glioblastoma are characterized by a high cellularity and large glomerular vessels. Brain metastasis
by contrast show the dense collagen vascular stroma, resulting in a very strong SHG signal. The
tissue speciﬁc signatures found in this comparison were used by a neuropathologist to perform a
blind analysis of the TPM images. The statistical results of this diagnostic procedure gave promis-
ing results, with high sensitivity (between 75 and 100%) to discriminate tumor from control tissue,
opening the doors to real-time optical biopsy. The low speciﬁcity (50%) of the technique can be
improved by training the neuropathologist with these images as the standard practice for H&E.
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A major common limitation between image comparison and H&E staining is the subjective diag-
nosis. For this reason, a real advantage of TPM is the combination of images with quantitative
measurements to build a computed diagnosis that could be used directly in vivo by the surgeon. In
this study, we explored two quantitative measurements, the spectral emission and the ﬂuorescence
lifetime to build a discriminative algorithm. The spectral measurement is sensitive to the nature
and the concentration of ﬂuorophores measured, thus giving access to information on the metabolic
evolution of tissues, such as indicators of redox status by following NADH and FAD [102, 218,
295]. On the other hand the FLIM measurement is sensitive to binding states, molecular inter-
ferences, and other aspects of the molecular environment such as temperature, molecular liaisons,
viscosity of the medium, and pH [296300]. Therefore, TPM-FLIM data can provide important
complementary information about the local biochemical medium that may aid in distinguishing
healthy from tumorous tissues. Time-resolved ﬂuorescence of endogenous response is a useful com-
plementing tool that separates pathological tissues based on their metabolism [104, 118]. The extra
quantitative dimensions of information provided by spectral and lifetime imaging could facilitate
diagnostic judgments. Consequently, three of the most signiﬁcant quantitative indicators found in
the exploratory analysis were combined to build a scoring system of brain tissue nature. These
indicators were the redox ratio to monitor the metabolic state[118, 217, 222, 295], the SHG inten-
sity to evaluate the density of collagen structures [299, 301] and the average ﬂuorescence lifetime
to track environmental and conformational changes [296300]. Taken separately these numerical
indicators gave us mixed results when discriminating tissues. For example, the Redox ratio failed
to be robust, although it did discriminate GBM from control most accurately, with the tumors
having higher ratios. This result is in accordance with literature [217] and is explained by increased
tumoral metabolic needs (Warburg eﬀect) resulting in changes in the NADH/FAD ratios [247]. The
SHG intensity on the other hand gave us a statistical diﬀerence between control and metastasis,
corresponding to the strong net of vessels and collagen matrix that form around the tumors cells
as also referred to in the literature[302]. The average lifetime was the most robust classiﬁer, where
the values for tumor and control tissues were signiﬁcantly diﬀerent with a shorter lifetime found in
tumor tissue. Nevertheless, when accounting for all three quantitative markers, as displayed in the
3D scatter plot of Figure 6a, classifying brain tissue was achieved. ., one could easily classify brain
tissues. These results underline the necessity of developing an endomicroscope with multimodality
capabilities for robust in vivo tissue interrogation.
All in all, these results based on tissue autoﬂuorescence signals coming from brain tumors
are taking part in the construction of an optical database that will be implemented in a two-
photon multimodal endomicroscope. A ﬁrst prototype of this intraoperative surgical tool is under
development in our laboratory and has shown great performances when it comes to collecting signals
[198, 221]. Compared to the diﬀerent diagnostic techniques such as frozen sections or formaldehyde
ﬁxed H&E stains performed by neuropathologists today, this method does not require any tissue
resection. On the contrary, the probe can be directly put in contact with the human brain while
performing a measurement. Another advantage is the turnaround time required to diagnose a tissue,
which is estimated to be less than a minute from the moment the surgeon holds the probe until
the results are displayed on the screen, as compared to at least thirty minutes for the above listed
methods. Additionally, compared to other techniques developed for the same purpose such as MRI
[82], PET [41] or exogenous ﬂuorescence guided endoscopy [279], our tool does not require the use
of any external agents, thus simplifying the work and limiting any biased classiﬁcation. As for the
techniques based on intrinsic signals such as OCT [139], or intraoperative ultrasound [238], these
simply act as imaging tools that demand the interference of an expert to fully interpret the results.
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By focusing the work on TPEF, this method gave us the possibility to combine imaging modalities
to quantitative measurements to reach unsupervised discrimination in real-time.
In conclusion, this preliminary study highlights the interest of a multimodal two-photon ex-
citation tool to guide intraoperative delineation of tumors' margins. It may be useful to tailor
intraoperatively the surgical resection of malignant brain tumors in addition to brain mapping. In
time to come, the present study will be extended to a larger cohort that includes diﬀerent brain
tumor subtypes. This study will address the question of whether the quantitative optical markers
studied here can be applied to inﬁltrating brain tissue located at tumor margins. The ﬁnal challenge
will be to translate the endomicroscope into the operating room and to be approved for in vivo
clinical studies.
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Chapter 6
Could multimodal and multiscale
optical analysis from DUV to NIR,
be a reliable tool for diagnosis of
primary and secondary tumor ?
6.1 Context of the study
In the previous chapters, the analyze of the autoﬂuorescence both spatially and quantitatively,
from visible to NIR, has been shown. It resulted in a discrimination between healthy tissue, primary
and secondary tumor. These results showed that the accuracy of the diagnosis could be improved
with a more in-depth study, exploiting the relationship between the diﬀerent molecules and analyz-
ing a larger excitation range. A campaign with an excitation from DUV to NIR was consequently
designed to increase the quantity of informations collected on tissue and to improve the discrimi-
nation. A collaboration with DISCO beamline scientists from synchrotron SOLEIL was initiated
to analyze our tissues under DUV excitation. Moreover, in the last chapter it was concluded that
multimodality is a key to develop reliable and robust algorithms. Consequently in this chapter, the
development of discrimination algorithms, which could be implemented intra-operatively, using the
multi-range excitation and the multi-modal detection, were explored more in-depth.
Previous we showed that NADH, FAD, Lipopigments and porphyrins, were the analyzed molecules
under one and two-photon excitations. These molecules gave an insight on tissue structure and
metabolism, elements impacted during tumor development. However using a DUV excitation will
excite other types of molecules present in tissue. For instance amino acids are also ﬂuorescent
when excited in the DUV range. In the brain two amino-acids are present and can consequently
be excited, the tyrosin and tryptophan which are structural units forming proteins. Monitoring
their signal can give information about new protein structure and dynamic [104]. Tryptophan is
also linked to NADH in tissue, enzymes carrying tryptophan favor NAD+ to NADH conversion
during oxydo-reduction, consequently metabolic changes involving NADH will result in variations
in tryptophan autoﬂuorescence response too. This observation has been at the origin of FLIM-
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FRET detection method based on the Trp-NAD(P)H interactions [303, 304]. Being able to register
the information of tryptophan autoﬂuorescence on the brain biopsy tissue will help to understand
the results found in the NADH/FAD variation. However with our two-photon set-up presented in
the previous chapter, tryptophan couldn't be detected, this is due to the fact that its ﬂuorescence
emission is around 355 nm which is outside our detectors spectral range (390 nm to 790 nm).
DUV excitation gave also access to the ﬂuorescence of structural proteins of collagen. In the
previous one and two-photon study collagen was only accessible through the SHG signal to high-
light its ﬁbrillar structure. However collagen is a major component of the extracellular matrix
(ECM), holding organs and cells together. The ECM is an important part of angiogenesis and
neoplasia mechanisms. The ﬁbrils of collagen are stabilized by cross-linking that results in aut-
oﬂuorescence signal and that can be a tool to monitor cancerous structural mechanisms [104]. In
literature monitoring of collagen with DUV excitation was demonstrated for two other types of tu-
mor. Georgakoudi et al. looked at endogenous ﬂuorescence emission in cervical lesions and Barett's
esophagus. Excitations between 340 and 420nm were used to build emission-excitation matrix and
extract collagen and NADH signal. A lower collagen signal was obtained in high-grade dysplasic
legions [305]. Another study from Pu et al. on patients suﬀering from prostate cancer, showed that
the collagen decrease in tumor region using a 340nm excitation wavelength. They looked at the
NADH/collagen ratio for a robust quantitative indicator of tissue nature [306]. Both study showed
that in parallel of a collagen decrease, an NADH increase could be associated to tumoral presence.
These two modiﬁcations resulted in a higher NADH/collagen ratio in prostate cancerous regions.
In brain tumor tissues this has never been observed in the literature yet, motivating study with
larger range of excitation.
To exploit all the possibilities of endogenous ﬂuorescence and highlight as seen the link between
the signal of the diﬀerent molecules, a large study with an excitation from the DUV to the NIR was
put in place. For this study, samples from patient with consent from the large frozen database of the
Sainte-Anne hospital were accessible and used, making it possible to have a statistically signiﬁcant
cohort. This large cohort allowed us to build a study testing more robust algorithms and ﬁnding
discriminative threshold that could be replicate clinically. These algorithms are based on spectral
molecular analysis from the DUV to the NIR, combining several indicators to discriminate tissue
nature and also ﬂuorescence lifetime in the NIR range.
Methods Frozen samples from the Saint-Anne database were brought to the IMNC lab in
Orsay. Thin slices of 10 microns were cut and ﬁxed in order to be analyzed on the diﬀerent set-ups.
The cohort contained biopsy from 51 patients (13 control from cortex, 17 GBM and 21 metastasis).
We ﬁrst analyzed the samples under DUV excitation using 275µm wavelength at the synchrotron
SOLEIL. In this excitation range were performed, a wide-ﬁeld imaging of the emitted ﬂuorescence
and a spectroscopic measurements on the same region. The slices were then imaged using the
two-photon bench-top microscope combined to a Ti-Sapphire laser. Images combining TPEF and
SHG signal were acquired at 890nm. Spectral response and ﬂuorescence lifetime were acquired at
810 and 890nm excitation. All these quantitative data were analyzed using homemade algorithms
optimizing the discrimination between tissue nature, the algorithms are based on spectral and
ﬂuorescence decay ﬁtting, spectral clustering and phasor approach for ﬂuorescence lifetime. The
slices were then stained using the hospital protocol for H&E staining.
Results and discussion Under DUV excitation, a deconvolution was applied on the spectral
response to monitor each molecule. Diﬀerent ratio giving a discrimination between control, pri-
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mary and secondary tumor were calculated : tryptophan/collagen, tryptophan/NADH and tryp-
tophan/tyrosin ratio. A discrimination based on the combination of these three signiﬁcant ratio
resulted in a sensitivity of 90% and a speciﬁcity of 73% and accuracy of 84%. In the two-photon
range two quantitative measurements were accessible the spectral and ﬂuorescence lifetime. Dif-
ferent molecular ratio were tested, the redox ratio to express the metabolic state of tissue and the
optical index to translate the vascularity in tissue. An algorithm based on the two spectral indica-
tors was tested and resulted in a sensitivity of 92% and a speciﬁcity of 95% and accuracy of 92%.
However as seen in the literature [252], combining the spectral lifetime to the spectral measurements
improved the results of the discriminative algorithm. Therefore in this chapter, a 3D-scoring system
based on the two spectral ratio and the average lifetime was build and resulted in sensitivity of
97% and a speciﬁcity of 100% and accuracy of 98.3%. In our results the most accurate algorithm
has been to that point the multi-contrast using a two-photon excitation. Having access to the
DUV measurements on the same region make it possible to try the performances of a multi-range
multimodal algorithm. A discrimination was made based on a the tryptophan-collagen ratio, the
optical index and the ﬂuorescence lifetime. This 3D-algorithm resulted in a 98,2% of accuracy to
discriminate tumor from control tissue. Results of the diﬀerent algorithms are summarized in the
Table 6.1.
UV-
spectral
only
TPEF -
spectral
only
TPEF-
spectral
and
lifetime
TPEF-UV
and
spectral-
lifetime
Sensitivity 90% 92% 97% -
Speciﬁcity 73% 95% 100% -
Accuracy 84% 92% 98,3% 98,2%
Table 6.1  Performances of the diﬀerent algorithms tried of this chapter
Looking at the accuracy of each algorithm, the spectral response using the two-photon excitation
gave more precision than the DUV excitation. This is the consequence of a higher rate of false
negative, 15,4%, in the DUV algorithm. This is a critical point in the perspective of improving
surgical resection, it will result in leaving in place regions which are tumorous, because diagnose as
healthy intra-operatively. Looking at algorithm only based on the spectral response, two-photon
excitation between 800 and 900nm gave the most accurate discrimination. However, as seen in the
conclusion of the previous chapter, the use of multimodal detection can improve the discrimination
of tumor tissue. In this study, the precision of bi-modal algorithm based on spectral and lifetime
detection was quantiﬁed to answer the question of discriminating primary and secondary tumor
from control tissues. These algorithms resulted in an improved accuracy from 92% to 98,3% with
a very low rate of false positive, 4,3%, which is very encouraging to translate the technology to
the clinic. The last used algorithm test the impact of adding a DUV information to a multimodal
algorithm. The data could be discriminated with the same accuracy (98,2%) than the two-photon
model. However it gave a complete discrimination between secondary tumor and control, where the
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two-photon multimodal algorithm gave a complete discrimination of the primary tumor compared
to the control and had showed false positive cases for secondary tumor discrimination. This shows
that depending on the tumor type, the molecules monitored with the DUV excitation could brought
more precision than the ratio accessible with the two-photon excitation.
This large scale study provide a large amount of data to test diﬀerent algorithms. All the
previous analysis based on quantitative measurements were done using ﬁtting algorithms [117,
128]. Fitting methods are known to be very dependent of initial parameters and so result in a
low reliability and reproducibility. In intra-operative diagnosis the repeatability and reliability
are important points to a successful technological transfer and failing to achieve that could kill a
development towards clinical use. In this study, non-ﬁtting algorithms were adapted and used on
both the spectral and ﬂuorescence lifetime data. For spectral data, a method was tested on UV
spectral maps to ﬁnd a discrimination, the cluster analysis. The clustering method has been already
extensively explored on the infrared spectra to answer questions like the diﬀerentiation of colon
cancer [307], the tumor heterogeneity in skin cancer [308] and tumor progression [309]. This method
resluted in high precision to diﬀerentiate structure and a possibility of automation for a systemic
diagnosis in clinical condition [308]. On our DUV data acquired at SOLEIL, a cluster algorith based
on the k-mean method was used and highlighted variations in the tryptophan/collagen ratio from
healthy to tumoral regions. This observation on the cluster analysis resulted in a classiﬁcation based
on the quantiﬁcation of the tryptophan/collagen ratio that gave a threshold to separate healthy
region from tumoral regions.
For FLIM analysis, two methods of non-ﬁtting can be found in the literature, the Laguerre
deconvolution [135] and the phasor approach [310]. Fereidouni et al. compared the performances
of the two methods to ﬁnd their advantages and limitations [311]. They conclude that the phasor
approach resulted in a very accurate estimation of the lifetime value and gave access to a graph-
ical 2D representation of the results compared to Laguerre coeﬃcients. The future user of such
technology will be surgeons who do not have the same technical background than us, having access
to a graphical results easy to interpret for non specialist will get their approval faster. For these
reasons, phasor approach was the one tested and developed on the data of this study. The two-
photon FLIM data were analyzed with this approach, and ﬁve distinct regions could be observed
on the phasor plot. It could be identiﬁed that two of them were dominant in tumor and the other
three in control tissue, resulting in a discrimination criteria that could signiﬁcantly diﬀerentiate the
tumor from control (p<0.05). However this method to extract a discrimination from FLIM analysis
failed to diﬀerentiate the tumor types (primary and secondary). So there is still work to do on this
non-ﬁtting method to get to the precision of previous presented ﬁtting method. In the literature
other teams have used the phasor with other criteria of discrimination for example determining the
fraction of free-bound NADH [115], this other approach could bring the precision needed in the
analysis of the phasor results. It would be a perspective study.
The algorithm found here based on multimodal and multi-range approaches resulted in reliable
discrimination between control, primary and secondary tumor. The reliable results especially using
multimodal algorithm, with false negative rate lower than 5%, is opening the way to automation
of brain tissue nature diagnosis. This is reinforced with the development of non-ﬁtting algorithm
such as the clustering that can be the ﬁrst step of automated classiﬁcation algorithms. However
this study presented the ﬁrst stage of algorithms development : the training phase. To get closer
to a reliable clinical use, the found discriminative thresholds and criteria should be tested on a new
set of data to evaluate algorithm robustness. These results and perspectives open the doors to the
idea of a diagnosis performed by an artiﬁcial intelligence and not a human operator.
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Through the chapter 2 to 6 a large database on the evaluation of primary and secondary tumor
compared to control tissue was build and resulted on the development of discriminative algorithm
that could be automated in an endomicrospe. These results support the development of two-photon
endomicroscope to provide to the surgeon automatized discriminative algorithms during the surgery.
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6.2 Paper: Multimodal analysis of central nervous system
tumor tissue endogenous ﬂuorescence with multiscale ex-
citation
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6.2.1 Introduction
Many Central Nervous System (CNS) tumors, such as glioblastoma and metastasis both pri-
mary and secondary, are inﬁltrating. Surgical resection is the main course of treatment for such
tumors. The outcome and life expectancy after these operations is very low and their improve-
ments is one of the major challenges in modern medicine. In recent years many new technologies
such as intra-operative ultrasound [87], intra-operative magnetic resonance imaging (ioMRI) [82],
confocal endoscopy [173] have been brought into the operating room to help guide surgeons in
resecting tumors. However none of these tools has been able to discriminate inﬁltrating tumors
margins (ITMs). These techniques have failed to oﬀer cellular-level resolution, and to detect the
low concentrations of tumor cells in inﬁltrating regions. As a consequence, the chosen surgical
approach is to maximize the extent of tumor removal while minimizing intrusion on the eloquent
brain area[312]. And while resection improves the outcome and life expectancy of the patient, the
surgeon still operates "blind" on the true nature of margins. To meet the challenge of discriminat-
ing ITM's intra-operatively, there has been a boom in developing surgical medical imaging tools
that can contrast brain tissues and discriminate cell types. Examining tissue autoﬂuorescence with
optical microscopy techniques is one answer to the demand for intra-operative ITM discrimination.
Several molecules produce an endogenous ﬂuorescence signal in the brain [102] and this signal can
change from one type of tissue to another. This diﬀerence can be used to distinguish tumoral regions
from healthy ones [103, 122, 135] . Following that direction, our group miniaturized two-photon
microscopy into a ﬁbered conﬁguration for intra-operative purpose. This endomicroscope enables
two imaging contrasts: two-photon autoﬂuorescence emission (TPEF) and second harmonic gener-
ation(SHG), with an excitation in the near infrared (NIR). The NIR excitation lies in the tissue
therapeutic window, resulting in less photodamage and a better penetration depth. In our set-up
we also choose to include several types of measurements: full ﬁeld imaging, micro-spectroscopy
and ﬂuorescence lifetime to provide the most reliable and reproducible response. To validate this
technical approach we built, in parallel, an optical database of the autoﬂuorescence response from
brain tissues which will be used to develop and test robust algorithms to automatically discriminate
tissue and validate automatic tissue analysis, potentially eliminating subjective reading of images
by a human operator. Multimodal study of endogenous ﬂuorescence on human tissue is relatively
new and, according to the literature, only a few tissue types have been explored. Our lab focused on
brain tissue endogenous ﬂuorescence by partnering with 1) the Saint-Anne hospital (Paris, France)
who provided biopsy samples and medical knowledge, and 2) Synchrotron SOLEIL who provided
access to a deep UV imaging platform at DISCO beamline, while the IMNC, performed two-photon
microscopy with a bench-top microscope.
This study searched for an objective optical marker to discriminate tumor from healthy tissue,
and to discriminate primary from secondary tumors. A large study on ﬁxed biopsy tissue of pri-
mary (glioblastoma), secondary (metastasis) tumor and control cortex was performed, with large
scale excitation ranging from deep-UV (DUV) to near infrared (NIR), and several modalities of
detection from qualitative, ﬂuorescence and lifetime imaging, to quantitative, spectral and lifetime
measurements. Finding a discriminating optical marker was made possible by exploiting multiple
contrast and building 2D and 3D discriminative algorithms for the DUV and NIR excitations indi-
vidually, and then in combination. Discrimination speciﬁcity and sensitivity were in the 70 to 100%
range, highlighting the power of optical analysis to discriminate the nature of tissue with enough
precision to be clinically useful. The qualitative results of our study were also used to compare
optical microscopy technology to the gold standard H&E staining. This comparison highlighted
discriminative histological structure in the optical images, and a "blind" pathologic analysis was
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Figure 6.1  (a) Schematic of the acquisition-analysis protocol from deep-UV to infrared excitation
(b) Deep-UV excitation-emission matrix. (c) Two-photon (NIR excitation) excitation-emission
matrix. The bottom line present how were ﬁtted tyrosin, tryptophan, collagen crosslinks and
NADH at 275nm (d), NADH, FAD, lipopigments, porphyrin I and porphyrin II at 810 nm (e) and
SHG, NADH, FAD, lipopigments, porphyrin I and porphyrin II at 890nm (f).
then performed directly on our images.
6.2.2 Materiel and methods
6.2.2.1 Study design
The samples were excited in the deep-ultraviolet (DUV) and the near infrared (NIR) range
on two diﬀerent platforms. The design of the study is presented in Figure 1. On both platforms
an excitation emission matrix was performed to highlight the diﬀerent excited components and to
select the optimal wavelengths for our study. Under DUV excitation we chose 275nm as the optimal
wavelength, being the most eﬃcient in set-up, and in exciting four components simultaneously:
Tyrosin (Tyr), Tryptophan (Trp), Collagen crosslinks (Col) and NADH.
In the NIR range we chose two excitation wavelengths: 810nm and 890 nm. Four molecules
and SHG were tracked: NADH, FAD, Lipopigments, Porphyrin. At 810nm excitation NADH
was optimally detected and at 890nm we obtained the best tradeoﬀ between SHG and emitted
ﬂuorescence [216]. Samples (Fig5.a.iv) underwent the following process : (1) large mosaic at 275nm
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Type Nb Patient Age Men Women
Control 13 35,2±7,4 9 4
Primary Tumor : GBM 17 68,3±11,4 12 5
Secondary Tumor :
Metastasis
21 58,8±12,2 10 11
TOTAL 51 54,1±17 31 20
Table 6.2  Description of samples
in the four detection channel (Tyr, Tryp, Col, NADH) (Fig6.1.a.ii) (2) selection of a region of
interest and spectral measurements at 275nm (Fig6.1.a.i) (3) Large mosaic at 890 nm (Fig6.1.a.v)
(4) selection of the same region of interest as in DUV to perform spectral (Fig6.1.a.vi) and FLIM
measurements (Fig6.1.a.vii) at 810 and 890 nm. Once data acquisition was completed, analysis
followed : (i) spectral ﬁtting of the data at each wavelength using homemade Matlab program
(Fig6.1.a.i & viii) (ii) Fitting of the lifetime data with Symphotime software (Fig6.1.a.ix) (iii)
Phasor analysis of the lifetime data (iv) construction of discriminative algorithm combining the
diﬀerent analysis results and (v) comparison with the gold standard histology(Fig6.1.a.iii).
6.2.2.2 Samples preparation
A collaboration with the anatomopathology and neurology departments of the Saint-Anne Hos-
pital (Paris, France) provide a large cohort of human biopsy samples. The protocol of experimenta-
tion was approved by the Institutional Review Board of Sainte Anne Hospital (Ref CPP S.C.3227).
Fifty-one individuals (31 males, 20 females; age average 54.1±17 year-old) were included and an
informed written consent was obtained from all patients prior to enrollment. Frozen human brain
tissues, conserved at -80◦C, were obtained from two types of tumor (21 metastasis samples, Meta;
17 glioblastoma samples, GBM) and Control specimens (13 patients with no history of tumor)
selected from epileptic surgery. The metastases were originated from lung, breast, bladder and
skin. The characteristics of the cohort are summarized in Table 6.2 . A dedicated transport (360◦,
France) brought the selected cohort to the IMNC laboratory (Orsay, France). Samples were con-
served at -80◦C, before being transferred to a -20◦ freezer 24 hours before being cut with a cryostat
(Leica CM 1950). Ten-micron slices were deposited on quartz coverslips and microscope slides, and
ﬁxed with an ethanol solution (100%). The quartz coverslips were brought to the Synchrotron in a
dedicated box, and the microscope slides were used for H&E staining and two-photon imaging on
the PIMPA platform.
6.2.2.3 Histological Process: Hematoxylin and Eosin Staining
A gold standard Hematoxylin and Eosin (H&E) staining was performed on one of the microscope
slices following the Sainte-Anne hospital protocol [61] whose steps are hydration, H&E staining,
dehydration, and toluene ﬁxation. Once stained the samples were imaged in a Digital Slide Scanner
NanoZoomer 2.0 (Hamamatsu Photonics K.K, Hamamatsu, Japan).
6.2.2.4 Deep-Ultraviolet imaging and spectral measurements
The Deep-Ultraviolet (DUV) measurements were performed on the DISCO beamline at the
Synchrotron SOLEIL [313]. Two set-ups, a full-ﬁeld microscope (Zeiss Axio-observer Z-1) and a
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microspectroﬂuorimeter (Olympus IX71), were used for this study. The samples were excited with
the continuous emittance from the DISCO beamline bending magnet between 275nm and 335nm.
The details of the set-up have been presented in other studies [314, 315]. A large mosaic of the
sample was made under the full ﬁeld microscope with an excitation wavelength of 275nm and four
emission ﬁlters (307-323nm, 323-357nm, 408-438nm and 435-455nm, Semrock, USA) in front of a
detector (CCD camera, Pixis BUV, Princeton Instrument, USA). Regions of interest were then
selected in this mosaic and spectral measurements were done with the microspectroﬂuorimeter at
the same excitation wavelength. One second integration time and a ten microns lateral step size were
applied. An Excitation-Emission matrix was also measured using the microspectroﬂuorimeter. An
emission spectrum was acquired for each excitation wavelength from 275nm to 335nm every 10nm.
6.2.2.5 Two-photon imaging and quantitative measurements
A two-photon benchtop microscope (TCS SP8 MP microscope, Leica Microsystems, Wetzlar,
Germany) combined with a Ti:sapphire laser source (Mai Tai DeepSee, Spectra-Physics, Santa
Clara, USA) was used to perform ﬂuorescence imaging (TPEF), emission spectra and ﬂuorescence
lifetime imaging (FLIM). The set-up and acquisition methods are described thoroughly in our
previous work [216, 223]. The measurements were recorded on the same region of the sample as
the one imaged with the DUV excitation. On each region TPEF and SHG image were recorded
using 890 nm excitation wavelength. Then spectral and FLIM analyses were performed using 810
and 890nm excitation wavelength. Excitation-Emission matrices were also measured by acquiring
a spectral stack at excitation wavelengths between 740 and 940 nm every 20 nm.
6.2.2.6 Data analysis
6.2.2.6.1 DUV analysis
DUV full-ﬁeld images were processed, using Image J, to create a merged image of the fourth
detection ﬁlter and to visually identify any diﬀerence between tissue regions. The spectral re-
sults were analyzed using lab-written Matlab script and the PLS toolbox (Eigenvector Research
Inc.,WA,United-States). Two types of analyses were performed on the data. First was a clus-
ter analysis to extract spectral signature of tumoral region, and second was a ﬁtting analysis to
compare tissues at a molecular scale. In the ﬁrst method, the data were ﬁrst preprocessed using
lab-written scripts developed by SOLEIL and IMNC teams, in order to: (1) reduce the noise, (2)
suppress dead pixels, (3) set-up a baseline, and (4) normalize to the maximum of the cohort. Then
a discriminative cluster analysis (DCA, K-Means) was applied to all the pixels of every images using
the PLS toolbox. The number of input clusters was chosen iteratively looking at the results, and
ﬁxed at ﬁve in our case. The second analysis applied on the spectral data was a spectral ﬁtting
of the diﬀerent molecular contributions. The ﬁt was performed using a lab-written Matlab script
previously used on visible and near infrared autoﬂuorescence data [216, 223] and adapted to the
DUV data. The results of the ﬁt were used to compare diﬀerent molecular ratios. The ratio between
tryptophan and collagen crosslinks was given a particular attention, but tyrosin/tryptophan and
tryptophan/NADH ratio were also computed to build a robust discriminative marker.
6.2.2.6.2 Two-photon analysis
TPEF images were processed using Image J, in order to produce both a good quality and
scaled image of the merged TPEF-SHG signal. The images were then compared with H&E images.
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After highlighting the histological structure on the TPEF images, a neuropathologist was asked
to perform a blind analysis. The analysis was done on paired TPEF and H&E images from 25
samples (10 metastases, 8 glioblastomas, 7 controls). First, a senior neuropathologist, blind to
the TPM results, performed an initial histopathological analysis. No specimen was excluded due
to lack of histopathological representativeness. Then, six months later, we presented a web-based
survey of the TPEF images (PNG TPEF/SHG images) and the participant was asked to classify the
sampled tissue in four categories: 1) GBM ; 2) Meta; 3) healthy tissue; or 4) unclassiﬁed. Although
completely blind to the initial histological analysis, the participants had access along with the TPM
images, to typical clinical data including patient's age, gender, clinical presentation, tumor location,
and pre-operative MRI images. These results were then compared to initial histological analysis to
calculate the accuracy of the diagnosis on TPEF images.
The spectral stacks were opened in Image J to extract ﬁve spectral region of interest (ROIs) in
each of the 810 and 890nm images, and then processed in Matlab. The obtained spectra were ﬁtted
using a lab-written Matlab script previously published and used on meningioma samples [216]. Five
autoﬂuorescent molecules were ﬁtted: NADH, Flavin adenine dinucleotide (FAD), Lipopigments,
Porphyrin I and Porphyrin II. The results of the ﬁt were used to compute two indicators according
to the literature [117, 222]. The oxydo-reduction ratio between NADH and FAD:
ROx =
FAD890
FAD890 +NADH810
(6.1)
And the optical index ratio between NADH and porphyrin:
OI =
PorphyrinI890
NADH810
(6.2)
The NADH values were extracted from the emission spectrum using 810 nm excitation wave-
length and the FAD and Porphyrin from the emission spectrum using 890 nm excitation wavelength.
To be comparable, the spectra were normalized by the excitation power.
As with spectral data, the FLIM data were analyzed using two methods, ﬁtting and non-ﬁtting,
which were developed. First, bi-exponential ﬁtting  the method implemented in the acquisition
software (Symphotime Vx64, Picoquant)-was used. On each image the same ﬁve ROI as for spectral
measurements were selected, and on each ROI the ﬂuorescence decay histogram was bi-exponentially
ﬁtted. The amplitude average lifetime was extracted from this ﬁt using a method previously pub-
lished on bladder tumor [316]. The second implemented method used a non-ﬁtting process, called
phasor analysis. We started with the time-correlated single-photon counting (TCSPC) detection
of ﬂuorescence decay curves at each pixel of a 3*3 mosaic image. The intensity of a 32*32 pixel
(a 28±m-side) square was added together to obtain the decay I(t) at each reduced pixel. In the
phasor approach, the decay I(t) at each pixel is transformed into two coordinates in a Cartesian
plot according to the following equations:
Si(w) =
∫∞
0
I(t)cos(ωt)dt∫∞
0
I(t)dt
(6.3)
Gi(w) =
∫∞
0
I(t)sin(ωt)dt∫∞
0
I(t)dt
(6.4)
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where, Si(ω) and Gi(ω) are the x and y coordinates of the phasor in the phasor plot, respectively;
ω is the angular repetition frequency linked to the signal length (L) and the sampling period (Ts)
by the relation: ω = 2pi/(LTs). We stored for each pixel Si(ω), Gi(ω) and Mi - the normalized
integration under the decay of each pixel to provide the phasor histogram of the 3*3 mosaic image.
A global phasor histogram grouping the data of all the samples (n=51) was plotted. Five areas were
selected on this global phasor histogram and the images were reconstructed with a ﬁve colors-scale
corresponding to selected area. Pixel colors criteria following Eq. 6.5 were used to compare the
data from each group.
log
%green pixel +%blue pixel
%red pixel +%yellow pixel
(6.5)
Value of ﬂuorescence lifetime was also determined in this analysis using an error ellipse method.
An ellipse that should contain 95% of phasor counts in each area was ﬁtted on the ﬁve areas of the
global histogram. The two intersections between the major axis and the circle segment are linked
to the two lifetimes and their contributions.
6.2.2.7 Statistical analysis
The diﬀerent computed ratios were compared statistically with t-test in Matlab to obtain a
p-value with a criteria of signiﬁcance at p<0.5. The representation in scatter plot and the blind
analysis were evaluated by deﬁning the sensitivity (Se) and speciﬁcity (Sp) of the discrimination
criteria, following Eq. 6.6 and Eq. 6.7.
Se =
TP
TP + FN
(6.6)
Sp =
TN
TN + FP
(6.7)
The variables were TP = True Positive, FP= False Positive, TN= True Negative and FN=
False Negative, deﬁned as: TP=Tumoral tissue classiﬁed as tumoral, FP=Control tissue classiﬁed
as tumoral, TN=Control tissue classiﬁed as healthy and FN=Tumoral tissue classiﬁed as healthy.
6.2.2.8 Multiscale discriminative algorithm
In the various excitation ranges the three best indicators were chosen: (1) Porphyrin/NADH
ratio using two-photon excitation, (2) Tryptophan/collagen crosslinks ratio at DUV excitation and
(3) the average lifetime using 890nm excitation. A region of interest measured in our protocol
could be then represented in the 3D-scatter plot with these three indicators as its coordinate.
The scatter cloud of a group was ﬁtted by a Gaussian ellipsoid using the mean and the standard
deviation as parameters for the covariance with the ellipse to cover 60% of the total probability
mass. The percentage of overlap between the ellipses for each group was then calculated to assess
of the performance of such algorithm.
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Figure 6.2  Analysis of the Deep-UV data. Comparison of the three tissue groups control (a,d,h),
glioblastoma (b,e,i) and metastasis (c,f,j) with diﬀerent analysis methods: wide-ﬁeld(WF) imaging
(a,b,c), spectral clustering (d,e,f) with a 5-cluster decomposition shown on a graph (g), map of the
tryptophan/collagen ration (h,i,j) with comparison of selected ROIs(k). Molecular analysis of the
tryptophan/collagen ratio (l), the tryptophan/NADH ratio(m) and the tyrosin/tryptophan ratio(n)
combined in 3-D scatter discrimination plot (o).
6.2.3 Results
In this large study, we ﬁrst look at the results under DUV excitation. The Figure 6.2 presents
a summary of the analysis results and discrimination reached in this excitation range.
Figure 6.2a.b.c shows an example of the superposition of the tryptophan (green) and collagen
channel of wide-ﬁeld (WF) image in each group. The control image presents an homogeneous color,
while in primary and secondary tumor some regions show a diﬀerent color, exposing a variation in
the tryptophan-collagen ratio in tumoral tissue. Based on this observation a method of clustering
was applied to the spectral data to validate this hypothesis and to see if two types of spectral
signatures were highlighted.
The ﬁgure 6.2.d.e.f shows the results of the spectral cluster analysis on the same region as the
one on the WF images. The spectra corresponding to each color are superposed in the ﬁgure 6.2.g.
The two dominant colors in control (red and pink) correspond to spectrum with a main peak in
the tryptophan range and a secondary peak in the collagen crosslinks range, where the diﬀerent
dominant colors (blue and cyan) in tumor correspond to spectrum with only one main peak in the
tryptophan range. These results led us to track the ratio between the two main peaks of the DUV
spectral response, the Tryptophan/collagen ratio.
Figure 6.2h.i.j gives an example of the Tryptophan/collagen ratio in a tissue of each group,
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Figure 6.3  Analysis of NIR data. Comparison of three tissue groups : control (a,e,k), glioblas-
toma(b,f,l) and metastasis (c,g,m) with diﬀerent imaging techniques H&E (a,b,c), TPEF imaging
(a,f,g) and FLIM (k,l,m). Results of the "blind" analysis on TPEF for diagnosis (d). Boxplot of
the spectral molecular analysis, redox ratio (h) and optical index (i), these results were combined
in a scatter plot (n). Boxplot of the average lifetime (j). 3D-scatter of the two molecular indicators
and the average lifetime to build a discriminative algorithm (o).
the ratio being higher in tumoral groups than in control group. The results of the selected ROI
are plotted in the Fig.6.2.k. A threshold value distinguishes tissue type: below 2.8 the tissue is
healthy, above 3 the tissue is tumoral. After validation of this method a larger statistical analysis
was performed on all the sets of tissue and new molecular ratios were tested. The results are
shown in Fig.6.2.l.m.n. The Tryptophan/collagen ratio showed a signiﬁcantly higher ratio in control
tissue (p<0.01). The Tryptophan/NADH ratio also showed the same trend but with less statistical
signiﬁcance (p=0.13). The third ratio, Tyrosine/Tryptophan, showed a lower value in tumoral
tissue than control (p<0.01). To ﬁnd a discriminative algorithm with statistical signiﬁcance, these
three molecular ratios were extracted in ﬁve ROI in diﬀerent types of tissue, and projected as
the coordinate of the ROI in a 3D-scatter plot (Fig6.2.o). A discriminative cross-section could be
drawn between tumoral tissue (red dots) and control tissue (green dots), with calculated algorithm
speciﬁcity of 73% and sensitivity of 90%. This discriminative algorithm has a high sensitivity,
making it a good diagnosis tool, ruling out tumor presence with precision. However it still gave a
non-negligible level of false positives.
The data obtained in the NIR excitation range were tested with similar approaches. The results
are shown in Figure 6.3.
The ﬁrst approach was to compare the TPEF images to the histological gold standard H&E
images to ﬁnd the structure used to discriminate tissues The TPEF images are a merger of autoﬂu-
orescence emission, red contrast, and SHG signal, green contrast. In the control, typical cortical
arrangement of neurons (dark violet triangular spot in H&E), showed a strong uorescent spot on
the TPEF images. In the glioblastoma,large vessels, identied by light pink structures in H&E and
lament in SHG green channel. The vessels are surrounded by a high density of tumor cells, identied
with an intense signal in the uorescence image. In the metastasis, strong neovascularization with
tumor cells entangled, light pink signal signal in H&E surrounded by high density of cells, were iden-
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tied on the TPEF images by a strong SHG signal with bright uorescent spots. Thereafter the TPEF
were given to senior neuropathologist for blind diagnosis in order to evaluate the capability of direct
diagnosis on TPEF images. The senior pathologist was able to discriminate tissues with a speciﬁcity
of 50% and a sensitivity of 75%. Next the quantitative results were analyzed on each TPEF image
region. A spectral response with a 810 and 890nm excitation was measured and diﬀerent molecular
indicators were calculated at diﬀerent regions of interest for every tissue. The two spectral markers
calculated were the redox ratio and the optical index. In Figure 6.3.h, the redox tended to be higher
in tumoral tissue and discriminative between tumor types (pcontrol−GBM<0.01, pcontrol−meta=0.06,
pGBM−meta<0.01). The optical index is also higher in tumoral tissue and can discriminate primary
from secondary tumor (pcontrol−GBM<0.01, pcontrol−meta=0.01, pGBM−meta<0.01). Complemen-
tary quantitative measurements were performed on the samples: extraction of the average lifetime
using a ﬁtting method applied on the various regions of interest, and boxplot comparison of dif-
ferent tissue types, as shown in Figure.6.3.j. This method could discriminate the three types of
tissue (pcontrol−GBM<0.01, pcontrol−meta<0.01, pGBM−meta<0.01). The results were combined to
develop a discriminative algorithm. First we used the two most eﬃcient indicators, optical index
and average lifetime (Figure 6.3.n.). Results with speciﬁcity and sensitivity respectively of 92 and
95% are shown in a 2D-scatterplot. To improve the diagnostic algorithm, a third piece of informa-
tion was added to represent the data in a 3D-plot (Figure 6.3.o.). A cross-section was drawn to
obtain a sensitivity of 97% and speciﬁcity of 100%.
The best method to directly discriminate tissue types was shown to be lifetime measurements.
We decided to investigate it more in detail by implementing another analysis method, called the
phasor approach [133] which helped to uncover a discriminative indicator without ﬁtting of data.
The results are shown in Figure 6.4.
Control, GBM and Metastasis decays were gathered on a global phasor counts, Fig.6.4.a. In
this phasor plot ﬁve local maximums of counts were observed and selected in order to assign a
diﬀerent color to pixels within each region. Each image using the phasor plot was displayed with
this color code. Examples are shown in Figure 6.4.b,c,d,I,j,k. and compared to the fast FLIM
images obtained by the microscope software. The images show green and blue dominant in control,
while red and yellow are more present in tumoral tissue. To quantify this diﬀerence a color ratio
was deﬁned and calculated in each sample. The results, comparing the tissue groups, are presented
in Figure 6.4.l. Each tumor could be diﬀerentiated from the control tissue (Control-GBM : p=0.03
and Control-Metastasis : p=0.02). However it did not give a signiﬁcant discrimination between
primary and secondary tumor. The green and blue areas, occupying the majority of healthy tissue,
had an average lifetime around 1.4-1.6 ns, while control had a mean average lifetime around 1.3ns
in the ﬁtting method. Yellow and red areas, occupying the majority of tumoral tissue, had average
lifetimes around 1.8-2 ns, while the GBM mean was around 1.6 ns and the metastasis mean around
1.9 ns in the ﬁtting method.
From DUV to NIR, various interesting discriminative indicators were highlighted. To improve
the capacity to discriminate not only control from tumor, but also tumor types from one another,
the three most eﬃcient indicators were combined for scatter plotting the groups in 3D space to
highlight discrimination. The results with the indicators, Porphyrin-NADH ratio at two-photon
excitation (Optical Index), Tryptophan collagen ration at DUV excitation (DUV ratio) and the
average lifetime at 890nm, are shown in the Figure 6.5.
This 3D algorithm was used to ﬁnd an accurate discrimination between a healthy region and
any tumoral region, Figure 6.5.a., the points of each type were approximated by an ellipsoid giving
an overlap of only 1.8%, resulting in high rate of tumor discrimination. This algorithm was also
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Figure 6.4  Phasor analysis of the FLIM : (a) Global phasor histogram with the selected zones and
the error ellipses. (e) Average lifetime ﬂuorescence decay calculated in each zones. (l) Boxplot of
the pixel colors criterion with p-values of the control-tumor test. Comparison of three tissue groups
control (b,f,i,m), glioblastoma (c,g,j,n) and metastasis (d,h,k,o) with rebuilt images of the phasor
analysis (b,c,d,I,j,k) and Fast FLIM of the microscope (f,g,h,m,n,o).
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Figure 6.5  Discrimination of tissue types combining three indicators: Porphyrin/NADH ratio
using two-photon excitation (Optical Index), Tryptophan/collagen ratio at DUV excitation (DUV
ratio) and the average lifetime using 890nm excitation. (a) Results comparing Control and any
tumor types. (b) Results for Control, primary tumor (GBM) and secondary tumor (Metastasis).
used to look for discrimination between tumor types, Figure 6.5.b., primary tumors had only 6.7%
overlap with secondary tumors. This second 3D-plot also showed that the secondary tumors could
be unambiguously discriminated from the control tissue.
6.2.4 Discussion
In this study excitation ranging from DUV to NIR, various detection contrasts, and multiple
methods of analysis were applied to biopsied brain tissue of three types: primary tumors (n=17),
secondary tumors (n=21) and controls (n=13). We demonstrated that: 1) Tumor could be discrim-
inated from control in the DUV excitation range using molecular ratio 2) The merged TPEF-SHG
images revealed features similar to those seen in standard neuropathology, and could discriminate
tumor from normal tissue 3) Quantitative TPM signals also discriminated between tissue types
combining molecular ratio and average lifetime 4) Lifetime measurements analyzed with a phasor
method gave a discriminating criteria signiﬁcantly (p<0.05) distinguishing control from tumor tis-
sue. 5) A multiscale discriminative algorithm, could graphically separate the tissue types in a 3D
plot.
First, using DUV spectral response and cluster analysis, we showed that a distinguishing spectral
signature for tumoral versus healthy tissues, quantiﬁed in the tryptophan and collagen peaks ratio
calculated on all spectral mosaic, with <2.8 being healthy, and >3 being tumoral. Few studies
have exploited DUV excitation of Tryptophan. Pradhan et al. [317] studied Tryptophan/NADH
and found a higher ratio in metastasis tissue, similar to our ﬁndings in ex vivo human brain tumor.
The autouorescence of collagen has also been studied in tumor with a UV excitation. Georgakoudi
et al. looked at cervical lesions and Barett's esophagus and found lower collagen signal in high-
grade dysplasic legions [340]. Pu et al. collagen emission in prostate cancer, and showed a decrease
in tumor region. They looked at the NADH/collagen ratio for a robust quantitative indicator
of tissue nature [306]. The actual state of art is often comparing one or two molecules to ﬁnd
discrimination. A four molecule analysis was performed to get closer to clinical expectations of
accuracy and repeatability. A 3D discriminative algorithm using three molecular ratios achieved
speciﬁcity of 73% and sensitivity of 90% and thus could be used as diagnostic tool. However, low
speciﬁcity indicates signiﬁcant false-positives when a tumor is detected.
Secondly, we used the NIR images superposing two modalities: ﬂuorescence emission and second
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harmonic generation, to highlight tissue structure comparable to the histological standard for tumor
diagnosis. A neuropathologist was asked to perform a histological diagnosis blind to the H&E
results. This test showed discrimination with a sensitivity of 75% and a speciﬁcity of 50%. Training
neuropathologists on TPEF images could improve these results since this trial was a rst time
experience using this imaging modality. Blind analysis of TPEF-SHG images have never been
performed before on brain tumor, but on other types of cancer, such as gallblader cancer [280],
breast masses [281], and liver cancer [282]. In these analysis, they found even higher results than
us with accuracy of discrimination around 90%, due to training of the neuropathologist on bigger
sets of data. Analysis directly on TPEF images have advantages over staining technique, such as
time management and tissue preservation, however it still requires a trained neuropathologist to
diagnose based on visual observation. The real advantage of optical microscopy in our study is
the capacity to provide more parameters and new measurements, feeding into data analysis and
visualization that support automated distinguishing of tissues. Two-photon excitation provides
other parameters besides ﬂuorescence intensity: the ﬂuorescence lifetime and SHG. We use the
power of these techniques to achieve a better discrimination of the nature of tissue by combining
the results of molecular analysis on emitted spectrum and the lifetime analysis of the same region.
The combination in 3D-plot of: (1) the average lifetime, (2) the FAD/NADH ratio and (3) the
Porphyrin/NADH gave the best discrimination with a 97% sensitivity and 100% speciﬁcity. This
type of analysis were already published only with visible, one-photon excitation [135]. Other groups
tried to build a 2D algorithm, using visible excitation : Liu et al [117] studied redox ratio and
spectral shape with a 89% sensitivity and a 97% speciﬁcity. Lin et al [124] analyzed ﬂuorescence
intensity and reﬂectance at 337nm, with a one-step algorithm yielding sensitivity and speciﬁcity
under 85%. A two-steps algorithm gave them better results (sensitivity, 100%, speciﬁcity, 76%).
However we can achieve similar results with a one-step algorithm, which is easier to implement in
a clinical workﬂow. Thirdly, using two photons imaging, only the ﬂuorescence lifetime produced
signiﬁcant discrimination among the three types of tissue (p<0.01). Due to their independence from
concentration, ﬂuorescence lifetime measurements have been the most popular technique. Several
teams have tried to implement it with various analysis algorithms to answer the question of glioma
margin resection. Sun et al [136] used the Laguerre coeﬃcient value and found a longer lifetime
in GBM than normal tissue with a p-value<0.05. They preferred this technique because there is
no deconvolution process of the data, avoiding any assumption on the decay shape. Another non-
ﬁtting technique is the phasor approach [133]. This is the second method we tried, since it oﬀers a
very graphical representation of data. The phasor approach showed ﬁve distinct regions, with some
being predominant in tumor and others in control tissue. From this a numerical indicator from
region repartition was exploited and resulted in a signiﬁcant diﬀerence between tissue types (0.023
< p-value< 0.031). However, compared to the exponential ﬁtting, primary and secondary tumor
could not be discriminate. Other exploitations of phasor plot exist [318], that could be implemented
to improve these results.
We took advantage of our multiscale analysis and designed a graphical discriminating algorithm
based on spectral DUVmeasurements, spectral NIR measurements, and lifetime NIR measurements.
We distinguished an ellipsoid region for each type of tissue. Primary tumor and control had only
1.8% of overlap. Secondary tumor and control had 0% overlap and primary and secondary tumor
had 6.7% overlap.
This study highlights the capability of discriminating brain tissue type from one another, tumoral
from control, but also tumor types from one another. This was achievable by combining the dierent
quantitative and qualitative measurements accessible with optical microscopy. The technique used
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in this study can be implemented in real-time in the operating room with fast and direct analysis.
These results are bringing us closer to clinical use and could improve the surgical practice of tumor
resection. The perspective of this study are to extend the work to fresh tissues and other tissue
types to get information closer to the in vivo condition and improve the discriminating algorithm.
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Chapter 7
Discussion and Conclusion
In this thesis project intrinsic ﬂuorescence signal of tissue has been extensively analyzed using
diﬀerent excitations and contrasts. Three goals can be extracted from this project : 1) to show
autoﬂuorescence signal, as a powerful contrast for brain tissues diagnosis, 2) to develop data analysis
and robust algorithms required to ﬁt into surgical workﬂow, providing reliable in vivo guidance,
and 3) comforting the development of the multimodal two-photon endomicroscope, presenting an
architecture resolving current issues in a clinical setting. Interesting and promising results have
been obtained for each step. In this last chapter, I will discuss their signiﬁcance, where they ﬁt in
the literature landscape, and look at the prospects of getting closer to clinical use.
7.1 Autoﬂuorescence as a diagnosis tool
At present, the key limitation of intra-operative techniques is the lack of cellular level reso-
lution imaging. To discriminate areas with very low concentrations of tumor cells, the standard
is still H&E-stained histopathology, an ex-vivo technique also used to diagnose tumor types and
grades. The aim of this work is to address this challenge and to present a technique that could be
implemented in the operating room and result in direct discrimination for the surgeon.
Two approaches have been explored and combined to answer this question. First, ﬁnding a label-
free imaging technique showing the same cellular features as the techniques now used in histology.
Secondly, being able to quantify and monitor cellular energetic metabolism, hemodynamic, or even
structural changes in order to identify anomaly in the tissue at a cellular scale and give an automated
answer to the surgeon. For this second point diﬀerent quantitative measurements were performed
on the autoﬂuorescence response of tissue using a large range of excitation from the deep-UV to
the NIR and on diﬀerent brain tissue cohorts.
7.1.1 Qualitative analysis of label-free ﬂuorescence images compared to
gold standard H&E-stained
Neuropathologists use H&E-stained images as a gold standard to identify brain tumor type and
grade. These diagnosis are based on the observation of tissue architecture observed by a pathologist.
Looking at three important groups of brain tumors, the diﬀerent features that are highlighted by
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pathologist are described here :
Glioblastoma tumor, a WHO grade IV glial tumor, is identiﬁed by [319] :
 Coagulation necrosis or microvascular proliferation with thickened vascular walls due to
increase in nuclei in vessel wall
 Hyper cellular with mitotic ﬁgures
 Pseudopalisading necrosis : tumor cells around necrotic zones.
Meningioma WHO grade I and II are identiﬁed by [320]:
 Lobulated architecture, often containing "meningothelial" whorls
 Syncytial cells with indistinct cell membranes
 Psammoma bodies
 Grade II have increased mitoses, cellularity and sheet-like growth pattern
 Grade II have areas of spontaneous necrosis
Metastasis, secondary brain tumor, revealed structures such as [321, 322]:
 Sharply demarcated from the surrounding brain
 Surrounding brain shows tissue depletion, neovascularization and gliosis
 Epithelial cells with discrete cell boundaries
 Dense vascular regions
Neuro-pathologic analysis happens ex-vivo and H&E staining is a long process, that takes several
hours to days. In order to have a shorter processing time to produce an image, the label-free
technique was explored. In this thesis two-photon microscopy was chosen to do the work. This
method gives access to the autoﬂuorescence of tissue but also to the diﬀuse signal of SHG from
non-centrosymmetric structures.
The two-photon imaging technique was used on three cohorts, ﬁrst to explore the possibility of
it on a large scope of brain tumors, second to discriminate the grade of meningioma and thirdly
to discriminate primary tumor glioblastoma and secondary metastasis tumor. In the chapter 3,
GBM, metastasis and meningioma were imaged in a ﬁrst exploratory study with a two-photon
excitation. In the TPEF-SHG images, area presenting organization and structure close to the H&E
standard were found. In the chapter 4, WHO grade I and WHO grade II of meningioma were
studied and TPEF-SHG images were compared to gold standard H&E. The SHG signal highlighted
the collagen whorls and psammoma, the sheet like architecture typical of grade II. In the chapters
5 and 6, primary and secondary brain tumor were discriminated using a two-photon microscope.
The TPEF-SHG images in glioblastoma highlighted typical structures such as enlarged vessels walls
(SHG) with surrounding dense cells (high TPEF intensity), and palisadic necrosis with circular-
like intense regions in TPEF images. The metastasis features could also be precisely highlighted
with SHG signal revealing the dense vascularity, and the cells architecture showing in the TPEF
signal. These observations were convincing enough to imagine the possibility of a diagnosis derived
directly from the two-photon images. In the literature on two-photon microscopy analysis of other
cancer types, blind analysis directly on the TPEF images has already been performed [280282],and
these studies resulted in high accuracy of diagnosis. The same approach was used in the chapter
5 to perform the ﬁrst blind analysis on brain tumor TPEF-SHG images, and this resulted in an
accuracy of 72% to discriminate tumor from healthy tissue. Tumor types were also diﬀerentiated
one from another resulting in an accuracy of 80%. The factor limiting higher accuracy was the
high rate of false positive 28% during this analysis. There were tissues that, based on the image,
could not result in any diagnosis. The solution for improvement at this point was better training
of the neuropathologist on the TPEF-SHG images as they are with the H&E images, using a
larger cohort of tissue. Another approach presented in chapter 5 proposes to use a deep-learning
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algorithm to transform the autoﬂuorescence images in a virtual histological stained image that the
neuropathologist could analyze with this already-known expertise.
Still, diagnosis based on a human judgement on an image presents high variability and often
low reliability among diﬀerent observers. Even the gold standard H&E analysis is subject to dis-
crepancies. Pathological analysis and reports are still the crucial central core of an oncological
diagnosis and choice of treatment course, making it a very sensitive point in the process and in
need of high accuracy [323]. However the diagnosis of CNS disease is the most challenging even
for the most experienced neuropathologist, and most especially in tumor diagnosis. A study was
made to look at the accuracy of diagnosis based on H&E stain between two diﬀerent observers. A
second opinion was performed on 500 cases and a major diagnostic error was found in 25% of cases
[324].The Childhood Brain Tumor Consortium looked at another source of discrepancies in intra-
observer reliability. Neuropathlogists had to re-evaluate a large number of their cases sometime
after the original, and it resulted in the same diagnosis in only 76% of cases [325]. The most errors
were in the glioma subtype, a crucial point given that most adult brain tumors fall into the glioma
category [323]. So even if H&E were to remain the gold standard, eﬀorts should be done to improve
diagnostic reliability, and strong challenges still remain in using such a subjective technique for
diagnosis.
Even if the ﬁrst direction was to improve the pathologist recall of diagnosis criteria and to
regularly edit the database and classiﬁcation of cancers, another direction taken was to use an
additional quantitative indicator as an added method for diagnosis. Immuno-histochemistery (IHC)
methods have appeared in the last two decades, as complementary to H&E-stained histology. These
methods are used to precisely identify the tumor cell type/origin, and to quantify cell proliferation.
They are even used to evaluate the boundary between tumor and the surrounding tissue using
speciﬁc antibodies to target proteins involved in important tumor process [326]. IHC brought
molecular information to the morphologic information provided by H&E-stained images to improve
accuracy of neuropathologist diagnosis. However these tests require a second set of staining and
so a longer process to arrive at a pathology report for the oncology team. We have seen before
that two-photon imaging can provide morphologic information close to the H&E standard in few
minutes or seconds. If this could be combined with an optical measure that provides molecular
information, this would result in accurate discrimination using only one label-free technique that
could be used in-vivo.
In the chapter 4, the grading of meningioma was explored and an IHC method, the Ki-67
proliferative index, was used to precisely assess the tumor grade. The spectral intensity of each
tissue was compared to the proliferative index and a direct correlation was found between the two
measurements, hinting that spectral response and more generally autoﬂuorescence emission could
translate molecular processes happening in tissue and give a precise quantiﬁcation of the tissue
nature. Based on that observation and knowledge of the molecules contributing to the spectral
emission, quantitative studies were performed on brain tissue using optical microscopy methods to
elaborate an automated discrimination method.
7.1.2 Quantitative measurements based on autoﬂuorescence emission
7.1.2.1 Redox ratio to monitor energetic metabolism
Two important cofactors of cellular energy metabolism are the NADH and FAD that can be
present in the cells in oxidized form (NAD+, FAD) or reduced form (NADH, FADN2), playing
donor and acceptor in ATP formation [114, 327]. Glycolysis and oxidative phosphorylation are the
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two main processes involved in energy metabolism. In the glycolysis process NAD+ is consumed to
produce NADH, and in the mitochondria at the end of the process FAD is consumed to produce
FADN2. In the oxidative phosphorylation process to produce ATP, NADH is the main donor while
FAD is the main electron and proton acceptor. Diﬀerence between healthy and tumor tissue is
the equilibrium between these two energy producing reactions. It has been shown that tumor
cells privilege glycolysis even in normal oxygen conditions, making NADH dominant compared to
FAD [114, 116]. NADH and FAD are two molecules that can produce an autoﬂuorescence signal
when excited at suited wavelength. Because they are complementary molecules in the cell energy
metabolism process, monitoring their ﬂuorescence ratio will translate the state of metabolism in
tissue. It can be deduced if the tissue is privileging a glycolysis or oxidative process and thus
showing if the tissue is tumoral or healthy. Diﬀerent ratios have been explored in the literature
depending on the tissue explored and the setup used.
 FAD/(NADH+FAD) [328]
 (FAD-NADH)/(FAD+NADH) [217]
 NADH/FAD [329, 330]
The ratio with NADH at the denominator resulted in higher response in tumor than in healthy
tissue [329, 330], translating a glycosides dominant pathway in energy production in tumor. On
the contrary, ratio with FAD in the denominator, resulted in lower response in tumor than healthy
tissue [217, 328], translating of the reduced use of oxidation phosphorylation pathway to produce
ATP.
In this thesis the redox ratio was used to discriminate the diﬀerent brain tumor regions from
healthy regions using diﬀerent formula of the redox ratio. In chapter 2, ﬁxed brain biopsies
of diﬀerent tumor types were studied under visible excitation (375 and 405nm) and the spectral
response was measured. NADH and FAD contribution to the spectrum were extracted using a ﬁtting
algorithm, and the redox ratio was calculated using the equation (FAD-NADH)/(FAD+NADH). All
the tumor tissue resulted in a lower redox ratio than the one found in control tissue (p<0.001),which
correlated with results in the literature [217]. However the types of tumor couldn't be discriminated
from one another signiﬁcantly. In chapter 5, a similar analysis was performed on fresh tissue to
compare primary and secondary tumor to healthy tissue, and the NADH/FAD ratio was used to
monitor the cellular metabolism. Control tissue had the lowest redox ratio, while secondary tumor
and primary had the highest ratios and could be signiﬁcantly discriminated from healthy tissue.
These results are correlated to the hypothesis of a favored glycolysis pathway in tumor tissue, as
already shown in the literature for other types of tumor [329, 330] and in rat brain tumor [117,
128].
Even if the redox ratio can highlight diﬀerences between tumor and healthy tissue and gives
a signiﬁcant discrimination in some cases, it is not reliable enough to be used alone as a deﬁnite
discrimination tool in the operating room. Other parameters of ﬂuorescence and molecular ratio
have been quantiﬁed to be complementary to the metabolic response and bring more reliability to
discrimination based on the intrinsic optical response.
7.1.2.2 Quantiﬁcation of ﬁber organization
Collagen is one of the main proteins of the ECM in tissue, varying in types and structures. Col-
lagen of type I and III are composed of triple-helical macromolecules that are non-centrosymmetric
and result in a SHG signal [301]. This optical modality can consequently be used to monitor ECM
organization in tissue and highlights changes due to cancer. In some major cancer types, systematic
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methods of quantiﬁcation have been developed to quantify diﬀerent cancer types [331]. Some teams
have looked at the ratio between SHG collagen signal and ﬂuorescence signal from elastic tissue,
sometime called the SAAID (SHG-to-AF Aging Index of Dermis) value [331]. It is a method used
in skin cancer for example to identify margins of basal cell carcinoma, with the highest SAAID
value in tumor [332, 333]. In breast [285] and ovarian cancer [331], the orientation of ﬁbers at
tumor-stroma boundaries (TACS) was used to quantify and classify into three stages of tumor from
early disease(TACS-1) to highly invasive tumor (TACS-3). Some teams also measured the organi-
zation of ﬁber using a Fourier transform method, for example in colonic cancer showing a certain
organization in cancer tissue compared to random organization of healthy regions [334]. In other
tumors, they only calculated the density of SHG pixels in the studied regions. With for example in
renal ﬁbrous, density and average value of SHG computed in three scores [283]. In the evaluation
of neck margin in pancreatic cancer, pixel density of collagen was evaluated [284].
In brain tumors, collagen ﬁber structures are not as present as in other tumor types such as
breast cancer or bladder cancer. The main groups showing signiﬁcant SHG signals are the metastasis
that developed dense vascular organization to migrate and also meningiomas that arise from dura
matter in a region made of highly ﬁbered organization. GBM could still result in more SHG signal
than control due to the thickened vessels walls. From these observations, a quantitative indicator
of SHG was used in the study of fresh biopsies from primary and secondary tumor. It was chosen
to track the intensity of SHG and resulted in signiﬁcant discrimination of the metastasis tissue.
GBM in some cases gave a higher intensity, however it was not always signiﬁcantly diﬀerent than
healthy tissue. In the literature, two studies looked closely at collagen ﬁbrillar formation in glioma
[335] especially GBM structures [336] and quantiﬁed the signal. In the ﬁrst study they looked at
TPEF-SHG images of glioma tissue compared to healthy cortex [335], and calculated the ratio of
SHG pixels to overall pixels in each analyzed region. The ratio was higher in glioma than cortex
tissue. This was explained by the fact that in cortex tissue the ECM has a special composition made
up mostly of hyaluronic acid, and is usually devoid of the ﬁbrillar proteins, such as collagen, usually
found in the rest body [337]. However glioma are presented with collagen deposition in connective
tissue and newly formed vessels, which will produce a stronger SHG signal. Another feature of
GBM is the enlargement of vascular structures compared to normal tissue. A study showed that
ﬁbrillar structures will form in the vascular elements of GBM and quantify the formation using the
ratio of SHG pixels to the number of TPEF pixels in the vascular region, ﬁnding non-zero values,
and conﬁrming that SHG could be a means to discriminate GBM based on its vascular formation
[336].
7.1.2.3 Indicator of the molecular compositions
Using visible or two-photon NIR infrared excitation, another molecule that plays a role in cancer
metabolism can be excited, the porphyrin. In a lot of tumor investigation, it has been shown that
porphyrin will accumulate more in the tumoral tissue compared to healthy ones [128, 330]. This
makes porphyrin an interesting tumoral marker. Teams have started to look at the ratio of NADH
over porphyrin as another molecular indicator. In tumor, this ratio has been found to be lower, due
to the higher accumulation of porphyrin compared to NADH. In chapters 2 and 6 this indicator
was measured on ﬁxed tissues of primary and secondary tumor using visible and two-photon exci-
tation. Tumor tissue showed a lower NADH/porphyrin ratio than the control tissues, concurring
with the literature.
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In this thesis we looked at other excitation ranges ,such as the deep-UV, to be able to monitor
more molecules emitting autoﬂuorescence. These results are presented in the chapter 6. In the
deep-UV range three new molecules could be excited : tyrosin, tryptophan, and collagen. These
molecules were explored to ﬁnd more reliable ratios or correlations between diﬀerent molecules
excited from DUV to NIR. This will possibly result in more reliable discriminations or a greater
understanding of molecular interactions and metabolism in tumor tissue. In this study the tryp-
tophan/collagen ratio has shown the best results for discriminating tissue. A non-ﬁtting method,
called clustering, was applied to the spectral map and it highlighted variations in the spectral re-
sponse of the tryptophan/collagen ratio. This ratio was also calculated using a ﬁtting method and
a statistical analysis between primary and secondary tumor. The tryptophan/collagen ratio was
higher in tumor than control (p<0,01), which is in correlation with the studied literature [305].
Using a non-ﬁtting method such as spectral cluster analysis is an interesting and powerful
method to reach automated diagnosis, that will be based on an artiﬁcial intelligence rather than
a human judgement. This technique has shown a growing development, in infrared spectroscopy
techniques, such as Raman and FT-IR [338, 339], applied to tumor tissue discrimination. Studies
presented results with unsupervised and automated algorithms, based on spectral lap clustering,
even more precise than histology in some cases to identify presence of tumor, highlighting also
inhomogeneity in the tumor regions [308]. In our work, the possibility to apply the cluster to DUV-
visible autoﬂuorescence spectroscopy was demonstrated. The automated algorithms developed in
infrared spectroscopy, could consequently be now transferred to the DUV-visible spectroscopy to
obtained also unsupervised discrimination with 2D representation.
7.1.2.4 Fluorescence lifetime
Spectral measurements have provided interesting indicators to discriminate tumoral from healthy
tissue. However, it has often failed to discriminate between tumor types, limiting the reliability and
speciﬁcity of this method. Another problem is the diﬃculty of separating the response at a molec-
ular level due to the spectral overlap between the ﬂuorescence emission of each of the molecules.
Molecules like NADH can be presented in two forms in tissue, free or bound to a protein, and
the spectral emission of each form is only separated by 20nm, making it diﬃcult to separate them
spectrally [114]. Finally, spectral measurements are strongly dependent of the concentration of ﬂu-
orophores, and regions with a low density of tumor cells failed to give a signiﬁcant discrimination.
To improve these results and to take advantage of all the possibilities of autoﬂuorescence, another
parameter, the ﬂuorescence lifetime, was tracked in a diﬀerent study. This measure is independent
from the concentration of ﬂuorophore but is mainly dependent on the ﬂuorophore microenvironment:
pH, temperature, concentrations of ions and oxygen, binding to other molecules or conformation
[114]. Combining this method with spectral measurements could oﬀer a powerful tool to study
tissue nature. Table 7.1, illustrates the obtained results using ﬂuorescence lifetime to discriminate
brain tissue types.
On fresh tissue, using either one or two-photon excitation, the ﬂuorescence lifetimes of NADH,
FAD, and porphyrin at 405nm, or their average two-photon lifetimes at 890 nm, were always lower
in tumor than in healthy tissue. Higher grades of meningioma also presented a lower ﬂuorescence
lifetimes, leading to the assumption that the more aggressive is the tumor, the lower is the ﬂuores-
cence lifetime.
The results tracking the NADH component showed a decrease in tumor tissue. This decrease
could be related to the diﬀerent forms of NADH, which presents diﬀerent lifetime values, 0.3 ns for
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Compared tissue
tissue τNADH τFAD τPph τavg
state 405nm 405nm 405nm 890nm
Control to Primary Glioma
fresh ↘ ↘ ↘ ↘
ﬁxed ≈ ↘ ↗
Control to Secondary Meta
fresh ↘ ↘ ≈ ↘
ﬁxed ↘ ↗
Primary G to Secondary M
fresh ↘ ≈ ↘ ↘
ﬁxed ↗
Control to Meningioma
fresh ↘ ↘ ↘
ﬁxed
Meningioma GI to Meningioma GII
fresh
ﬁxed ↘ ↘ ↘
Table 7.1  Summary of the ﬂuorescence lifetime results for the diﬀerent brain tissue discrimination
studied in this thesis. ↘ : decrease , ↗ : increase , ≈ : same order in lifetime value.
the free form and 1.8 for the bound form [114]. Free NADH is localized in the cytosol and plays
a major role in the glycolysis process, while the bound form is localized in mitochondria and is an
actor in oxidative phosphorylation [114, 340]. It has been explained previously that tumor tend to
favor a glycolysis state, resulting in more abundant free NADH and therefore shorter lifetimes.
It could be possible to monitor metabolic state by studying the ﬂuorescence lifetime of free and
bound form of molecules. To exploit the free-bound fraction of NADH in ﬂuorescence lifetime,
more graphical analysis methods have been developed. The lifetime results presented until this
point have been extracted with a bi-exponential ﬁtting method. However a non-ﬁtting method has
been developed and provides direct graphical results of the free/bound fraction of NADH or FAD.
This method is called the phasor FLIM [133, 310, 341].
This method was implemented in the study described in chapter 6 of my thesis, looking at the
discrimination between primary and secondary ﬁxed brain tumor tissues. The phasor plot showed
ﬁve distinct regions in the pixel analysis that were associated with diﬀerent colors and re-projected
on false-color images. From that color criteria were used to separate tumor from healthy region.
This method showed a high accuracy in separating tumoral from healthy tissue, however was not
speciﬁc enough to diﬀerentiate primary from secondary tumor. To improve the accuracy of phasor
plot analysis and to take advantage of its graphical representation, teams have developed a method
to easily access the free-bound fraction of NADH [341]. This technique can also be applied to the
measurements of the free-bound FAD fraction and is currently under development in the lab for
further tissue studies.
7.1.3 From multimodal detection to automated algorithms
In the literature, studies based on ﬂuorescence spectroscopy or ﬂuorescence lifetime have been
able to highlight some discrimination [105, 130, 131, 332, 342]. Combining these two modalities
improves signiﬁcantly the sensitivity and speciﬁcity of a discriminative algorithm, as shown, for
example, by Butte et al. [252]. See table 7.2.
Other teams have tried using multi-contrast techniques for discriminating the nature brain
tissue in order to improve the accuracy of their discriminative algorithm. Using a multi-contrast
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Meningioma Normal Dura Normal Cortex
N=75 N=17 N=5
Spectral values only Sensitivity 61% 65% 100%
Speciﬁcity 73% 66% 98%
Time resolved values only Sensitivity 84% 77% 100%
Speciﬁcity 100% 91% 90%
Spectra+time-resolved values Sensitivity 89% 100% 100%
Speciﬁcity 100% 91% 99%
Table 7.2  Comparison of discrimination algorithm on a study of meningioma and dura matter
[252]
approach based on reﬂectance and spectral analysis, Lin et al. performed a pilot clinical trial on 26
brain tumor patients [124].two excitation wavelengths of 460nm and 620nm, and built a two-steps
algorithm combining the ﬂuorescence emission and the reﬂectance at each excitation wavelength.
This algorithm gave a sensitivity of 100% and a speciﬁcity of 76% between glioma inﬁltrative
margin and normal brain tumor [124]. Toms et al. tried two modality of discrimination using
337nm excitation wavelength [125]. For glioma solid tumor regions compared to healthy cortex
they obtained a sensitivity of 80% and speciﬁcity of 89%, and for glioma inﬁltrative regions, a
sensitivity of 94% and speciﬁcity of 93% [125]. This method gave promising results but wasn't able
to produce the same performance as the combination of spectroscopy and lifetime measurements
shown previously.
In this thesis, the approach of spectral and lifetime measurements was chosen to discriminate
tissue. In the chapters 2, 3 and 4, it was shown that each technique was able to give dis-
crimination on ﬁxed and fresh tissue with statistical signiﬁcance. The ﬁrst multimodal algorithm
for tissue discrimination was tried in the chapter 5, where freshly extracted biopsies of primary
and secondary brain tumor were observed using two-photon excitation, and combining spectral,
ﬂuorescence lifetime and SHG signals. A 3D representation combining the redox ratio, the SHG
intensity and average lifetime gave a clear distinction between healthy tissue, primary tumor and
secondary tumor. In chapter 5, a large cohort of ﬁxed brain tumor tissue was accessible and an
algorithm developed using multi-range and multi-modal analysis from deep-UV to NIR. The results
are summarized in table 7.3.
Our results showed that the multi-modal algorithm combining spectral and ﬂuorescence lifetime
provided the best accuracy, higher than 98%. It was then tried a multi-modal and multi-range
algorithm that combined NIR previous indicator to a molecular ratio in the DUV excitation range.
This resulted in a similar 98% accuracy, which conﬁrmed our results using two-photon excitation,
but did not improve it.
In the development of a discriminative algorithm, several stages are necessary to reach clinical
use. First is the training phase where the discriminative thresholds are determined. This were done
in the various chapters of this thesis, where thresholds have been tested using diﬀerent algorithms.
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Spectral
only
(275nm)
Spectral
only (810-
890nm)
Spectral-
lifetime(810
and
890nm)
Spectral-
lifetime(275,
810 and
890nm)
Sensitivity 90% 92% 97%
Speciﬁcity 73% 95% 100%
Overlap 1,8%
Table 7.3  Diﬀerent algorithm tried on ﬁxed tissue for discrimination between primary and sec-
ondary brain tumor in chapter 5.
Second,the test phase, were the thresholds have to be tested on a larger cohort. This stage is
a continuing part of the work of this study. Next, the algorithms have to be automated and
implemented in a measuring tool, which will lead to the stage of clinical trials. A prototype is
under development in my research team in order to reach in vivo test. The last phase during these
tests will be algorithm optimization to achieve the most reliable tool and certiﬁcation for clinical
use.
7.2 Optical development towards an intra-operative endomi-
croscope
7.2.1 First bi-modal non linear endomicroscope
I have had the opportunity to conduct my research project in a dynamic team, around an idea
that has received substantial ﬁnancial support. Several PhD candidates and interns were involved
with the project before and during my PhD, giving me the possibility to participate to their work
in order to be able to take part in all the diﬀerent aspects of such a large project. When I started
my PhD at the lab, the development of the two-photon endomicroscope had already started. The
architecture of the ﬁrst prototype had been chosen and put in place in a lab setting. See ﬁgure 7.1.
The chosen architecture was a pulsed MaiTai laser tunable from 690 to 1040nm. A pre-
compensation unit was used at the output of the laser. The unit was made of a 50cm SMF ﬁber and
a GRISM line [195]. A 2 m DCF ﬁber was used to excite tissue using a GRIN lens as an objective.
The emitted ﬂuorescence was collected by the same GRIN and DCF ﬁber to be sent into a spec-
trometer for this ﬁrst prototype. The ﬁrst endomicroscope prototype provides bi-modal spectral
and lifetime detection. However the ﬁnal goal is to add to it two PMTs to image ﬂuorescence and
SHG signal.
Using this setup two studies were performed previously to my PhD. In the ﬁrst one various
commercially available DCF's were tested and compared to determine if one of them might be
suited for two-photon excitation and detection at the same time [196]. In the second study the
collection capacities were further tested looking at the resolution obtained combining the ﬁber to
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Figure 7.1  Set-up of the ﬁrst developed two-photon endoscope [196].
diﬀerent GRIN lenses [197]. The tested ﬁbers were three step-index DCF's (Fibercore, Liekki,
Nufern) and one micro-structured DCF (Crystal Fiber). Measured optical characteristics using
800nm excitation wavelength were summarized in table 7.4.
The comparison showed that the micro-structured Crystal Fiber gave the best features at the
excitation, with the shortest pulse to date in the literature (24 fs) and a very good average power
(50mW) for exciting tissues [196]. The Crystal Fiber DCF was also characterized at the collection
using various GRIN lenses and showed poorer lateral resolution compared to other ﬁbers [197]. The
better performances of the Crystal Fiber were due to the high NA of the inner cladding, which is
needed for two-photon detection [196], where its poorer lateral resolution was due to a too large
core diameter, 16µm. The Crystal Fiber is also the most expensive of the four ﬁbers, which is
a drawback for its prospective use in clinical settings [197]. These two studies showed that an
adequate ﬁber did not yet exist, but that it should ideally have a conﬁguration close to the Crystal
Fiber DCF with a smaller core diameter. To achieve that, a collaboration was put in place with
the group of Alexandre Kudlinsky (PHLAM, UMR8523, Lille) to build a customized DC-PCF. The
characteristics of such ﬁber are detailed below :
 Micro-sctructured crystal ﬁber : hole-to-hole spacing and hole diameter respectively 3.5µm
and 0.41µm.
 Central core diameter = 6.4 µm (single-mode at 800 nm), NA core (800 nm) = 0.097
 NA inner cladding (450nm) = 0.27
During my PhD, I participated in the work of the team post-doc on the characterization of the
customized DC-PCF in the endomicroscope setup. Two papers were published and are presented
in appendix A and B.
In the ﬁrst study, appendix A, ﬁve meters of this new DC-PCF ﬁber were placed in the two-
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Manufacturer Core-Inner
cladding ∅
(µm)
Core-Inner
cladding
NA
Pulse
dura-
tion(fs)
Average
power(mW)-
Pulse
energy(nJ)
Fibercore 3,6 - 100 0,19 - 0,25 40 9 - 0,11
Liekki 5,5 - 125 0,15 - 0,46 37 5 - 0,06
Crystal Fiber 16 - 163 0,04 - 0,64 24 50 - 0,14
Nufern 9 - 105 0,12 - 0,2 31 11 - 0,14
Table 7.4  Comparison of pulses caracteristics at the output of four commercial DCF using a
800nm excitation wavelength with the ﬁrst bi-modal endomicroscope prototype [196].
photon endomicroscope setup. The same characterization as for the commercial ﬁbers was applied
to be able to compare the results and reach some conclusions on the performance of this custom
made one. Measurements were performed using two laser pulse durations, 100 and 300 fs, with an
excitation wavelength from 750 to 900nm. At a preferred wavelength of 800nm the endoscope was
able to produce 33 fs pulse duration, at the output of a ﬁve meter of DC-PCF, without any objective
lens, and 40fs using a GRIN lens. Over the entire range of excitation wavelength, the pulse was
under 60 fs at the ﬁber output. The customized DC-PCF gave a better simulated lateral resolution
(0.58 µm with a GRIN) than the most-suited commercial ﬁbers. Using very short pulses to excite
ﬂuorophores resulted in a higher collection eﬃciency. These results met all the speciﬁcations deﬁned
as having the best excitation-collection performance in a two-photon conﬁguration. These results
answered all the speciﬁcations deﬁned to have the best excitation-collection performance in a two-
photon conﬁguration.
To detail the high collection eﬃciency of such a ﬁber, a second study was conducted where
the DC-PCF was placed in the visible endoscope used in chapter 2 and 3 and compared to the
bi-ﬁber conﬁguration and to a multimode commercial conﬁguration. The results are presented
in appendix B. Moreover, in this study, the ﬁrst spectral and lifetime measurements on tissue
using this custom-made ﬁber with visible excitation were presented. The use of the DC-PCF
in the endoscopic conﬁguration showed collection eﬃciency four times better than the two other
conﬁgurations. This result is due to the small core, 6.4 µm, allowing excitation in a small focal
volume and the large clad, allowing optimal collection of emitted ﬂuorescence.
Using this setup, quantitative measurements were performed on the exogenous ﬂuorophores,
ﬂuorescein and rhodamine B, then on brain freshly extracted ex-vivo tissues. Lower ﬂuorescence
intensity was found in tumor tissue with a diﬀerent spectral shape for each group. The lifetime
values of each ﬂuorophore were also shorter in tumor than control. This result showed that our
custom DC-PCF was the best candidate to optimize autoﬂuorescence collection. Moreover it was
also shown that the combination of ﬂuorescence intensity, spectral width and ﬂuorescence lifetime
could give a reliable discrimination between tumor and healthy region.
151
7.2. OPTICAL DEVELOPMENT TOWARDS AN INTRA- . . .
7.2.2 Position and improvement of our set-up compared to two-photon
endomicroscopy state of the art
In the literature, few studies presenting the architecture of an endomicroscope based on a DCF
ﬁber can be found. Two groups have developed endomicrosocpes based on the commercial ﬁbers
mentioned earlier. Fu et al. developed a two-photon endomicroscope based on the Crystal Fiber
DCF [190]. They used 1 m of ﬁber to send 80 fs pulse at the output of a MaiTai laser at 800
nm to a sample. They found a 6 µm axial resolution and approximately 1 µm lateral resolution.
Collection eﬃciency was improved compared to a SMF, but not compared to other commercially
available DCF's. They were able to perform TPEF-SHG imaging using a MEMS as a scanning
system and this endomicroscope was then used in in vitro studies on cancerous cells [343] and on
mice with gastrointestinal abnormalities [180, 344]. Chang et al. developed an endomicroscope with
the Liekki DCF to perform FCS measurement [345]. Comparing the DCF to a SMF, they found
increased collection and better resolution. This endomicroscope until that time had been tested
only on cytometry measurements in vitro and in vivo in mice [346]. Two other groups took the
same direction as we did and based their development on a customized DCF. Liang et al. used a
customized DCF and compared it to the Nufern and Fibercore commercial DCFs [347]. They used
75cm of DCF with a core diameter of 5 µm, a core NA of 0,12 and an inner cladding NA of 0,35.
They obtained a lateral resolution of 0,7 µm and an axial resolution of 6,5 µm. Compared to the
other DCF, they found an improved two-photon excitation and collection eﬃciency, and a reduced
ﬁber background noise. In this prototype they used a piezoelectric system to scan the sample and
obtained TPEF-SHG images. They also calculated the redox ratio in order to have a quantitative
indicator. The endomicroscope has been tested only on samples of ex vivo mouse liver and in vivo
experiments have been done on anesthetized mouse kidney. Ducourthial et al. also developped
an endomicroscope using a customized DC-PCF from the PhLAM laboratory, but with a diﬀerent
architecture than ours. The ﬁber used in their set-up has an inner core of 3,5 µm diameter and
0,13 NA at 800 nm and a microstructure to maintain polarization. They used 5 m of this ﬁber
with a GRISM pre-compensation unit to obtain a 38 fs pulse at the output with 800nm excitation.
Their endomicroscope had transverse and axial resolutions respectively of 0,8 µm and 12 µm. The
system was tested on ex vivo and in vivo on the kidney of an anesthetized mouse.
With our conﬁguration we obtained better lateral and axial resolution than in the literature,
with an improved collection eﬃciency compared to the commercial DCF. Compared to literature
we also: 1) implemented and presented a multimodality of detection to obtained more reliable
and reproductible discrimination. 2) Build an optical database on brain tissue autoﬂuorescence re-
sponse, that will be implemented in the endomicrosocpe. And 3) reached a miniaturization suited
to slide the probe into existing clinical tools. Another advantages is the use of a 5-meter long
ﬁber. Only one other group used this length. Other ﬁbers were 1 meter long or less, which is not
suitable to ﬁt in the operating room environment. The teams using short ﬁbers did not assess the
pulse duration at the output, which in our study appeared to be an important factor for improving
the excitation and collection eﬃciency. However using sub-100fs pulses is uncommon compared to
classical two-photon microscopy conﬁgurations that generally use pulses of 100 fs or more. There
is therefore only little knowledge of the impact of this ultra-short pulses on a biological material,
such as animal or human tissue. One study can be found in the literature looking at the impact of
pulse duration between 15 and 400 fs on human skin excised tissue [348]. The study ﬁrst showed as
in our study that shorter pulses resulted in higher TPEF and SHG emitted signal. Then the study
looked at the tissue autoﬂuorescence response using sub-20fs pulses and 120fs pulses at diﬀerent
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penetration depths. They didn't ﬁnd any distortion in the spectral response using sub-20fs pulses.
This ultra short pulses, on the contrary, resulted in a higher intensity and penetration depth for
both the SHG and TPEF response, improving the quality of detected signal [348]. Even if this
study seems to hint that sub-20 fs will not have a negative impact on tissue and will result in a
better TPEF-SHG response, this still a very limited study and some other parameters should be
evaluated. For instance, no measurements were made on the photobleaching that could be induced
with such pulses, neither on the local temperature changes. In order to conﬁrm the clinical appli-
cability of our designed endomicroscope, a study was conducted with the post-doc of the group on
brain biopsy tissue monitoring the spectral response and the ﬂuorescence lifetime to evaluate the
position and negatif eﬀect of these interesting short pulse for clinical applications. The endomicro-
scope was used to excite ex-vivo ﬁxed samples from 40 to 200 fs, and the spectral and ﬂuoroescence
lifetime responses were evaluated. The spectral measurements resulted in similar conclusions as
in the literature. Shorter pulses improved 8 times the collected intensity but did not aﬀect the
spectral shape. Fluorescence lifetime detection acted as a probe of any environmental changes,
such as temperature, viscosity and broken molecular links. The lifetime results were not aﬀected by
the sub-100 fs pulses, revealing that no local damage was done to the tissue with these shorter pulses.
As of this point we have developed a bi-modal endoscope able to perform two-photon excitation
with collection eﬃciency and without causing any tissue damage. The next step for the instru-
ment development is to implement a scanning system in order to combine spatial response with
quantitative measurements and to oﬀer a known and comfortable modality to surgeons. Two types
of scanning systems have been favored in the literature for implementation in endomicroscopes.
These are the piezoelectric system [347] and the MEMS [190]. The PZT systems have been able
to reach smaller probe diameter [203, 347]. However the algorithms to reconstruct the images and
the overall stability of the system is better using MEMS, making it an interesting choice too [190].
We have been working at ﬁrst on a piezoeletric solution to reach a miniaturization of the probe
to under 2mm of diameter, a size not available in a MEMS probe. However MEMS have recently
been used in a millimetric-diameter OCT probe [349], opening the door to a collaboration in order
to adapt this technology into a two-photon endomicroscope probe. This solution would oﬀer more
stability than a piezo probe and a more accessible computing system. The two conﬁgurations are
currently being developed in the group. The scanning system remains a technological barrier to
overcome. This step requires overcoming several technical challenges: miniaturization, speed, and
a large ﬁeld of view, all in order to provide synchronized images in a multimodal instrument.
7.3 Towards other problematics : the bladder cancer
Our method and resulting technology are not limited to answering questions on brain tumor
tissue. This is a universal technology that could address the diﬀering expectations of surgeons and
solve issues such as lack of micro-scale resolution, slow acquisition time, and reliability of intra-
operative feedback. Taking a step back from the problem of brain tumor discrimination, the area
of bladder tumor surgery also presents intra-operative challenges that could improve the quality
of patient management. The surgeons need to evaluate the grade of the tumor to understand
how it has inﬁltrated the bladder tissues and to choose the appropriate surgical protocol. Getting
this information in real-time during the ﬁrst surgery, will shorten patient management time and
improved surgical outcomes.
153
7.3. TOWARDS OTHER PROBLEMATICS : THE BLADDER . . .
Miniature intraoperative tools going through the urinary tract have already been developed to
give surgeons a method of assessing tumor nature before the surgical intervention. One endomi-
croscopy technique has made it beyond the exploratory phase, is currently nearing completion of
clinical validation, and will start to be implemented in a multi-center study. It is confocal laser
endomicroscopy (CLE) using ﬂuorescein as a contrast agent [350].
Figure 7.2  Optical biopsy of bladder mucosa using probe-based confocal laser endomicroscopy
(CLE). CLE of normal, low/high grade papillary bladder cancer, CIS, and inﬂammation shown
with corresponding white light cystoscopy (WLC) and hematoxylin and eosin (HE) staining of the
biopsy [351].
This technique has been used to provide images showing structures similar to the ones used in
H&E-stained images as shown in ﬁgure 7.2. Basing a diagnosis on an imaging modality is relatively
subjective. In order to make it a standard, as reliable as possible, an atlas of the diagnostic features
for normal, benign, and cancerous tissue has been presented in the literature [352]. Still this
technique showed some limitations : 1) The contrasts until now have been obtained with exogenous
contrast agents, introducing bias and requiring ethics committee approvals; and 2) there is only one
detection contrast, resulting in low reliability and reducing the possibility of automated diagnosis.
In order to address the ﬁrst limitation of CLE, an optical technique based on intrinsic optical signal,
the OCT, has been developed and used intra-operatively in bladder cancer evaluation. Nevertheless
this technique still provides only an imaging technique and consequently lacks the possibility of an
automated diagnosis. Morever the image provided by OCT requires an expert to be interpreted.
At the exploratory stage, few studies can be found using label-free microscopy techniques with
quantitative detection [217, 222, 353]. Aboumarzouk et al. used a visible excitation to perform
spectral measurements on bladder tissue [353]. They tried three quantitative indicators to dis-
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criminate malignant regions from benign ones: the area under the ﬂuorescence intensity curve, the
mean emission wavelength, and the ratio between emitted porphyrin and NADH intensity. The
means emission wavelengths and porphyrin/NADH ratio gave the most signiﬁcant discrimination.
The ratio was higher in malignant tissue supporting the idea of porphyrin accumulation in tumor.
Palmer et al., in another study, used UV excitation to look at the NADH and FAD spectral re-
sponse and NIR excitation to monitor the porphyrin. Two indicators were computed to discriminate
tissue, the redox ratio (NADH/FAD) and the NADH/porphyrin ratio [222]. They found a higher
NADH/porphyrin ratio in tumor, a result agreeing with the previous study in literature. They also
showed discrimination with the redox ratio but with an opposite trend than in other studies.
The study used various excitation wavelengths to determine three quantitative indicators: the
SAAID ratio to look at the density of SHG signal compared to the autoﬂuorescence, the redox ratio
(FAD-NADH/FAD+NADH) and the lifetime measurement of free-bound fraction of NADH and
FAD. Each of these indicators resulted in a discrimination between healthy mucosa and carcinoma
in situ tumor.
These few studies demonstrated that optical endomicroscopy could be applied to bladder tissue
discrimination. We therefore decided to test the acquisition and analysis methods developed on
brain tumor to bladder tissue discrimination, in order to test the power and robustness of such
techniques. The ﬁrst explorative study designed, was set to answer the clinical question of grade
identiﬁcation among healthy tissue, low grade and high grade bladder tumors. The results obtained
with a two-photon microscope are presented in appendix C.
A cohort of sixteen biopsies was explored and composed of ﬁve low grade, ﬁve high grade
urothelial carcinoma and six non-tumoral urothelium. The samples were examined under 870nm
excitation wavelength using a two photon microscope. TPEF-SHG images were compared to the
H&E standard. The organization of the urothelial cells were highlighted in the TPEF image and
served as criteria of diﬀerentiation between grades, similar to the H&E standard. The SHG image
gave access to the architecture of the stroma and the lamina propria, other important structures
in the diagnosis of tumor type and grade in bladder. These ﬁndings and comparisons to the H&E
stained images are presented in ﬁgure 7.3.
A quantitative analysis was also performed and combined with the spatial the spatial results.
The spectral response and FLIM images were acquired, and the redox ratio and average lifetime
were determined. The redox ratio was signiﬁcantly higher in the healthy urothelium compared
to tumor samples (p<0.001). Moreover, it was able to discriminate low grade from high grade
tumors. The low grade has a signiﬁcantly higher redox ratio (p=0.002) than high grade tumor.
The second quantitative measurement was the average ﬂuorescence lifetime, which translated the
balance between free and bound FAD. The average lifetime was shorter in healthy tissue compared
to tumor (p=0.002 and p<0.001), and the low grade had a shorter lifetime value than high grade
(p<0.001). These results mean that the free FAD form was more prevalent in tumor tissue, which
agrees with the ﬁndings of Cicci et al. in their analysis of CIS [217].
With this study, it was shown that the spatial and quantitative techniques developed using a
two-photon excitation can be transferred to other types of cancer. These results opened a bit more
the door to a clinical transfer of two-photon endomicroscopy, assuring the clinical relevance of such
project.
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Figure 7.3  Comparison between hematoxylin-eosin Safran staining (a-c) with two-photon ﬂuores-
cence images at 870 nm excitation wavelength, red color for the ﬂuorescence signal and green color
for the SHG signal (d-f) of three tissue types: healthy (a, d), low-grade tumor (b, e) and high-grade
tumor (c, f). Scale: 100 µm. Star: Fibrovascular cores, arrow: Urothelial cells.
7.4 Conclusion
Technical conclusion This work presents the largest database, known to this day, on the aut-
oﬂuorescence response of brain tissue to answer the question of tumor demarcation. The database
groups results into several brain tissue types : healthy cortex and dura matter, primary glioma
and meningioma tumor and secondary metastasis tumor. The analysis contains measurements of
1) optical coeﬃcients, 2) spectral response with one-photon, deep-UV and visible excitation and
two-photon NIR excitation, 3) two-photon imaging of ﬂuorescence, 4) results on SHG signal, and
5) ﬂuorescence lifetime with one and two-photon excitation. These large sets of data multimodal
algorithms were developed to ﬁnd relevant thresholds and to highlight the possibility of providing
reliable automated discrimination of brain tissue types. Combined with the technical developments
achieved by the research team to develop a multimodal two-photon endomicroscope, clinical trans-
fer can be considered and supported. Moreover such methods were also able to produce an answer
on bladder tumor grading, showing the capacity to be a universal tool answering diﬀerent surgi-
cal challenges. Multimodal two-photon endomicroscopy is presenting itself as a major technical
breakthrough for intra-operative diagnosis.
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Personnal conclusion In this PhD, I was able to work in a strong multi- disciplinary environ-
ment. I discovered the interaction on a daily basis with a team of surgeons and neuropathologists
to be a completely "other" type of science that requires adapting one's communication and to reach
compromise in the team's work. Developing technology to improve medical imaging has to be based
on strong collaboration with a hospital team. These collaborations are very enriching scientiﬁcally
and push you to develop better communication skills, to work productively with people with diﬀer-
ent kinds of knowledge and scientiﬁc backgrounds. This collaborative work was extended to a third
part, DISCO beamline, and started during my master's thesis. I was there from the start of the
collaboration and was able to learn how to build a project with diﬀerent parties, and make it into
a successful collaboration using the diﬀerent expertise of each person. Working on such a dynamic
project, involving several parties and a large research team, gave me the opportunity to work on a
large set of publications and to present my work in several international conferences even getting
the chance to be awarded best student poster in a session of 2017 Photonic West conference.
This thesis was also built by overcoming diﬃculties, which was part of the learning process.
One of the ﬁrst diﬃculties was in collaborating with the hospital. The studies were based on
biopsy sample imaging and it implies that several factors come together: surgery has to happen,
the patient had to be contacted to sign a consent, and the sample had to be large enough to get a
piece for research. All these requirements have made it diﬃcult sometimes to have a dataset large
enough for statistics in a short period of time. Working around these diﬃculties required ﬁnding
solutions with the medical teams to optimize the process and the communication. The other major
diﬃculties were with natural catastrophe. I had to face the consequences of two ﬂoods, slowing
work, creating administrative challenge and diﬃculties in collaboration. However this is bound to
happen in a long project and consequently developed capacity in project management.
In conclusion, this was a successful PhD thesis and a strong learning experience in a dynamic,
experienced and very welcoming research team. I have truly committed to this project during these
three years and I would like to continue working on it and be a part of those people who will bring
it to the clinical setting as a regular tool.
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Abstract: In this work, we present a detailed characterization of a small-
core double-clad photonic crystal fiber, dedicated and approved for in vivo 
nonlinear imaging endomicroscopy. A numerical and experimental study 
has been performed to characterize the excitation and collection efficiencies 
through a 5 m-long optical fiber, including the pulse duration and spectral 
shape. This was first done without any distal optics, and then the 
performances of the system were studied by using two kinds of GRIN 
lenses at the fiber output. These results are compared to published data 
using commercial double clad fibers and GRIN lenses. 
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1. Introduction 
Two-Photon Microscopy (TPM) has become a standard technique extensively used for 
imaging optically thick biological tissues [1]. It is able to provide a wealth of information 
about specific structures without exogenous fluorescent labels. This performance is achieved 
through various endogenous contrasts: (1) Second Harmonic Generation (SHG), to highlight 
specific elements, such as myosins and collagens [1], and (2) fluorescence under two photon 
excitation (TPE), to investigate endogenous fluorophores, such as reduced nicotinamide 
adenine dinucleotide (NADH) and Flavin, a well-known biomarkers of cellular energy 
metabolism [3,4]. TPM provide intrinsic sectioning, lack of out-of-focus photobleaching, a 
localized phototoxicity, important penetration depth due to decreased scattering from long 
infrared excitation wavelengths and absence of overlapping between excitation and emission. 
Despite these advantages, the TPM is still limited to laboratory thick tissues testing. 
Currently, its main applications are focused on fixed or ex vivo samples and in vivo tests are 
limited to animals. The systems available nowadays to image in vivo human tissues are 
macroscopic and can only be applied at the skin level [4,5]. A more dedicated solution to 
study in vivo and in situ human tissues could be nonlinear endomicroscopy. It presents the 
advantages of TPM and gives the possibility to an in vivo and in situ tissues imaging without 
resorting to a surgical biopsy, thanks to the use of a thin and elongated optical fiber coupled 
with miniaturized objective lens instead of the microscope objective. It allows less invasive 
tests and earlier detection of diseases. 
The development of such nonlinear endomicroscopic systems requires a specific attention 
to the choice of the endoscopic fiber. It should be able to preserve the temporal confinement 
of short pulses that need to be delivered to the distal optics for different excitation 
wavelengths. For that, dispersion pre-compensation schemes are usually employed. This fiber 
should also have a small core diameter to reach high imaging resolution via miniaturized 
optics as well as a high inner cladding numerical aperture (NA) to be able to collect 
endogenous weak fluorescence signals. This is usually done using so-called double-clad fibers 
(DCFs). 
By referring to the literature, and to our previous study, different commercially available 
DCFs were compared and characterized with and without miniaturized objective [6,7]. The 
DCF DC-165-16-P from NKT Photonics [8], a microstructured fiber, turned out to be the best 
in terms of single-mode delivery of ultrashort pulses around 800 nm. However, its core 
diameter (around 16 µm) is a real problem for the miniaturization of the distal optic. The 
resulting optical resolution is inevitably altered and worse, compared to a DCF with a smaller 
core but a doped inner cladding, such as the Fibercore SMM900. Based on these results we 
were convinced that the ideal fiber did not exist yet. Consequently, it was necessary to 
conceive a specific DCF combining a small and undoped silica core with a high inner 
cladding numerical aperture (NA). Such a fiber will deliver high-quality excitation pulses 
with a low level of optical aberrations in the distal optics, and the highest level of nonlinear 
signal collection with miniaturized optical lenses. Such a small-core double-clad photonic 
crystal fiber (DC-PCF), specially designed for the two-photon endomicroscope, has been 
published recently in the context of the development of an endomicroscope [9,10]. This fiber 
was able to achieve efficient non-linear endomicroscope images. 
This work represents a continuity of our previous studies based on characterization of 
commercial DCFs [6,7]. Here we extend it to the very recently introduced small-core double-
clad photonic crystal fiber (DC-PCF) joined to different GRIN lenses [9,10]. We provide a 
full characterization of the output short pulse properties and collection efficiency from a 
scattering sample for input pulse duration in the range 100-300 fs and wavelength of 750-900 
nm as a function of pump power, showing efficient femtosecond pulse delivery of the system 
made of the DC-PCF coupled to a GRISM pre-compensation scheme and GRIN lenses over 
this whole range of parameters. 
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2. Materials and methods 
2.1. Customized DC-PCF design 
This customized DC-PCF is shown in Fig. 1(a) and 1(b). The hole-to-hole spacing and 
relative hole diameter are respectively 3.5µm and 0.41. The central core has a diameter of 6.4 
µm and is single-mode at 800 nm. It is surrounded by an air/silica microstructured region of 
40 µm diameter. The DC-PCF used here is 5 m-long, which is 5 times longer than commercial 
fibers typically used for the same purpose. The NA of the small core at 800 nm is 0.097, the 
second order dispersion coefficient is β2 = 2.9x10−26 s2/m and the nonlinear parameter is γ = 
10.5W−1.km-1 at this wavelength. The fiber presents a second microstructure (ring of large air 
holes) to separate the collecting inner cladding from the outer maintaining cladding. The size 
of the bridge between the air holes will determine the NA of the inner cladding: the smaller is 
the bridge, the higher is the numerical aperture [11]. Here the thickness of silica bridges 
between air holes is around 500 nm, and the NA of the inner cladding was measured to be 
0.27 at 450 nm. This fiber regroups the advantages of a microstructured fiber, by using an 
undoped core to avoid autofluorescence, but has a smaller core diameter than the NKT 
Photonics DCF, giving a better axial and lateral resolution. 
 
Fig. 1. A. Scanning electron microscope image of the DC PCF. a) Core region surrounded by 
an air-silica microstructure b) Collecting cladding c) Low index air cladding d) Maintaining 
cladding. B. Details of the air-silica microsctructure around the core. 
2.2. Setup design for ultra-short pulse delivery characterization 
The architecture of the proposed endomicroscope, presented in Fig. 2, is composed of a 
femtosecond titanium sapphire oscillator (Ti:Sa, Mai Tai DeepSee, eHP, Spectra physics). A 
Faraday Isolator (FI), placed at the laser output, avoids back reflection from the fiber input 
face and destabilization of the pulse in the laser cavity. 
A pre-compensation unit is used to compensate dispersion (second and third orders 
simultaneously) and nonlinear effects (mainly self-phase modulation) appearing inside the 
endoscopic fiber [10]. This unit is composed of a first polarization-maintaining single mode 
fiber (SMF) (0.5 m) used to broaden the spectrum in order to be able to reach a shorter pulse 
duration afterwards [12]. It is followed by a GRISM-based anomalous stretcher, consisting in 
the assembly of a diffraction grating with a prism [6,7,12]. Pulses are then coupled into the 
endoscopic DC-PCF. It allows simultaneous excitation by the small core and fluorescence 
collection from the tissue by the inner cladding. The focusing of the light in the specimen is 
achieved using a specific miniature GRIN lens. The response through the 5 m-long DC-PCF 
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and the GRIN lenses was characterized spectrally and temporally using respectively a 
spectrometer (FLAME-S-VIS-NIR-ES 1, Ocean optics spectrometer, France) and an 
autocorrelator (Mini-PMT-NIR, AA11.08.01.03, APE). Two different pulse durations were 
set at the output of the laser cavity using the Deepsee system. The first one, around 300 fs, is a 
pulse duration used classically in nonlinear microscopy. The second one, around 100 fs, is 
close to the optimal pulse duration obtained when using a Deepsee after the laser oscillator. 
This DC-PCF has been made to excite the sample and collect fluorescence signals at the 
same time, using a dichroic mirror, Fig. 2. Laser light goes through the GRIN lens to be 
focalized on the sample (Rhodamine) insuring maximum excitation. Fluorescence emitted by 
the Rhodamine is detected by the second core of the DC-PCF and lead through the dichroic 
mirror to the spectrometer (QE Pro, Ocean optics spectrometer, France). 
 
Fig. 2. Experimental setup. 
2.3. GRIN lenses 
Two different GRIN lenses adapted to wavelengths between 800 and 900 nm were used. The 
first one (GRIN 1) coded GT-MO-080-018-810 has a 1.4 mm diameter. It is a complex optical 
system with a spherical lens and two GRIN lenses fabricated with a special gradient profile. 
Its object space NA is 0.8, and the image space NA is 0.18. The total length of this lens is 
7.53 mm. In the second lens (GRIN 2) coded GT-MO-080-0415-810, the image space NA is 
0.4 and the length is 4 mm. Both GRINs, fabricated by GRINTECH, are mounted in stainless 
steel tubing. The differences in the image space NA could affect the collection of the fiber 
output signal. The difference in length could also affect dispersion and pulse duration. 
3. Results 
3.1 Efficient excitation using the DC-PCF fiber for different excitation wavelengths and cavity 
output pulse duration 
Two different pulse durations were set at the output of the laser cavity using the Deepsee 
system. The first one, around 300 fs, is a pulse duration used classically in nonlinear 
microscopy. The second one, around 100 fs, is close to the optimal pulse duration obtained 
when using a Deepsee after the laser oscillator. These two extreme durations allow us to 
estimate the capacity of our system to optimize the pulse at the output of the endoscopic fiber. 
These measurements were performed for different excitation wavelengths from 750 to 900 
nm. The temporal measurements to characterize the fiber and the two GRINs are summarized 
in Table 1. At each wavelength, the GRISM line mentioned above was optimized in order to 
get the shortest pulse duration at the output of the system. The pulse duration is obtained by 
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measuring the full width at half maximum (FWHM) from the autocorrelator data using a 
Gaussian profile for the deconvolution. 
For a pulse duration of 300 fs at the output of the laser cavity, the shortest pulse duration 
at the output of the endoscopic fiber is approximately 42 fs for a 810 nm excitation 
wavelength. This value decreases to 33 fs with a laser output cavity pulse at 100 fs, presented 
in Fig. 3(b). Moreover, by fixing the laser pulse duration at the output of the cavity to 100 fs, 
we notice that the difference between the shortest and the longest pulse duration at the output 
of the DC-PCF is 72 fs at the different wavelength, while for a 100 fs laser pulse duration the 
difference is only 27 fs. The variability of the output pulse duration of the system especially 
for 100 fs cavity pulse duration is low, highlighting the tenability of our setup. This point is 
especially important in the context of in vivo endogenous fluorescence imaging which 
frequently requires the use of different excitation wavelengths depending upon the tissue 
nature. 
Table 1. Measured Pulse Duration at the Output of the Endoscopic Fiber Alone, with 
Grin 1 and with Grin 2 for Different Laser Cavity Pulse Durations 
 Laser Cavity output pulse at 300 fs Laser Cavity output pulse at 100 fs 
DC-PCF DC- PCF + 
G1 
DC- PCF + 
G2 
DC-PCF DC-PCF + 
G1 
DC-PCF + 
G2 
750 nm 72 ± 3,6 84 ± 4,2 80 ± 4 60 ± 3 70 ± 3,5 65 ± 3,25 
780 nm 69 ± 3,45 76 ± 3,8 74 ± 3,7 55 ± 2,75 62 ± 3,1 59 ± 2,95 
800 nm 45 ± 2,25 65 ± 3,25 63 ± 3,15 33 ± 1,65 50 ± 2,5 45 ± 2,25 
810 nm 42 ± 2,1 53 ± 2,65 51 ± 2,55 33 ± 1,65 42 ± 2,1 40 ± 2 
860 nm 64 ± 3,2 75 ± 3,75 87 ± 4,35 49 ± 2,45 58 ± 2,9 58 ± 2,9 
890 nm 85 ± 4,25 136 ± 6,8 93 ± 4,65 55 ± 2,75 75 ± 3,75 70 ± 3,5 
900 nm 114 ± 5,7 150 ± 7,5 105 ± 5,25 58 ± 2,9 90 ± 4,5 78 ± 3,9 
3.2 Coupling GRINs lenses to the DC-PCF 
Two conditions are required for nonlinear absorption: spatial and temporal confinement of the 
excitation pulses. Temporal confinement is obtained thanks to the optimal adjustment of the 
GRISM line, compensating simultaneously for the second and the third orders of dispersion of 
the endoscopic system. For spatial confinement, this new fiber was also coupled with GRIN 
lenses. By that, spatial and temporal confinements of the excitation are acquired for efficient 
nonlinear excitation. Consequently, imaging of tissues with a high resolution is expected. The 
GRIN lens with a radial refractive index and a high numerical aperture (NA) has been already 
validated for clinical use [13] due to their flat surface and small diameter. 
Since the 100 fs laser pulses give the best performances as shown above, we chose to 
analyze the effect of the GRIN lenses on the pulse duration at the endoscopic system output 
with this laser setup. Adding respectively GRIN1 or GRIN2 at the DC-PCF output affects 
marginally the response of the pulse duration. For example, at 810 nm, we have the pulse 
duration values of 33 fs, 42 fs, and 40 fs respectively for the DC-PCF alone, the DC-PCF 
coupled to the GRIN1 and the DC-PCF coupled to the GRIN2. This difference of 24% or 19% 
between the fiber alone and the fiber coupled to GRIN 1 or 2 is due to the two distinct 
dispersion characteristics of these two GRIN lenses. This means that adding GRIN lenses do 
not affect the pulse duration confinement significantly; subsequently excitation quality is not 
affected. These results are also highlighted in Fig. 3(c). 
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Fig. 3. The laser excitation is set to 800 nm (a) Delivery of the fundamental mode of the light 
after adjusting the collimation at the first fiber output. (b) The autocorrelation duration of the 
pulse at the output of DC-PCF obtained by adjusting the laser pulse duration respectively at 
300 fs and 100 fs. (c) The optimal pulse duration obtained without GRIN and with GRIN 1 and 
GRIN 2. (d) Spectral characterization of the laser output and PhLAM fiber output. For these 
measurements, the wavelength and output power used were 800 nm and 20 mW (e) Pulse 
duration variation as a function of fiber output. 
Experimentally, GRIN 2 gave a slight advantage in pulse duration compared to GRIN 1 at 
each wavelength, on average 7% shorter for GRIN 2, except at 860 nm where the pulse 
duration was the same. The spectral analysis performed on the short pulse throughout the 
setup is shown in Fig. 3(d). This figure presents the spectral shape at the laser cavity and the 
DC-PCF output. The DC-PCF output spectrum is wider than at the output of the laser thanks 
to the shaping module before the endoscopic fiber. This allows to obtain shorter compressed 
pulses. Figure 3(e) shows the variation of the DC-PCF pulse duration at the core with the laser 
operating at mean power. In the range from 2 mW to 24 mW, we note a reduction of pulse 
duration with higher power, from 66 fs at 2 and 4 mW, to 39 fs at 22 and 24 mW. 
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The DC-PCF was also compared numerically to the best commercial DCF presented in 
our previous study [7]. These numerical tests were performed with a Zemax (Optics Studio 
14.2, Zemax LLC) simulation. The DC-PCF was coupled to two different GRIN lenses. The 
first one was a custom designed (GT-IRLS-050-11-50-NC) in order to be compared with our 
results previously published results [7], and the second one was the commercial GRIN 1 (GT-
MO-080-018-810) used in the experimental measurements. The axial and lateral resolutions 
of the coupling of the fiber into these GRINs were characterized. These two parameters were 
computed in accordance with a method taken from the literature [14]. It represents the 
resolution at the FWHM, calculated from the spot in the focal plane of the GRIN, using a 
Gaussian beam approximation to simulate the output of the fiber and the propagation through 
the optics. The results are summarized in Table 2. The DC-PCF has a lateral resolution 2.5 
times higher than the NKT Photonics DCF, and is 5-6 times better regarding the axial 
resolution, and only slightly less resolved than the Fibercore one (1.8 times less resolved). 
Table 2. Resolution of the Excitation Spot in the Focal Plan of the Two GRIN Lenses 
Coupled to Our Fiber 
 Homemade GRIN GRIN-GT-MO-080-018-810 
Fiber Core-
Cladding 
diameter
s 
Core 
NA 
Lateral 
resolution 
(µm) 
Axial 
resolution 
(µm) 
Waist 
size 
(µm) 
Lateral 
resolutio
n (µm) 
Axial 
resolution 
(µm) 
Waist 
size 
(µm) 
Fibercore 
(SMM900) 
3.6-100 0.19 0.22 0.33 0.26 0.32 0.80 0.38 
Crystal Fiber 
(DC-165-16 
P) 
16-163 0.04 1.00 7.99 1.20 1.44 16.61 1.73 
DC-PCF 
(T904B) 
6.4-268 0.097 0.40 1.28 0.48 0.58 2.67 0.69 
3.3 Fluorescence collection efficiency using the DC-PCF 
As explained in the introduction, the ability of a DCF to be used as an endoscopic fiber not 
only depends on its excitation properties, but also on its ability to collect the signal emitted by 
samples. The collection efficiency depends on the size of the DCF inner cladding (second 
core) and of its NA. The influence of the pulse duration and average power on the 
fluorescence emission level is analyzed here using Rhodamine as fluorescent solution. 
Fluorescent signal emitted by Rhodamine was characterized as a function of (i) the duration 
of the excitation pulse at the output of the DC-PCF, Fig. 4(a), and (ii) the output average 
beam power while the pulse duration is kept constant, Fig. 4(b). In this part, we used 1mM of 
rhodamine placed after the GRIN 2 lens. First we set the beam power at 14 mW at the focal 
volume, and we changed the pulse duration. We note that the fluorescence signals decrease by 
increasing pulse duration, but they were still detected until 330 fs, Fig. 4(a). This experiment 
confirms the importance of using short pulse duration to enhance the fluorescent signal. In 
second time, we set the pulse duration to 60 fs and we increase the power beam from 1 mW to 
20 mW on focal volume. Note that 20 mW is more than sufficient for exciting endogenous 
fluorophores of tissues. This fiber is not autofluorescent and that was confirmed by measuring 
the collected fluorescence without sample at the output of the system. This measurement is 
defining the level of dark current and is not changing when increasing the power. We note 
that the fluorescence signals emitted decrease by decreasing the beam excitation power, Fig. 
4(a). The variation of the excitation power, for fixed pulse duration, shows that it could be 
possible to reach 40 mW at the output of the DC-PCF while keeping the same spectral shape 
and without expecting autofluorescence from the fiber. 
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Fig. 4. Backward TPF from Rhodamine with the DC-PCF (a) Fluorescence intensity as a 
function of the DC-PCF and GRIN output pulse duration, normalized to the TPF intensity at 60 
fs, (b) Rhodamine TPF as a function of the pulse peak power at DC-PCF output. 
3.4 Transmission of the DC-PCF on a wide spectral range 
In the majority of the cases, the endoscopic imaging requires to use various excitation 
wavelengths according to the aim of the study, and especially if based on the analysis of the 
endogenous molecules. Even when the excitation wavelength is fixed, various endogenous 
molecules can emit. To verify if this fiber is optimal for a wide range of excitation wavelength 
or for the collection of the emitted fluorescence by different molecules, a specific study is 
needed. For this, a spectral lamp (HPX-2000 Family, Ocean Optics, France) was used as 
sample. For this purpose, a monochromator devices was used to select wavelengths of this 
spectral lamp. The beam was collected at the output of this monochromator (Scanning 
Monochromator MonoScan2000, Ocean, Optics, France) and injected in the inner cladding of 
the DC-PCF. The beam power was measured at the input and output of this fiber to calculate 
the transmission coefficient every time we change the wavelength. The transmission from 
different wavelength and at a fixed fiber - sample distance was measured in order to define 
the transmission coefficient. Results prove that this fiber is able to collect different 
wavelength ranging from 200 to 1000 nm). We do not have an important variation in 
transmission coefficient except around wavelengths 340 nm and 850 nm, which presented the 
maximum of transmission coefficient. 
4. Discussion and conclusion 
A new double-clad photonic crystal fiber for nonlinear imaging has been presented and 
characterized experimentally and numerically. First, by using the shortest pulse possible at the 
laser cavity output, combined to a GRISM line, we were able to reach a pulse duration of 33 
fs at the output of a 5 m endomicroscopic customized fiber without a miniaturized GRIN lens, 
and 40 fs at the output of the fiber coupled to a miniaturized GRIN lens. These values 
represent significant improvements over previously reported two-photon imaging that up to 
now have been restricted to picosecond pulses [15]. Obviously, we can fix the pulse 
compression to around 100 fs. In the future, we envisage making a study, which will allow us 
to estimate the potential benefits of these extremely short pulse durations for tissue imaging. 
This homemade fiber is 5-meters-long, which is appreciably much longer than the 1-meter-
long commercial DCF usually tested in endomicroscopy setups. We have demonstrated that 
our setup is able to compensate for the dispersion through such long fibers, and to provide 
pulses as short as those obtained with 1-meter-long fibers. This presents a real advantage in 
medical imaging applications, indeed a 5-meters-long fiber will allow the placement of the 
optical head in the operating room, while the laser and compression system can be kept 
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outside in a non-sterilized environment. Secondly, by comparing our results to those 
previously reported [6] using a DCF, we note that in our case the spectral broadening after the 
DC-PCF is approximately the same. With this spectral large band, we hope to be able to 
excite different endogenous molecules. Thirdly, in order to ensure the coherence in our 
imaging studies, we can adjust our system in such a way as to minimize pulse duration 
variation when the excitation wavelength is changed. In addition, for all possible excitation 
wavelengths, we can obtain pulse durations shorter than 60 fs at the output of our DC-PCF by 
using laser pulse duration of 100 fs. This ensures a temporal confinement required for an 
optimal nonlinear excitation. The collection efficiency was measured for different pulses 
duration showing the importance of using short pulses when we expect tissue imaging. For a 
fixed pulse duration, experimental results show the enhancement of fluorescence signal with 
excitation power. 
Finally, this new fiber coupled to a GRIN lens has a significantly better simulated 
resolution than other microstructured DCF (NKT Photonics DC-165-16 P) used in literature 
for endoscopic imaging and is not far from the performance of the best commercial DCF 
either, the Fibercore SMM900. Moreover, our fiber delivered shorter pulses than those 
generated by the Fibercore one [6], thus showing that the new DC-PCF has the advantages of 
an undoped core fiber, no risk of parasite autofluorescence, while maintaining an acceptable 
resolution for imaging with the same pulse duration performance. 
The influence of the pulse duration and average power on the fluorescence collection was 
analyzed. We note that the fluorescence signals decrease by increasing pulse duration, but 
they were still detectable until 330 fs. The fluorescence signals emitted decrease by 
decreasing the beam excitation power. 
Indeed the critical resolution with deep tissue imaging is the axial resolution, it has to be 
smaller than the characteristic size of the observed sample in order to have a sharp image and 
achieve z sectioning, here for the DC-PCF the axial resolution is about 1.5 μm and the 
smallest characteristic size we obverse in our biopsy sample, using a classical two-photon 
microscope, is approximately 10 microns. Finally, the characterization of the excitation and 
collection path through the DC-PCF shows that we found the homemade architecture to 
answer our technical specifications. 
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We present a customized small-core double-clad photonic
crystal fiber for spectral and fluorescence lifetime measure-
ments of human samples. In this Letter, the new fiber has
been characterized on different fluorophores and samples of
human brain tumor; a comparison to a bi-fiber homemade
system and a commercial fiber probe was made. © 2016
Optical Society of America
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Minimally invasive surgery is becoming the gold standard
of surgery today, even in surgical neurological oncology.
Surgeons use several techniques to perform operations with
a smaller wound opening, making it safer than classical open
surgeries. In the 21st century, surgery requires new tools de-
signed to slide into small surgical approaches and capable of
giving fast and precise information on the tissue [1]. In order
to provide clinically useful data on the human brain, endo-
scopic systems need to overcome the lack of precise guidance.
The new mainstream approach is the use of multimodal optical
detection. We aim to develop a multimodal multiphoton en-
domicroscope by working on a specific customized small-core
double-clad photonic crystal endoscopic fiber (DC-PCF)
which is able to achieve visible and IR excitation for multimo-
dal analysis. Moreover, if our endoscopic fiber is able to achieve
visible and IR excitation, it offers the possibility to add a
varifocal objective [2,3] at the output of the system. Thus,
it allows a large field of view and a high resolution in the same
endomicroscope.
The customized microstructured DC-PCF is based on a
central single-mode core with a diameter of 6.4 μm. The core
is surrounded by an air/silica microstructured region of 40 μm
diameter. The fiber presents a second microstructure (ring of
large air holes) to separate the collecting inner cladding from
the outer maintaining cladding. The thickness of the silica
bridges between the air holes is around 500 nm. The NA of
the inner cladding is around 0.27 at 450 nm.
We prove the efficiency of this fiber to achieve ultrashort
pulses for an efficient nonlinear excitation and collection [4].
In this Letter, we focus on the capacity of this fiber to
achieve visible excitation, as well as to accomplish spectral
and lifetime measurements from endogenous fluorescence of
freshly extracted human samples.
In order to do this, the new DC-PCF fiber was brought into
a fibered setup at the Saint-Anne hospital to replace a bi-fiber
configuration used in a previous study [5–7]. This setup was
placed in the Neuropathology Department of Sainte Anne
Hospital (Paris, France) near the operating room to achieve
measurements, as close as possible, to in vivo conditions.
Bimodal optical signature characterization was performed on
freshly resected samples taken during surgical resection of
human brain tumors. These studies had the approval of the
Sainte Anne Hospital Review Board (CPP: S.C. 3227).
The architectures of the new setup and the previously
validated setup are presented in Fig. 1. The excitation was
accomplished using a diode laser from Picoquant, emitted at
405 nm (LDHP-C-405B, FWHM 60 ps, Picoquant GmbH,
Berlin, Germany) with a maximum power of 1 mW. The
power and the repetition frequency are tunable. The repetition
frequency varies between 2.5 and 40 MHz. The 405 nm ex-
citation was chosen because it is able to excite five different
endogenous molecules: nicotinamide adenine dinucleotide
(NADH), flavin (FAD), lipopigment, porphyrin, and chlorin.
For spectroscopic measurement, the fluorescence was directed
toward a computer controlled spectrometer (QE 6500, Ocean
Optics, Dunedin, USA) characterized by 1.5 nm as spectral
resolution over a 200–1000 nm spectral range. The spectral
measurements were processed using a homemade Matlab script
[6]. Fluorescence lifetime was measured using an electronic
acquisition card (Time Harp 200, Picoquant) that ensures
synchronization between the laser and the detector (PMT)
from PicoQuant (PMA 182) with a temporal resolution of
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220 ps. A motorized filter wheel (FW102C, Thorlabs, Newton,
USA) was placed in the collection path, allowing us to select the
emission band. We used five filters (Semrock, New York, USA)
to separate the five endogenous fluorophores: 450 10 nm,
52010nm, 55030nm, 62010nm, and 680 10 nm.
Data were adjusted by a mono-exponential fit via FluoFit soft-
ware (FluoFit, PicoQuant) to recover the lifetimes from the
measured fluorescence decays. The criterion for an acceptable
fit was a χ2 value less than 1.0, and the residuals were distrib-
uted around 0 within the interval 4 and −4. This procedure
allows the reconstruction of a histogram of photon counting
as a function of the time of fluorescence decay [8].
System 1 (bi-fiber probe): this customized bi-fiber system [as
shown in Fig. 1(a)] uses a first fiber (HCG M0200T, multi-
mode, core ∅200 μm) for the excitation and a second one
(HCGM0365T, multimode, core∅365 μm) to collect fluores-
cence (silica/silica step index fibers of inherent spatial resolution
of 0.5 mm). A long pass filter (SR 405, Semrock, New York,
USA) is placed in the collection path to remove the reflective
signal due to the laser to the fluorescent signal. A beam splitter
sends 70% of the fluorescent signal to the spectrometer and
the remaining 30% into the PMT for lifetime measurements.
System 2 (DC-PCF fiber probe): in this configuration, only
one fiber is used [as shown in Fig. 1(b)], to perform the
excitation and the collection. We compared a commercial
multi-mode fiber (QP600-1-UV-VIS, multi-mode, core
∅600 μm, Ocean Optics) and our customized small-core
double-clad photonic crystal fiber (DC-PCF, single mode, core
∅6.4 μm) using this setup. As presented in Figs. 1(c)–1(f ), the
laser beam is injected into the fiber to excite endogenous fluo-
rophores of the human sample. The emitted fluorescent signal
is collected by the same optical fiber. A dichroic filter
(Di02-R405-25 × 36, Semrock) removes the laser reflection,
and only the fluorescent signal provided from the sample
reaches the detectors. The remaining part of the setup is the
same as in the bi-fiber configuration.
We compared one meter of DC-PCF with the bi-fiber sys-
tem and the commercial multi-mode fiber described previously.
This Letter was performed on a rhodamine B solution. The
compared performances were the spectral shape, fluorescence
collection efficiency, and fluorescence lifetime measurements.
The spectral shape of the collected fluorescence for the same
excitation power from rhodamine using these three different
fibers is presented in Fig. 2(a). The DC-PCF fiber restitutes
a perfect rhodamine spectrum Fig. 2(a), and at each laser power
has a collection efficiency four times better than the two other
systems Fig. 2(b). This result is due to the small core of DC-
PCF, allowing an excitation in a small focal volume and
the large clad, allowing an optimal collection of emitted
fluorescence.
Table 1 shows the lifetime measurements of a rhodamine
solution with different fibers: DC-PCF is able to measure
the lifetime of a fluorophore as precisely as the two validated
fibers. It gives values in accordance with the literature [9,10].
Specific attention to the robustness of our lifetime acquis-
ition system is required prior to any measurement on human
samples. We performed different measurements with the DC-
PCF fiber on the well-known fluorophores rhodamine B and
fluorescein. The concentration, solvent and pH of the solu-
tions, and parameters affecting the lifetime measurements
[6,7,11,12] were varied to validate the accuracy of our system.
All other experimental parameters were kept the same.
Table 2 summarizes the lifetime measurements conducted
on rhodamine B and the fluorescein solution. Two parameters
changed: first, the concentration of the fluorophore in a solu-
tion of methanol and, second, the pH. The fluorescence life-
time of rhodamine B in methanol stayed constant over the
concentration from 10−4 M to 10−6 M with a mean value
2.2 0.06 ns which is comparable to the literature value of
2.38 0.07 ns. The only value where it changes is at 10−2 M,
where the lifetime decrease is due to the reabsorption process
at a higher concentration of the fluorophore; this has already
Fig. 1. Experimental set-up: (a) system 1 where the excitation and
fluorescence collection are done with two different optical fibers and
(b) system 2 where the excitation and fluorescence collection are per-
formed with the same optical fiber. (c) Spot at the output of a mono-
core optical fiber presenting a Gaussian form. (d) Profile of the spot at
the output of a monocore optical fiber. (e) Spot at the output of the
DC-PCF presenting microstructures surrounding the main core.
(f ) Profile of the spot at the output of the DC-PCF.
Fig. 2. (a) Fluorescence emission from rhodamine B
(C  0.1 mM) collected through three different fibers at a laser
excitation power of 40 μW. (b) Maximum of collected fluorescence
for different excitation laser power through three different fibers.
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been described in the literature [13]. We also made measure-
ments at different pH values to validate the accuracy of our
probe. These measurements were compared to the literature.
The rhodamine is known to have a constant fluorescence life-
time through changes of pH, where the fluorescein presents a
slight change of 0.6 ns from a basic to an acid solution [10].
Table 2 shows that we were able to have this level of precision
with our system.
After these promising first results, the system was
used on a small cohort of fresh human samples provided by
the Sainte Anne Hospital Neurosurgery Department (Paris,
France). The cohort had 12 samples from three different
groups: two tumor groups glioblastoma (n  4) and metastasis
(n  5), and one control group (n  3), provided from
epilepsy surgery. The spectral and lifetime measurements were
performed on the different samples with an excitation wave-
length of 405 nm. After an optical analysis, all tissue specimens
were formalin-fixed and returned to the Neuropathology
Department of Sainte Anne Hospital. All samples underwent
gold standard pathological analysis using both WHO 2007 and
Sainte Anne’s classifications.
Figure 3 shows the mean emission spectra for each sample
group. We see a first distinction between tumorous and control
groups: the maximum intensity of metastasis and glioblastoma
groups is six times lower than the maximum intensity of the
control group. These measurements show the sensitivity and
success of this new DC-PCF fiber to accomplish measurements
on endogenous fluorescence in human samples. To go further
in the spectral analysis, we used a Matlab script developed in
the lab to fit the different endogenous molecules that emit fluo-
rescence in brain tissues. This script has already been used and
validated in previous studies [6,7].
Figure 4 regroups the fitted data from metastasis, glioblas-
toma, and control groups. We note that in the two tumorous
groups, porphyrin fluorescent emission is two times higher than
in the control group, as shown in Figs. 4(b) and 4(c). In the
metastasis group, the NADH is higher than in the control
group and the glioblastoma group. Figure 4(d) represents a
superposition of the average spectral response from each tissue
group. It shows that the tumorous samples have a broader
emission spectrum, mainly at the longer wavelength. Each
Table 1. Lifetime Measurements of the Rhodamine B (RdB) with Different Collecting Fibers
DC-PCF
τ (ns)
Bi-fiber
τ (ns)
Multi-mode fiber
τ (ns)
Literature
τ (ns)
Rd (B) c  0.1 mM 1.98 0.06 1.98 0.04 1.93 0.05 1.75 1.80
Table 2. Lifetimes of Rhodamine B (RdB) and Fluorescein in Nanoseconds (ns)
Concentration (M) 10−2 10−4 10−5 10−6
RdB (methanol) Exp. 1.56 0.04 1.98 0.05 2.24 0.08 2.23 0.04
RdB Lit. [14] 1.68 0.05 2.43 0.08 2.41 0.07 2.32 0.06
pH 7 5
Fluorescence in Exp. 4.61 0.05 4.16 0.2
Fluorescence in Lit. [10] 4.2 0.1 3.6 0.1
RdB (PBS) Exp. 1.79 0.2 1.79 0.2
RdB Lit. [10] 1.8 0.1 1.8 0.1
Fig. 3. Emission spectra of different fresh human samples using a
405 nm excitation wavelength.
Fig. 4. Spectral emission of (a) the control group, (b) the glioblas-
toma group, and (c) the metastasis group with the five fluorophores
fitted. (d) Superposition of normalized spectrum from each group.
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group has a specific spectral shape, as previously described
[11,12].
Following endogenous spectral modification could allow
non-invasive early detection of metabolic anomalies. NADH
and FAD [15,16] play important roles in a wide range of cel-
lular oxidation-reduction reaction. These natural biomarkers
are diagnostic indicators of anomalies under different
pathological conditions [17–19].
Nevertheless, despite first previous promising results
[20,21], it seems that spectral analysis alone does not provide
sufficient information on the histological nature of the tissue to
help surgeons during intervention.
We developed a multimodal setup to obtain more data on
the sample. These more complementary data can help building
a robust matrix of criteria recognizing the tissue type during
surgery: healthy or tumoral. In this setup, fluorescence lifetime
measurement has been added to the spectral analysis. On each
sample of the three groups (glioblastoma, metastasis and con-
trol), four regions of interest have been measured to establish
the mean lifetime of the group. Table 3 shows the results of
these lifetime measurements. For each endogenous fluoro-
phore, the value of the control group is greater than the
two tumorous groups. However, there is no evident trend to
discriminate the two tumorous groups. Analyzing each fluoro-
phore within a larger series could be interesting to define the
best threshold between different tissue types.
This experiment was conducted at the Sainte-Anne hospital
and has given us the opportunity to work with fresh resected
samples. Our research raises the possibility that a new micro-
structure fiber could be the best candidate to achieve an ideal
multimodal endomicroscopic system. In contrast to commer-
cial optical fibers, it allows reduction of the spectral acquisition
time and uses a minimum of beam power at the output of the
optical fiber. In addition, this fiber proved accurate in spectral
and lifetime measurements when compared to the measure-
ments in the literature. With this system, we were also able
to give preliminary results on a human cohort and to distin-
guish three indicators of sample tumoral nature that seem to
exist: a lower fluorescence intensity, a broader spectrum, and
shorter lifetime value. This Letter represents the preliminary
step before a study on more samples and in vivo during surgery,
in order to help neurosurgeons during tumor resection.
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Abstract:  
 
In the framework of urologic oncology, mini-invasive procedures have increased in the last few 
decades particularly for urothelial carcinoma. One of the essential elements in the management of this 
disease is still the diagnosis, which strongly influences the choice of treatment. The histopathologic 
evaluation of the tumor grade is a keystone of diagnosis, and tumor characterization is not possible 
with just a macroscopic evaluation. Even today intraoperative evaluation remains difficult despite the 
emergence of new technologies which use exogenous fluorophore. This study assessed an optical 
multimodal technique based on endogenous fluorescence, combining qualitative and quantitative 
analysis, for the diagnostic of urothelial carcinoma. It was found that the combination of two photon 
fluorescence, second harmonic generation microscopy, spectral analysis and fluorescence lifetime 
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imaging were all able to discriminate tumor from healthy tissue, and to determine the grade of tumors. 
Spectral analysis of fluorescence intensity and the redox ratio used as quantitative evaluations showed 
statistical differences between low grade and high grade tumors. These results showed that multimodal 
optical analysis is a promising technology for the development of an optical fiber setup designed for 
an intraoperative diagnosis of urothelial carcinoma in the area of endourology. 
 
 
 
 
1. Introduction 
 
With more than 79,000 new cases and a projection of 16,390 deaths in 2017 in the US[1], bladder 
cancer is one of the deadliest cancer worldwide. For urologists, bladder cancer (BC) and upper urinary 
tract transitional cell carcinoma (UUT-TCC) are principal issues in urologic oncology. It is therefore 
critical to diagnose these tumors during endoscopy procedures (cystoscopy or ureteroscopy depending 
of the tumor localization) in order to confirm lesions macroscopically and to collect a tissue sample to 
confirm histopathologic characteristics. For specific cases of urothelial carcinoma (BC and UUT-
TCC), determination of the histopathological grade of urothelial tumors is one of the keystones in the 
oncological management. The tumor grade impacts the treatment strategy at various levels, from the 
type of surgery, to the role of chemotherapy, to the chronological steps in management. In the case of 
a high grade tumor a total ablation of the organ (radical surgery) may be necessary whereas  
conservative treatment can be a valid option for low grade tumors associated with bladder cancer and 
upper urinary tract transitional cell carcinoma (UUT-TCC) [2], [3]. A critical step is proper resection 
of lesions due to a high risk of recurrence[4] particularly for low grade urothelial  carcinoma. This is 
achievable if both lesion detection and diagnosis are optimal. In this framework, peri-operative 
screening of tumor characteristics could be a valuable support to the surgeon to adapt the surgery and 
to plan postoperative cares.  
With the development of minimally invasive surgery, the use of miniaturized technology has become a 
standard procedure, especially for UUT-TCC and BC. For UUT-TCC, flexible ureteroscopy with laser 
photovaporization allows a reduction in both surgical morbidity and renal function impairment [5], 
This article is protected by copyright. All rights reserved.
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[6]. New technologies have been developed to help the surgeon with intraoperative discrimination of 
urothelial carcinoma[7], [8]. Enhanced imaging techniques such as Photodynamic diagnosis (PDD) 
with 5-ALA[9], Narrow Band Imaging system(NBI)[10], real time optical coherence tomography 
(OCT)[11] and confocal laser endomicroscopy (CLE)[12] are now proposed for diagnosis. However, 
all of these technologies have limitations including low specificity (NBI), or difficulty of 
interpretation by the doctors (OCT, CLE), compared to the gold standard histological diagnosis,  due 
to the lack of multimodality and database images.  
After two decades of becoming increasingly popular, two photon microscopy (TPM) has now become 
an important technique for biological tissue imaging. The development of miniaturized high-numerical 
aperture optics[13], lasers with optimized pulse delivery [14], and miniaturized scanning system[15], 
[16] has opened the way for clinical applications. Nonlinear microscopy, as classical confocal 
imaging, can provide an analysis of tissue using only endogenous labels, and thus eliminates the need 
for exogenous fluorescence labeling. Second Harmonic Generation (SHG) can access characteristics 
of tissue structure which have a non-centrosymmetric geometry, such as extra-cellular matrix, muscle 
fibers, walls of blood vessels, while two photon endogenous fluorescence (TPEF) measurements can 
detect and show the presence of endogenous fluorophores associated with cellular metabolic activity 
(reduced nicotinamide adenine dinucleotide: NADH and flavin adenine dinucleotide: FAD).  
TPM offers several advantages such as intrinsic sectioning, lower photobleaching, lower and localized 
phototoxicity, higher penetration depth into the tissues, and an absence of overlap between excitation 
and emission [17]–[20]. Above all, it provides a different endogenous contrast analysis compared to 
standard microscopy and confocal endomicroscopy. Although the heterogeneity of tissue structure can 
lead to complex signal interpretation, endogenous fluorescence analysis of urothelial tissue could be a 
promising way to avoid metabolic alteration related to external markers[21], [22].  The multimodal 
technique is an improved alternative to the unimodal one since it highlights tumors characteristics 
more specifically and precisely.  
Nevertheless, non-linear flexible endoscopy imaging development remains a challenge. Although 
some modalities such as SHG have already been evaluated in-vivo[23] and multiphoton microscopy 
This article is protected by copyright. All rights reserved.
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evaluated on urothelial and prostate samples[24], [25], only one study so far has explored the potential 
of multimodal optical analysis in the area of uro-oncology[26].  
This preliminary study was conducted to establish the efficiency of a multimodal imaging process 
based on endogenous fluorescence analysis to discriminate grades of urothelial tumours as done in 
histopathologic grading. For that reason, we conducted a qualitative and quantitative study, using 
different contrasts to define optical markers of tumours grade.  This study show that optical imaging 
and analysis could provide reproducible and reliable clinical results.   
To the best of our knowledge, this preliminary study assesses for the first time the ability of 
multimodal optical analyses to identify pathological features and histopathological grades associated 
with urothelial carcinoma, in a manner consistent with classical histopathological evaluation. 
 
 
2. Material and Methods 
 
2.1 Sample management 
 
This prospective monocentric study had included a collection of samples from patients suspected to 
have an urothelial carcinoma at fibroscopy or on imagery. The institutional review board (IRB) of the 
Tenon Hospital center – University Pierre-Marie Curie approved the study (IRB-00003835), all the 
following methods were performed in accordance with the relevant guidelines and regulations issue in 
this protocol and informed consent were signed by the patients. 
After endoscopic biopsy or resection, urothelial samples were fixed in a formalin zinc solution. 
Immediately after, the samples were transferred on a specific nonlinear multimodal set-up to perform 
the acquisitions. After the multimodal optical analysis, the samples were conditioned and analyzed by 
the pathologist. Detailed clinical data including age at diagnosis, past medical history including 
urothelial carcinoma and previous treatment were recorded, such as histopathological data.  
 
2.2 Confocal, two-photon microscopy and fluorescence lifetime imagingon a microscopic 
multimodal setup 
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A Mai Tai DeepSee Ti:sapphire laser with automated dispersion compensation (Spectra-Physics, 
Santa Clara, USA) was used as the source for a TCS SP8 MP microscope (Leica Microsystems, 
Wetzlar, Germany) to perform two-photon microscopy. The set-up allows us to record imaging, 
emission spectra and lifetime fluorescence. The laser cavity had over 2.4 W of average power at 800 
nm and was tunable from 690 nm to 1040 nm. Two supersensitive Leica hybrid nondescanned (HyD 
NDD) detectors recorded the faintest structures from deep-tissue sections. For two-photon imaging 
experiments, fluorescence was collected after the microscope objective via a dichroic beamsplitter, 
transparent to wavelengths greater than 680 nm. The collected visible spectrum was split by another 
dichroic cube (FF495-Di03-25 × 36, Semrock, New York, USA) into two channels toward the HyD 
NDD detectors. This configuration minimized loss in the fluorescence collection. The presence of two 
additional filters (FF01-448/20-25 and FF01-520/35-25, Semrock, New York, USA) on the dichroic 
cube set the detection band, respectively one to collect Second Harmonic Generation(SHG) signal and 
the other one to collect the endogeneous fluorescence.  
A hybrid detector was used to perform the spectral acquisition. A prism dispersed the fluorescence and 
the spectral detected band was selected with a specific motorized split mirror placed before the hybrid 
detector. The spectral resolution was 10 nm, covering the range from 380 nm to 780 nm. Spectral 
acquisition and single-photon counting technology fluorescence lifetime imaging were couples by a 
unique system which integrated hardware and software (PicoQuant GmbH, Berlin, Germany) with the 
high-end confocal system Leica TCS SP8 MP. 
A spectral mosaic was acquired on a 3x3 images area selected with the microscope software: a spectral 
measurement was made for each image of the mosaic then the software merged the information to give 
a mean spectrum of the mosaic. For fluorescence lifetime imaging measurements, a mosaic of 9 
images per sample were analyzed using appropriate excitation wavelengths. The image size was 512× 
512 pixels, at 100 Hz and represented the average of 10 frames.  
Four different optical signals on the region of interest (ROI) were recorded with our multimodal setup: 
1) one and two-photon spectral analysis, 2) two-photon fluorescence lifetime imaging measurement, 
This article is protected by copyright. All rights reserved.
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3) SHG imaging, and 4) fluorescence imaging under one- and two-photon excitation.  
2.3 Histopathology analysis 
 
All the samples were analyzed by the same senior uropathologist using hematoxylin-eosin-saffran 
(HE) staining without prior knowledge of the two-photon analysis status. Results were given 
according to the WHO 2016 classification for urothelial carcinoma[27]. Correlation between point-to-
points optical indexes, imaging abnormalities and pathological examination of biopsy samples in each 
particular tumor type and grade was performed. All samples were categorized and classified as healthy 
urothelium or high grade or low grade tumor by the pathologist. 
2.4 Data Analysis 
 
2.4.1 Spectral analysis 
 
             Five circular Regions of interest (ROI) of 200μm diameter were placed on each spectral 
mosaic stack at the 870nm excitation wavelength. A spectrum was generated for each ROI using 
Image J to calculate the mean intensity of each image of the stack. This spectrum was then fitted using 
a Matlab script developed in the lab and previously used in rat and human brain tumors[28], [29]. The 
script was readapted to urothelial tissue, two components where identify in the emitted response: the 
nicotinamide adenine dinucleotide (NADH) and the flavin adenines dinucleotide (FAD). Indeed, the 
absence of oxygen or a need to increase glucose catabolism cause an increase in NADH fluorescence. 
Hence, the redox ratio is already well-known to be associated with malignant transformation[30]–[32]. 
Different excitation wavelengths were used. For each excitation wavelength a fit was applied to 
extract the contribution of the different molecules. Figures 1.a.b. show the response of endogenous 
molecules using two different excitation wavelengths. As shown, 810 nm excitation wavelength don’t 
give access to the SHG. Exciting with 870 nm could be reasonable to collect the metabolic molecules 
as well as SHG. Consequently, to avoid experimental bias and propose the fastest method to analyze 
tissue only the 870nm wavelength was used in all our analysis. We extracted from this fit the 
maximum intensity at the max emission wavelength of each component (Imax-NADH, Imax-FAD) to then 
calculate a redox ratio, see Figure 1.c.  
This article is protected by copyright. All rights reserved.
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3. Results  
 
3.1 Samples characteristics: 
 
 
In our study, fourteen patients were enrolled prospectively, including sixteen samples of normal and 
tumoral urothelium. Among them, fifteen samples were of bladder origin and one from the upper-
urinary tract. Amongst them, ten represented urothelial carcinoma (five reported as low grade tumors 
and five as high grade tumors). Six samples of non tumoral urothelium were also examined. 
 
 
3.2 Correlation between two-photon fluorescence images and Hematoxylin and Eosin 
staining 
 
To highlight the performances of non-linear microscopy in tissue diagnosis, we compared our images 
with the histological analysis, considered as gold standard. Results are shown in Figure 2. 
Three major urothelial aspects were identified by fluorescence and compared with the 
histopathological morphology. First a healthy layer of urothelial cells, second low grade tumor 
architecture displaying exophytic growth with a fibrovascular core and increased layers of urothelial 
cells without major atypia or necrosis, and third an invasive high grade tumor, with major atypia and 
also with exophytic features and a fibrovascular core, typical for pTa tumours (pathologically staged 
non invasive papillary carcinoma). Moreover, the SHG signal gave us access to the architecture and 
characteristics of the stroma and the lamina propria and could also be compared with the histological 
features. 
The TPF images were collected through the whole sample, from the epithelial surface to the deepest 
part, mostly to the detrusor muscle. After the determination of the grade by the multimodal optical 
analysis, the histopathological images (see Figure 2) were chosen by the pathologist for a better 
correlation to the TPF images, in order to highlight the specific structures.  
Normal urothelium (Figure2; 2a,2d) showed multilayered cells without disorganized architecture, the 
cells were identify in histological images by dark violet spots and in TPEF images by dark hole in the 
homogeneous red fluorescent signal, highlighting easily the organization of the layers. There was no 
This article is protected by copyright. All rights reserved.
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Figure 5. Fluorescence Lifetime analysis at 870nm excitation wavelength. FLIM images of (a) healthy, (b) low 
and (c)high grade tumor cells, (d) respective average lifetime histogram of each image.(e) Variation of mean 
amplitude lifetime between healthy urothelium, low grade and high grade tumor compared in fifteen ROIs in 
each type of tissue. 
 
4. Discussion and conclusion 
 
The multimodal optical analysis of urothelial samples from bladder and urinary upper tract has proven 
its capacity to characterize the urothelium and discriminate healthy tissue, low grade and high grade 
tumor. This characterization was achieved by a qualitative and a quantitative analysis. These 
preliminary results are promising for the development of a peri-operative diagnostic tool. 
Multiphoton microscopy is a rising technology in the field of tissue analysis. Its intrinsic 
characteristics make it an increasingly studied technique even in urology[25], [33]. Indeed, in urology, 
some studies have already shown a good correlation between multi-photonic microscopy and 
histopathologic imaging. Yadav et al. have demonstrated the discrimination of periprostatic neural 
tissue on a rat model with using 780 nm as excitation wavelength excitation[25]. For urothelial 
carcinoma, Jain et al.[33] have assessed the diagnostic potential of this technique in identifying and 
differentiating benign from malignant flat bladder lesion, especially carcinoma in situ (CIS). These 
studies have shown a good correlation between multi-photonic microscopy and histopathology. 
However, none of them have performed a quantitative analysis such as spectral analysis or FLIM 
analysis. Multimodality as quantitative and qualitative analysis is important for reliable and precise 
b c
d
e
a
3ns
1ns
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response. Moreover, Jain et al. have focused only on the capacity to detect CIS but have not sought to 
determine papillary tumors characteristics especially the grade. As PDD and NBI are performant tools 
for the CIS diagnosis, it is more interesting to develop a specific peri-operative tool able to help 
determine the histologic grade in order to improve oncologic management. 
When multiphoton microscopy is used alone, it is still limited by the difficulty of easily recognizing 
abnormal aspects such as intranuclear modifications. In our study, multiphonic imaging also lead us to 
recognize and discriminate structures as seen in histopathology. In particular, it was possible to 
discern healthy urothelium from low and high grade tumors. It is very interesting and promising that 
optical imaging could be used for live peri-operative histology. It offers high resolved, rapid images 
comparable to histological images. But because of the learning curve for the tissue recognition and 
potential intraoperative variability, imaging alone is not sufficient for a reproducible diagnostic tool. 
This is why, multimodality by adding quantitative analysis to qualitative makes major contribution to 
clinical applicability in endo-urology. 
Our study has shown that fluorescent spectral analysis can discriminate among different types of 
urothelial tissue from healthy to high grade tumors. Likewise, the redox ratio and FLIM analysis were 
able to significantly distinguish tissues characteristics. To date, only one study has used the 
multimodality for urothelial evaluation. Cicchi et al. have assessed TPM for healthy bladder mucosa 
and CIS. Their results shown a potential difference between both groups even with the redox ratio 
analysis. But again, the limitation to the diagnosis of CIS is a limitation for a real applicability 
comparatively to our study which was focused on the grade. To evaluate the redox ratio, different 
formula are proposed in the literature but we decided to take the most used[21], [26], [34].  
Discrimination was also obtained by using the FLIM analysis. The FLIM data are bi-exponential 
fitted, each component fitted will be associated to one of the form of FAD in tissue, either protein-
bound or free. The average amplitude lifetime translates the distribution between free and bound FAD, 
having longer average lifetime In tumoral tissue means that the free FAD is in higher concentration. 
This change in the ratio of protein-bound FAD is a consequence of the impact of the Warburg effect.  
In tumor, an increased metabolizing of glucose to lactate by neoplastic tissue compared with healthy 
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tissue[35]. Indeed the major co-enzyme in this reaction are NADH and FAD. This is in correlation 
with previous results shown on healthy bladder mucosa compared to in situ carcinoma [33]. 
 
There are some limitations to discuss. First, we analyzed fixed samples. This could lead to some 
modifications of the fluorescence and the redox ratio analysis compared to an in-vivo analysis. Indeed, 
the NADH and FAD concentration decrease after the excision of the tissue and that could affect the 
performance of redox ratio analysis. Nevertheless, our analysis has been able to discriminate the 
different tissue as  described in the previous literature for the redox ratio in healthy and tumoral 
tissues[21], [26], [34], [36]–[38]. This means that the redox ratio is also a promising tool for an in-
vivo evaluation. The other limitation of our study is the low number of samples included. To confirm 
our results, we need to increase the number of samples and work on fresh biopsy analysis. 
These preliminary results confirm the potential of multimodal optical analysis and represent the first 
step for the development of a laser fiber optical tool for peri-operative diagnosis. The possibility of 
discriminating the tumor’s grade during the surgery is an essential tool for the oncologic management.  
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Graphical Abstract  
In urologic oncology, quality and rapidity of diagnosis is an influent element in the choice of 
treatment. Intraoperative imaging techniques could help in real-time the surgeon in decision making. 
This paper presents a new technology for intraoperative assessment of the nature of bladder tissue. A 
multimodal tools with two-photon exciton and quantitative-qualitative detection. Histological 
landmarks were found in two-photon images of biopsy and  quantitative measurements gave  
numerical indicators of malignancy. 
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Titre : Base de données sur le signal d’autofluorescence des tissus pour améliorer le diagnostic per-
opératoire des tumeurs cérébrales 
Mots clés : Base de donnée, autofluorescence, tumeurs cérébrales, deux-photon, endomicroscopie 
Résumé : Le premier traitement standard pour 
les tumeurs cérébrales est la résection 
chirurgicale. Dans cette procédure un enjeu 
important demeure, l’identification des berges 
tumorales pour assurer une résection totale et 
éviter le risque de récidive pour le patient. A ce 
jour aucune technique d’imagerie peropératoire 
n’est capable de résoudre l’infiltration tumorale 
du tissu sain. La norme pour le diagnostic des 
berges tumorales est l’analyse histologique des 
biopsies. Une méthode ex vivo qui requiert un à 
plusieurs jours pour fournir un rapport 
pathologique final, un lapse de temps qui peut 
s’avérer fatal pour le patient.  La microscopie 
optique a récemment été développée vers une 
utilisation clinique peropératoire pour répondre 
à cet enjeu. Dans cette thèse, la technique de 
microscopie à deux-photons a été préférée pour 
essayer de répondre à cette problématique. Cette 
méthode donne accès à deux contrastes 
d’imagerie, la génération de seconde 
harmonique et l’émission de fluorescence, qui 
peuvent être combinés à des mesures 
quantitatives, tel que la spectroscopie et le 
temps de vie de fluorescence. Combiner ces 
quatre modalités de détection donnera une 
information complète sur la structure et le 
métabolisme de la région observée. Pour 
soutenir le développement technique vers une 
sonde endomicroscopique visant une utilisation 
peropératoire, les données en résultants doivent 
être fiables, et se montrer d’un intérêt pour le 
chirurgien. Par conséquent, une base de données 
sur le signal d’autofluorescence des tissus a été 
construite et présentée dans ce manuscrit, avec 
des algorithmes capables de discriminer de 
façon fiable les régions tumorales des régions 
saines. Des algorithmes qui ont montré le 
potentiel d’être automatisé dans une 
configuration clinique, afin de fournir une 
réponse en temps-réel au chirurgien. 
 
 
 
Title : Tissue database of autofluorescence response to improve intra-operative diagnosis of 
primitive brain tumors 
Keywords :  Database, autofluorescence, brain tumors, two-photon, endomicroscopy 
Abstract: The first standard approach for brain 
tumor treatment is the surgical resection. In this 
protocol an important challenge remains, the 
identification of tumor margins to ensure a 
complete resection and avoid risk of tumor 
recurrence. Nowadays no intra-operative means 
of contrast are able to resolve infiltrated 
regions from healthy tissue. The standard for 
tumor margin diagnosis is the histological 
analysis of biopsies. An ex vivo method that 
requires one to several days to issue a final 
pathological reports, a time lapse that could be 
fatal to the patient. Optical microscopy has 
recently been developed towards an intra-
operative clinical use to answer this challenge. 
In this work, the technique of two-photon 
microscopy, based on the autofluorescence of 
tissue, has been favored. This technique gives 
access  to  two  imaging contrasts, fluorescence 
imaging and second harmonic generation and 
emission of fluorescence, and can be combined 
to quantitative measurement, such as 
spectroscopy and fluorescence lifetime. The 
combination of these four modalities of 
detection will give a complete structural and 
metabolic information on the observed region. 
To support the technical development towards 
an endomicroscopic probe, the resulted data 
have to be reliable and proved to be of interest 
for the surgeon. Consequently, an extensive 
database of the autofluorescence response of 
brain tumor tissue has been constructed and 
presented in this manuscript, with algorithms 
able to discriminate with reliability tumoral 
from healthy regions. Algorithms that have 
shown potential to be automatized in a clinical 
setting, in order to give a real-time answer to 
the surgeons. 
 
